Rank,OrgStudyId,BriefTitle,StartDate,CompletionDate,OverallStatus,StudyType
1,BTX-BCI-016-PRT,Breast Cancer Index (BCI) Registry,"April 14, 2021",December 2028,Recruiting,Observational
2,2018-TJ-BCD,Diagnosis Value of SEMA4C in Breast Cancer,"September 1, 2023","September 1, 2024",Not yet recruiting,Observational
3,Breast cancer,Role of Sorcin and Annexin A3 in Breast Cancer Patients,"January 20, 2019","September 30, 2019",Unknown status,Observational
4,BC-BOMET,Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases,"January 13, 2020","November 12, 2024",Recruiting,Observational
5,241391,A Study to Identify Breast Cancer (IDBC),"January 24, 2019","December 31, 2022",Unknown status,Observational
6,IL-TM-B1-01,Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay,"January 22, 2018","July 1, 2019",Unknown status,Observational
7,FH-Risk 2.0 Research Protocol,FH-Risk 2.0: Updating Breast Cancer Risk Estimates,"March 1, 2022","October 31, 2024",Recruiting,Observational
8,ID-RPSBC-01-20201012,Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples,"October 13, 2020","June 30, 2023",Recruiting,Observational
9,IRST174.22,What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?,"February 6, 2020",February 2026,Recruiting,Interventional
10,ANILERGİNN,Weight Loss and Breast Cancer,"December 15, 2022","May 1, 2026",Not yet recruiting,Observational
11,32155120.7.0000.0072,Breast Cancer Survivors: Main Physical and Psychosocial Problems After Completion of Treatment,"October 5, 2020","November 1, 2022",Unknown status,Observational
12,GCO 17-2188,Increasing African Immigrant Womens Participation in Breast Cancer Screening,"February 5, 2020",June 2023,Recruiting,Interventional
13,233756,The HIFUB Study (HIFU in Breast Cancer),"May 1, 2022","November 1, 2022",Not yet recruiting,Interventional
14,D16196,A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers,"May 24, 2018","April 5, 2021",Completed,Interventional
15,RO1912-30902,RCT Comparing 2 Radiotherapy HypoFractionation Schedules In Breast Cancer Patients,"January 1, 2020","February 1, 2022",Unknown status,Interventional
16,UMCC 2021.087,Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid,"May 12, 2022",May 2023,Recruiting,Interventional
17,LNs Staging of Breast cancer,Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.,October 2018,December 2021,Unknown status,Interventional
18,SA18i0002,The Effect of a Patient Decision Aids for Breast Cancer Screening,"July 1, 2021","October 31, 2022",Recruiting,Interventional
19,494936,Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening,February 2023,"November 11, 2035",Recruiting,Interventional
20,042210,Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer,"June 15, 2023","June 30, 2028",Not yet recruiting,Interventional
21,Yuan Shifang-1,Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device,January 2020,December 2022,Unknown status,Observational
22,(818)109A-57,Mobile Application Support for Women With Breast Cancer Undergoing Chemotherapy,"May 16, 2021","December 31, 2023",Recruiting,Interventional
23,21 SEIN 01,Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.,"March 31, 2021","July 29, 2022",Completed,Interventional
24,18-181,Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening,"January 30, 2019","May 30, 2026",Recruiting,Interventional
25,catheter guided chemo-infusion,Catheter Guided Chemo-infusion in Breast Cancer,April 2023,May 2025,Not yet recruiting,Interventional
26,2020/132,Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS),"June 1, 2021","February 1, 2022",Completed,Interventional
27,17-689,Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening,"May 17, 2018","August 30, 2023","Active, not recruiting",Interventional
28,831804,[18F] F-GLN by PET/CT in Breast Cancer,"April 5, 2019",December 2024,Recruiting,Interventional
29,PI-2842,Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women,"July 1, 2018","December 31, 2019",Completed,Observational
30,NCC2985,Characteristics and Treatment Trends of Young Breast Cancer in China,"November 1, 2021","October 1, 2024",Not yet recruiting,Observational
31,260281,Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer,"August 13, 2020","December 31, 2025",Recruiting,Observational
32,V1 11.12. 2020 (C.I.R.E.C.),Onco-liq: Kit for Breast Cancer Diagnosis.,"September 1, 2021","August 1, 2023",Recruiting,Observational
33,154/2019,Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery,"December 2, 2019","February 25, 2024",Suspended,Interventional
34,Amr Ahmed,"The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism","January 1, 2023","January 31, 2024",Not yet recruiting,Interventional
35,CLM-INS-004,PERSONAL - Sleep In Breast Cancer,"January 15, 2022","August 3, 2022",Completed,Observational
36,2022-11-076-002,Comparison of Ultrasound and Breast MRI for Breast Cancer Detection,"May 28, 2023","May 28, 2028",Not yet recruiting,Interventional
37,Health Literacy of Breast Ca,The Effect of Breast Cancer Screening Training,"February 15, 2023","December 30, 2023",Not yet recruiting,Interventional
38,miRNA in breast cancer,Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer,"December 1, 2021","December 25, 2023",Not yet recruiting,Observational
39,MC1933,Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer,"January 13, 2021","January 15, 2042",Recruiting,Observational
40,RADIOVAL,Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning,"June 1, 2023",December 2025,Recruiting,Observational
41,CE21096B,Factors Affecting Rehabilitation Time for Postoperative Complications Among Breast Cancer Patients,"May 1, 2021","May 1, 2023",Recruiting,Observational
42,ZY(2018-2020)-CCCX-2005-04,Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer,"May 25, 2020","May 31, 2024",Recruiting,Interventional
43,MicroRNA in breast cancer,Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients,"March 1, 2022","March 1, 2024",Not yet recruiting,Observational
44,GEICAM/2016-04,Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse Risk,"September 14, 2018","December 31, 2024",Recruiting,Observational
45,22IC7498,Behavioural Science Messages in Breast Cancer Screening,"July 15, 2022","January 15, 2023",Completed,Interventional
46,BMIBC,Impact of Body Mass Index on Outcomes of Breast Cancer Management,"February 12, 2018","August 12, 2019",Unknown status,Observational
47,3.0840453,Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53,"December 2, 2018","February 22, 2022",Completed,Observational
48,18 SEIN 11,"Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.","June 7, 2019",December 2025,Recruiting,Interventional
49,HKG-KZ-BrCa-101,"Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC","June 1, 2018","September 1, 2021",Terminated,Observational
50,Hibiscuss,"Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope","June 26, 2019","December 31, 2021",Completed,Observational
51,Pro00107118,A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer,"April 7, 2022","October 1, 2024",Recruiting,Observational
52,SNAPS Breast Cancer,SNAPS Breast Cancer Patient Study Breast Cancer Patients,"September 1, 2024","December 31, 2026",Suspended,Observational
53,17-447,Imaging With [11C]Martinostat in Breast Cancer,"February 1, 2020","October 31, 2024",Withdrawn,Interventional
54,22-509,Breast Cancer Survivor Educational Intervention,"February 28, 2023","August 31, 2023",Recruiting,Interventional
55,ZCHBC022,Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC,"September 16, 2022","December 30, 2025",Recruiting,Observational
56,R.18.02.34.R1.R2,Association of Hepatitis C Virus With Breast Cancer,"September 1, 2019","June 1, 2020",Completed,Observational
57,ID-BCRPS-02-20220913,The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population,"September 14, 2022","December 31, 2022",Recruiting,Interventional
58,112991,Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer Radiotherapy,"January 1, 2019","December 31, 2021",Unknown status,Observational
59,17-01549,Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer,"July 23, 2018","January 23, 2025",Recruiting,Interventional
60,TET-21-001,Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants,"October 4, 2021",October 2023,Recruiting,Observational
61,202101073,Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool,"April 19, 2021","August 30, 2021",Completed,Interventional
62,"estPerMed 1, Breast",Personalised Risk-based Breast Cancer Prevention and Screening,"October 1, 2018",December 2020,Unknown status,Interventional
63,68824072019,Risk Reduction Program for Women Having High Risk of Breast Cancer,"April 1, 2018","September 1, 2021",Completed,Interventional
64,3055,Correlation of Predictive Accuracy of PREDICT Version 2.2 of Indian Women With Operable Breast Cancer,"November 15, 2018","December 31, 2022","Active, not recruiting",Observational
65,20220303swj0211,The Psychology Intervention on Disease Acceptance and Quality of Life in Breast Cancer Patients,"October 20, 2022","October 20, 2024",Not yet recruiting,Interventional
66,RC20_0532,Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid,"January 1, 2023","January 1, 2025",Not yet recruiting,Interventional
67,Breast Cancer Risk,Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study),"November 1, 2022","December 30, 2029",Recruiting,Observational
68,KMUHIRB-E(I)-20200041,"Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment","September 18, 2020","August 15, 2022",Completed,Interventional
69,VGHKS18-CT11-17,CEDM as a Screening Tool for Breast Cancer in Higher-risk Women: A Prospective Study,"January 1, 2019","December 31, 2021",Completed,Observational
70,832165,Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT,"February 11, 2019",February 2027,Recruiting,Observational
71,ICO-2019-08,Interest of Touch-massage in Hospital Day Care,"October 7, 2019","May 12, 2020",Completed,Observational
72,biomarkers in breast cancer,Circular RNA and Chemerin in Breast Cancer Patient,October 2023,December 2025,Not yet recruiting,Observational
73,GEICAM/2017-07,Registry Study of Pregnancy and Breast Cancer,"November 18, 2019",January 2040,Recruiting,Observational
74,LCCC2207,"Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians","July 15, 2022","July 15, 2025",Recruiting,Observational
75,MCC-21448,Study of Screening Brain MRIs in Stage IV Breast Cancer,"December 21, 2021","August 31, 2023",Recruiting,Observational
76,4452,Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer,"January 19, 2021",December 2024,"Active, not recruiting",Interventional
77,2017-0588,Implementation of a Web-based Decision Aid for Breast Cancer Surgery,"April 4, 2019","May 12, 2020",Completed,Observational
78,SK-421-BRCA,A Digital Solution for Breast Cancer Patients,"July 15, 2022","September 1, 2023",Recruiting,Interventional
79,autotaxin1,Autotaxin: a Potential Biomarker for Breast Cancer.,"January 1, 2019","March 15, 2021",Completed,Interventional
80,UPCC 19121,Role of the Immune Environment in Response to Therapy in Breast Cancer,"October 3, 2022","December 31, 2032",Recruiting,Observational
81,DS8201-A-U302,"DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]","August 9, 2018",April 2024,"Active, not recruiting",Interventional
82,CCR 5113,PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer Risk,"September 16, 2020",December 2023,"Active, not recruiting",Interventional
83,21-480,A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania,April 2023,May 2023,Not yet recruiting,Observational
84,LQ005,Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer,"February 14, 2019",April 2022,Unknown status,Observational
85,ICO-N-2017-02,Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse,"May 29, 2018","December 3, 2020",Terminated,Interventional
86,medicin,Autotaxin (ATX) as a Marker for Breast Cancer,"May 1, 2021","November 1, 2022",Unknown status,Interventional
87,METCZ20200211,Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes,"August 1, 2021","February 9, 2022",Completed,Interventional
88,2021LC2210,Remote Breast Cancer Screening Study,"September 1, 2021",August 2025,Recruiting,Observational
89,17-581,Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds,"March 9, 2018","August 27, 2018",Completed,Observational
90,2020-A00058-31,Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening,"May 31, 2021",May 2027,Recruiting,Interventional
91,NCC3299,Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology,"April 1, 2022","December 31, 2022",Recruiting,Observational
92,351-19,mULM to Support Breast Cancer Diagnosis and Therapy,"April 26, 2021",December 2023,Recruiting,Interventional
93,ESR-21-21505,The Treatment Situation of Chinese County Population With Breast Cancer,"September 29, 2022",September 2024,Recruiting,Observational
94,LUMHS/REC/-17,Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer,"July 1, 2020","January 15, 2021",Unknown status,Observational
95,PekingUPH10B004,Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients,"April 2, 2021","December 31, 2026",Recruiting,Interventional
96,2014P002688a,Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care System,"July 1, 2020","March 25, 2022",Completed,Observational
97,ODELIA,A Retrospective Analysis of Magnetic Resonance Imaging Data for Breast Cancer Screening in the Open Consortium for Decentralized Medical Artificial Intelligence,"January 1, 2023","December 31, 2027","Active, not recruiting",Observational
98,CD3-MUC1 in breast cancer,Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer,"May 20, 2019","July 5, 2020",Withdrawn,Interventional
99,LCCC 1829,Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA,"November 6, 2018","December 15, 2030",Recruiting,Interventional
100,2022-080,"Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer","August 4, 2022","July 30, 2025",Recruiting,Interventional
101,2018-TJ-BCP,SEMA4C as a Relapse Biomarker in Breast Cancer,"September 1, 2022","August 1, 2026",Not yet recruiting,Observational
102,20218,A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy,"January 29, 2019","November 1, 2022",Completed,Interventional
103,2017-03-002A,PET/MR Radiomics for Breast Cancer Diagnosis,"July 6, 2018","December 31, 2022",Recruiting,Observational
104,LA LEAST,Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer,"September 23, 2019","May 1, 2029",Recruiting,Interventional
105,1905795920,Breast Cancer Self-Efficacy Scale for Partners,"September 1, 2019","March 1, 2022",Terminated,Observational
106,2015-004027-31,HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer,"March 8, 2019","December 31, 2023",Recruiting,Interventional
107,4-2018-0254,Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer,"October 2, 2018","June 3, 2023",Recruiting,Observational
108,BREACE,Exercise in Older Women With Breast Cancer During Systemic Therapy,"November 15, 2018","December 1, 2023",Recruiting,Interventional
109,495077,18F-FDG PET/CT Imaging for Breast Cancer,"February 16, 2023","December 31, 2032",Recruiting,Interventional
110,CCR4684,"Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours","May 9, 2019","July 1, 2024",Recruiting,Interventional
111,211753,BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity,"March 9, 2022",August 2024,Recruiting,Interventional
112,1705018188,Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer,"March 15, 2018","March 4, 2022",Terminated,Interventional
113,22-136,"A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer","June 6, 2022","June 6, 2025",Recruiting,Interventional
114,CDK-HeCOG-2019,Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy,"January 1, 2019","January 2, 2021",Completed,Observational
115,2020-0327,Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer,"January 1, 2018","August 1, 2020",Completed,Observational
116,RECO_CT29B,Investigation of Urinary Biomarkers for the Detection of Breast Cancer,"December 21, 2022",April 2024,Recruiting,Interventional
117,SH ABCD,Autoantibodies in Breast Cancer Detection,"July 24, 2018","November 1, 2028",Recruiting,Observational
118,D8531C00002,A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy,"March 30, 2023","September 18, 2036",Not yet recruiting,Interventional
119,SOLTI-1910,Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.,"March 25, 2022",March 2024,Recruiting,Interventional
120,1905202-3,ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies,"July 1, 2019","July 1, 2023",Recruiting,Observational
121,Targeted axillary dissection,Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy,"December 1, 2023","August 1, 2025",Not yet recruiting,Interventional
122,2022-8048-23560,Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives,"January 1, 2023","March 30, 2023",Recruiting,Observational
123,2021-0215,BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer,"January 10, 2022",May 2024,Recruiting,Interventional
124,GFY202001,Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy,"January 1, 2020","June 30, 2023",Recruiting,Observational
125,2019-A01861-56,Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients,"December 4, 2019",October 2027,Recruiting,Observational
126,18-634,Elevate! : An Elderly Breast Cancer Cohort Study,"February 19, 2019","November 1, 2028",Recruiting,Observational
127,20 KHCC 202,Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer,"April 1, 2021","July 1, 2023",Recruiting,Observational
128,IRB # 21-0026,Tear Based Sample Collection Breast Cancer Detection,"April 28, 2021","September 15, 2025","Active, not recruiting",Observational
129,IRB00002991,Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART),"December 10, 2021","March 1, 2024",Recruiting,Observational
130,17-398,Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer,"January 22, 2018","April 29, 2019",Completed,Interventional
131,LCCC 1954,Patient-centered Communication About Healthy Weight in Early Breast Cancer,"June 15, 2020","September 29, 2020",Completed,Observational
132,ESR-17-12934,Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer,"January 1, 2018","July 1, 2019",Unknown status,Observational
133,69HCL22_0613,Effect of Physical Activity in Patients With Breast Cancer.,September 2022,February 2023,Withdrawn,Observational
134,LCCC2213,Metastatic Breast Cancer-Specific Prognostic Tool,"September 20, 2022","October 1, 2024",Recruiting,Observational
135,IC 2018-01,Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer,"July 25, 2018","September 20, 2020",Completed,Interventional
136,IC 2020 08,Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer.,"January 25, 2021","December 20, 2021",Completed,Interventional
137,PI17/00834,Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening,"January 30, 2019","December 31, 2021",Completed,Interventional
138,PekingUMCH-FAPI-BC-1,Characterizing Breast Cancer With 68Ga-FAPI PET/CT,"May 1, 2021","December 31, 2023",Recruiting,Interventional
139,PekingUMCH-FAPI-BC-2,Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT,"May 10, 2022","June 30, 2023",Recruiting,Interventional
140,FMASUMD232/2021,Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma,December 2021,January 2024,Not yet recruiting,Observational
141,Breast immune checkpoint,Relationship Between Breast Cancer Subtypes and Immune Checkpoints,"May 1, 2022","December 15, 2022",Completed,Observational
142,180034,ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma,"January 17, 2018","October 7, 2021",Completed,Interventional
143,IRB17-0721,Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer,"February 12, 2018",September 2022,"Active, not recruiting",Interventional
144,BCL IDE,Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer,"December 23, 2020",July 2023,Recruiting,Interventional
145,REO 027,A Window-of-opportunity Study of Pelareorep in Early Breast Cancer,"March 29, 2019","April 20, 2022",Terminated,Interventional
146,CentroHLO_EFBreastCancer,Evaluating and Following Breast Cancer Patients in a Better Way,"June 1, 2019","December 31, 2020",Unknown status,Observational
147,elastography in breast cancer,Shear Wave Elastography Assessment of Neoadjuvant Chemotherapy Response in Patients With Invasive Breast Cancer,December 2021,March 2023,Not yet recruiting,Observational
148,2018-177-IMP-EXP-4,Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer,"January 19, 2019","September 30, 2022",Recruiting,Observational
149,V3-MOMMO-01,Open Label Immunotherapy Trial for Breast Cancer,"July 1, 2018","December 31, 2019",Unknown status,Interventional
150,PROICM 2020-01 OST,Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer,"September 18, 2020","July 6, 2021",Completed,Observational
151,077-2019,Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Chest-wall and Locally-Advanced Breast Cancer,"July 31, 2020","June 30, 2024",Recruiting,Interventional
152,18-281,Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer,"March 21, 2019","January 31, 2024",Recruiting,Observational
153,2021-A02676-35,Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment,"January 9, 2023",December 2026,Recruiting,Observational
154,84434789,Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials,April 2024,April 2026,Not yet recruiting,Observational
155,2021-004,Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 Study,"November 4, 2021","September 28, 2022",Recruiting,Observational
156,CBS-PIK3CA,Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC,"October 11, 2019","June 11, 2023","Active, not recruiting",Observational
157,Juçara Phd Thesis,Emotional Evaluation and Reconstructed Breast Satisfaction,"July 1, 2019","February 28, 2022",Unknown status,Interventional
158,18 SEIN 08,The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.,"August 28, 2020","July 9, 2021",Terminated,Interventional
159,ARNA Breast 2021,"In Vitro Study of the Liquid Biopsy Test System of the Diagnostic Value, in Women With Various Forms of Breast Cancer","May 21, 2021","December 31, 2021",Unknown status,Observational
160,SNP-17-001,Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer,"September 21, 2018","November 11, 2020",Completed,Observational
161,2021-012,Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE),"October 27, 2022","October 27, 2024",Recruiting,Interventional
162,69HCL18_0769,Awareness About Breast Cancer Screening,"January 24, 2019","February 7, 2019",Completed,Observational
163,2394,Predictive Model of Axillary Nodal Status After Neoadjuvant Chemotherapy in Breast Cancer Patients,"February 4, 2020","January 31, 2024","Active, not recruiting",Observational
164,CASE12119,Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer,"June 29, 2021",June 2024,Recruiting,Interventional
165,18-124,ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer,"August 22, 2018","August 30, 2029","Active, not recruiting",Interventional
166,18-461,Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment,"January 18, 2019",January 2024,"Active, not recruiting",Observational
167,2020-KY-064,Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer,"December 1, 2020","December 31, 2023",Recruiting,Observational
168,3049,Evaluating Breast Cancer Patients Modesty During Radiotherapy. A Multicentric Study,"June 3, 2020","September 28, 2022",Completed,Observational
169,EFC16133,"Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity","February 17, 2022","October 13, 2022",Terminated,Interventional
170,82944089,Discovering Factors in Metastatic Breast Cancer Patients Clinical Trial Experiences,"March 25, 2023","March 25, 2025",Not yet recruiting,Observational
171,NewGiza University Protocol 1,The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study,"November 16, 2021","March 31, 2022",Not yet recruiting,Observational
172,s66248,Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment,"April 26, 2022",February 2025,Recruiting,Interventional
173,964635,The Benefit of Surgery in Stage IV of Breast Cancer,"November 20, 2020","December 20, 2021",Unknown status,Interventional
174,3/19,Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging,"May 29, 2019","May 28, 2023",Recruiting,Observational
175,SCCC-11118; STU-2018-0015,Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer,"November 27, 2018","November 30, 2024","Active, not recruiting",Interventional
176,19-003085,"GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance","October 17, 2019","December 31, 2024",Enrolling by invitation,Observational
177,2019402,Supportive Effects of Craniosacral Therapy for Female Patients With Breast Cancer and Their Partners,May 2023,December 2024,Not yet recruiting,Interventional
178,RADIO-SLEEP,Sleep Disorders Prior to and During a Course of Radiotherapy for Breast Cancer,"June 1, 2021","June 30, 2022",Not yet recruiting,Interventional
179,Protocol EMIT-1,Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer,"October 29, 2018","December 31, 2043","Active, not recruiting",Observational
180,17/09/621_Myosin VI,Nuclear Myosin VI - a Therapeutic Target in Breast Cancer,"May 5, 2019",December 2020,Unknown status,Observational
181,2017/1356,Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome,"August 1, 2019","April 1, 2021",Completed,Observational
182,IC 2016-07,"FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France","March 8, 2018",March 2021,Unknown status,Observational
183,left breast cancer,Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer,"April 27, 2022","November 30, 2023",Not yet recruiting,Observational
184,180212-1,IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry,"February 27, 2018","February 27, 2028",Recruiting,Observational
185,19-001,Individualizing Surveillance Mammography for Older Breast Cancer Survivors,"May 16, 2019","July 1, 2021",Completed,Interventional
186,CTRP6 in Breast Cancer,The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer,"November 1, 2020","October 1, 2022",Unknown status,Observational
187,CESM in breast cancer,Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy,"December 1, 2021","January 1, 2024",Not yet recruiting,Observational
188,UCaenNormandie,A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile),"February 14, 2022",September 2024,Enrolling by invitation,Interventional
189,SOLTI-1903,Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer,"October 20, 2020","July 30, 2024","Active, not recruiting",Observational
190,Vitamin D in breast cancer,Prognostic Value of Vitamin D Levels in Egyptian Females With Breast Cancer,"September 1, 2018","September 1, 2021",Unknown status,Observational
191,17-552,Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening,"April 18, 2018","December 30, 2023","Active, not recruiting",Interventional
192,CCR5348,Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer,"November 1, 2021","November 1, 2027",Not yet recruiting,Interventional
193,19HLSEIN02,Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC,"June 15, 2020","January 31, 2021",Completed,Observational
194,STUDY00011606,Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women,"August 22, 2022","November 15, 2022",Recruiting,Interventional
195,03/21,"A Prospective Single-center Cohort Study ""Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients""","October 1, 2022","August 1, 2023",Not yet recruiting,Interventional
196,AHQU-2021007,Genetic Predictors of Response to Acupuncture for Cancer-related Fatigue Among Breast Cancer Patients After Chemotherapy,"April 1, 2022","October 31, 2023",Recruiting,Interventional
197,D8530C00003,"A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer","November 2, 2020","June 9, 2023",Recruiting,Interventional
198,2019-05-157,Genetic Characteristics of Metastatic Breast Cancer Patients,"July 17, 2019","July 31, 2024",Recruiting,Interventional
199,200056,"BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)","May 4, 2021","October 22, 2021",Terminated,Interventional
200,182-20-CA,18F-fluoroestradiol (FES) PET/CT for Breast Cancer,"January 15, 2021","December 15, 2023",Recruiting,Interventional
201,Shengjing-LCG008,Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy,"August 1, 2021","August 1, 2027",Not yet recruiting,Interventional
202,NeoRadUKD,NeoRad Breast Cancer Study,"July 1, 2020","December 31, 2030",Not yet recruiting,Interventional
203,KY20192114-C-1,Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study),"August 1, 2019","December 31, 2021",Unknown status,Observational
204,STUDY19060359,Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania,"October 23, 2019","March 28, 2026",Recruiting,Interventional
205,2019.089,Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment,"September 1, 2019","June 1, 2023",Recruiting,Observational
206,Xist,XIST Gene Deletion in Breast Cancer Therapy,"March 1, 2020","March 1, 2022",Unknown status,Observational
207,UEM0002,Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors.,"October 1, 2018","December 31, 2019",Withdrawn,Interventional
208,004181,Together After Cancer,"January 1, 2023","March 1, 2026",Recruiting,Interventional
209,HERMIONE 13,Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer,"September 24, 2021","September 30, 2023",Recruiting,Observational
210,STANDPOINT,Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer,"December 31, 2020","December 31, 2022",Recruiting,Observational
211,NL75855.091.21,Evaluation of Contrast Enhanced Breast CT for Diagnosis and Staging of Breast Cancer,"August 1, 2022","August 1, 2025",Not yet recruiting,Observational
212,CASE5118,Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity,"March 21, 2019","December 1, 2023",Recruiting,Observational
213,21 SEIN 09,"Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.","June 23, 2022",June 2025,Recruiting,Interventional
214,CINEICC-3-IAT,Mind Programme for Women With Breast Cancer,"January 2, 2023","August 31, 2025",Recruiting,Interventional
215,Bakircay University,Training With Mobile Application in Breast Cancer,"January 10, 2018","April 17, 2018",Completed,Interventional
216,HR-HER2-RWS-01,The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.,"August 1, 2022","December 31, 2026",Recruiting,Observational
217,01-BR-003,Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer,"July 2, 2020","March 17, 2022",Completed,Observational
218,21149002,The Effect of Virtual Reality on Anxiety and Fatigue in Women With Breast Cancer Receiving Adjuvant Chemotherapy,"April 4, 2022","November 30, 2022",Completed,Interventional
219,21-528,Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment,"May 7, 2021","December 1, 2023","Active, not recruiting",Observational
220,DS8201-0002-EAP-MA,EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan,"November 11, 2022",April 2023,Recruiting,Observational
221,AAAU1629,FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments,May 2023,July 2024,Not yet recruiting,Interventional
222,BC-NEO-IIT-SHR1316-SHR6390-RT,Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment,"November 12, 2021","October 15, 2023",Recruiting,Interventional
223,2020-12/898,Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery,"February 1, 2021","October 1, 2021",Completed,Observational
224,CHUBX 2016/19,Adaptation of a Knowledges Exchange Portal Between (KEP) Healers and Patients : Obstacles and Sources to KEP Use for Breast Cancer Women,"March 16, 2018","June 17, 2019",Completed,Observational
225,IRB202100182 -N,All-extremity Exercise During Breast Cancer Chemotherapy,May 2023,"May 31, 2024",Recruiting,Interventional
226,PI-0538-2017,Breast Cancer and Its Relationship With the Microbiota,"January 1, 2018","December 31, 2022","Active, not recruiting",Observational
227,21/4657,Health Technologies Readiness in Breast Cancer Patients,"March 1, 2021","August 31, 2021",Completed,Observational
228,2020[84],HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody,"August 24, 2020","September 30, 2022",Unknown status,Interventional
229,2019-KY-001-003,PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer,"May 17, 2019","November 16, 2022",Completed,Interventional
230,AbantIBU,Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer Surgery,August 2018,November 2019,Withdrawn,Interventional
231,121K686,Online Group Therapy for Breast Cancer,"January 15, 2022",October 2022,Recruiting,Interventional
232,06-2020,Prevalence of Depression and Anxiety Among Breast Cancer Patients,"May 17, 2021","March 10, 2022",Completed,Observational
233,NADOPTIC,Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging,"January 27, 2020","January 27, 2023",Unknown status,Interventional
234,CHIR-07-Sentimag,Magseed and Magtrace Localization for Breast Cancer,"May 4, 2020","December 31, 2023",Recruiting,Observational
235,Pro00020917,Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer,"March 3, 2020",February 2025,Recruiting,Interventional
236,Breast Cancer,"Effects of Continuous and Interval Physical Training Through the Intensity of the Incremental Shuttle Walk Test, on Functional Capacity and Quality of Life in Women With Malignant Breast Cancer During Chemotherapy Treatment","January 20, 2023","December 30, 2025",Not yet recruiting,Interventional
237,BSU,The Effect of Metformin on Breast Cancer Patients,"June 1, 2019",October 2020,Unknown status,Interventional
238,URomLS Prot.0930/2021Rif. 6528,To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study),"September 1, 2022","January 27, 2023",Completed,Interventional
239,SOLTI-1716,Pembrolizumab + Paclitaxel in Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2-negative (HER2-) Non-luminal (by PAM50) Advanced Breast Cancer After Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitors Progression,"July 21, 2020","November 1, 2024","Active, not recruiting",Interventional
240,2020-0724,"Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study","November 3, 2020","December 31, 2022",Recruiting,Observational
241,LCCC 1749,Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging,"February 28, 2018","November 15, 2025",Recruiting,Interventional
242,GIMI-IRB-20005,Multi-4SCAR-T Therapy Targeting Breast Cancer,"June 1, 2020","December 31, 2023",Recruiting,Interventional
243,22-x145,Cryoablation vs Lumpectomy in T1 Breast Cancers,"June 30, 2023","December 31, 2030",Not yet recruiting,Interventional
244,17-PP-19,Peri-gravidic Exposure to Endocrine Disrupting Persistent Organic Pollutants,"April 15, 2019","November 15, 2021",Recruiting,Observational
245,2015-4-6-003,Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops.,"January 13, 2020","June 15, 2024",Recruiting,Interventional
246,FIRST,FreezIng bReaST Cancer in Brazil: a Before-after Study,"September 15, 2022","July 15, 2024",Not yet recruiting,Interventional
247,PUMCH-BREAST-ctDNA screening,Clinical Application of ctDNA in Early Screening of Breast Cancer,"June 1, 2019","June 1, 2021",Unknown status,Observational
248,147/19,Breast Cancer: Feasibility of an Educational Intervention,"December 1, 2019","November 9, 2020",Completed,Interventional
249,STUDY00001641,Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women,"July 16, 2022","December 1, 2024",Recruiting,Interventional
250,PetrovRIO,Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB),"October 8, 2019","December 10, 2028",Recruiting,Interventional
251,MD 177/2021,Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer,August 2022,August 2023,Not yet recruiting,Observational
252,A5481177,A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting,"November 22, 2021","December 2, 2022",Recruiting,Observational
253,2017-KY-19,The Establishment of a Survival Prediction Model for ER Positive / HER-2 Negative Advanced Breast Cancer,"January 1, 2020","December 31, 2024",Recruiting,Observational
254,Radiotherapy in breast cancer,Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).,"April 1, 2023","April 1, 2023",Not yet recruiting,Observational
255,19-001004,Brain Health in Breast Cancer Survivors,"March 11, 2020","March 15, 2025",Recruiting,Observational
256,19049,Specialist Recommendation on FBC (Familial Breast Cancer) Chemoprevention Prescribing,"July 22, 2019","December 31, 2019",Completed,Observational
257,Z211100002921033,The Detection of Cell-in-cell Structure (CICs) in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy,"October 1, 2021","October 1, 2024",Recruiting,Observational
258,CFDAIIUASABFDOBC,Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer,July 2018,July 2020,Unknown status,Observational
259,Breast cancer neoadjuvant,Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy,"March 1, 2022","January 1, 2023",Recruiting,Observational
260,wanghaibo,Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer,"October 8, 2022","March 31, 2027",Not yet recruiting,Interventional
261,2020-KY-063,Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer,"July 1, 2020","July 1, 2022",Unknown status,Observational
262,PUMCH-BC502,Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients,"April 25, 2019",March 2025,Recruiting,Observational
263,852-20,"Breast Cancer, Reasoning, and Activity Intervention","November 3, 2021","March 31, 2026",Withdrawn,Interventional
264,SYSEC-KY-2018-018,Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients,"September 1, 2019","July 30, 2021",Unknown status,Observational
265,19-045,A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients,"March 22, 2019",March 2024,"Active, not recruiting",Observational
266,PROICM 2019-16-BCU,Evaluation of Sexual Quality of Life for Breast Cancer,"February 10, 2020","July 31, 2020",Completed,Observational
267,IBCSG 59-19,Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer,"August 27, 2019","November 1, 2026",Recruiting,Interventional
268,33293720.9.0000.5505,Tele-rehabilitation in Women With Breast Cancer During COVID-19 Pandemic.,"March 2, 2020","December 2, 2022","Active, not recruiting",Interventional
269,199080,Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening.,"December 17, 2018",July 2024,Recruiting,Interventional
270,SLN SPECT,Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT,July 2018,September 2022,Unknown status,Interventional
271,SOLTI-1907,Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer,"March 15, 2021","February 24, 2025",Recruiting,Interventional
272,SDS-HER-01-2018,Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer,"August 24, 2022","March 2, 2023",Completed,Interventional
273,APHP211502,Breast Cancer Prevention and Screening Membership,"May 31, 2022","April 1, 2032",Recruiting,Interventional
274,ISTMET-BHWGI2022-1,Preoperative Radiotherapy and Systemic Therapy Following Surgery in de Novo Metastatic Breast Cancer,"March 1, 2022","March 31, 2028",Recruiting,Observational
275,SCHBCC-N024,Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer,"May 1, 2020","May 1, 2025",Recruiting,Interventional
276,Cpetptmrbc,Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer,"October 1, 2021","May 1, 2023",Not yet recruiting,Observational
277,4817,Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation,"March 1, 2022","June 1, 2023",Recruiting,Observational
278,EEBC,Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients,"April 1, 2022","December 1, 2025",Recruiting,Observational
279,symptom of breast cancer,Trajectory Analysis of Symptom Distress and Cancer-related Fatigue After Adjuvant Chemotherapy in Breast Cancer Female,"May 29, 2021","July 31, 2024",Not yet recruiting,Observational
280,IEO 0761/,Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast Cancer,"June 1, 2018","December 31, 2022",Recruiting,Observational
281,CELC-G-301,Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1),"September 30, 2022","September 30, 2026",Recruiting,Interventional
282,CARMA-2101,Cohort Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients Derived Organoids,"September 1, 2021","September 1, 2023",Not yet recruiting,Observational
283,RWD_abemaciclib,Real-world Data in Patients With Breast Cancer Treated With Abemaciclib,"October 6, 2021","December 1, 2024",Recruiting,Observational
284,Tiresias,To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer,"September 1, 2020","September 1, 2025",Recruiting,Observational
285,A5481125,Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.,"May 15, 2019","March 12, 2021",Completed,Observational
286,20-1789.cc,Sexual Health in Breast Cancer Patients,"December 1, 2020",December 2024,Recruiting,Observational
287,ML40952,Tw HER2 Positive Breast Cancer Productivity & Utility Study,"December 24, 2018","December 31, 2019",Unknown status,Observational
288,DBCG Proton trial,The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer,"June 1, 2020","June 1, 2037",Recruiting,Interventional
289,OOTR-N016/KBCRN-B-003/HT-PAB,"Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer","July 16, 2019","December 23, 2021",Completed,Interventional
290,710/2021,The Effect of Arm Exercises on Arm Oedema After Breast Cancer Surgery,"April 18, 2022","May 30, 2024",Recruiting,Interventional
291,19-003028,Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring,"September 1, 2019","November 29, 2028",Recruiting,Observational
292,KL166-IIS-001,HER2-positive Breast Cancer Project Initiated by Investigators,"June 1, 2022","December 31, 2024",Not yet recruiting,Interventional
293,V2_16-04-2020,Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant Therapy,"May 14, 2020","December 31, 2022",Recruiting,Observational
294,N19ASC,Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy,January 2020,July 2027,Not yet recruiting,Interventional
295,SNBvsPET/MRI 2,Axillary Staging in Early Breast Cancer: SNB vs PET/MRI,"July 3, 2020","February 14, 2025",Recruiting,Interventional
296,dingxwyh01,Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer,"December 1, 2018","September 30, 2020",Unknown status,Interventional
297,SNUH_FMI,Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer,September 2019,July 2021,Unknown status,Interventional
298,2022/0035986,Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study,"May 9, 2022",May 2024,Recruiting,Interventional
299,RF-2013-02358165,Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial),"January 17, 2018",December 2020,Unknown status,Interventional
300,18-516,GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases,"February 11, 2019","November 30, 2025",Recruiting,Interventional
301,2022106,Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer,"October 26, 2022","December 1, 2026",Not yet recruiting,Observational
302,19-147,Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer,"August 9, 2019","September 18, 2020",Completed,Interventional
303,dingxwyh02,The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer,"December 1, 2018","September 30, 2020",Unknown status,Interventional
304,19 SEIN 14,E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.,"February 28, 2020","July 21, 2021",Completed,Interventional
305,AURORA,New Techniques to evAlUate Response to neOadjuvant Treatments in bReast cAncer (AURORA),"December 1, 2020",December 2022,Unknown status,Interventional
306,17/0765,Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies,"April 1, 2019","February 28, 2027",Not yet recruiting,Observational
307,BR02/03/21,Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer,"December 6, 2021","December 31, 2025",Recruiting,Interventional
308,2018-9529,TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer,"December 12, 2018","June 1, 2024",Recruiting,Interventional
309,1186,The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population,"March 30, 2022","January 20, 2023",Completed,Observational
310,REaCT-HER TIME,Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy,"December 13, 2021",September 2023,"Active, not recruiting",Interventional
311,01-2021,"Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.","January 1, 2021","December 1, 2021",Unknown status,Observational
312,D9673R00011,Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients,"February 24, 2022","May 31, 2023",Recruiting,Observational
313,APHP211593,Molecular Signature for Breast Cancer,March 2023,December 2023,Not yet recruiting,Observational
314,SOLTI-1911,Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer,"May 3, 2022","July 1, 2030",Recruiting,Interventional
315,IC 2018-08,Breast Cancer Risk After Diagnostic Gene Sequencing,"October 22, 2019","March 3, 2022",Completed,Interventional
316,AHQU-2021006,Genetic Predictors to Acupuncture Response for Arthralgia Induced by Aromatase Inhibitors in Patients With Breast Cancer,"November 25, 2021","November 30, 2023",Recruiting,Interventional
317,Breast Cancer,The Relationship Between the Differences in Blood Cytokine Values in Breast Cancers.,"August 1, 2020","May 1, 2022",Completed,Observational
318,FLA 18-057,Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese Patients,"February 22, 2021","December 31, 2023",Recruiting,Observational
319,V2011201,Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer,"March 15, 2023","May 26, 2024",Withdrawn,Interventional
320,HERdi PREDICT,A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies,"December 20, 2019",June 2023,Recruiting,Observational
321,HCB-ONC001 (ML41519),Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy,"September 23, 2020",December 2026,Recruiting,Interventional
322,IRB-300002157,RAD 1802: Pilot Trial of Dose Adapted Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI),"August 20, 2019",December 2025,Recruiting,Interventional
323,IAyas2,The Validity and Reliability of FIT-HaNSA in Breast Cancer Patients,"February 1, 2021","September 1, 2022",Unknown status,Observational
324,A5481176,A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark,"February 24, 2022","August 1, 2022",Completed,Observational
325,Shengjing-LCG009,Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients,"August 1, 2021","August 15, 2027",Recruiting,Interventional
326,OTT-19-06,"A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer","June 8, 2021","August 15, 2022",Completed,Interventional
327,20210312,Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer,"March 1, 2021","May 30, 2021",Unknown status,Observational
328,FAST feasibility in CU,Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer,"December 10, 2018",May 2024,Recruiting,Interventional
329,Sentinel lymph node biopsy,Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients,February 2023,March 2025,Not yet recruiting,Observational
330,BC001,Moving on After Breast Cancer Plus- for Breast Cancer Survivors,"March 10, 2019","July 5, 2022",Completed,Interventional
331,SOC.04/20-21,Breast Screening Atypia and Subsequent Development of Cancer in England,"December 1, 2021","November 30, 2022",Enrolling by invitation,Observational
332,UT BCS ECS Study,Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors,"January 27, 2020","September 1, 2020",Withdrawn,Interventional
333,oddie2,Artificial Intelligence for breaST canceR scrEening in mAMmography (AI-STREAM),"February 1, 2021","December 31, 2024",Recruiting,Observational
334,FMASU R61/2020,Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt,"July 20, 2020",December 2020,Unknown status,Observational
335,18-109,A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors,"September 14, 2018",September 2023,Recruiting,Observational
336,19-509,Genetic Testing for All Breast Cancer Patients (GET FACTS),"January 31, 2020","November 1, 2023","Active, not recruiting",Interventional
337,19-277,Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients,"November 26, 2019",May 2023,"Active, not recruiting",Interventional
338,UW 20-064,Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy,"October 15, 2020","December 31, 2028",Recruiting,Interventional
339,UC-0105/1701,SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer,"March 15, 2018","November 18, 2022",Terminated,Interventional
340,20-1039,Couples QOL in Metastatic Breast Cancer,"January 1, 2021","August 31, 2024",Recruiting,Interventional
341,BRAR1,of Androgen Receptor Expression in Breast Cancer With or Without BRCA Mutation,"July 1, 2021","December 31, 2024",Recruiting,Observational
342,18-1025,Coping Together After Breast Cancer,"May 24, 2019","May 1, 2023","Active, not recruiting",Interventional
343,IRB16-0396,"Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening","September 17, 2020","September 14, 2021",Recruiting,Observational
344,09.2019.984,Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema,"January 7, 2020",April 2020,Unknown status,Interventional
345,O4M-B001,Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients,"June 1, 2020",October 2020,Unknown status,Interventional
346,TaiHao TVGH2020-07-006AC#1,Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes,"January 30, 2023","March 31, 2023","Active, not recruiting",Interventional
347,STGKS001,Artificial Intelligence in Large-scale Breast Cancer Screening,"April 1, 2021",December 2024,"Active, not recruiting",Interventional
348,19-086,"AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)","May 30, 2019",December 2024,"Active, not recruiting",Interventional
349,CNER 202107/05,eHealth Intervention for Medication Adherence in Breast Cancer Survivors,"October 4, 2021","February 28, 2023",Recruiting,Interventional
350,Optimune Trial,Evaluating a Novel Web-based Intervention for Breast Cancer Survivors,"March 16, 2018","April 30, 2022",Terminated,Interventional
351,1808019498,Converting HR+ Breast Cancer Into an Individualized Vaccine,"March 17, 2020","December 30, 2025",Recruiting,Interventional
352,Emotional security&mastectomy,Emotional Security and Quality of Life Among Breast Cancer Patient Who Have Undergo Mastectomy,"June 1, 2021","December 31, 2021",Unknown status,Observational
353,HYGEE,Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.,"September 24, 2020","September 9, 2023","Active, not recruiting",Interventional
354,A5481115,Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan,"August 31, 2019","November 30, 2023",Recruiting,Observational
355,Breast Audit,The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study,"February 28, 2022","May 1, 2022",Completed,Observational
356,STU-2018-0370,Infrared Imaging for Breast Cancer Modeling,"June 13, 2019","June 1, 2022",Completed,Interventional
357,MRI in breast cancer,Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy,May 2022,December 2024,Not yet recruiting,Observational
358,Prix Ruban Rose/2021/FF-01,Personalized Follow-up After Breast Cancer Surgery Via Electronic Patient Reported Outcomes,"April 1, 2021","June 30, 2022",Completed,Interventional
359,Pyrotinib neoadjuvant,Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer,"April 15, 2023","September 30, 2025",Not yet recruiting,Interventional
360,FUSCC-OMIT,A Trial Evaluating the Efficacy of Metastasectomy in Patients With Oligo-Metastatic Breast Cancer(OMIT),"December 10, 2019","March 10, 2025",Recruiting,Interventional
361,SMC 2021-02-102,"Selective Omission of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm studyTrial","September 27, 2021","December 31, 2028",Enrolling by invitation,Interventional
362,BSMMU/2019/8874,Effect of Vitamin C and E in Breast Cancer Patients Undergoing Chemotherapy,"October 10, 2019","September 15, 2020",Unknown status,Interventional
363,20210601,Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study,July 2022,June 2025,Recruiting,Observational
364,99mTc-ADAPT6 vs 99mTc-DARPinG3,Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3,"May 1, 2022","January 21, 2023",Recruiting,Interventional
365,Telemonitoring BCS,"Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors","August 1, 2021",December 2021,Recruiting,Interventional
366,CCTG MA.39,Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer,"May 30, 2018","December 30, 2027",Recruiting,Interventional
367,IRB-2022-166,"Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study","August 30, 2022","March 31, 2027",Not yet recruiting,Observational
368,2490,Characterization of Extracellular Vesicles in Breast Cancer Patients,"December 1, 2020",September 2023,Recruiting,Observational
369,19/317-2101,Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients,"May 8, 2020",May 2024,Recruiting,Interventional
370,2021-1116,Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks,January 2023,December 2029,Not yet recruiting,Interventional
371,SPT-2021-002,Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer,"March 12, 2022","December 31, 2025",Not yet recruiting,Interventional
372,s66248-aim2,Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity,"April 26, 2022",February 2025,Recruiting,Interventional
373,Cardiac safety study,Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab,"July 5, 2019","December 30, 2021",Recruiting,Observational
374,BGB-290-201,Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China,"June 22, 2018","April 14, 2021",Completed,Interventional
375,10038,Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*),"January 15, 2020","January 15, 2035",Recruiting,Interventional
376,Pro00085352,Examining Bioactivity of PVSRIPO in Invasive Breast Cancer,"June 30, 2019",December 2022,Recruiting,Interventional
377,EORTC 1745-ETF-BCG,Adjuvant Palbociclib in Elderly Patients With Breast Cancer,"June 14, 2019","September 30, 2032","Active, not recruiting",Interventional
378,4523,Acupuncture Treatment of Vasomotor Symptoms in Breast Cancer Patients,"November 25, 2021","December 25, 2024",Recruiting,Interventional
379,17-455,The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer,"June 21, 2018","May 31, 2025","Active, not recruiting",Interventional
380,01AB21- PIK3CA,Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.,"August 25, 2022","June 30, 2025",Recruiting,Interventional
381,ICO-N-2017-12,Clinico-biological Data Collection Study of Metastatic Breast Cancer,"December 24, 2018","December 30, 2036",Recruiting,Interventional
382,Optimune Trial Add-on,Evaluating a Novel Web-based Intervention for Breast Cancer Survivors,"September 1, 2018","September 1, 2020",Completed,Interventional
383,2018396H,TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer,"September 17, 2019","September 17, 2022",Unknown status,Interventional
384,PROICM 2020-05 SKY,Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.,"February 11, 2021",August 2025,Recruiting,Interventional
385,GEICAM/2019-01,Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients,"October 2, 2020","February 28, 2033","Active, not recruiting",Interventional
386,69HCL18_0310,Descriptive Observational Study of the Evolution of the Lifestyle Alteration in Patients With Breast Cancer,"November 27, 2018","October 19, 2020",Completed,Observational
387,2004-261-112,Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer,"October 1, 2020","December 16, 2020",Terminated,Observational
388,MA-BC-Ⅱ-040,Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer,August 2022,May 2024,Not yet recruiting,Interventional
389,APHP190505,Circulating Fetal Cells and Breast Cancer,"May 14, 2021",May 2025,"Active, not recruiting",Observational
390,2019-1183,A Phase I Dose Escalation Study of Single Fraction Ablative Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer,"December 25, 2019",August 2025,Recruiting,Interventional
391,IJB-NERABRAIN-ODN-007,Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer,"November 24, 2021","November 24, 2021",Withdrawn,Interventional
392,19-066,Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer,"July 26, 2019",February 2025,Recruiting,Interventional
393,EH18-203,The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer,"November 8, 2018","February 10, 2020",Completed,Interventional
394,22-280,Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors,"October 18, 2022","October 18, 2024",Recruiting,Observational
395,BakircayU,Factors Affecting Functionality in Breast Cancer Survivors,"December 17, 2019","September 30, 2021",Completed,Observational
396,A211801,Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation,"February 23, 2022",December 2033,Recruiting,Interventional
397,SGK-SFC-001,Susan G. Komens ShareForCures,"November 17, 2022",November 2032,Enrolling by invitation,Observational
398,CAAE: 39277420.8.0000.5313,Adaptations to Breast Cancer and Exercise Using Telehealth (ABRACE: Telehealth),February 2021,March 2023,Unknown status,Interventional
399,D361DC00001,Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292),"May 10, 2021","January 5, 2029",Recruiting,Interventional
400,PekingUMCH-NM25,99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer,"December 7, 2019","December 31, 2020",Completed,Interventional
401,5354-CL-1201,A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery,"August 10, 2022","September 30, 2023",Recruiting,Interventional
402,MO39485,"A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America","February 21, 2020","November 28, 2025","Active, not recruiting",Observational
403,SOC.03/20-21,"English Mammography Screening Outcomes by Age, Frequency and Test Threshold","January 1, 2021","December 30, 2023",Enrolling by invitation,Observational
404,2019-228,Prophylactic Irradiation to the Contralateral Breast for BCAs Patients,"January 1, 2023","December 1, 2029",Recruiting,Interventional
405,800646,Intervening on Womens Health for Rural Young Breast Cancer Survivors,"October 15, 2021","April 30, 2024",Recruiting,Interventional
406,NP 1521/19,Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer,"March 27, 2020","March 27, 2025","Active, not recruiting",Interventional
407,DARE,"DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer","February 9, 2021","December 15, 2026",Recruiting,Interventional
408,M2020 UK01,Breath Test to Predict Breast Cancer and Outcome of Mammography,March 2021,March 2023,Unknown status,Observational
409,[2019]52,HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02,"July 29, 2019","March 30, 2022",Completed,Interventional
410,TRA05-GEFPICS,Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer,"April 24, 2020","June 30, 2023","Active, not recruiting",Observational
411,NOV2016PhD818,Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention.,"June 6, 2020","March 31, 2021",Completed,Interventional
412,BCP28,CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC,"November 1, 2020","December 30, 2022",Recruiting,Observational
413,GEICAM/2017-01_IBCSG 62-20_BIG,Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET),"September 14, 2021",September 2026,Recruiting,Interventional
414,PekingUMCH-FES-BC-1,Characterizing Breast Cancer With 18F-FES PET/CT,"May 1, 2021","December 31, 2024",Recruiting,Interventional
415,GCO 17-00563,Integrated Intervention for Breast Cancer Survivors With Diabetes,"January 27, 2022",September 2023,Recruiting,Interventional
416,EudraCT 2020-005200-19,Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC),"February 6, 2023","December 31, 2024",Not yet recruiting,Interventional
417,D9673C00007,A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer,"June 22, 2021","February 9, 2024",Recruiting,Interventional
418,LY2022-028-B,Pre-operative Therapy in Breast Cancer,"November 1, 2022",November 2030,Recruiting,Observational
419,ATADEK-2021/14/16,Breast Cancer and Kinesiophobia and Physical Activity,"August 1, 2021","May 15, 2022",Completed,Observational
420,J21125,Cardiometabolic Screening Program,"June 3, 2022","June 1, 2027",Recruiting,Interventional
421,2018-9567,Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer,"January 8, 2019","December 1, 2025",Recruiting,Observational
422,UBRS20139,Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling,"September 23, 2022","September 1, 2025",Recruiting,Interventional
423,TQB3616-III-03,Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer,March 2023,January 2027,Not yet recruiting,Interventional
424,20 SEIN 13,Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer,"February 12, 2021",February 2024,Recruiting,Interventional
425,MD.21.09.521.R,The Significance of Radiologically Detected Intramammary Lymph Nodes in Prediction of Axillary Lymph Nodes Status in Breast Cancer Patients,"September 14, 2021","March 4, 2023","Active, not recruiting",Observational
426,20190283,SABER Study for Selected Early Stage Breast Cancer,"August 5, 2020",August 2025,Recruiting,Interventional
427,FISH in breast cancer,Partial PTEN Deletion in Breast Cancer,"November 1, 2021","January 30, 2025",Not yet recruiting,Observational
428,NCC3075,Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer,"January 1, 2022","December 31, 2024",Not yet recruiting,Interventional
429,CSPC-DMS-BC-13,Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.,"July 7, 2019","May 1, 2020",Completed,Observational
430,19900601,Effect of Lymphedema Prevention Program Based on Theory of Knowledge-attitude-practice on Postoperative Breast Cancer Patients,"March 1, 2020","December 8, 2020",Completed,Interventional
431,DBCG RT Recon,Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy,"January 1, 2020",November 2033,Recruiting,Interventional
432,PROICM 2019-11 PRA,A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer,"December 4, 2020","December 1, 2032",Recruiting,Interventional
433,201819010.4,Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients,"October 15, 2020","January 15, 2021",Unknown status,Observational
434,2018NTLS176,Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer,"August 8, 2019",January 2025,Recruiting,Observational
435,SPHIC-TR-BCa2022-01,A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer,"January 10, 2023","January 10, 2026",Recruiting,Interventional
436,SRMBCNabP2022,Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer,"April 20, 2022","June 30, 2023",Not yet recruiting,Interventional
437,C3441020,Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer,"August 27, 2018","September 23, 2020",Terminated,Interventional
438,18ON009,Developing a Diagnostic Tool to Predict Response to Chemotherapy,"November 7, 2019","May 31, 2021",Unknown status,Observational
439,FDRT-BC009,FSRT in Breast Cancer Patients With Brain Metastases,"July 1, 2019",July 2022,Unknown status,Interventional
440,18-223,Olaparib + Sapacitabine in BRCA Mutant Breast Cancer,"October 1, 2018","June 22, 2025","Active, not recruiting",Interventional
441,MCC-20897,DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer,"August 11, 2022",April 2025,Recruiting,Interventional
442,21-3576.cc,Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients,"June 29, 2021","June 1, 2025",Recruiting,Observational
443,IIT2018-01-McArthur-IPI,Peri-Operative Ipilimumab+Nivolumab and Cryoablation in Women With Triple-negative Breast Cancer,"November 12, 2019",June 2026,Recruiting,Interventional
444,BCHRD201,AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer,August 2020,August 2021,Unknown status,Interventional
445,BrIMA,Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer,"June 17, 2022",July 2023,Recruiting,Interventional
446,ChanghaiHTB,Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy,"August 1, 2022","May 1, 2031",Not yet recruiting,Interventional
447,2018-00838; ch20Weber2,Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS),"August 7, 2018",December 2036,Recruiting,Interventional
448,WSG-AM09,A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1),"August 18, 2020","May 31, 2022",Completed,Interventional
449,UC-0107/1903,Patients Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer,"October 1, 2021",September 2025,Recruiting,Interventional
450,PANONC-1 Version: 1.1,Neoadjuvant Treatment of Breast Cancer,March 2022,December 2031,Not yet recruiting,Observational
451,AB-MR for Second Breast Cancer,Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing,"May 1, 2018",June 2022,Unknown status,Observational
452,AHQU-2021005,Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer,"December 1, 2021","December 1, 2023",Recruiting,Interventional
453,2019/FO244363,Long-term Effects of Breast Cancer Treatment,"July 1, 2019","June 30, 2022",Unknown status,Observational
454,BC-2019,The Influence of Treatment Position (Prone vs. Supine) on Whole Breast Target,"January 1, 2019","November 1, 2023",Recruiting,Interventional
455,KYJJ-2021-186,Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients,"March 1, 2019","March 1, 2029",Recruiting,Observational
456,18-058,"Exercise, Fitness and Tumor Profiling in Breast Cancer Patients","January 31, 2018",January 2024,"Active, not recruiting",Observational
457,19-188,"Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial","November 18, 2021","July 31, 2024",Recruiting,Interventional
458,BCSCO003,Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China,"September 5, 2019",December 2025,Not yet recruiting,Observational
459,SP00049673,Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB,"November 26, 2019","May 1, 2021",Completed,Interventional
460,DSCN-EHT-NIS-BC001,A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer,"March 15, 2023","May 31, 2023",Recruiting,Observational
461,17-512,Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer,"January 30, 2018","June 30, 2025","Active, not recruiting",Interventional
462,SCBCS025,"Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China","December 4, 2020","December 31, 2024",Recruiting,Interventional
463,19-239,Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.,"October 9, 2019",December 2024,Recruiting,Interventional
464,LC2019L06,Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy,"February 1, 2020",December 2027,Recruiting,Interventional
465,GEICAM/2016-03,Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies,"January 18, 2018",January 2048,Recruiting,Observational
466,Breast Screening with DWI,Breast Cancer Screening With Diffusion-weighted MRI in Women at High Risk for Breast Cancer,"April 3, 2019",December 2022,Unknown status,Observational
467,HNCH-BC003,Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients,"April 15, 2020","May 1, 2022",Withdrawn,Interventional
468,21-183,"Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation","April 20, 2021",April 2024,Recruiting,Observational
469,02AB21-TucErBit,"A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer","November 17, 2022","May 26, 2025",Recruiting,Interventional
470,IRB-48150,68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer,"March 19, 2019","June 18, 2024",Suspended,Interventional
471,ICO-2019-03,Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives,"November 5, 2019","October 22, 2024","Active, not recruiting",Observational
472,Soh-Med-23-01-07,Prognostic Value of Some Biochemical Markers in Breast Cancer,February 2023,December 2023,Not yet recruiting,Observational
473,IUSCC-0613,An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer,"January 19, 2018","May 27, 2020",Completed,Interventional
474,Breast Cancer Screening,Diffusion-Weighted MRI for Breast Cancer Screening in Women With a Personal History of Breast Cancer,"June 30, 2021","November 30, 2024",Not yet recruiting,Observational
475,16-145,Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy,"July 17, 2019",August 2024,Recruiting,Interventional
476,A5481144,HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes,"November 18, 2019","February 12, 2021",Terminated,Observational
477,D133FR00138,ALEXANDRIA Study Egypt,"October 29, 2018","January 24, 2021",Completed,Observational
478,State University of São Paulo,Aerobic Training in Treatment for Breast Cancer,"July 1, 2018","November 30, 2020",Completed,Interventional
479,21-440,Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer,"July 13, 2022",November 2023,Recruiting,Interventional
480,YM107109E,Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life,"January 11, 2019","July 6, 2019",Completed,Interventional
481,GEICAM/2020-08,Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer,"March 8, 2023",August 2026,Recruiting,Interventional
482,2023-09,Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer,"February 7, 2023","March 1, 2024",Recruiting,Interventional
483,ARV-471-BC-201,A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery,"February 15, 2023",June 2024,Recruiting,Interventional
484,grid.412416.4,The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer,"June 5, 2018","December 20, 2019",Completed,Observational
485,18-333,A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy,"February 1, 2019","December 31, 2024","Active, not recruiting",Interventional
486,MA-BC-II-024,Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC),"June 15, 2021","June 30, 2025",Not yet recruiting,Interventional
487,intestinal flora study,A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer,"January 18, 2021","December 30, 2022",Recruiting,Observational
488,ML42450,"Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey","March 22, 2021","August 8, 2022",Completed,Observational
489,GNC-035-103,"A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer","November 26, 2021","November 30, 2023",Recruiting,Interventional
490,DS8201-A-U301,DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02],"August 1, 2018",September 2024,"Active, not recruiting",Interventional
491,2018-09-007A,Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools,"November 22, 2018","August 31, 2026",Recruiting,Observational
492,M18DMB,ModraDoc006/r in Patients With Breast Cancer,"January 30, 2019","November 9, 2020",Completed,Interventional
493,ZNJC201935,Nomogram to Predict Breast Cancer Related Lymphedema,"December 11, 2020","December 31, 2027",Recruiting,Interventional
494,Microbiome_BC&PnC,Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients,"May 12, 2022",August 2025,Recruiting,Observational
495,R148/2021,TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients,"July 24, 2022",September 2023,Recruiting,Observational
496,SCHBCC0N026,A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC,"January 20, 2020","December 31, 2021",Recruiting,Interventional
497,MUKDEN-09,"Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer","December 20, 2022","December 10, 2027",Recruiting,Interventional
498,NACAGEP,"Gene Expression Profiling to Help Define the Need for Neo-Adjuvant Chemotherapy in HR+, HER- Breast Cancer Patients","November 14, 2022","November 14, 2024",Recruiting,Observational
499,2017MayPR898,A Communication Skills Package to Prevent Fear of Cancer Recurrence,"September 1, 2018",February 2020,Unknown status,Observational
500,RGT-419B_01-101,"First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer","March 4, 2022","August 28, 2024",Recruiting,Interventional
501,NCC 2019-0098,Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching Program,"May 14, 2019","June 30, 2022",Completed,Observational
502,21-003046,"Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer","July 21, 2022","June 15, 2024",Recruiting,Interventional
503,SSGJ-302H-mBC-IIT-01,Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC,"January 4, 2021","December 30, 2022",Recruiting,Interventional
504,KY2019-070,Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer,"December 16, 2019",August 2028,Recruiting,Interventional
505,A5481155,"Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy","June 30, 2020","December 31, 2020",Completed,Observational
506,D8530C00001,Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.,"October 11, 2018","April 15, 2024",Recruiting,Interventional
507,APHP191059,BIOPSY SCANNER LLTECH© Technology for Diagnosis of Breast Cancer,"April 28, 2020","September 15, 2021",Unknown status,Observational
508,BT006,Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases,"September 18, 2019",March 2022,Recruiting,Interventional
509,1R01CA236860-01A1,Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors,"February 1, 2021","December 31, 2025",Recruiting,Interventional
510,310-17-SZMC,Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer,"April 18, 2019","June 15, 2021",Unknown status,Interventional
511,CINDERELLA,Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.,"June 1, 2023",December 2025,Not yet recruiting,Interventional
512,2017-01282 (BASEC),Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer,"January 13, 2020","February 5, 2020",Terminated,Interventional
513,CCR5214,"Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression",August 2021,August 2024,Not yet recruiting,Interventional
514,MCC-21757,Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer,"November 4, 2022","November 1, 2026",Recruiting,Interventional
515,K2022-025-01,A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer,"December 10, 2022","December 10, 2025",Not yet recruiting,Interventional
516,PUMCH-MUSD,A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis,"June 12, 2020","June 1, 2023",Recruiting,Observational
517,0720222005,The Postoperative Radiotherapy in N1 Breast Cancer Patients,"August 1, 2022","December 31, 2033",Recruiting,Interventional
518,D967UC00001,"Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)","April 26, 2021","December 30, 2029",Recruiting,Interventional
519,PLEASURABLE,"Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer","May 12, 2019","December 10, 2025","Active, not recruiting",Interventional
520,21822,"COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer","October 18, 2019","April 30, 2023",Withdrawn,Interventional
521,CTNZ-2017-01,Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy,"June 10, 2019","October 15, 2021",Completed,Interventional
522,20-649,"Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer","July 21, 2021","December 1, 2029",Recruiting,Interventional
523,2020-08-06R,Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic Resonance,"October 30, 2020",September 2023,Recruiting,Observational
524,Qassim QDs-VELD,Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer,"September 15, 2019","December 13, 2022",Unknown status,Interventional
525,HR-BLTN-III-EBC,A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer,"July 12, 2019","July 31, 2024","Active, not recruiting",Interventional
526,COV-19 BUMDC,COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer,"January 1, 2020","January 31, 2021",Completed,Observational
527,14-833-02,Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study,"May 27, 2018","December 31, 2019",Completed,Interventional
528,17-519,Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis,"May 1, 2018","September 30, 2025","Active, not recruiting",Interventional
529,Radiotherapy in Breast Cancer,Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients,"January 1, 2018","June 30, 2019",Completed,Interventional
530,2020-A01423-36,Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients,"November 27, 2020","November 9, 2029",Recruiting,Observational
531,STML-ELA-0222,Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer,"January 24, 2023","August 31, 2026",Recruiting,Interventional
532,C3441055,Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m,"December 17, 2021","June 30, 2022",Completed,Observational
533,CRF-NHI01,Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue,"September 8, 2021","December 31, 2023",Recruiting,Observational
534,H-41818,Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer,"March 4, 2020",December 2030,Recruiting,Interventional
535,CLUE-BCL,Evaluation of the Treatment Response in Breast Cancer Related Lymphedema,"July 11, 2019","December 11, 2019",Completed,Interventional
536,nihan25,Women on Breast Cancer Health Belıefs and Screenıng Behavıors,"August 15, 2022","April 15, 2023",Recruiting,Interventional
537,2020-0927,Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer,"December 13, 2021","December 31, 2024",Recruiting,Interventional
538,2020FES,16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer,March 2020,March 2021,Unknown status,Interventional
539,PRO00034502,Tell us Your Food Story,"October 1, 2019","November 20, 2020",Withdrawn,Observational
540,Breast cancer in females,Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer,September 2023,December 2023,Not yet recruiting,Observational
541,SCLND0919,Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer Patients With Ipsilateral Supraclavicular Lymph Node Metastasis,"February 27, 2019","April 30, 2022",Unknown status,Interventional
542,PUMA-NER-6203,A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib,"June 30, 2020","December 28, 2021",Completed,Interventional
543,KBCSG-24,Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NAC (OPTIMIST),"September 22, 2022",March 2031,Recruiting,Interventional
544,AHQU-2021001,Effect of Oxygen Inhalation on Fatigue After Chemotherapy of Breast Cancer in High Altitude Area,"March 1, 2021","December 31, 2022",Recruiting,Interventional
545,Fenofibrate in Breast Cancer,Fenofibrate Role in Breast Cancer Patients,"January 1, 2023","February 1, 2024",Recruiting,Interventional
546,AHQU-2021003,Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer,"February 1, 2021","January 31, 2023",Recruiting,Interventional
547,2018LS148,BAriaTric Surgery After Breast Cancer Treatment (BATS),April 2023,February 2025,Not yet recruiting,Interventional
548,PekingUMCH-BCa093,68Ga PET/CT Imaging in Breast Cancer Patients,"November 15, 2022","December 31, 2024",Recruiting,Interventional
549,ADA,"An Integrative Intervention Based on Physical Activity, Nutrition and Supportive Care (the ADA Program) to Improve the Quality of Life of Breast Cancer Survivors",December 2022,November 2025,Not yet recruiting,Interventional
550,514-0213/21-5000,Insulin Sensitivity After Breast Cancer,August 2021,September 2026,Recruiting,Interventional
551,CentroHLOBreastUnit,HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer,"May 1, 2018","May 1, 2020",Unknown status,Interventional
552,CCR4965,Evaluating a Digital Tool for Supporting Breast Cancer Patients,"October 1, 2019","December 30, 2022","Active, not recruiting",Interventional
553,GCO 21-0699,"Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer","September 29, 2021",September 2024,Recruiting,Interventional
554,DBCG RT Natural Trial,Partial Breast Versus no Irradiation for Women With Early Breast Cancer,"September 5, 2018","September 1, 2035",Recruiting,Interventional
555,IPNCb-01,Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer,"November 1, 2021","December 1, 2023",Recruiting,Interventional
556,CSPC-KAL-BC-12,Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer,"June 1, 2019","December 1, 2024",Not yet recruiting,Interventional
557,003-2017,Stereotactic Body Radiation Therapy for Breast Cancer,"July 17, 2018","July 17, 2023",Recruiting,Interventional
558,Breast cancer treatment,The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer,October 2022,September 2023,Not yet recruiting,Interventional
559,18-561,NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer,"March 8, 2019","April 19, 2023","Active, not recruiting",Interventional
560,E19137,Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile,"July 2, 2019",May 2021,Suspended,Observational
561,Vitamin D and breast cancer,Vitamin D and Calcium Supplementation in Breast Cancer,November 2022,October 2023,Not yet recruiting,Interventional
562,SYSEC-KY-KS-2021-182,Quantitative Assessment of Diffusion Spectrum Imaging in Breast Cancer,"August 20, 2021","August 19, 2022",Recruiting,Interventional
563,CASE6119,Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer,"October 1, 2021","September 1, 2023",Recruiting,Interventional
564,KX-ORAX-CN-007,A PK Study of Oraxol in Breast Cancer Patients,"April 22, 2019","December 9, 2020",Completed,Interventional
565,NCC2018M-042,Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ),"November 1, 2018","September 1, 2021",Unknown status,Interventional
566,CTO-IUSCCC-0803,Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis,"January 18, 2023","July 31, 2023",Recruiting,Observational
567,55791222.0.0000.5313,Water and Land-based Aerobic Training in Breast Cancer Survivors,"September 1, 2022","August 30, 2025",Not yet recruiting,Interventional
568,UF-BRE-002,Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients,March 2020,March 2023,Withdrawn,Interventional
569,18-010602,Screening CEDM in Intermediate and High-Risk Patient Populations,"February 15, 2019","May 31, 2021",Completed,Observational
570,GIM21 - LiqERBcept,Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial),"November 7, 2018","January 12, 2022",Completed,Interventional
571,BREAST-SK-001,"Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.","January 1, 2020","January 1, 2023",Unknown status,Interventional
572,LR19/011/50551,Increasing Knowledge of Alcohol as a Risk Factor for Breast Cancer Among Women Attending Breast Screening Services,"February 5, 2021","December 2, 2021",Completed,Interventional
573,STU00201961A,A Research Study for Latina Women Undergoing Breast Cancer Treatment,"September 10, 2019","July 1, 2022",Completed,Interventional
574,18-641,"Young, Empowered & Strong (YES): The Young Womens Breast Cancer Study 2- Focus on Intervention Pilot","May 23, 2019","September 19, 2019",Completed,Interventional
575,CLEE011O12301C,A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer,"December 7, 2018","May 29, 2026","Active, not recruiting",Interventional
576,HIRSLANDEN 01 SAKK 23/18,Intelligent Vacuum Assisted Biopsy Immediately Before Surgery as an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer,"August 17, 2020",June 2025,Recruiting,Interventional
577,CCH-IRB-190414-P,Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy in the Management of Breast Cancer-Prospective Study,"October 1, 2019","February 28, 2022",Recruiting,Interventional
578,348455,Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer,"July 1, 2018","December 31, 2023","Active, not recruiting",Interventional
579,SOLTI-2101,Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype,"March 28, 2022","March 1, 2027",Recruiting,Interventional
580,Zz123456.,The Effect of the Mobile Application-based Support Program on the Outcomes of Breast Cancer Patients in the Pandemic,"July 15, 2022","February 15, 2024",Recruiting,Interventional
581,GBG102 - SASCIA,Sacituzumab Govitecan in Primary HER2-negative Breast Cancer,"October 28, 2020","March 30, 2029",Recruiting,Interventional
582,PROICM 2018-05 BCU,Sexual Quality of Life in Women During the First Year of Adjuvant Hormonal Treatment for Breast Cancer.,"May 2, 2018","October 30, 2019",Completed,Observational
583,CAAE: 91570318.5.0000.5149,Nutritional Status and Pharmacological Treatment: Impact on the Toxicity and Quality of Life of Patients With Colorectal and Breast Cancer,"November 1, 2018",December 2019,Unknown status,Observational
584,FWA00015574/6-01-2019/korany,Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment,"October 20, 2019","June 30, 2020",Completed,Interventional
585,SYSKY-2022-030-01,Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer,"July 15, 2022","May 31, 2027",Not yet recruiting,Observational
586,UI-ROD-OCTU02,MicroRNA Profiles in Triple Negative Breast Cancer,"November 29, 2021",August 2023,Recruiting,Interventional
587,KY20182079-F-1,Breast Cancer Treatment Based on Organ-like Culture,"January 2, 2019","December 15, 2021",Unknown status,Observational
588,PN-301-21,"Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer","February 28, 2022",December 2025,Recruiting,Interventional
589,Radiation in breast cancer,Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery,"December 1, 2021","April 1, 2023",Unknown status,Observational
590,4-2018-0160,Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer,"April 11, 2018","April 11, 2023",Unknown status,Observational
591,ROCK,Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer,"May 1, 2018","May 1, 2024",Recruiting,Interventional
592,SOLTI-1805,"A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression","December 22, 2020","April 30, 2023",Recruiting,Interventional
593,KY20202075-F-2,Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer,"November 30, 2022","July 30, 2025",Recruiting,Interventional
594,06805118.2.1001.5404,Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer,"October 2, 2019","October 2, 2030",Recruiting,Interventional
595,ID4060,Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer,"November 1, 2019","May 31, 2022",Completed,Observational
596,AN.MCME.CR.12,Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation,"August 1, 2019","August 1, 2022",Unknown status,Interventional
597,MedOPP293,Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer,"August 5, 2021",March 2028,Recruiting,Interventional
598,iOM-110383,A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer,January 2019,April 2019,Withdrawn,Interventional
599,IRST174.25,Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation,"March 31, 2023",March 2032,Recruiting,Interventional
600,EUROPA,ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer,"February 8, 2021","February 8, 2030",Recruiting,Interventional
601,HM022BC3C01,A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer,"January 19, 2022",June 2024,Recruiting,Interventional
602,UF-BRE-007,Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients,"March 22, 2023",January 2026,Recruiting,Interventional
603,SOLTI-2103,NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial,"November 25, 2022","July 31, 2030",Recruiting,Interventional
604,SOLTI-1503,Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer,"December 10, 2018","April 27, 2025","Active, not recruiting",Interventional
605,0023041/i,MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGING,"September 12, 2022","September 22, 2025",Recruiting,Observational
606,LQ009,Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study,March 2022,September 2027,Not yet recruiting,Interventional
607,BGB-900-2001-IIT,"A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)","April 1, 2021","June 30, 2023",Recruiting,Interventional
608,CLEE011H2301,Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer,"March 31, 2018","November 17, 2025",Withdrawn,Interventional
609,2020_61,Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.,"July 13, 2021",July 2025,Recruiting,Observational
610,ONAWA (SOLTI-1802),Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer,"November 6, 2020","April 30, 2021",Completed,Interventional
611,1,Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction,"June 27, 2022","May 1, 2029",Recruiting,Interventional
612,STUDY00010776,REJOIN Trial for Older Breast Cancer Survivors,"June 15, 2021",December 2023,Recruiting,Interventional
613,CASE13119,Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer,April 2023,December 2024,Not yet recruiting,Interventional
614,ZX-2021-FES-ESTROTIMP-4,Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer,"February 8, 2022",June 2025,Recruiting,Interventional
615,2017-0499,"Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer","April 30, 2018","February 10, 2022",Completed,Interventional
616,IIT-UM2018001,Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation,"July 3, 2020","December 1, 2023",Recruiting,Interventional
617,UPCC 17120,Telehealth Weight Loss Program for Breast Cancer Survivors,"July 19, 2021",December 2023,"Active, not recruiting",Interventional
618,Shengjing_002,Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer,"September 1, 2019","September 30, 2022",Recruiting,Interventional
619,IRB-57723,Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer,"February 3, 2021",February 2026,Recruiting,Interventional
620,3764,Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis,"January 1, 2018","April 1, 2021",Unknown status,Interventional
621,D8530C00006,"A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer","September 29, 2020","December 29, 2023","Active, not recruiting",Interventional
622,115858,SIGNAL During a COVID-19 Pandemic,May 2020,November 2022,Withdrawn,Interventional
623,CCH-IRB-190414-R,Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy for Breast Cancer,"August 22, 2019","December 31, 2021",Unknown status,Interventional
624,UCCS20110,Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer,"July 28, 2021","July 1, 2023","Active, not recruiting",Interventional
625,Shengjing-LJY04,Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer,"October 1, 2019","September 30, 2029",Recruiting,Observational
626,2019-004559-35,Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial),"June 15, 2020","July 15, 2027",Not yet recruiting,Interventional
627,GEICAM/2017-04,Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA),"June 12, 2018","June 21, 2022",Completed,Observational
628,KARMA Kontrast,KARMA Kontrast - a Controlled Trial Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer,"November 9, 2020","May 31, 2022",Unknown status,Interventional
629,ACE-Breast-03,"ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)","April 5, 2021",December 2025,"Active, not recruiting",Interventional
630,BREAST,BRaziLian outcomE for metAStatic breasT Cancer,"September 13, 2021","December 31, 2024",Recruiting,Observational
631,FMBSUREC/10102021/Rabie,"Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients""","October 30, 2021","December 30, 2024",Recruiting,Interventional
632,1808-42,Survey Study: Financial Impact of Breast Cancer Treatment,"September 4, 2018","November 30, 2024","Active, not recruiting",Observational
633,2020-535,Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy,"November 15, 2020","July 15, 2025",Recruiting,Interventional
634,RP-20-013,Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer,October 2022,July 2025,Withdrawn,Interventional
635,EF141,Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy,January 2018,October 2019,Withdrawn,Interventional
636,STUDY00001225,The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project,"March 20, 2023",June 2027,Recruiting,Interventional
637,CCR5119,KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer,"June 16, 2020","December 31, 2026",Recruiting,Interventional
638,3475-756,"Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)","December 27, 2018","January 24, 2031","Active, not recruiting",Interventional
639,21-271,Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity,"August 27, 2021","August 27, 2023",Recruiting,Observational
640,STUDY2019000317,Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer,"October 3, 2018","October 3, 2028",Recruiting,Observational
641,FirstHCMU_CB_001,Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast,"July 1, 2020","January 15, 2021",Unknown status,Observational
642,2022-0055,A Study for the Neoadjuvant Treatment of Breast Cancer,"July 10, 2022","December 20, 2027",Recruiting,Interventional
643,WEFITTER,Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib,"April 22, 2022",April 2023,Recruiting,Interventional
644,A5481178,A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.,"October 12, 2022","March 31, 2023","Active, not recruiting",Observational
645,ARO-2015-1,Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer,"March 5, 2021","June 30, 2025",Recruiting,Interventional
646,HNCH-MBC11,Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer,"June 1, 2022","December 30, 2024",Not yet recruiting,Interventional
647,SOLTI-1507,Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients,"February 25, 2020","August 12, 2024",Recruiting,Interventional
648,DKFZ-2019-008,Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE),May 2023,December 2029,Not yet recruiting,Interventional
649,20170328,Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer,"August 1, 2018","December 31, 2021",Completed,Interventional
650,SHPD005,Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer,"October 16, 2018","April 16, 2023",Recruiting,Interventional
651,dAGEs,"Dietary Advanced Glycation End Products, Inflammation and Oxidative Stress in Breast Cancer Patients","March 3, 2020","June 30, 2023",Recruiting,Observational
652,20-124,YES Study - Newly Diagnosed/Metastatic Intervention,"September 16, 2020","March 1, 2028",Recruiting,Interventional
653,NIR-THERMA-02,A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers,"December 15, 2018","January 30, 2020",Completed,Observational
654,LaPemERLA,Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole,"February 15, 2023","December 31, 2026",Recruiting,Interventional
655,E7389-M082-602,A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants,"January 25, 2018","June 30, 2018",Completed,Observational
656,Pro00020138,Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer,"June 11, 2019","September 1, 2024",Recruiting,Interventional
657,18-394,DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC,"November 5, 2018","September 1, 2030","Active, not recruiting",Interventional
658,2019SABE028,The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial Functions,"July 1, 2020",December 2021,Recruiting,Interventional
659,IIBSP-PRO-2021-10,Prehabilitation for Breast Cancer Surgery,"November 1, 2021","November 1, 2023",Recruiting,Interventional
660,SYSUCC-015,Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer,"November 11, 2021",December 2028,Recruiting,Interventional
661,REO 026-1,Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer,"October 11, 2021",July 2023,"Active, not recruiting",Interventional
662,STUDY00001233,Novel Thermal Imaging Technique for Breast Screening,"November 15, 2022","December 31, 2025",Recruiting,Observational
663,2019.429,Effectiveness of Character Strengths-based Intervention Among Breast Cancer Patients,"May 4, 2020","December 20, 2020",Completed,Interventional
664,CP7-005,A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients,"May 31, 2019","July 31, 2023",Recruiting,Interventional
665,2021/193780(REK),Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole,"December 1, 2022","December 1, 2024",Recruiting,Interventional
666,INCASE0518,Artificial Intelligence vs Physicians for Breast Cancer Patients Information,"November 1, 2018","January 20, 2019",Completed,Observational
667,123123,Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer Patients,"March 10, 2020","November 30, 2024",Recruiting,Interventional
668,JTU-6H-20211011001,Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer,"December 1, 2021",March 2024,Recruiting,Interventional
669,INST 1607,Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging,"April 16, 2018","December 31, 2024",Recruiting,Observational
670,CIMS-4FMFES-2021-3966,4FMFES-PET Imaging of ER+ Advanced Breast Cancers,"November 1, 2020","December 31, 2023",Recruiting,Interventional
671,SOLTI-1718,Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer,"July 23, 2020","November 29, 2021",Terminated,Interventional
672,Yunwei Wei 2019-09-13,Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy,"September 12, 2019","October 15, 2020",Unknown status,Observational
673,HLX11-BC301,A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer,"April 25, 2022","December 30, 2025",Recruiting,Interventional
674,Zoledronic Acid In Breast Ca,Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole,"September 30, 2021","September 30, 2023",Recruiting,Interventional
675,6788,Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer,"January 1, 2018",January 2019,Unknown status,Observational
676,Tacrolimus_2020,Tacrolimus as Treatment of Breast Cancer-Related Lymphedema,"September 22, 2020","January 6, 2022",Completed,Interventional
677,KSRAD001,Using AI to Select Women for Supplemental MRI in Breast Cancer Screening,"April 1, 2021","July 1, 2025",Recruiting,Interventional
678,Stage 2 compression therapy,Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema,"June 1, 2021","December 31, 2022",Not yet recruiting,Interventional
679,CASE5120,Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer,"December 28, 2020",December 2023,Recruiting,Interventional
680,PROICM 2020-07 VIS,Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work,"September 13, 2021",May 2023,Recruiting,Interventional
681,CL1-81694-003,S 81694 Plus Paclitaxel in Metastatic Breast Cancer,"January 4, 2018","June 8, 2020",Completed,Interventional
682,Shengjing-LCG005,Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer,"July 19, 2021","November 30, 2026",Recruiting,Interventional
683,2020.KB.SAG.069,The Effect of Mobile Lymphedema Self-Care Support Program on Self-Care in Women With Breast Cancer-related Lymphedema,"September 1, 2021","December 1, 2021",Recruiting,Interventional
684,NCC1824,Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR,"September 17, 2018",June 2021,Unknown status,Observational
685,INNOVBC,A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer,February 2018,December 2019,Unknown status,Interventional
686,R20-003,Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Breast Cancer,"June 1, 2023","July 1, 2025",Recruiting,Interventional
687,MedOPP319,CB-103 Plus NSAI In Luminal Advanced Breast Cancer,"May 6, 2021",May 2023,"Active, not recruiting",Interventional
688,WO39391,A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer,"August 2, 2018","August 24, 2025","Active, not recruiting",Interventional
689,NCC1867,The Psychology of Chinese Breast Cancer Patients,"April 25, 2019","December 31, 2021",Enrolling by invitation,Observational
690,20-157,Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD),"December 16, 2020","December 1, 2023",Recruiting,Interventional
691,2-102-21,Towards Early Detection of Breast Cancer in High Risk Population,"March 1, 2022","May 1, 2024",Not yet recruiting,Observational
692,HunanCH-BC-001,Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer,"October 1, 2022","October 1, 2025",Not yet recruiting,Observational
693,2021.693,mHealth Usage Among Nigeria Women Diagnosed With Breast Cancer Receiving Chemotherapy,"September 1, 2022","December 1, 2023",Recruiting,Interventional
694,GENEXAN,GENe EXpression After Regional or General ANesthesia in Patients Undergoing Breast Cancer Surgery,"March 1, 2021","March 1, 2022",Unknown status,Interventional
695,HSC20160245H,Improving Adherence to EHT Among Breast Cancer Patients,"May 3, 2021",June 2025,"Active, not recruiting",Interventional
696,GRO-06-001,ABUS for Early-stage Breast Cancer,"August 15, 2019","August 15, 2022",Unknown status,Interventional
697,Neveen,"Demographic , Clinicopathological Characteristics and Survival of Breast Cancer","April 1, 2021","December 31, 2024",Not yet recruiting,Observational
698,Melody_002,"Melody®, a Lab Developed Test for Breast Cancer for Women With Dense Breast Tissue","October 1, 2021",October 2024,Recruiting,Observational
699,REC-H-PHBSU-21010,Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints,"April 26, 2021","August 26, 2022",Completed,Interventional
700,16D.674,Prospective Breast Cancer Biospecimen Collection,"May 10, 2018","January 22, 2021",Unknown status,Interventional
701,YOUNGBC-22,"Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer","September 1, 2022","January 1, 2024","Active, not recruiting",Interventional
702,SMC- 5725-18,The Breast Cancer Personalized Nutrition Study,"July 17, 2019",December 2025,Recruiting,Interventional
703,2000025837,Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer,"December 23, 2019",July 2023,"Active, not recruiting",Interventional
704,DS8201-A-U305,A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05),"December 4, 2020","December 31, 2030",Recruiting,Interventional
705,2020/33,Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer,"July 16, 2021",June 2028,Recruiting,Interventional
706,2018.016,Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA,"May 22, 2018",December 2024,Recruiting,Interventional
707,HE071-CSP-021,A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer,"June 11, 2021","May 30, 2024",Recruiting,Interventional
708,Shengjing_001,Study on Bisphosphonates Targeting Triple-negative Breast Cancer,"September 1, 2019","August 31, 2022",Recruiting,Observational
709,PREDIX II HER2,Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer,"May 23, 2019","June 30, 2021",Terminated,Interventional
710,ATADEK 2022-17/27,The Effect of Wearable Vibration Therapy on Shoulder Functionality in Individuals Receiving Adjuvant Radiotherapy After Breast Cancer Surgery,"November 1, 2022","February 15, 2023",Recruiting,Interventional
711,CHIR-01-sentinel,Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy,"January 1, 2018","November 30, 2020",Completed,Interventional
712,R.20.05.834,Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.,"June 5, 2020","May 1, 2023",Recruiting,Interventional
713,MCC-20902,Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer,"October 12, 2021","December 9, 2025","Active, not recruiting",Interventional
714,D3615C00001,Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer,"April 16, 2020","June 7, 2024","Active, not recruiting",Interventional
715,SMC-2019-05-021 (2),Real-time Interactive Digital Healthcare System in Patients With Breast Cancer; Randomized Controlled Trial,"April 1, 2020","November 17, 2021",Completed,Interventional
716,PUMCH-BC501,Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery,"April 1, 2019",March 2025,Recruiting,Observational
717,17/209,The Tomosynthesis Trial in Bergen - Part 2,"January 1, 2018",June 2023,"Active, not recruiting",Interventional
718,PCS-001,Breast Cancer Liquid Biopsy Trial,"September 28, 2020","July 31, 2023",Recruiting,Observational
719,1563/2018,Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery,"July 20, 2019","December 20, 2020",Unknown status,Interventional
720,C3441053,Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer,"August 20, 2021","October 11, 2021",Completed,Observational
721,18-603,"Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors","October 28, 2019","December 1, 2021",Completed,Interventional
722,2021-0170,Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer,"January 31, 2022","June 30, 2025",Recruiting,Interventional
723,PUMCH-SBSBC,Survival Benefits of Statins in Breast Cancer Patients,"March 28, 2019","June 28, 2024",Recruiting,Interventional
724,B27IB3856,UCLA Breast Cancer Survivor Health Promotion Research Study,"April 1, 2022",June 2023,Recruiting,Interventional
725,2018.08.ST,Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma,"March 1, 2019","March 9, 2022",Terminated,Interventional
726,YYS-20200305,Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer,"October 9, 2020","July 20, 2022",Completed,Interventional
727,CAN04CLIN005,Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.,"January 11, 2022",August 2026,Recruiting,Interventional
728,ORIN1001-001,ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer,"May 25, 2019","March 30, 2023","Active, not recruiting",Interventional
729,YOUNGBC-7,18F-FES PET/CTs Additional Clinical Value in ER+ BC,"February 15, 2019","June 20, 2019",Completed,Observational
730,LUN_MMG_121,Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer,"June 15, 2020","January 13, 2021",Completed,Observational
731,Breast Cancer-RISS,Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Surgeries,"August 31, 2020","March 1, 2021",Completed,Interventional
732,LCCC2105,Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities,"July 2, 2021","October 10, 2021",Completed,Observational
733,STML-ELA-0322,"ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study",August 2023,August 2025,Not yet recruiting,Interventional
734,RJrapidplan,RapidPlan Models Establishment for Node-Positive Breast Cancer Treated With Hypofractionation Using Edge/Truebeam,"December 15, 2021","December 15, 2024",Recruiting,Observational
735,2-049-18,Randomised Controlled Study of Physical Exercise Intervention in Breast Cancer Patients at Risk of Anthracycline-induced Cardiomyopathy: The EMBRACE Study,"February 1, 2020","August 30, 2030",Recruiting,Observational
736,MIES-BCNAT,Multimodal Imaging Evaluation System of Axillary Lymph Node Staging and Treatment Strategy for Breast Cancer Neoadjuvant Therapy,"January 1, 2021","December 31, 2023",Not yet recruiting,Observational
737,MACSSI (ET18-150),MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire),"February 22, 2021","November 15, 2024",Recruiting,Observational
738,HNCH-BC010,A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer,"May 11, 2022","September 30, 2024",Recruiting,Interventional
739,22SCH740,STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER),May 2023,May 2027,Not yet recruiting,Interventional
740,eMOUVOIR-1901,Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients,"December 18, 2020",December 2024,Recruiting,Interventional
741,NCC2019-0142,Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy,"July 3, 2019","June 30, 2034",Enrolling by invitation,Observational
742,20G.605,Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer,"November 24, 2020","January 1, 2024",Recruiting,Interventional
743,19-002792,Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer Patients,"May 17, 2019","August 1, 2026",Recruiting,Interventional
744,UT BCS Sleep Study,Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors,"January 15, 2020",July 2020,Withdrawn,Interventional
745,919PP17,Protective Role of Vitamin D in Breast Cancer Patients Treated With Doxorubicin,"September 1, 2019","May 1, 2020",Completed,Interventional
746,H-50349,Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer,"February 15, 2023","September 1, 2029",Not yet recruiting,Interventional
747,NIS12501,"A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib","July 8, 2022",February 2023,Recruiting,Observational
748,B002-101,B002 in Patients With HER2-positive Breast Cancer,"May 28, 2019","April 26, 2022",Completed,Interventional
749,"2016-051-000001, 2563",Investigating Barriers for Decision Making in a Danish Breast Cancer Screening Context,"June 22, 2022",November 2022,Recruiting,Interventional
750,MCC-21378,Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer,"May 31, 2022",May 2026,Recruiting,Interventional
751,010006,Integrin α6-targeted SPECT Imaging of Breast Cancer,"March 8, 2018","June 30, 2019",Completed,Interventional
752,20210504,MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer,"January 1, 2019","June 30, 2023",Recruiting,Observational
753,2021-0358,A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC),"November 16, 2021","December 29, 2024",Recruiting,Interventional
754,18-2444.cc,Facial Skin Health Tracking Feasibility in Breast Cancer Patients,"January 24, 2020",August 2024,Recruiting,Observational
755,LACUDY,Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient,"December 20, 2022","February 28, 2023",Not yet recruiting,Interventional
756,CSPC-DMS-BC-17,Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer,"October 1, 2019","January 1, 2021",Unknown status,Interventional
757,UC-0105/1815,"Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis","October 21, 2019","March 30, 2025","Active, not recruiting",Interventional
758,NCC3340,A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer,"February 1, 2022","June 1, 2024",Recruiting,Interventional
759,YOMA,Effects of Yoga on the Quality of Life of Breast Cancer Patients,"May 9, 2022",December 2024,Recruiting,Interventional
760,2022-7735,Life After Breast Cancer - Impact of a Life Coach,"September 15, 2021","September 1, 2023",Not yet recruiting,Interventional
761,IRB00130428,The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer,"February 20, 2019","November 26, 2023","Active, not recruiting",Interventional
762,GS-US-595-6184,Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physicians Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy,"December 12, 2022",January 2031,Recruiting,Interventional
763,HR BLTN 014,Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer,"April 1, 2020",May 2023,"Active, not recruiting",Interventional
764,C4891023,TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B),"March 1, 2023","October 6, 2027",Recruiting,Interventional
765,SYSU-2022-02,"Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.",February 2023,August 2024,Recruiting,Interventional
766,GO40987,"A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer","July 26, 2019","May 25, 2021",Completed,Interventional
767,HR-BLTN-008,"Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer","November 6, 2019","March 31, 2023",Recruiting,Interventional
768,OkanU2,Influence of Multidisciplinary Breast Tumor Board on Physician Decision,"August 13, 2018","November 13, 2019",Unknown status,Observational
769,HNCH-MBC08-BM02,Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases,"April 29, 2022",May 2024,Recruiting,Interventional
770,TRICIA,TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence,"December 5, 2019",June 2023,Recruiting,Observational
771,19-003532,Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers in Patients Undergoing Regional Nodal Irradiation for Breast Cancer,"October 1, 2019",October 2023,Recruiting,Observational
772,PALBOCOMP,Analysis of Palbociclib Treatment in Patients With Advanced Breast Cancer Within a Compassionate Use Programe,"September 18, 2018","September 1, 2019",Completed,Observational
773,SNF4,Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer,"February 1, 2023","June 1, 2027",Recruiting,Interventional
774,MA-BC-II-006,Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC),"May 20, 2020","February 28, 2024",Recruiting,Interventional
775,17/013,Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer,"August 1, 2018",June 2023,"Active, not recruiting",Interventional
776,LACOG 0221,"Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil","October 1, 2021","March 20, 2023",Recruiting,Observational
777,SNF3,PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer,"February 1, 2023","June 1, 2027",Recruiting,Interventional
778,1780,Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.,September 2022,June 2025,Not yet recruiting,Observational
779,2020 - 176,Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer,"January 15, 2021","December 15, 2021",Unknown status,Interventional
780,HR-TNBC-HN100,SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer,January 2020,January 2023,Unknown status,Interventional
781,YANWQ002,the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis,"February 1, 2020","December 31, 2020",Unknown status,Observational
782,2018-68-1461,Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer,"August 1, 2018",July 2024,Recruiting,Interventional
783,STU00206180,A Web-Based Tool to Improve Breast Cancer Survivorship,"May 29, 2019","May 1, 2022",Completed,Interventional
784,MR-01,Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI,"January 3, 2022","July 1, 2024",Recruiting,Observational
785,2019-09-09,Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer,"January 1, 2019","January 1, 2025",Recruiting,Interventional
786,UBRS20013,Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer,"June 1, 2023","June 1, 2026",Not yet recruiting,Interventional
787,HR-BLTN-014,Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer,"August 15, 2019","April 15, 2021",Unknown status,Interventional
788,SPI-POZ-101,A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer,"July 13, 2018","April 17, 2019",Terminated,Interventional
789,EC/TMC/108/17,Hypo-Fractionated Radiotherapy in Breast Cancer,"January 2, 2018","January 3, 2023",Unknown status,Interventional
790,SGRT-BC,Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer,"April 1, 2022","April 1, 2027",Recruiting,Interventional
791,CMUH108-REC3-090,A Study to Evaluate the Safety and Clinical Outcome of Using FR-Mask in Breast Cancer Patients With Radiation-irritated Skin After Radiotherapy,"September 6, 2019",December 2021,Unknown status,Interventional
792,PALBOSPAIN,Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer,"July 31, 2021","June 8, 2022",Completed,Observational
793,RC48-C012,A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2,"September 29, 2020","December 30, 2023",Recruiting,Interventional
794,261\\2021,Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic Therapy,June 2022,May 2024,Not yet recruiting,Interventional
795,ERIBRAIN-IPC 2017-014,Eribulin in Brain Metastases From HER2-negative Breast Cancer,"February 26, 2019","April 14, 2020",Withdrawn,Interventional
796,CYH33-G103,"Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer",April 2021,December 2022,Unknown status,Interventional
797,OTT 18-02,Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT),"September 17, 2019","April 9, 2022",Completed,Interventional
798,SYSA1901-002,Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer,"January 9, 2023","February 21, 2026",Recruiting,Interventional
799,YBCSG-21-03,Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer,"December 15, 2020","February 25, 2023",Unknown status,Interventional
800,EBaran,The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.,"November 28, 2019","December 1, 2021",Unknown status,Interventional
801,99mTc-ADAPT6,99mTc-ADAPT6-based HER2 Imaging in Breast Cancer,"June 5, 2019","September 5, 2020",Completed,Observational
802,2019-0088,Proton Accelerated Partial Breast Irradiation,"July 1, 2020","July 8, 2021",Withdrawn,Interventional
803,R20-030,Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI,"December 31, 2023","August 31, 2027",Recruiting,Interventional
804,NL77000.029.21,Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients,"August 24, 2022",March 2035,Recruiting,Interventional
805,MUKDEN 07,A Study of SHR-A1811 Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients,"March 16, 2023","February 28, 2029",Recruiting,Interventional
806,OstacoliMIND&BC,Mindful-life: Mindfulness Based Intervention vs Cognitive Behavioral Therapy in Patients With Breast Cancer,"January 1, 2022","December 31, 2022",Unknown status,Interventional
807,NCC3286,A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway,April 2022,August 2024,Recruiting,Interventional
808,HR-BLTN-010,A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer,"September 30, 2019","August 30, 2022",Unknown status,Interventional
809,CMUH106-REC3-137,Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors,"March 28, 2018","December 31, 2021",Completed,Interventional
810,2010134480,Prospective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer Patients,"January 19, 2021",January 2023,Unknown status,Interventional
811,DS8201-A-U303,Trastuzumab Deruxtecan (DS-8201a) Versus Investigators Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04],"December 27, 2018",March 2023,"Active, not recruiting",Interventional
812,H18-02581,"Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers","January 7, 2019","December 31, 2023",Not yet recruiting,Interventional
813,SMX 22-002,Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,March 2023,June 2026,Not yet recruiting,Interventional
814,18-371,"Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial","January 15, 2019","December 1, 2024","Active, not recruiting",Interventional
815,K171005J,"Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility","September 9, 2018","March 17, 2020",Completed,Interventional
816,X-XJTU1AFLSY-93,"Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038","June 1, 2022","October 30, 2024",Recruiting,Interventional
817,9745,CESM ABMR Breast Cancer Screening Trial,"January 3, 2018","December 31, 2022",Completed,Observational
818,2019/2452,Impact of a Breast cAncer Survivorship Interprofessional Community Care Model,"March 1, 2021","July 20, 2022",Completed,Interventional
819,J1836,"Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer","November 13, 2018","December 31, 2023","Active, not recruiting",Interventional
820,20-104,"Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)","September 10, 2021","January 21, 2022",Completed,Interventional
821,SCHBCC-N030,Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS),"May 15, 2020","May 15, 2027",Not yet recruiting,Interventional
822,D967JC00001,A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer,"December 28, 2020","December 30, 2025",Recruiting,Interventional
823,STUDY00022698,MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals,"September 7, 2022","August 31, 2025",Recruiting,Observational
824,CLEE011AUS64,A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors,"April 15, 2020","June 15, 2020",Completed,Observational
825,SCAN-B-rec,Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec),"January 21, 2019","December 1, 2030",Recruiting,Observational
826,LMengmeng,An Online Psychosocial Intervention for Fear of Cancer Recurrence in Breast Cancer Survivors,"September 30, 2022","December 30, 2023",Recruiting,Interventional
827,NCC1888,Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib,"August 20, 2021","September 1, 2023",Not yet recruiting,Interventional
828,XZP-3287-3002,A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer,February 2022,December 2025,Not yet recruiting,Interventional
829,R21-072,Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI),"June 1, 2023","August 2, 2027",Not yet recruiting,Interventional
830,HCI131027,Functional Precision Oncology for Metastatic Breast Cancer,"February 16, 2021",August 2025,Recruiting,Interventional
831,SCHBCC-N025,A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS),"October 1, 2019","September 1, 2022","Active, not recruiting",Interventional
832,ERC/2020/10/11 (26/10/2020),Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model,"December 8, 2021","October 31, 2023",Recruiting,Interventional
833,19-055,A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients,"July 11, 2019","December 31, 2026",Recruiting,Interventional
834,SLNB-ACP,Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents,"September 21, 2018",May 2027,Enrolling by invitation,Observational
835,20F.259,Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation,"December 7, 2020","April 1, 2024",Recruiting,Interventional
836,AI-BMRI,Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women,"September 1, 2021","September 30, 2025",Recruiting,Observational
837,2019/1318,Exercise in Breast Cancer Survivors,"September 8, 2020","March 2, 2023",Completed,Interventional
838,BC-P29,Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT,"July 3, 2020",September 2028,Recruiting,Interventional
839,Smart,An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy,"March 7, 2022","December 7, 2022",Not yet recruiting,Interventional
840,OMICS Mark,Metabolomics Explores Biomarkers for Metastatic Breast Cancer,"October 1, 2019","February 1, 2023",Unknown status,Observational
841,RS-NAT01,Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy,"November 1, 2019","December 30, 2022",Unknown status,Interventional
842,2021/32,The Effect of Self-compassion on Breast Cancer,"May 15, 2022","November 15, 2022",Not yet recruiting,Interventional
843,SMX 20-001,Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,"September 29, 2020","February 10, 2023","Active, not recruiting",Interventional
844,BOMB,Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis,"May 9, 2020","December 31, 2026",Recruiting,Interventional
845,XuzhouMedSch3,Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery,"September 20, 2018",February 2020,Unknown status,Interventional
846,MC220301,Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer,"February 14, 2023","January 30, 2027",Recruiting,Interventional
847,FUSCC-TNBC-BLIS,Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer,"May 1, 2023","February 28, 2026",Recruiting,Interventional
848,TeMP 2021,The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.,"March 29, 2022","April 1, 2028",Recruiting,Interventional
849,SMC 2018-07-014-011,Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device,"August 10, 2018","December 31, 2020",Unknown status,Observational
850,D931CC00001,Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer,"November 7, 2022","December 7, 2026",Recruiting,Interventional
851,WuhanU,Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP,"January 5, 2022","September 20, 2027",Not yet recruiting,Interventional
852,2022-017,Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer,"April 1, 2023","January 1, 2024",Recruiting,Observational
853,Stage 1 Compression Therapy,Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema,"July 1, 2021","December 31, 2022",Not yet recruiting,Interventional
854,GEICAM/2018-03,Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer,"May 21, 2021","July 24, 2024",Recruiting,Observational
855,4298,mHealth for Breast Cancer Survivors With Insomnia,"April 5, 2022",March 2023,Recruiting,Interventional
856,018-745,LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer,"September 5, 2019",December 2023,"Active, not recruiting",Interventional
857,20-371,Niraparib + Dostarlimab In BRCA Mutated Breast Cancer,"December 18, 2020","July 17, 2029",Recruiting,Interventional
858,HBMUFH-101,A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer,August 2019,December 2021,Unknown status,Interventional
859,2019-KY-051,Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer,July 2019,July 2025,Recruiting,Interventional
860,GCX-BCT-06,Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy,"January 11, 2019",January 2029,Recruiting,Interventional
861,213355,Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer,"April 12, 2018","March 31, 2020",Completed,Interventional
862,2022-0056,A Study for the Adjuvant Treatment of Breast Cancer,"July 10, 2022","December 20, 2027",Recruiting,Interventional
863,20192755,Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer,"July 1, 2019","February 7, 2023",Completed,Interventional
864,K3_K1_2,An Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Physical Pain,"January 20, 2022","June 30, 2025",Recruiting,Interventional
865,MEDOPP437,PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin,July 2023,July 2027,Not yet recruiting,Interventional
866,BC-P31,Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer,"July 14, 2022","June 15, 2024",Recruiting,Observational
867,EORTC-1550-BCG,Dissecting the Pathways of Therapy Resistance in Early Breast Cancer,"July 8, 2020","July 31, 2023",Recruiting,Observational
868,D9670C00001,"Study of Trastuzumab Deruxtecan (T-DXd) vs Investigators Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer","July 24, 2020","June 19, 2026",Recruiting,Interventional
869,ACR A4707,Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts,"March 1, 2023","January 1, 2027",Not yet recruiting,Interventional
870,42127,Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity,December 2021,December 2026,Not yet recruiting,Observational
871,handan1,Circulating Tumor Cells Screen for Breast Cancer,"February 20, 2020","June 20, 2023","Active, not recruiting",Observational
872,IOM-120465,Tucatinib in Patients With Locally Advanced or Metastatic HER2-positive Breast Cancer Who Received at Least Two Prior Anti-HER2 Treatment Regimens.,"May 21, 2022",May 2027,Recruiting,Observational
873,2-025-19,Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?,"June 20, 2019","December 31, 2021",Unknown status,Observational
874,OTT 20-11 (IT-02),INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer,"March 25, 2021","March 1, 2023",Recruiting,Interventional
875,PREBCA,Progressive Relaxation Training in Breast Cancer Patients Receiving Aromatatase Inhibitor Therapy,"October 25, 2019","September 24, 2020",Completed,Interventional
876,OBU-SC-BB-BC-II-010,"Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer","December 1, 2020","December 31, 2023",Recruiting,Interventional
877,20-09022641,Combined Immunotherapies in Metastatic ER+ Breast Cancer,"November 12, 2020","October 31, 2025",Recruiting,Interventional
878,D9673R00025,A Study of Patients Receiving T-DXd (Trastuzumab Deruxtecan) for Treatment of HER2+ Unresectable and/or Metastatic Breast Cancer,"March 15, 2023","December 31, 2025",Not yet recruiting,Observational
879,SaglikBilimleriU_DU,Investigation of the Effect of Education on Symptom Management on Symptom Management in Patients With Breast Cancer,"July 1, 2022","April 1, 2023",Recruiting,Interventional
880,mTPVB SPPB Ver 2,Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery,"February 1, 2023","January 31, 2025",Not yet recruiting,Interventional
881,SYSKY-2023-129-01,Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer,"February 16, 2023","December 1, 2025",Recruiting,Interventional
882,R868/18-IEO 916,Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back,"December 6, 2018","December 31, 2021",Recruiting,Observational
883,309424,Breast CANcer Risk Assessment in Younger Women: BCAN-RAY,"May 31, 2023","May 1, 2025",Not yet recruiting,Observational
884,Melody_001,"Validation of Melody®, a Tear-based Screening Assay for Breast Cancer","June 1, 2021",December 2025,Enrolling by invitation,Observational
885,UW20035,Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer,"May 24, 2021",November 2023,Recruiting,Interventional
886,19-1812.cc,"Fertility Changes Due to Cancer: an Investigation of Meaning, Psychological Distress, and Psychologi","January 11, 2021",December 2024,"Active, not recruiting",Observational
887,I3Y-NS-O003,Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients With Symp-tomatic Visceral Metastases or High Tumor Burden,"December 22, 2020",December 2024,Recruiting,Observational
888,ID-TMS-02-20201012,CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population,"January 1, 2021","June 30, 2024","Active, not recruiting",Interventional
889,ACE-Breast-07,ARX788 in Breast Cancer With Low Expression of HER2,"October 20, 2021","June 30, 2023",Recruiting,Interventional
890,CABC012,Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer,"February 21, 2019","January 26, 2023","Active, not recruiting",Interventional
891,2019-053,Intervention to Promote Breast Cancer Screening Among American Indian Women,"October 3, 2020","December 31, 2024","Active, not recruiting",Interventional
892,SNB vs PET/MRI 1,Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI,"November 4, 2019","April 1, 2024",Recruiting,Interventional
893,NIHR 128311,Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy,"February 26, 2021","February 28, 2030",Recruiting,Interventional
894,AITIC,Artificial Intelligence in Breast Cancer Screening Programs in Córdoba (AITIC),July 2021,June 2023,Recruiting,Interventional
895,Pro00104868,Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer,"September 1, 2020","August 1, 2025",Recruiting,Interventional
896,RG_16-108,NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer,"May 22, 2019","December 31, 2025",Recruiting,Observational
897,STUDY00000023,TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer,"April 17, 2019","December 31, 2023","Active, not recruiting",Interventional
898,2022/0132,The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors,"August 15, 2022","February 15, 2024",Not yet recruiting,Interventional
899,2021C0128,"Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors","January 18, 2022",June 2023,Recruiting,Observational
900,GMI-1359-210,A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer,"November 21, 2019","August 25, 2021",Terminated,Interventional
901,20_RIPH3_06,Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique,"October 28, 2020","December 28, 2025",Recruiting,Observational
902,SHERO,"Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer","June 1, 2020","May 31, 2030",Not yet recruiting,Interventional
903,MA-BC-II-023,Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy,"March 1, 2023","March 25, 2026",Recruiting,Interventional
904,0494-22-RMB,A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.,"December 25, 2022","December 31, 2027",Recruiting,Interventional
905,ICO-A-2018-10,Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery,"March 19, 2019","October 19, 2022","Active, not recruiting",Interventional
906,REG-074-2020,Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer,"June 23, 2021","April 30, 2024",Recruiting,Interventional
907,Woman health,Whole Body Vibration Training and Breast Cancer Risk Factors,"August 1, 2019","September 1, 2020",Completed,Interventional
908,CSIIT-C39,Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer,"November 1, 2022","December 31, 2023",Recruiting,Interventional
909,99mTc-ZHER2,Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.,"December 22, 2021","March 1, 2023",Enrolling by invitation,Interventional
910,HCC 22-003,Preoperative Irradiation for Stage I Breast Cancer,"February 8, 2023",September 2027,Recruiting,Interventional
911,FAST-F-PG01,Ultra-hypofractionated Radiotherapy in Breast Cancer Patients,"July 21, 2021","July 21, 2026",Recruiting,Observational
912,20-001670,Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring,"November 16, 2020","November 15, 2024",Recruiting,Observational
913,CSIIT-C03,Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy,"October 30, 2020",December 2022,Unknown status,Interventional
914,IBCSG 55-17,To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH),"April 16, 2019",March 2023,"Active, not recruiting",Interventional
915,WO42633,A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy,"May 4, 2021","October 26, 2034",Recruiting,Interventional
916,2022-05093-02,The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.,"March 17, 2023","December 31, 2033",Recruiting,Interventional
917,NRG-BR007,"De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)","June 7, 2021",July 2041,Recruiting,Interventional
918,NCCH2113,Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study,"May 24, 2022","September 30, 2027",Recruiting,Observational
919,YU-FTR-ST-01,"The Effects of Upper Extremity Lymphedema on Posture, Upper Extremity Functions, and Quality of Life","May 2, 2022","October 31, 2022",Completed,Observational
920,CLP0008,Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients,"September 1, 2020",December 2025,Recruiting,Interventional
921,18-040,Topical Calcipotriene Treatment for Breast Cancer Immunoprevention,"November 7, 2018","July 31, 2025",Recruiting,Interventional
922,UPCC 01121,Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer,"June 1, 2021",May 2028,Recruiting,Interventional
923,Molecular imaging of HER2,Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3,"February 10, 2020","October 4, 2021",Completed,Interventional
924,OP-1250-002,A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients,"December 10, 2021",December 2023,Recruiting,Interventional
925,GEICAM/2018-06,"Trial to Evaluate Diarrhoea Discontinuations at 3 Cycles in Patients With Early-stage HER2+, HR+ Breast Cancer Treated With Neratinib Plus Loperamide Versus Neratinib Dose Escalation Plus Loperamide Administered as Needed Versus Neratinib Plus Loperamide Plus Colesevelam (DIANER)","August 31, 2022",January 2030,Recruiting,Interventional
926,26272819.3.0000.0068,Breast Cancer and Intrauterine Contraception,"August 6, 2020","December 31, 2022",Recruiting,Interventional
927,SA20I0060,Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema,"December 1, 2021",June 2023,Recruiting,Interventional
928,1094/2020,Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy,"April 16, 2020","August 31, 2025",Withdrawn,Interventional
929,WO42133,"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)","September 4, 2020","November 24, 2021",Completed,Interventional
930,Soh-Med-23-01-34,EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast,January 2023,March 2023,Not yet recruiting,Observational
931,110-163-F,A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients,"April 8, 2022","April 7, 2023",Recruiting,Interventional
932,MUKDEN 06,A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients,"May 23, 2022","December 30, 2026",Recruiting,Interventional
933,KN035-TH-HER2,KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer,"September 1, 2019","January 1, 2022",Unknown status,Interventional
934,HNCH-MBC09-BM03,Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE),"May 30, 2022",May 2024,Recruiting,Observational
935,COSMOPOLITAN,Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer,"October 1, 2019","May 1, 2026",Recruiting,Interventional
936,21-VIN-0166/SAN-0647,"A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer","April 7, 2022","October 20, 2022",Completed,Interventional
937,E19059,Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer,"March 5, 2019","December 31, 2023",Recruiting,Observational
938,ISB 1302-103,Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer,"April 8, 2020","July 24, 2020",Terminated,Interventional
939,0063-17,A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients,"July 10, 2018","July 31, 2024",Recruiting,Interventional
940,M16-735,A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC),"January 4, 2018","October 5, 2018",Terminated,Interventional
941,NCT20210157-AI-ROL,Artificial Intelligence in Breast Cancer Screening in Region Östergötland Linkoping,"October 15, 2021","February 15, 2022",Completed,Observational
942,19-524,Effects of Exercise in Patients With Metastatic Breast Cancer,"January 8, 2020","July 1, 2027",Recruiting,Interventional
943,HR-BLTN-002,A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physicians Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer,"August 15, 2019","December 30, 2021",Unknown status,Interventional
944,CTO-IUSCC-0684,Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer,"April 1, 2020","July 1, 2024",Recruiting,Interventional
945,Tele-Relax,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,"January 20, 2021","December 1, 2022",Completed,Interventional
946,NCC1865,A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer,"December 22, 2018","June 22, 2022",Unknown status,Interventional
947,A5481126,Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy,"February 24, 2021","March 24, 2023",Completed,Interventional
948,KCSG BR18-16,Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer,"August 1, 2019",December 2022,"Active, not recruiting",Interventional
949,D9673R00028,PROVIDENCE - Real-world Study in Patients With HER2-positive Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan and Offered PRO-React Onco,"October 31, 2022","December 31, 2029",Not yet recruiting,Observational
950,LY01005/CT-CHN-303,Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®,"October 15, 2020","August 30, 2022",Recruiting,Interventional
951,IFG-08-2019,Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON),"July 11, 2021",January 2023,Recruiting,Interventional
952,BC-Genetics,Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients,"August 1, 2020","April 1, 2023",Recruiting,Observational
953,XZP-3287-3001,A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer,"November 16, 2021",November 2029,Recruiting,Interventional
954,GEP,Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC),"October 8, 2020","October 31, 2022",Unknown status,Interventional
955,2019/2632,An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer Surgery,"November 19, 2019","October 31, 2021",Unknown status,Interventional
956,BTCRC-BRE18-337,"Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers","April 17, 2019",June 2023,Recruiting,Interventional
957,UMMCHTNBC,Telemonitoring Hypertension and Breast Cancer,"February 1, 2023","August 31, 2023",Not yet recruiting,Interventional
958,J18138,Automated Method for Breast Cancer Detection,"March 7, 2019","December 15, 2020",Terminated,Interventional
959,19-09020752,CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer,"March 4, 2020","December 31, 2028",Withdrawn,Interventional
960,RC31/21/0368,Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk,"October 6, 2021","February 1, 2022",Completed,Interventional
961,20-503,Feasibility of Fasting & Exercise in Pts With HR+ MBC,"January 15, 2021","July 31, 2023","Active, not recruiting",Interventional
962,PGG-BCA2121 / MK-3475-C99,Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA),"November 9, 2021","January 15, 2027","Active, not recruiting",Interventional
963,ACTRN1261000928213,A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.,"March 20, 2018",April 2022,Recruiting,Interventional
964,Pro2020002182,Breast Cancer and Resistance Exercise Program,"December 1, 2020","January 1, 2025",Recruiting,Interventional
965,160178,"Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer","August 15, 2018","January 13, 2023","Active, not recruiting",Interventional
966,MRG002-004,A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer,"June 30, 2021",October 2023,Recruiting,Interventional
967,BC-Pyrotinib-NVB,Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer,"January 1, 2021","February 6, 2022",Completed,Interventional
968,SYSUCC-016,GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer,"February 8, 2022","February 8, 2024",Recruiting,Interventional
969,19-396,Liquid Biopsies and Imaging in Breast Cancer,"January 2, 2019",December 2021,Unknown status,Interventional
970,Shengjing-LJY07,Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer,"March 1, 2022","August 31, 2027",Recruiting,Interventional
971,HMPL-012-SPRING-R103,Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer,April 2023,August 2025,Not yet recruiting,Interventional
972,CA209-7FL,"Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer","November 20, 2019","January 15, 2024","Active, not recruiting",Interventional
973,NCC2021291,A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN),"June 21, 2022",July 2028,Recruiting,Interventional
974,2022-A02271-42,Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.,"February 23, 2023",February 2024,Recruiting,Observational
975,20-2338,Effects of Pinkwashed Alcohol Ads in an Online RCT,"January 11, 2023","January 19, 2023",Completed,Interventional
976,CNIL-2033408,Chronic Pain and Minor Breast Cancer Surgery,"April 1, 2019","December 31, 2019",Completed,Observational
977,22-5307,Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease,November 2022,July 2025,Not yet recruiting,Interventional
978,CEP0431/2018 arm 2,LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2),"September 30, 2019",September 2023,Recruiting,Interventional
979,REG-028-2021,Multimodal Pain Treatment for Breast Cancer Surgery - a Prospective Cohort Study,"April 19, 2021","April 19, 2023",Recruiting,Observational
980,MA-BC-II-035,Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer,"October 1, 2022","December 31, 2026",Enrolling by invitation,Interventional
981,F2017000 (UAB 17112),Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer,"September 6, 2019","December 30, 2024",Recruiting,Interventional
982,22040,Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer,"April 7, 2020","June 7, 2025",Recruiting,Interventional
983,CTMS 17-0037,Imipramine on ER+ve and Triple Negative Breast Cancer,"July 5, 2019",March 2023,"Active, not recruiting",Interventional
984,D0816R00025,Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer,"May 30, 2020","September 30, 2022",Completed,Interventional
985,201801559A3,Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer,"November 12, 2018","October 24, 2020",Unknown status,Observational
986,MedOPP238,POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer,"March 16, 2022","March 16, 2022",Withdrawn,Interventional
987,BTCRC-BRE19-409,"Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer","February 12, 2021",January 2025,Recruiting,Interventional
988,2020-0342,Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer,"April 30, 2023","December 31, 2024",Not yet recruiting,Interventional
989,25IB-0023,Exercise Study for Breast Cancer Survivors,"November 25, 2019",December 2020,Unknown status,Interventional
990,919PP18,Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO),"October 29, 2019","June 28, 2022",Completed,Interventional
991,18-002,A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy,"May 23, 2018",May 2024,"Active, not recruiting",Interventional
992,CMTNCMB,Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test,"May 14, 2019","March 1, 2021",Unknown status,Observational
993,ZYYY-BC-001,Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer,"September 1, 2022",December 2024,Recruiting,Interventional
994,CAAE: 82691818.0.0000.5154,Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.,"May 13, 2018","December 20, 2019",Unknown status,Interventional
995,2022/0226,Risk Factors for Shoulder Joint Motion Restriction,"August 15, 2022","February 15, 2024",Not yet recruiting,Observational
996,PMD-026-1-001,Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer,"November 14, 2019",March 2024,"Active, not recruiting",Interventional
997,SYSUCC-011,Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer,"October 10, 2018","October 30, 2020",Terminated,Observational
998,18432,Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease,"March 4, 2019","July 31, 2023","Active, not recruiting",Interventional
999,2020-KY-140,Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer,"October 14, 2020","December 14, 2030",Recruiting,Interventional
1000,2020-KY-125,Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer,"September 9, 2020","September 9, 2024",Recruiting,Interventional
1001,CRE2018013,Effects of Exercise Training at Different Timeline on Shoulder Dysfunction After Breast Cancer Modified Radical Mastectomy,"September 10, 2018","May 31, 2020",Completed,Interventional
1002,RS1637/21,Single-cell RNAseq Breast Cancer,"December 14, 2021","December 31, 2024",Recruiting,Observational
1003,SPHIC-TR-BCa2022-02,A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction,"January 10, 2023","September 1, 2028",Recruiting,Interventional
1004,SURVIVE,Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer,"December 7, 2022",December 2035,Recruiting,Interventional
1005,SYSUCC-008,Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer,"January 1, 2018","July 30, 2018",Completed,Interventional
1006,S64752,Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer,"January 22, 2021","June 24, 2022",Completed,Observational
1007,20201101.2,"Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer","April 30, 2021","April 30, 2025",Not yet recruiting,Interventional
1008,2020-KY-125,Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer,"September 9, 2020","September 9, 2024",Recruiting,Interventional
1009,CDR0000643461,Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.,September 2020,September 2021,Unknown status,Observational
1010,4352,Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions,"January 1, 2019","December 1, 2020",Unknown status,Interventional
1011,IRB_00137018,A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors,"March 24, 2021","January 1, 2024",Recruiting,Interventional
1012,OSU-21065,Impact of Dietary Inflammatory Potential on Breast Cancer Risk,"March 1, 2022","December 31, 2024",Not yet recruiting,Observational
1013,MCC-19765,Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases,"January 30, 2019","January 14, 2024","Active, not recruiting",Interventional
1014,20-1866.cc,Promoting Informed Choice for Breast Cancer Screening,"August 7, 2020",August 2025,Recruiting,Observational
1015,IB 2015-01,High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study,"June 7, 2018",January 2021,Unknown status,Interventional
1016,2022-0353,Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors,"January 12, 2023","May 31, 2025",Recruiting,Interventional
1017,2018/TMC/133/IRB/31,One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer,"March 26, 2019","March 26, 2029",Recruiting,Interventional
1018,LCCC 1931,LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+),"March 12, 2020","June 15, 2025","Active, not recruiting",Interventional
1019,ENDO-RESIST,Determinants of Acquired Endocrine Resistance in Metastatic Breast Cancer: A Pilot Study,"February 4, 2019","December 31, 2022",Recruiting,Observational
1020,BRE 354,A Study of U3-1402 in Subjects With Metastatic Breast Cancer,"May 3, 2021","November 30, 2023",Recruiting,Interventional
1021,EORTC QLQ BR45,Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer,"June 14, 2019","December 17, 2021",Completed,Observational
1022,21-325,Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries),"September 21, 2022","September 21, 2023",Recruiting,Observational
1023,A5481167,Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea,"December 20, 2021","June 30, 2023","Active, not recruiting",Observational
1024,4-2018-0264,Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16),April 2022,May 2023,Not yet recruiting,Interventional
1025,SYSUCC-017,Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer,"March 21, 2022","October 1, 2024",Recruiting,Interventional
1026,2016-0537,Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer,"January 29, 2018","January 1, 2026","Active, not recruiting",Interventional
1027,CCR4884,PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer,"August 11, 2020","July 1, 2024",Recruiting,Interventional
1028,IR-1.1,Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway,"February 2, 2021","February 2, 2027",Not yet recruiting,Interventional
1029,MEN1611-01,MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer,"July 19, 2018","July 31, 2022","Active, not recruiting",Interventional
1030,A5481145,"A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer","May 24, 2021","February 22, 2022",Completed,Observational
1031,20-5215.0,An Impact Assessment of a Culturally Tailored Online Psychosocial Program for Chinese Immigrant Women With Breast Cancer,"October 1, 2020",December 2022,Recruiting,Interventional
1032,SGNTUC-028,A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer,"March 7, 2022","June 30, 2027",Recruiting,Interventional
1033,UW16151,Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy,"January 29, 2018",August 2023,Recruiting,Observational
1034,STU-2022-0385,Real-time Intraoperative Breast Cancer Visualization for Margin Assessment,"February 18, 2020","January 31, 2024",Recruiting,Interventional
1035,Concordance,Concordance Between Liquid and Tissue Biopsy,"July 1, 2020",December 2022,Recruiting,Observational
1036,IMAP-CM,Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material,"May 21, 2021","March 13, 2022",Completed,Interventional
1037,BC-RWS,Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer,"December 10, 2022","January 1, 2024",Not yet recruiting,Interventional
1038,69HCL21_1085,Evaluation of the Diagnostic Performance of a Bra Prototype to Detect Breast Cancer,"March 30, 2023","August 30, 2023",Recruiting,Interventional
1039,C4891001,A Study to Learn About a New Medicine Called ARV-471 (PF-07850327) in People Who Have Advanced Metastatic Breast Cancer.,"March 3, 2023","May 15, 2028",Recruiting,Interventional
1040,SYSUCC-020,"Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.","October 3, 2022","April 1, 2025",Recruiting,Interventional
1041,1234,Monitoring of Chronic Conditions in Breast Cancer,"June 15, 2022","June 15, 2028",Recruiting,Observational
1042,BreastctDNA01,Breast Cancer Liquid Biopsy Stratification,"October 1, 2018",October 2023,"Active, not recruiting",Observational
1043,SGNTUC-025,A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer,"December 1, 2020","October 31, 2025",Recruiting,Interventional
1044,KOTK/2022/12550,Patient-centered Breast Cancer Teleprehabilitation,"January 30, 2023","August 31, 2024",Recruiting,Interventional
1045,SRB_201808_163,Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE),"February 25, 2019","January 30, 2029",Recruiting,Interventional
1046,3-2021-0026,"Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)","May 1, 2021","March 30, 2027",Not yet recruiting,Interventional
1047,BC-P26,Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer,"August 1, 2019","January 31, 2020",Completed,Interventional
1048,SCHBCC-N029,Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer,"May 1, 2020","April 1, 2025",Recruiting,Interventional
1049,AIRC IG-23118,Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer,"July 31, 2021",March 2029,Recruiting,Interventional
1050,21-159,ATEMPT 2.0: Adjuvant T-DM1 vs TH,"June 16, 2021","May 1, 2028",Recruiting,Interventional
1051,D8532C00001,A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease,"January 28, 2021","February 1, 2029",Recruiting,Interventional
1052,TMS01190510,Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels,"September 6, 2019","June 30, 2021",Completed,Interventional
1053,PUMCH-MIRC213,99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer,"September 7, 2022","December 31, 2023",Recruiting,Interventional
1054,1752/20,Local Therapy for ER/PR-positive Oligometastatic Breast Cancer,"April 1, 2021","April 1, 2031",Recruiting,Interventional
1055,RG1121129,"Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial","January 5, 2022","November 10, 2022",Completed,Interventional
1056,SBMASTER,The MASTER Study (MAmmary Cancer STatin ER Positive Study),"January 4, 2021","January 1, 2035",Recruiting,Interventional
1057,SMC 2020-11-051,Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study,"March 12, 2021","December 30, 2025",Recruiting,Interventional
1058,6037248,Using a Blood Test to Monitor Metastatic Breast Cancer Treatment,"April 1, 2023",April 2026,Not yet recruiting,Observational
1059,2016-A01344-47,Adapted Physical Activity for Breast Cancer HER2 Positive Patient,"April 27, 2018","August 31, 2024",Recruiting,Interventional
1060,1807187-2,Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE),"September 18, 2018",June 2025,Recruiting,Interventional
1061,21-123,Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer,"October 8, 2021","October 8, 2024",Recruiting,Interventional
1062,Ketogenic Diet,Effects of Ketogenic Diet in Overweight and Obese Women With Breast Cancer,"January 30, 2022","January 30, 2025",Not yet recruiting,Interventional
1063,TJ-IRB20211128,Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer,"December 31, 2021","December 31, 2026",Recruiting,Observational
1064,20-172,Taking AIM at Breast Cancer,"August 13, 2021","June 15, 2026",Recruiting,Interventional
1065,Lilly-I3Y-US-I026,Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer,"April 21, 2022",June 2023,Recruiting,Interventional
1066,FNF201830,Health-promoting Lifestyle in a Genetic Counseling Clinic,"November 13, 2019","March 4, 2022",Completed,Observational
1067,N-20180090,Analgesic Effect of Resistance Training for Breast Cancer Survivors,"August 10, 2020","September 23, 2021",Completed,Interventional
1068,A231901CD,Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions,"January 15, 2021",January 2027,Recruiting,Interventional
1069,UC-BCG-2103,Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk,"October 12, 2022",November 2034,Recruiting,Interventional
1070,I236,CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer,"October 17, 2018","December 31, 2023","Active, not recruiting",Interventional
1071,D0816C00018,To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.,"January 17, 2018","October 8, 2021",Completed,Interventional
1072,CMUH108-REC1-113,Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients,"May 18, 2020","July 31, 2023",Recruiting,Interventional
1073,PRO00028602,Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer,"March 17, 2021",August 2024,Recruiting,Interventional
1074,2019-7-Non-NSU Health,Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts,"February 8, 2019","December 31, 2021",Completed,Interventional
1075,ALT-P7,"Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients","January 11, 2018","January 15, 2021",Completed,Interventional
1076,PRO00028925,"Fulvestrant+Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer","February 25, 2021","December 1, 2026",Recruiting,Interventional
1077,HUB-PSI-CAMAD,Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression,"May 10, 2022","June 29, 2022",Terminated,Interventional
1078,DRLCOLCT001,"Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-","April 19, 2021","August 19, 2022",Recruiting,Observational
1079,GCO 17-1585,Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer,"January 30, 2019","May 29, 2020",Terminated,Interventional
1080,K160913J,Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer,"April 1, 2019",January 2027,"Active, not recruiting",Interventional
1081,131916,Financial Toxicity in Breast Cancer Surgery,"July 18, 2022","February 1, 2025",Recruiting,Observational
1082,REP0121,To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer,"April 19, 2022",July 2024,Withdrawn,Interventional
1083,BC-CIH-H-RWS,H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study,"January 23, 2022","August 23, 2024",Recruiting,Interventional
1084,YDPLD191016-I1-SYSU-001,Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients,"February 7, 2021","June 30, 2023",Recruiting,Observational
1085,LCCC1820,Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer,"June 1, 2020","September 7, 2020",Withdrawn,Interventional
1086,AMCI-001,PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer,"May 7, 2019",December 2023,Recruiting,Interventional
1087,IRB15-1005,Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer,November 2018,June 2019,Withdrawn,Interventional
1088,22/409-3611,Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients,"October 25, 2022","October 25, 2030",Recruiting,Interventional
1089,SYSEC-KY-KS-2022-056,Study on the Correlation Between the Quantitative Parameters of Mr Mean Cell Size Imaging and the Histopathological Characteristics of Breast Cancer,"May 11, 2022","July 1, 2023",Not yet recruiting,Interventional
1090,FDRT-BC016,Neoadjuvant Radiation in Locally Advanced Breast Cancer,"March 1, 2021",December 2025,Recruiting,Interventional
1091,Genetic study and TDM,Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen,"September 1, 2019",December 2020,Unknown status,Observational
1092,2019.046,Lifestyles and Breast Cancer,"May 29, 2020",December 2024,Recruiting,Interventional
1093,Fukui-2019-1,Exercise Post-Diagnosis of Breast Cancer,"August 28, 2019","September 1, 2026",Recruiting,Interventional
1094,UPCC 10117,"Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer (""GLACIER"")","February 26, 2019","November 12, 2019",Withdrawn,Interventional
1095,GC101-21K177,Study on TIL for the Treatment of Advanced Breast Cancer,"November 19, 2021","December 20, 2024",Recruiting,Interventional
1096,RF-2016-02363686,Tomosynthesis as Primary Test for Breast Cancer Screening,"July 15, 2019","June 30, 2026",Recruiting,Interventional
1097,2021-0768,A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer,"April 1, 2022","August 20, 2026",Recruiting,Interventional
1098,2020-0708,"Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study","July 23, 2021","April 1, 2026",Recruiting,Interventional
1099,A5481136,Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region,"October 1, 2021","August 31, 2022",Recruiting,Observational
1100,4-2020-1453,"Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing (MUTATION2)",July 2021,December 2022,Not yet recruiting,Interventional
1101,TILS001 trial,Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS,"July 25, 2022","September 30, 2027",Not yet recruiting,Interventional
1102,V3002401,Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer,"October 12, 2021","April 30, 2023","Active, not recruiting",Interventional
1103,2020-004696-41,Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy,"February 24, 2022",February 2025,Recruiting,Interventional
1104,BR01/02/21,"Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor",January 2022,August 2025,Not yet recruiting,Interventional
1105,69HCL16_0536,Facilitate and Sustain Return to Work After Breast Cancer,"May 21, 2021",December 2023,Recruiting,Observational
1106,20-347,"A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer","January 11, 2021","September 1, 2030",Recruiting,Interventional
1107,SCBCG-006,A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients,"July 25, 2018","December 31, 2028",Recruiting,Interventional
1108,S1709-101-888,Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer,"June 29, 2018","December 30, 2022","Active, not recruiting",Interventional
1109,21-600,Early Intervention,June 2023,"June 30, 2025",Not yet recruiting,Interventional
1110,LCCC2241,Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer,March 2023,"December 8, 2023",Not yet recruiting,Observational
1111,6010121027,Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy,"March 29, 2021","September 25, 2023",Recruiting,Interventional
1112,MA-BC-II-020,Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer,May 2021,December 2025,Not yet recruiting,Interventional
1113,FDRT-BC008,Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer,"September 1, 2018","October 30, 2028",Recruiting,Interventional
1114,YLiu,Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer,July 2021,"December 31, 2022",Recruiting,Observational
1115,2018-A02191-54,Needs Assessment After Cancer in Patients Treated for Breast Cancer,"December 1, 2018","February 1, 2019",Completed,Observational
1116,ICO 13-001,Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer,"July 5, 2018","February 5, 2023","Active, not recruiting",Interventional
1117,ARV-471-mBC-102,"ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer","September 8, 2022",February 2024,Recruiting,Interventional
1118,NL68820.091.19,Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance,"August 2, 2021",December 2023,Recruiting,Interventional
1119,FS-1502-III1-01,FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer,"March 31, 2023","January 31, 2026",Not yet recruiting,Interventional
1120,114,The Effect of Reiki on Symptom Control and Quality of Life in Breast Cancer Patients,"February 1, 2023","August 31, 2023",Not yet recruiting,Interventional
1121,IIT2018-17-McArthur-TCDRT,"Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer",July 2022,July 2027,Withdrawn,Interventional
1122,NCC2493,Radiotherapy for Extracranial Oligometastatic Breast Cancer,"April 6, 2021","April 30, 2026",Recruiting,Interventional
1123,38341220.8.0000.0072,"Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery","March 4, 2021","December 31, 2026",Recruiting,Interventional
1124,2018-A01128-47,EMDR Psychotherapy for Anxious-depressive Symptoms in Breast Cancer Patient,"November 5, 2018","February 5, 2026",Recruiting,Interventional
1125,CH-BC-059,A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）,"August 9, 2018","October 30, 2023",Enrolling by invitation,Interventional
1126,GRACE,GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer,"October 1, 2022","January 1, 2024","Active, not recruiting",Interventional
1127,2020-154,Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema,"February 22, 2021",February 2028,Recruiting,Interventional
1128,20 KHCC 91,SBRT for Breast Cancer Oligometastases,"June 1, 2020","June 1, 2026",Recruiting,Interventional
1129,LRP/PegGCSF/2016/004,Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer,"March 6, 2018","January 9, 2019",Completed,Interventional
1130,IIT-CRM2020001,Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature,"March 8, 2022",November 2025,Recruiting,Interventional
1131,20-505,A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer,"April 21, 2021",January 2025,Recruiting,Interventional
1132,SYSUCC-019,"Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial","August 1, 2022","December 1, 2024",Recruiting,Interventional
1133,275078,Digitally Distributed Yoga for Women Treated for Breast Cancer,"October 1, 2021","October 1, 2028",Recruiting,Interventional
1134,Neo-ACT,Physical Exercise During Preoperative Chemotherapy for Breast Cancer,"November 9, 2022",December 2027,Recruiting,Interventional
1135,CA209-929,"Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients","February 14, 2018","May 29, 2019",Terminated,Interventional
1136,New theory(Tamoxifen&retinoic),"Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.",August 2021,December 2021,Not yet recruiting,Interventional
1137,CTO-IUSCC-0715,Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs,"February 17, 2020","August 9, 2022",Completed,Interventional
1138,IIT-0026,Prognostic Indicators for Radiation-induced Breast Fibrosis,April 2023,December 2026,Not yet recruiting,Observational
1139,Neo-program 2021.02.23,Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment,"December 16, 2022","April 30, 2024",Recruiting,Interventional
1140,IIT-2017-NeoPACT,Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer,"September 4, 2018",November 2024,"Active, not recruiting",Interventional
1141,SP0048722,Optimizing Quality of Life in Women Living With Metastatic Breast Cancer,"April 24, 2019","March 8, 2021",Completed,Interventional
1142,CLEE011ABR02,Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer,"March 23, 2021","October 29, 2021",Completed,Observational
1143,GO42784,"A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physicians Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)","August 27, 2021","November 21, 2033",Recruiting,Interventional
1144,145314,Safety and Efficacy of Ga68 Αvβ3 IAC PET/CT for Diagnosis and Clinical Management in Angiogenic Breast Cancer Patients,"August 30, 2022","August 30, 2024",Not yet recruiting,Interventional
1145,REaCT-70,Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer,"August 19, 2021",September 2024,Recruiting,Interventional
1146,07102022_SR,Consciousness-based Ayurveda Lifestyle Program for Improving Quality of Life in Survivors of Breast Cancer,"September 1, 2022","June 1, 2023","Active, not recruiting",Interventional
1147,RadiaAce001,The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients,"July 14, 2021",October 2022,Recruiting,Interventional
1148,ARV-471-mBC-101,A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer,"August 5, 2019",February 2024,Recruiting,Interventional
1149,20-0140-A,MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study,"September 1, 2021","July 1, 2022",Withdrawn,Interventional
1150,2021000247,"Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer.","December 15, 2021",December 2032,Recruiting,Interventional
1151,1216-4-011,Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients,"January 15, 2021","July 5, 2022",Completed,Interventional
1152,GIM24-PALBO-BP,Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy,"July 16, 2019","July 31, 2023",Recruiting,Interventional
1153,EUBREAST-01,Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST,"January 13, 2021",December 2028,Recruiting,Interventional
1154,BTCRC-BRE16-042,"Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients","January 29, 2018","September 1, 2024",Recruiting,Interventional
1155,Glnz87?,The Effect of Guided Imagery Based on the Health Promotion Model on the Quality of Life in Breast Cancer Patients,"February 1, 2022","November 15, 2022",Completed,Interventional
1156,TVD-101-002B,Study of TTI-101 in Combination for Participants With Metastatic Hormone Receptor (HR)-Positive and Human Epidermal Receptor 2 (HER2)-Negative Breast Cancer,"January 9, 2023",February 2025,Recruiting,Interventional
1157,D9673R00004,"Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status","May 28, 2021","April 26, 2022",Completed,Observational
1158,IBISCO Trial,Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer,"January 1, 2023","December 31, 2026",Recruiting,Interventional
1159,SYSEC-KY-KS-2019-055-001,MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02),"May 28, 2019","May 30, 2025",Recruiting,Observational
1160,SYSEC-KY-KS-2019-099,Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy,"January 1, 2019","July 1, 2019",Completed,Observational
1161,18-115,Physiotherapy Program for Breast Cancer Women Following Surgery: A Pilot Clinical Trial,"September 1, 2018","February 1, 2021",Completed,Interventional
1162,201808046,Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma,"August 30, 2018","March 22, 2026","Active, not recruiting",Interventional
1163,IC 2021-08,Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment,"February 17, 2023","November 13, 2024",Recruiting,Interventional
1164,NBC Che001,Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy,"July 13, 2021","November 6, 2022",Completed,Interventional
1165,6222/22.03.2017,Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer,"October 1, 2018","October 1, 2019",Unknown status,Interventional
1166,18-217,Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job,"June 7, 2018",June 2023,Recruiting,Interventional
1167,AI Yoga Study on Facebook - 1,Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors,"September 4, 2018","October 19, 2018",Completed,Interventional
1168,ONC-010,EndoPredict® Extended Endocrine Trial (EXET),"July 2, 2019","March 31, 2022",Terminated,Observational
1169,CSPC-KAL-BC-16,Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer,"November 20, 2019","September 20, 2022",Unknown status,Interventional
1170,21-161,A Study of Attention and Memory Processes in Breast Cancer Survivors,"May 6, 2021",May 2024,Recruiting,Observational
1171,TT420X2101,Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer,"January 8, 2019","December 30, 2021","Active, not recruiting",Interventional
1172,OMERIC-1904,Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer,"September 8, 2020",September 2023,Recruiting,Interventional
1173,CTO-IUSCCC-0781,Exercise in Metastatic Breast Cancer: EMBody,March 2023,December 2027,Not yet recruiting,Interventional
1174,178-2018,Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy,"October 1, 2019","September 1, 2022",Recruiting,Observational
1175,ACE-Breast-06,ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases,"July 14, 2021","June 30, 2023",Recruiting,Interventional
1176,UPCC 15121,Breast Cancer Outreach Among Primary Care Patients,"October 25, 2021","April 25, 2022",Completed,Interventional
1177,CHLOBREASTASP,"Breast Cancer Active Surveillance, Alternative Option, Aspirin Included","June 1, 2018","May 31, 2023",Not yet recruiting,Interventional
1178,202207198RINB,Can ILR Reduce the Risk of Arm Lymphedema?,"February 14, 2023",August 2028,"Active, not recruiting",Interventional
1179,OMC2018/01,Implementing Patients´ Competence in Oral Breast Cancer Therapy,March 2020,December 2021,Unknown status,Observational
1180,NEXT-BRCA,Implementing Exercise Into Clinical Practice in Breast Cancer Care,"October 3, 2019","December 31, 2023","Active, not recruiting",Interventional
1181,REaCT-Wellness,A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer,"August 19, 2022",July 2026,Recruiting,Interventional
1182,CLEE011AFR01,Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France,"December 15, 2022","June 28, 2027",Recruiting,Observational
1183,AB PoC 2021 RUS,Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast Cancer,"June 16, 2021","December 31, 2021",Recruiting,Observational
1184,Versión 4- 20/09/2020,Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors,"September 1, 2020","December 1, 2021",Completed,Interventional
1185,HS-10352-102,A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer,"January 12, 2022","December 31, 2025",Recruiting,Interventional
1186,578-21-FB,Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy,"March 2, 2022","September 1, 2031",Recruiting,Interventional
1187,LPM-008,The LightPath® and 68Ga-RM2 in Breast Cancer Study,"November 30, 2018",November 2023,Not yet recruiting,Interventional
1188,2019.444,Fibrotic Focus in Breast Cancer,"December 1, 2019","November 30, 2023",Not yet recruiting,Observational
1189,MedOPP167,Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients,"April 30, 2019","March 31, 2021",Terminated,Interventional
1190,BCSPilot01,A Combined Exercise Training Program for Women Living With Breast Cancer,"February 1, 2023","August 30, 2023",Not yet recruiting,Interventional
1191,IRB00048455,Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone,"January 31, 2019",October 2023,Recruiting,Observational
1192,DATOS-20220624-ASJF-Efecto car,Cardioprotective Effect of Acute Exercise in Breast Cancer Patients,"January 23, 2023",October 2024,Recruiting,Interventional
1193,2022-009,Thero2-01S22 in HER2-positive Breast Cancer,"May 15, 2023","May 15, 2027",Not yet recruiting,Interventional
1194,1107210020,Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer,"September 17, 2020","February 15, 2022",Completed,Observational
1195,FZPL-Ⅲ-303,A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physicians Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation,"July 13, 2020","June 30, 2025",Recruiting,Interventional
1196,NSABP FB-13,Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer,"October 22, 2018","January 30, 2021",Completed,Interventional
1197,SYSUCC 019,Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients,"June 15, 2022","December 31, 2025",Recruiting,Interventional
1198,CCR5654,"Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer","July 21, 2022","August 31, 2023",Enrolling by invitation,Observational
1199,107CS-6,Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer,"July 25, 2018",April 2022,Unknown status,Interventional
1200,KCT 005,"A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery","June 1, 2021","December 31, 2021",Recruiting,Interventional
1201,DFP22-0020,Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer,March 2023,August 2024,Not yet recruiting,Interventional
1202,BRE 381,Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer,March 2023,July 2026,Not yet recruiting,Interventional
1203,2014CB543202-03,Acupuncture for Breast Cancer Related Lymphedema,November 2019,April 2021,Unknown status,Interventional
1204,G1T28-212,"Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer","November 19, 2021","March 13, 2023",Completed,Interventional
1205,PI-2021-3,Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer,"August 2, 2021","May 1, 2024",Recruiting,Interventional
1206,2021-KY-124-001,Aesthetic Outcomes of Oncoplastic Breast Surgery for Breast Cancer in the Upper Inner Quadrant,"January 18, 2022",November 2022,Recruiting,Interventional
1207,SCHBCC-NO28,Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer,"April 21, 2020","April 30, 2030",Recruiting,Interventional
1208,2022-YXZX-YX-08,Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis,"April 1, 2023","August 31, 2025",Not yet recruiting,Observational
1209,NCKUH SLNB,The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients,"May 20, 2021",December 2022,"Active, not recruiting",Observational
1210,ID-RCB 2022-A01488-35,Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI,May 2023,May 2027,Not yet recruiting,Interventional
1211,CCM 1505,Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer,"March 24, 2022",June 2024,Recruiting,Interventional
1212,C4891006,TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A),"February 23, 2023","June 12, 2027",Recruiting,Interventional
1213,MA-BC-Ⅱ-021,Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer,"March 25, 2021","December 31, 2022",Recruiting,Interventional
1214,042110,CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage,"April 6, 2022","November 28, 2027","Active, not recruiting",Interventional
1215,UKM14_0016,Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography,"July 5, 2018","March 31, 2025","Active, not recruiting",Interventional
1216,PER.CIN.BN.95.III,Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer,"August 11, 2018","May 27, 2020",Completed,Interventional
1217,21-5021,Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN),"September 22, 2021","December 1, 2024",Recruiting,Interventional
1218,2021-0840,Acupuncture for Psychoneurological Symptoms Among Breast Cancer Survivors,"November 1, 2021","May 31, 2025","Active, not recruiting",Interventional
1219,OV-121,Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP,"June 20, 2018",May 2023,"Active, not recruiting",Interventional
1220,RJBC-HFRNI,Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment,"February 21, 2019",December 2027,Recruiting,Interventional
1221,CTRIAL-IE 17-13,Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer,"November 12, 2019","November 2, 2020",Terminated,Interventional
1222,FDRT-BC017,Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer,"September 20, 2021",August 2027,Recruiting,Interventional
1223,2018-0601,Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women,"July 15, 2019","March 31, 2023",Recruiting,Interventional
1224,19-005860,Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors,"April 1, 2021","December 30, 2023","Active, not recruiting",Observational
1225,BC-09638,GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.,"March 21, 2022","March 1, 2027",Recruiting,Interventional
1226,2020-495,Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer,"September 20, 2020","September 20, 2027",Recruiting,Interventional
1227,A231701CD,Increasing Patients Engagement in Breast Cancer Surgery Decision-Making,"March 1, 2019","December 15, 2023","Active, not recruiting",Interventional
1228,00005038,Family History and Breast Cancer Education Trial,"April 1, 2021","September 30, 2022",Completed,Interventional
1229,OSU-22013,Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer,"June 13, 2022","October 31, 2025",Recruiting,Interventional
1230,D967JC00002,A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer,"December 17, 2020","August 10, 2023","Active, not recruiting",Interventional
1231,LB1802,Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer,"July 22, 2019",March 2024,Recruiting,Observational
1232,18/028,"Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer","September 25, 2019",December 2024,Recruiting,Interventional
1233,WO40324,"A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer","June 14, 2018","November 16, 2023","Active, not recruiting",Interventional
1234,CLEE011A2206,"Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.","August 29, 2018","December 11, 2024","Active, not recruiting",Interventional
1235,20-151,Refining Local-Regional Therapy for IBC,"June 2, 2021","December 1, 2027",Recruiting,Interventional
1236,2020(55),Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer,"March 1, 2021","October 30, 2030",Recruiting,Interventional
1237,I-3364822,Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer,"May 1, 2023","February 28, 2029",Not yet recruiting,Interventional
1238,CASE3118,Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer,"January 14, 2019",September 2023,"Active, not recruiting",Interventional
1239,m-VCAP1,Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer,"January 1, 2022",June 2023,Recruiting,Interventional
1240,CS003-BC,Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer,"March 1, 2022","June 30, 2023",Recruiting,Interventional
1241,ML39208,A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment,"June 12, 2018","April 19, 2019",Completed,Interventional
1242,19-133,An Online Research Study: BrainHealth in Breast Cancer Survivors,"June 1, 2022","June 1, 2024",Recruiting,Interventional
1243,H-43432,Sitravatinib in Metastatic Breast Cancer,"September 22, 2021","January 3, 2023",Terminated,Interventional
1244,Contralateral Screening,Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer,"May 1, 2022","January 31, 2026",Recruiting,Observational
1245,HCRN BRE18-334,"Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer","August 24, 2021","January 31, 2034",Recruiting,Interventional
1246,Geneplus2020BC01,ctDNA Monitoring in Early Breast Cancer,"November 29, 2019",June 2024,Recruiting,Observational
1247,2007-206-1145,"Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer","May 1, 2022","January 31, 2026",Not yet recruiting,Observational
1248,AC699-001,Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer,"December 29, 2022","December 31, 2024",Recruiting,Interventional
1249,2020-010,Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer,"December 15, 2021","December 15, 2029",Recruiting,Observational
1250,20140299,Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases,"March 19, 2018","December 3, 2021",Completed,Interventional
1251,ACT16105,Phase 2 Study of Amcenestrant (SAR439859) Versus Physicians Choice in Locally Advanced or Metastatic ER-positive Breast Cancer,"October 22, 2019","September 29, 2023","Active, not recruiting",Interventional
1252,2020-07-064-002,Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors,"October 26, 2020","December 31, 2021",Completed,Interventional
1253,STUDY-20-01174,Increasing Breast Cancer Screening in Chinese Immigrants,"July 1, 2021","December 13, 2022",Completed,Interventional
1254,UC-BCG-2204,Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer,"May 1, 2023","May 1, 2026",Not yet recruiting,Interventional
1255,MD-127-2019,Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study),"March 1, 2020","April 30, 2022",Unknown status,Interventional
1256,ICO-N-2019-04,[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers,"June 11, 2020","July 21, 2021",Completed,Interventional
1257,2019.629,Artificial Intelligence in Mammography-Based Breast Cancer Screening,"July 1, 2020","June 30, 2024",Recruiting,Observational
1258,2020-005722-28,Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer,"May 11, 2021","June 11, 2026",Recruiting,Interventional
1259,TMZ-TNBC,Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC),"April 1, 2023","December 1, 2027",Not yet recruiting,Interventional
1260,RJBC-SHF RNI,Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer,"December 1, 2020","December 30, 2026",Recruiting,Interventional
1261,PYHOPE-BC-104,Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer,"June 3, 2021","May 31, 2024",Recruiting,Interventional
1262,UW17107,ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer,"November 13, 2018","February 13, 2021",Terminated,Interventional
1263,EORTC-1617-QLG-BCG,Follow-up in Early and Locally Advanced Breast Cancer Patients,"October 14, 2020",April 2023,"Active, not recruiting",Observational
1264,SAMuhammad,Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt,December 2018,December 2020,Unknown status,Interventional
1265,HREBA.CC-21-0429,Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy,"October 20, 2022","June 30, 2023",Recruiting,Interventional
1266,ShantouCH02,Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index,"August 1, 2021","December 30, 2024",Recruiting,Interventional
1267,202201100,A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors,"October 14, 2022","January 31, 2024",Recruiting,Interventional
1268,SIM-1907-02-SERD-101,"Phase I Study to Evaluate SCR-6852 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer","May 18, 2022","September 8, 2025",Recruiting,Interventional
1269,KCSG BR19-15,T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer,"December 19, 2019","July 31, 2020",Unknown status,Observational
1270,PekingUPH10B003,Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients,"March 28, 2021","December 31, 2026",Recruiting,Interventional
1271,2020-AHL-001,"Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer",May 2023,"September 1, 2025",Not yet recruiting,Interventional
1272,19-586,Prolonged Nightly Fasting in Breast Cancer Survivors,"July 24, 2020","July 5, 2022",Completed,Interventional
1273,CTMS# 19-0028,Effects of Creatine Supplementation in Breast Cancer Survivors,"September 30, 2020",September 2024,Recruiting,Interventional
1274,2/108/7,What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?,"May 2, 2018",June 2019,Unknown status,Interventional
1275,LQ006,Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer,"April 19, 2019","December 31, 2021",Unknown status,Interventional
1276,Metastatic Breast Cancer,"Τreatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer","January 31, 2019","January 31, 2024",Recruiting,Observational
1277,YOUNGBC-17,Real-world Study of UTD1 in Chinese Advanced Breast Cancer,"April 1, 2022","May 1, 2023",Recruiting,Observational
1278,ABLE02,A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer,"June 24, 2020",June 2024,Recruiting,Interventional
1279,2017-0071,"Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer","August 20, 2018","December 31, 2024","Active, not recruiting",Interventional
1280,NL63209 041 18,MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer,"March 4, 2019",November 2031,Withdrawn,Interventional
1281,MCC-21-BRE-54,"Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer","February 18, 2022",October 2036,Recruiting,Interventional
1282,GE-280-401,Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients,"January 5, 2023","October 2, 2025",Recruiting,Observational
1283,2019-A02195-52,Immunomonitoring of Breast Cancer Patients During Systemic Treatment,"May 26, 2020","May 26, 2024",Recruiting,Interventional
1284,IRB00158622,Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings,"November 11, 2018","December 30, 2020",Completed,Interventional
1285,EOC202A1101,Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer,"October 16, 2018","December 25, 2021",Completed,Interventional
1286,HUM00140468,Acupressure for Pain and Opioid Use Among Breast Cancer Patients,"September 17, 2018","October 17, 2019",Terminated,Interventional
1287,CER2021,"Prevalence of Lymphedema in Valle Del Cauca, Colombia.","January 18, 2018","December 31, 2021","Active, not recruiting",Observational
1288,MCC-19-15740,Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters),"March 1, 2021","December 31, 2024",Recruiting,Interventional
1289,IIT-0005,Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting,"August 28, 2019",September 2021,Unknown status,Interventional
1290,IB 2017-05,Brief Intervention for Tobacco and Alcohol Risk Reduction for Couple During Breast Cancer Treatment.,August 2019,August 2022,Unknown status,Interventional
1291,K180603J,Advanced MR Techniques for Breast Cancer Detection,July 2019,July 2024,Withdrawn,Interventional
1292,NL58040.091.16,Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance,"February 19, 2018","July 31, 2019",Terminated,Interventional
1293,NEO-01,OA for Breast Cancer NAC Response,"March 30, 2021","January 4, 2023",Completed,Interventional
1294,CLEE011A3201C,Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer,"February 25, 2019","March 15, 2023","Active, not recruiting",Interventional
1295,Shengjing-LCG004,Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT,"July 19, 2021","November 30, 2026",Recruiting,Interventional
1296,SYSU-CSCO-2020,Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and Pertuzumab,"February 1, 2020","February 1, 2025",Not yet recruiting,Interventional
1297,2014CB543202-02,Warm Acupuncture for Breast Cancer Related Lymphedema,"January 18, 2018","December 26, 2020",Completed,Interventional
1298,2019-09-023,Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial,"July 1, 2020","June 30, 2025",Not yet recruiting,Interventional
1299,MD 134/2022,Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy,September 2022,December 2023,Not yet recruiting,Observational
1300,18-2562.cc,Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey,"October 30, 2019",June 2024,Recruiting,Interventional
1301,LUN_DBT_121,"Multi-Reader, Multi-Case, Cross-Over, Retrospective Study to Evaluate Effectiveness of Lunit INSIGHT DBT","March 22, 2022","February 28, 2023",Recruiting,Observational
1302,A5481093,A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib),"March 1, 2024","April 30, 2024",Not yet recruiting,Observational
1303,s63338,The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot Study,"June 5, 2021","January 31, 2022",Completed,Interventional
1304,99mTc- RM26,Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26,"February 1, 2021","June 1, 2023",Enrolling by invitation,Interventional
1305,On4Rehab Pilot Trial,Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-based,"May 1, 2021","September 30, 2021",Completed,Interventional
1306,GO 22/41,Reliability and Validity of The 6 Minute Pegboard and Ring Test in Patients With Breast Cancer,"March 1, 2022","November 30, 2022",Completed,Observational
1307,2019-KY-049,Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer,"July 17, 2019","July 6, 2022",Unknown status,Interventional
1308,2019/00283,A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors,"November 1, 2020","December 31, 2022",Recruiting,Observational
1309,NCC2129,Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer,"December 28, 2019","January 30, 2023",Unknown status,Interventional
1310,PROTECT,Prospective Surveillance for Breast Cancer-Related Lymphedema,"January 4, 2021",December 2024,Recruiting,Interventional
1311,IRB18-0970,A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer,"February 18, 2019",December 2025,Recruiting,Interventional
1312,001,Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer,"February 20, 2022","December 20, 2024",Not yet recruiting,Interventional
1313,AAAT4412,Breast Elasticity Imaging During Neoadjuvant Chemotherapy,"June 14, 2021",January 2024,Recruiting,Interventional
1314,07068-02,Oxygen Partial Pressure After Breast Cancer Surgery,"February 23, 2023","June 1, 2024",Recruiting,Observational
1315,SHR-A1811-III-306,SHR-A1811 Versus Investigators Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial,"May 30, 2023","June 30, 2026",Not yet recruiting,Interventional
1316,MedOPP168,"Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer","April 30, 2019","March 2, 2022",Terminated,Interventional
1317,ATOS-Z-201,(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer,"February 14, 2023",July 2025,Recruiting,Interventional
1318,CFT / sp123,A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer,"December 1, 2023","May 31, 2025",Not yet recruiting,Interventional
1319,SBU-PCWRT-BREAST,Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer,"July 15, 2022",August 2029,Recruiting,Interventional
1320,I239,CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer,"December 19, 2019","December 31, 2022","Active, not recruiting",Interventional
1321,PI20/596,"Long-term Outcomes After Breast Cancer Liver Metastasis Surgery: an European, Retrospective, Snapshot Study","March 15, 2021","July 31, 2021",Unknown status,Observational
1322,REO 028,A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study,"June 10, 2020",July 2024,"Active, not recruiting",Interventional
1323,OBU-BC-II-079,Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer,January 2023,July 2024,Not yet recruiting,Interventional
1324,200277,Focused Ultrasound and Gemcitabine in Breast Cancer,"January 27, 2022",January 2025,Recruiting,Interventional
1325,EC/2017/0200,Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.,"January 1, 2018","December 31, 2023",Recruiting,Interventional
1326,99mTc-DARPinG3 breast cancer,99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast Cancer With Metastatic Lymph Nodes Before Targeted Therapy,"December 20, 2022","December 1, 2023",Enrolling by invitation,Observational
1327,CFT/sp123,"A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer",September 2019,"February 28, 2021",Withdrawn,Interventional
1328,ANLO-BC,Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer,"March 22, 2022","October 1, 2024",Recruiting,Interventional
1329,20200628GD,Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer,"July 8, 2020","July 31, 2022",Unknown status,Interventional
1330,MA-BC-II-026,Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC),"July 10, 2022","December 31, 2026",Not yet recruiting,Interventional
1331,LQ007,Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer,"April 19, 2019","December 31, 2021",Unknown status,Interventional
1332,RFTMBCPW,Fulvestrant in Metastatic Breast Cancer,"August 1, 2018","October 1, 2021",Unknown status,Interventional
1333,D9268C00001,"A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigators Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)","October 18, 2021","August 15, 2025","Active, not recruiting",Interventional
1334,BCD-178-2,Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer,"January 30, 2023","January 31, 2026",Recruiting,Interventional
1335,FDRT-BC012,Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer,"January 1, 2021","December 31, 2026",Recruiting,Interventional
1336,ET17-203 DISCO,Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer,"May 18, 2018","September 23, 2022",Completed,Interventional
1337,CA209-7A8,A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer,"October 18, 2019","July 27, 2021",Completed,Interventional
1338,2103254164,Pioglitazone Therapy Targeting Fatigue in Breast Cancer,"December 23, 2021",April 2023,Recruiting,Interventional
1339,HNCH-BC008,Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer,"September 28, 2021",September 2028,Recruiting,Interventional
1340,KY20192081-F-1,Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer,"August 21, 2019","August 21, 2022",Unknown status,Interventional
1341,2021.240,Effectiveness of Mobile Messenger-initiated Reminder on Biannual Mammography Adherence in Breast Cancer Screening,"June 1, 2022","May 31, 2024",Not yet recruiting,Interventional
1342,YOUNGBC-16,MammaPrint Value for Pre-menopausal Breast Cancer Patients,"July 15, 2022","July 15, 2024",Recruiting,Observational
1343,2021-1201,3D Printed Breast Models in the Surgical Management of Breast Cancer,"July 31, 2023","February 28, 2027",Not yet recruiting,Interventional
1344,KC19EESI0325,Real-time Interactive Digital Healthcare System in Post Operation Patients With Breast Cancer; Pilot Study,"October 21, 2019","April 27, 2020",Completed,Interventional
1345,SHR6390-Ib/II-201,A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer,"March 22, 2018","June 30, 2022","Active, not recruiting",Interventional
1346,1711-048-898,Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer,"March 23, 2018","December 31, 2022",Recruiting,Interventional
1347,HERMIONE-10,Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer,"March 22, 2021",March 2023,Recruiting,Observational
1348,Luminal A sirt1,Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis,"January 1, 2019","December 30, 2020",Unknown status,Observational
1349,UC-0140/1711 - UCBG3-06,Study on Androgen Receptor and Triple Negative Breast Cancer,"March 14, 2018","July 20, 2022",Completed,Interventional
1350,SCBCG-022,A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients,"June 15, 2018","June 15, 2023",Not yet recruiting,Observational
1351,EVER-132-002,Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC),"November 23, 2020",March 2024,"Active, not recruiting",Interventional
1352,S2010,"Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study","March 29, 2023","May 1, 2028",Recruiting,Interventional
1353,RSRB00066846,"A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer","July 5, 2018","July 1, 2022",Completed,Interventional
1354,AC682-001,A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer,"November 12, 2021",September 2023,Recruiting,Interventional
1355,YOUNGBC-24,Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer,"November 1, 2021","July 1, 2024","Active, not recruiting",Observational
1356,16-007764,Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography,"September 1, 2018","April 30, 2019",Withdrawn,Interventional
1357,N19MIM,Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial,"March 23, 2021","May 1, 2030","Active, not recruiting",Interventional
1358,22-002857,"Assessment of the Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Systemic Therapy and Surgery, UTMOST Trial","June 1, 2023","October 1, 2024",Not yet recruiting,Observational
1359,SYSU005,Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation,"June 16, 2021","June 1, 2025",Recruiting,Interventional
1360,IRB-59141,Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer,"February 23, 2023",March 2024,Recruiting,Interventional
1361,18-8214-BO,Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer,"June 12, 2019","February 19, 2020",Completed,Interventional
1362,HR-BLTN-001,Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC,March 2019,December 2020,Unknown status,Interventional
1363,MC200302,"Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study","June 9, 2021","May 15, 2025",Recruiting,Observational
1364,UMCC 2018.016,The ConnectedCancerCare Pilot Study (CCC),"August 8, 2018","August 30, 2019",Completed,Interventional
1365,18-621,Tucatinib + Abemaciclib + Herceptin for HER2+ MBC,"June 28, 2020","September 22, 2020",Withdrawn,Interventional
1366,2021-A03091-40,Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer,"February 1, 2023","June 1, 2026",Not yet recruiting,Interventional
1367,PLATO study,PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate,"November 8, 2019","December 31, 2028",Recruiting,Interventional
1368,2018-05-0155,Improving Brain Function After Breast Cancer Study,"September 28, 2018","January 30, 2020",Completed,Interventional
1369,YOUNGBC-6,Real World Study of Lapatinib Among Metastatic Breast Cancer Patients,"January 10, 2019","May 20, 2020",Completed,Observational
1370,DokuzEU.Com.Garments,COMPRESSION GARMENTS in BREAST CANCER-RELATED LYMPHEDEMA,"March 30, 2019","August 29, 2019",Completed,Observational
1371,STOP-BC Trial,Sulindac and Breast Density in Women at Risk of Developing Breast Cancer,"November 20, 2020",February 2027,Recruiting,Interventional
1372,Pro00088926,Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer,"May 7, 2019","December 31, 2022","Active, not recruiting",Interventional
1373,B00157,A Pilot Study of Ultrasound-guided Vacuum-assisted Excision of Breast Cancers,"June 25, 2018","May 31, 2021",Completed,Observational
1374,TP.102.17.22.PAR,Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection,"March 9, 2023","November 30, 2024",Recruiting,Interventional
1375,SMX 18001,Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,"September 20, 2019",February 2024,"Active, not recruiting",Interventional
1376,AABCSR,Stress Reactivity Among African American Breast Cancer Survivors,"October 19, 2018","July 20, 2021",Completed,Observational
1377,Fudan University,NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy,"July 3, 2018","September 1, 2021",Unknown status,Interventional
1378,ZN-c5-002,A Study of ZN-c5 in Participants With Breast Cancer,"January 3, 2020","May 25, 2021",Completed,Interventional
1379,A5481166,Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan,"April 20, 2022","June 30, 2024","Active, not recruiting",Observational
1380,CALORIE,Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy,"February 1, 2019","February 1, 2021",Unknown status,Interventional
1381,4-2020-1131,Talazoparib Maintenance Therapy in Triple-negative Breast Cancer,March 2021,"March 1, 2024",Not yet recruiting,Interventional
1382,TEBICA002,Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells,"August 1, 2019","February 1, 2022",Completed,Interventional
1383,145358,"A Phase I/II Multicenter, Open-Label Study of Lu-177-αvβ3-IAC, for the Treatment of Angiogenic Breast Cancer Patients.","January 30, 2023","August 30, 2024",Not yet recruiting,Interventional
1384,NRG-BR008,Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer,"March 13, 2023","February 1, 2037","Active, not recruiting",Interventional
1385,D081CC00012,LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS),"March 7, 2023","December 14, 2026",Recruiting,Observational
1386,CWCD118B12201,Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer,"September 15, 2023","July 18, 2029",Not yet recruiting,Interventional
1387,P.T.REC/012/002968,RESISTANCE VERSUS AEROBIC EXERCISES ON Breast Cancer Patients,"December 12, 2020","April 1, 2021",Unknown status,Interventional
1388,EFC15935,Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer,"October 14, 2020","December 29, 2023","Active, not recruiting",Interventional
1389,202202045MIPA,Olaparib Maintenance Therapy in Metastatic Breast Cancer,"December 12, 2022","December 31, 2025",Recruiting,Interventional
1390,LCCC 1639,"Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC","November 28, 2018","October 11, 2019",Terminated,Interventional
1391,IIT-2021-ASSET,Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer,"March 28, 2022",June 2024,Recruiting,Interventional
1392,S-detect 2019,Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer,"January 1, 2019","January 1, 2021",Completed,Observational
1393,BC-NEO-IIT-SHR6390,SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.,"August 2, 2021","March 31, 2023",Completed,Interventional
1394,A5481154,Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole,"February 3, 2021","November 30, 2025","Active, not recruiting",Observational
1395,GDWCH-001,Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer,"November 1, 2021","December 30, 2024",Not yet recruiting,Interventional
1396,21090645,Omega-3 and Vitamin D Supplementation in Breast Cancer Women,"April 20, 2022","December 30, 2022",Recruiting,Interventional
1397,22-07025006,Diabetes Care for Breast Cancer Patients,"February 21, 2023",December 2026,Recruiting,Interventional
1398,AHQU-2021004,Acupuncture for Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast Cancer,"October 20, 2021","June 1, 2023",Recruiting,Interventional
1399,SMC-2018-10-062,Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer,"April 22, 2019","March 30, 2021",Completed,Interventional
1400,20-1434.cc,Cancer Patient Perspectives During COVID-19,"August 24, 2020",June 2023,"Active, not recruiting",Observational
1401,ABY-025-MI301,A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer,"August 22, 2018","November 1, 2025",Recruiting,Interventional
1402,Tmab-TK006-102b,Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases,May 2018,May 2019,Unknown status,Interventional
1403,IFOM-CPO007/2019/PO006,A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer,"July 16, 2020",December 2026,Recruiting,Observational
1404,Ahead-BC-20170323,Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer,"March 15, 2018","March 15, 2020",Unknown status,Interventional
1405,Pro00107216,The Effect of Intermittent Fasting on Body Composition in Women With Breast Cancer,"December 2, 2021",August 2023,Withdrawn,Interventional
1406,FMSU2017-002B,Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study,"April 6, 2018","August 31, 2018",Completed,Observational
1407,B2017-11,Neoadjuvant Goserelin for Triple Negative Breast Cancer,March 2018,March 2023,Unknown status,Interventional
1408,2019-A01592-55,Transcutaneous Breast Cancer Diagnosis by Canine Odorology,"February 3, 2020","March 30, 2024",Suspended,Interventional
1409,STUDY00003282,Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer,"September 22, 2021",May 2025,"Active, not recruiting",Interventional
1410,P20CA217199-9492018,A Community Dance Intervention Engaging Breast Cancer Survivors in a Middle-income Country,"March 1, 2019","August 31, 2020",Completed,Interventional
1411,2022-0651,The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts,"December 5, 2022","December 31, 2027",Recruiting,Observational
1412,MINERVA,Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management,"April 27, 2022",April 2026,Recruiting,Interventional
1413,SCBCG-021,A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients,"June 15, 2018","June 15, 2023",Not yet recruiting,Observational
1414,2019/044,Evaluation of the Effect of Mediterranean Diet on Breast Cancer Patients,"October 22, 2019","January 20, 2021",Completed,Interventional
1415,114421,Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care,"November 5, 2018","November 16, 2020",Completed,Interventional
1416,AMC2020-17,Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy Intervention,"July 1, 2018","September 1, 2019",Completed,Interventional
1417,HREBA.CC 19-0363,Rise Up After Breast Cancer,"January 1, 2020","August 31, 2020",Completed,Interventional
1418,YOUNGBC-10,Pyrotinib Plus Vinorelbine in HER2+ Metastatic Breast Cancer Patients,"May 15, 2018","May 15, 2021",Completed,Observational
1419,H20-03123,Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.,"March 15, 2021","December 31, 2023",Recruiting,Interventional
1420,18-004803,Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes,"October 30, 2018","December 1, 2019",Terminated,Interventional
1421,18-0234,The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors,"April 1, 2019","August 31, 2020",Completed,Interventional
1422,EA1183,"Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study","April 2, 2020","August 31, 2027",Recruiting,Interventional
1423,SYS-C-201801-5010,Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer,"May 1, 2018","May 1, 2030",Recruiting,Interventional
1424,CLIN-52014-452,Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment,"June 9, 2022","July 30, 2024",Recruiting,Observational
1425,CLAG525B2101,"A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer","July 2, 2018","November 24, 2021",Completed,Interventional
1426,CABC - Kreftfor project - SEB,Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions,"January 15, 2021","December 31, 2035",Recruiting,Interventional
1427,CSPC-KAL-AE-01,Real-world Study for the Safety of Albumin-Bound Paclitaxel in Recurrent or Metastatic Breast Cancer,September 2019,February 2022,Unknown status,Observational
1428,ZN-c5-003,A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer,"November 12, 2020","October 24, 2022",Completed,Interventional
1429,Radiodermatitistalita60,The Use of Photobiomodulation in the Management of Radiodermatitis in Breast Cancer Patients,November 2022,August 2024,Not yet recruiting,Observational
1430,CSIIT-C21,A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer,"July 10, 2022","July 10, 2024",Not yet recruiting,Interventional
1431,15-017,Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer,"September 10, 2018",July 2022,Unknown status,Interventional
1432,M14ABC,"A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients","May 15, 2018","July 1, 2022",Terminated,Interventional
1433,20201540,Prospective Evaluation of Targeted Axillary Dissection (TAD),"March 1, 2022",March 2025,Recruiting,Interventional
1434,MEDOPP447,Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer,"May 15, 2022",October 2024,Withdrawn,Interventional
1435,34615/4/21,The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer,"June 10, 2021","November 5, 2022",Completed,Interventional
1436,YXH2022ZX02167,Neoadjuvant Effect of Albumin Binding Paclitaxel Compared With Common Paclitaxel in Breast Cancer：an Observational Single Center Study of Clinical Efficacy in Adjuvant Chemotherapy,"November 4, 2022","June 16, 2025",Recruiting,Observational
1437,MEDOPP367,Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status,"February 22, 2022","February 28, 2024",Recruiting,Observational
1438,GE-226-004,Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer,December 2023,December 2024,Not yet recruiting,Interventional
1439,HSEARS20210816002,The Effects of a Nurse-led mHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy,"June 7, 2022","February 28, 2023",Recruiting,Interventional
1440,LACOG 0419,Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer,"January 12, 2021","August 23, 2029",Recruiting,Interventional
1441,21-06023682,"De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You","January 12, 2022","December 31, 2028",Recruiting,Observational
1442,201708076,Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer,"January 10, 2018","June 26, 2019",Completed,Interventional
1443,HRS-8080-I-101,A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults,"February 17, 2022","July 31, 2025",Enrolling by invitation,Interventional
1444,TWT-203,"CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer","May 27, 2022",August 2025,Recruiting,Interventional
1445,CHB18.04,Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer,"October 16, 2018","January 14, 2022",Completed,Interventional
1446,BOOG 2018-01,Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study,"February 27, 2019","May 1, 2032","Active, not recruiting",Interventional
1447,NCCH1607,"PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY","February 9, 2018",April 2025,"Active, not recruiting",Interventional
1448,WO42312,"A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physicians Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)","November 27, 2020","November 27, 2023","Active, not recruiting",Interventional
1449,RCVDBCIIR005,Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer,"March 1, 2023","August 31, 2024",Not yet recruiting,Interventional
1450,201805027RSA,East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction,"October 18, 2018",July 2028,Recruiting,Observational
1451,2022-0431,A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC),"June 30, 2023","March 29, 2024",Not yet recruiting,Interventional
1452,KY20222062-C-1,"Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer","November 1, 2022","December 31, 2023",Not yet recruiting,Interventional
1453,IRB-2022-348,Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery,"July 15, 2022","September 10, 2023",Not yet recruiting,Interventional
1454,CO41101,A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.,"November 25, 2019","February 28, 2023",Completed,Interventional
1455,CBYL719C1201,Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer,"November 20, 2020","October 2, 2027",Recruiting,Interventional
1456,SYSA1802-CSP-006,A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC),"October 1, 2021","October 1, 2023",Recruiting,Interventional
1457,NL69081.041.19,The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY Trial,"August 28, 2019","September 1, 2023",Recruiting,Interventional
1458,2021P002871,Optimizing Functional Recovery of Breast Cancer Survivors,"August 28, 2019","March 31, 2023","Active, not recruiting",Interventional
1459,STUDY00018504,"Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer","December 12, 2018","December 31, 2026",Recruiting,Interventional
1460,99mTc-DARPinG3,99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy,"May 1, 2022","January 31, 2023",Completed,Observational
1461,SCHBCC-N034,Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D),"July 1, 2021","June 30, 2026",Not yet recruiting,Interventional
1462,KY2022-097-B,CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer,April 2023,"December 30, 2028",Not yet recruiting,Observational
1463,SYSEC-KY-KS-2019-054-001,Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01),"May 28, 2019","January 1, 2025",Recruiting,Observational
1464,KY2019-023,Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer,"June 18, 2019",November 2026,"Active, not recruiting",Interventional
1465,D926XC00001,A Study of Dato-DXd With or Without Durvalumab Versus Investigators Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03),"November 28, 2022","March 27, 2030",Recruiting,Interventional
1466,IRFMN-BRC-7103,Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer,"March 5, 2018","July 25, 2023","Active, not recruiting",Interventional
1467,4469,PIK3CA in HER2+ BC and pCR Trial,"May 2, 2022","September 1, 2023","Active, not recruiting",Interventional
1468,CCR5316,A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer,"March 30, 2022","September 1, 2030",Recruiting,Interventional
1469,NHP,Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer,"March 1, 2021","February 28, 2023",Unknown status,Interventional
1470,S2020-300-01,Sonazoid Contrast-enhanced Ultrasound in Assessing Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer Patients.,"August 1, 2020",December 2021,Unknown status,Observational
1471,JU 2020/1732-51,Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer,"September 1, 2020","December 31, 2023","Active, not recruiting",Interventional
1472,BL-M02D1-101,A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors,"May 20, 2022",May 2024,Recruiting,Interventional
1473,STU00216520,Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia,"January 19, 2023","November 30, 2026",Recruiting,Interventional
1474,20805,BATs in Patients With Breast Cancer and Leptomeningeal Metastases,"February 26, 2019","December 14, 2021",Terminated,Interventional
1475,STUDY00000675,Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer,"July 16, 2021","December 31, 2024",Recruiting,Interventional
1476,BC2,A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer,"February 20, 2019","December 20, 2025",Not yet recruiting,Interventional
1477,ICO-2020-25,Imaging Performance Assessment of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Metastatic Triple Negative Breast Cancer Patients,"September 21, 2021",June 2024,Recruiting,Interventional
1478,NICSO-GINSENG,American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients,"November 29, 2018",August 2020,Unknown status,Interventional
1479,YO41137,"A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer","February 5, 2020","November 11, 2025","Active, not recruiting",Interventional
1480,PUMCH-BC500,Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer,"April 25, 2019",March 2025,Recruiting,Observational
1481,ATADEK-2018 / 9,KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery,"September 3, 2018","August 5, 2019",Completed,Interventional
1482,ONA-XR-103,Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer,"December 2, 2022","April 30, 2026","Active, not recruiting",Interventional
1483,PELICAN-IPC 2015-016,Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer,"July 24, 2018","April 30, 2025",Recruiting,Interventional
1484,2022-0315,Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer,"February 9, 2023","December 31, 2032",Recruiting,Interventional
1485,ADIGYN,Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer,"January 20, 2021",September 2030,Recruiting,Interventional
1486,201900115B0,Evaluation of the Effects of the Couple-based Family Nursing for Women With Breast Cancer,"March 14, 2019","January 7, 2020",Completed,Interventional
1487,NSABP FB-12,Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling,"May 14, 2018","October 30, 2023",Recruiting,Interventional
1488,Soh-Med-22-05-24,Dosimetric Comparison of Three Radiation Techniques for Hypofractionated Whole Breast Radiotherapy in Early Breast Cancer,"July 20, 2022","August 1, 2025",Not yet recruiting,Observational
1489,KCSG BR19-13,High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx),"February 11, 2020",February 2025,Recruiting,Interventional
1490,CO40016,"A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer","January 6, 2018","January 4, 2023",Completed,Interventional
1491,CTFSp161,Personalised Disease Monitoring in Metastatic Breast Cancer,"May 8, 2019","January 31, 2030",Recruiting,Observational
1492,RJBC1901,Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer,"September 9, 2019","April 30, 2020",Terminated,Interventional
1493,HRS-1358-I-101,A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer,"February 7, 2023","June 30, 2025",Enrolling by invitation,Interventional
1494,AAAS2359,Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition,"January 25, 2020","January 25, 2021",Unknown status,Interventional
1495,2021-A02664-37,Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.,"May 27, 2022",October 2024,Recruiting,Interventional
1496,RTM 2015,Microwave Radiometry for the Diagnosis and Monitoring of Breast Cancer,September 2019,February 2020,Withdrawn,Observational
1497,UW22095,Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer,"November 16, 2022",November 2025,Recruiting,Interventional
1498,HREBA.CC-18-0657,Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer,"April 23, 2019","December 31, 2023",Enrolling by invitation,Interventional
1499,FILBLAU1022,Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy,May 2023,December 2024,Not yet recruiting,Interventional
1500,BC-IIT-SHR6390-FMTN,A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.,"May 26, 2021","September 30, 2023","Active, not recruiting",Interventional
1501,38RC19.362,Feasibility Study on the Characterization of the Immune Profile of Young Patients After Treatment for Breast Cancer,"June 15, 2020",November 2021,Unknown status,Observational
1502,Breast-Chi-2022,Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor,"July 10, 2019","August 1, 2022",Recruiting,Observational
1503,HMPL-012-SPRING-R101,An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer,"July 1, 2022",July 2025,Recruiting,Interventional
1504,CBYL719C2303,"Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-postitive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.","November 29, 2021","September 23, 2026",Recruiting,Interventional
1505,YOUNGBC-19,Chidamide in Combination With Abemaciclib and Fulvestrant in Breast Cancer Patients Previously Treated With Palbociclib,"July 1, 2022","May 1, 2023",Recruiting,Interventional
1506,ADG106-T6002,"A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer","May 19, 2022",February 2030,Recruiting,Interventional
1507,D20148,Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI),"August 13, 2021",September 2024,Recruiting,Interventional
1508,07-2021/EK OUSA,Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery,"November 1, 2021","December 1, 2023",Not yet recruiting,Interventional
1509,2019000486,"Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer","December 30, 2020",June 2025,"Active, not recruiting",Interventional
1510,ShandongCHI-08,Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients,"September 20, 2018","September 20, 2019",Unknown status,Observational
1511,US-MAM,The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.,"April 1, 2020","March 31, 2023",Recruiting,Observational
1512,TRIO036,"Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer","August 25, 2020","July 4, 2022",Completed,Interventional
1513,MD.22.07.674,Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients,"March 1, 2022","December 15, 2023",Recruiting,Interventional
1514,NCC2167,Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine,"April 1, 2020","December 31, 2023",Recruiting,Interventional
1515,VICC BREP 1898,Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer,"July 18, 2019",July 2024,"Active, not recruiting",Interventional
1516,Breast PTC,Postoperative Identification of Tumor Cells at the Lumpectomy Site of Patients With Early Breast Cancer,"August 17, 2021","August 30, 2026",Suspended,Interventional
1517,P0268,Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients,"January 1, 2018","August 20, 2018",Completed,Observational
1518,2107239-9,Reverse Triple Negative Immune Resistant Breast Cancer,"June 30, 2022",March 2023,Recruiting,Interventional
1519,173-18-CA,Perioperative Mindfulness Proposal,"July 31, 2019","December 31, 2023",Recruiting,Interventional
1520,Velocity,Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer,"March 1, 2022","August 28, 2023",Recruiting,Interventional
1521,CAPRICE-IPC 2020-053,A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr,March 2023,December 2027,Not yet recruiting,Interventional
1522,LV,"Breast Cancer, Omics, and Precision Medicine",January 2022,December 2023,Not yet recruiting,Interventional
1523,H-1905-141-1035,Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer,"February 18, 2020","December 31, 2025",Recruiting,Interventional
1524,UW 18-526,The Effect of Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy,"March 26, 2019","October 31, 2020",Completed,Interventional
1525,RJBC1801,Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer,"April 1, 2019",October 2022,Recruiting,Interventional
1526,CBYL719C2202,"Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant","April 6, 2022","May 10, 2023","Active, not recruiting",Interventional
1527,Alpha-Lipoic Acid,Alpha-Lipoic Acid in Breast Cancer Patients,"March 1, 2019","October 30, 2020",Completed,Interventional
1528,EUBREAST-2 INDAX,Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy,"January 1, 2021","December 31, 2029",Withdrawn,Interventional
1529,EF 160,Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer,"October 30, 2020","June 30, 2025",Recruiting,Interventional
1530,NSABP FB-14,Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer,"May 3, 2019","June 30, 2024","Active, not recruiting",Interventional
1531,PUMCH-BC503,Evaluation of Prognostic Monitoring for Young Breast Cancer Patients,"April 25, 2019",March 2025,Recruiting,Observational
1532,TIPN in China,Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer,"August 23, 2019",December 2020,Unknown status,Observational
1533,EG017,To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.,"February 28, 2023","June 29, 2026",Not yet recruiting,Interventional
1534,I241,Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer,"January 27, 2023",June 2028,Recruiting,Interventional
1535,853.4,"Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer","February 18, 2019","December 31, 2019",Unknown status,Interventional
1536,ICON CA209-9FN,Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer,"January 21, 2018","May 11, 2027","Active, not recruiting",Interventional
1537,HCRN BRE20-468,"Ribociclib And Endocrine Treatment of Physicians Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer","September 13, 2022",December 2027,Recruiting,Interventional
1538,TOL2506A,Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer,"July 1, 2021","April 30, 2025",Recruiting,Interventional
1539,2019-A02500-57,Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol),"January 24, 2020","February 11, 2022",Completed,Interventional
1540,UTAR- 8068/000,A Systemic Approach to Study the Traditional Chinese Medicine as an Adjuvant Treatment in Breast Cancer Patients,"April 22, 2022",April 2024,Recruiting,Interventional
1541,201711073,"MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer","September 30, 2018","February 28, 2021",Withdrawn,Interventional
1542,AI-BMRI-S,Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast Cancer,"February 28, 2022","September 30, 2025",Recruiting,Observational
1543,1400,Tahini and Dermatitis in Breast Cancer,"May 8, 2021","July 15, 2021",Not yet recruiting,Interventional
1544,MOST Pain,Optimizing Psychological Treatment for Pain After Breast Cancer,"September 1, 2022","October 1, 2024",Recruiting,Interventional
1545,2021-04,Smart Bra for Diagnosing Breast Cancer,"April 19, 2022","November 19, 2022",Not yet recruiting,Interventional
1546,HRHB-CB001,"Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer","March 1, 2020","March 1, 2024",Not yet recruiting,Interventional
1547,SH APBI RISE,Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen for patIents With Favorable Risk breaSt cancEr,"March 1, 2022","March 31, 2027",Recruiting,Interventional
1548,E7389-M065-401,"A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer","March 28, 2018","June 28, 2019",Completed,Interventional
1549,1812850942,Telephone Support for Metastatic Breast Cancer Patients,"June 20, 2019","September 19, 2023","Active, not recruiting",Interventional
1550,UPCC 04119,BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy,"December 7, 2020",August 2024,Recruiting,Interventional
1551,Prix Ruban Rose/2020/FF-03,Multidisciplinary Care Pathway With Electronic Patient Reported Outcomes (ePRO) Post-operative Follow-up of Breast Cancer Surgery Complications to Optimize Patient Quality of Life,"July 25, 2022",July 2024,Recruiting,Interventional
1552,31052019,Implementation of a CDSS in Oncology Patients During COVID-19,"March 11, 2020","April 15, 2021",Completed,Interventional
1553,JCOG1919E,A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer,"January 21, 2021","June 30, 2025",Recruiting,Interventional
1554,852000,FES BPET-DBT in Newly Diagnosed Breast Cancer,April 2023,January 2026,Not yet recruiting,Interventional
1555,19-300,Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer,"August 30, 2019","August 30, 2024",Recruiting,Interventional
1556,HR-BLTN-003,Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer,"June 26, 2019","December 31, 2023","Active, not recruiting",Interventional
1557,L21-076,Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers,January 2024,June 2027,Not yet recruiting,Interventional
1558,2020-A00398-31,Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer,"November 19, 2021","May 31, 2026",Recruiting,Interventional
1559,SBU-SBRT-BREAST-NO-SX,Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery,"August 19, 2020","August 31, 2027","Active, not recruiting",Interventional
1560,BCT 2102,Tucatinib Together With Pembrolizumab and Trastuzumab,"March 7, 2023",September 2025,Recruiting,Interventional
1561,IUSCC-0680,Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors,"October 2, 2019","September 1, 2023",Recruiting,Interventional
1562,GBG105,"Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer","January 2, 2023",January 2027,Recruiting,Interventional
1563,AQUAFIT-2018,Water-based Versus Land-based Exercise for Breast Cancer Survivors,"September 1, 2020","April 30, 2023",Recruiting,Interventional
1564,Moderate Dose Omega-3,Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer,"February 5, 2018","March 1, 2021",Unknown status,Interventional
1565,A5481168,Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC,"June 2, 2022","November 30, 2022",Recruiting,Observational
1566,201900180,89Zr-atezolizumab PET Scan and Lobular Breast Cancer,"December 18, 2019","May 1, 2022",Terminated,Interventional
1567,GUMPTION,Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer,"February 1, 2021",January 2023,Recruiting,Interventional
1568,MA40,Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor,"December 1, 2020","December 31, 2026",Recruiting,Interventional
1569,Pro00104863,"Exercise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Breast Conservation Therapy for Women With Early Stage Breast Cancer",September 2021,September 2022,Withdrawn,Interventional
1570,RnaDx-BRV-BC- 01,RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy,"April 26, 2018","October 26, 2025",Recruiting,Interventional
1571,18-000718,"Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer Patients","November 28, 2018",November 2024,"Active, not recruiting",Interventional
1572,KN026-201,Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer,"December 31, 2019","December 31, 2025","Active, not recruiting",Interventional
1573,SGNTUC-016,A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer,"October 2, 2019","April 30, 2024",Recruiting,Interventional
1574,OCOG-2019-RHEAL,Hypofractionated LocoRegional Radiotherapy in Breast Cancer,"February 10, 2021","December 31, 2027",Recruiting,Interventional
1575,27600,Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer,"November 1, 2022","February 1, 2027",Recruiting,Interventional
1576,2021C0102,"Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer Survivors","January 18, 2022",April 2023,Recruiting,Observational
1577,KN026-208,Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer,"August 9, 2021","February 15, 2023",Recruiting,Interventional
1578,CSIIT-C10,Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors,"February 7, 2022","December 30, 2022",Not yet recruiting,Interventional
1579,CAAP CA,Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment,"January 30, 2019",February 2021,Unknown status,Interventional
1580,ZN-c5-001,A Study of ZN-c5 in Subjects With Breast Cancer,"December 8, 2018","December 22, 2022",Completed,Interventional
1581,MA-BC-II-018,"Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial","April 20, 2021","December 31, 2028",Recruiting,Interventional
1582,KY20223267-1,PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer,"January 1, 2020","December 31, 2023",Recruiting,Interventional
1583,NL74126.091.20,Adherence Improving Self-Management Strategy (AIMS) in Breast Cancer Patients Using Adjuvant Endocrine Treatment (AET),"December 13, 2020","December 31, 2022",Unknown status,Interventional
1584,20P.020,"Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer","December 21, 2020","January 1, 2024",Withdrawn,Interventional
1585,iOM-110393,Self-efficacy Coaching for Women With Breast Cancer,"March 16, 2018","November 22, 2018",Completed,Interventional
1586,JTU-6H-20211230001,Effect of the Axillary Lymphatic /Vein Reflux Ratio on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer,"December 1, 2021",March 2024,Recruiting,Observational
1587,2020-007,Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04),"September 29, 2020","September 6, 2021",Completed,Interventional
1588,SCHBCC-N041,SNF Platform Study of HR+/ HER2-advanced Breast Cancer,"December 30, 2022","December 1, 2026",Recruiting,Interventional
1589,LAE205INT3101,Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer,"February 18, 2022","December 30, 2024",Recruiting,Interventional
1590,201911047,Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer,"September 14, 2020","March 3, 2021",Terminated,Interventional
1591,RAD1901-308,Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer,"May 10, 2019",August 2024,"Active, not recruiting",Interventional
1592,HNCH-BC006,Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer,"September 18, 2020","December 31, 2023",Recruiting,Interventional
1593,CTO-IUSCCC-0758,Breast Cancer BRCA1 Carriers: a Pilot Study,"November 1, 2021","December 31, 2024",Withdrawn,Observational
1594,IOM-050371,Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line,"May 24, 2018","November 30, 2022",Completed,Interventional
1595,SHEPHERD-2021-2,Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis,"August 1, 2022",July 2026,Recruiting,Observational
1596,ICPS002/20,Radiofrequency Ablation (RFA) in Breast Tumors,"May 1, 2020","December 15, 2024",Recruiting,Interventional
1597,KCSG-BR18-13/TR-03,Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer,"December 3, 2019",December 2021,Unknown status,Interventional
1598,ICO-2020-28,Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases,"December 3, 2021",February 2024,Recruiting,Interventional
1599,FUSCC-T-sunflower,Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower),"November 1, 2022","March 1, 2026",Not yet recruiting,Interventional
1600,SPI-GCF-104,"Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer","March 11, 2020","June 30, 2025",Recruiting,Interventional
1601,ALTERBC008,A Phase Ⅱ Study of Anlotinib Combined With Tislelizumab and AT in the Neoadjuvant Treatment of Triple-negative Breast Cancer,"August 1, 2021","July 31, 2023",Recruiting,Interventional
1602,2019-0550,Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer,"August 9, 2019","September 27, 2026","Active, not recruiting",Interventional
1603,2017-004909-41,Prevention of Cardiac Dysfunction During Breast Cancer Therapy,"January 14, 2019","September 14, 2025","Active, not recruiting",Interventional
1604,CSIIT-C18,Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer,"August 18, 2021","September 18, 2023",Recruiting,Interventional
1605,IBIO-301,A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer,"March 18, 2018","September 22, 2023","Active, not recruiting",Interventional
1606,BTP-66732,"A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer",June 2022,"July 31, 2025",Not yet recruiting,Interventional
1607,1401,Grape Juice and Dermatitis in Breast Cancer,"May 8, 2021","July 15, 2021",Not yet recruiting,Interventional
1608,21-698,Alcohol and Breast Cancer (ABC) Trial,"August 9, 2022","August 31, 2024",Recruiting,Interventional
1609,05022020,FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS,"January 1, 2019","January 1, 2020",Completed,Observational
1610,CLOVER,Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer,"July 3, 2018","November 1, 2025",Recruiting,Interventional
1611,LOXO-PIK-21001,A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors,"May 11, 2022",May 2025,Recruiting,Interventional
1612,NOGGO B3,Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer,"July 17, 2018","October 1, 2032","Active, not recruiting",Observational
1613,DPMBC301,Compare the Efficacy and the Safety of Doxorubicin and Cyclophosphamide Followed by Taxotere Versus Doxorubicin and Cyclophosphamide Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer,"February 1, 2022",December 2024,Not yet recruiting,Interventional
1614,CSPC-KAL-BC-11,Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer,"November 20, 2019","June 20, 2021",Unknown status,Interventional
1615,21-225,A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery,"November 19, 2021",November 2025,Recruiting,Interventional
1616,IRB-2021-04,Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy,"December 22, 2022","June 1, 2026",Recruiting,Interventional
1617,2022JC-55,Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.,"August 1, 2022","July 31, 2027",Not yet recruiting,Interventional
1618,SYHX2011-001,A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer,"March 31, 2022","October 30, 2022",Not yet recruiting,Interventional
1619,HER2BRAIN,TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN),"October 1, 2021","September 30, 2025",Not yet recruiting,Interventional
1620,ET17-093 BreastImmune03,Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease,"July 2, 2019","December 1, 2023","Active, not recruiting",Interventional
1621,RJBC2001,"Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer","May 30, 2020","December 30, 2027","Active, not recruiting",Interventional
1622,BELIEVE@BC,Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer,"May 1, 2022","October 1, 2025",Not yet recruiting,Interventional
1623,GB491-005,A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer,"June 2, 2021","February 1, 2024",Recruiting,Interventional
1624,H-2009-079-1157,Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency,"May 25, 2021","May 10, 2025",Recruiting,Interventional
1625,012342QM,Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer,May 2019,April 2025,Not yet recruiting,Interventional
1626,IC 2020-20,Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy,"September 20, 2021",September 2024,Recruiting,Interventional
1627,GDWCH002(TNBC),ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer,"October 1, 2021","May 1, 2024",Not yet recruiting,Interventional
1628,HNCH-MBC10,A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer,"June 28, 2022","June 28, 2024",Not yet recruiting,Interventional
1629,HR-BLTN 015,A Multi-cohort Phase II Study of HER2-positive and Triple-negative Breast Cancer Brain Metastases.,"March 30, 2020","January 30, 2022",Unknown status,Interventional
1630,197520,Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer,"March 11, 2021","March 1, 2029",Recruiting,Interventional
1631,KA22053,The 24 Hour Effects of Remedial Exercises With and Without Compression Therapy on Breast Cancer-related Lymphedema,"May 16, 2022","December 10, 2022",Completed,Interventional
1632,AI-Breast-US,"Using Deep Learning Methods to Analyze Automated Breast Ultrasound and Hand-held Ultrasound Images, to Establish a Diagnosis, Therapy Assessment and Prognosis Prediction Model of Breast Cancer.","February 1, 2020","September 1, 2024",Recruiting,Observational
1633,HIFU202207,To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer,"September 1, 2022","December 30, 2024",Not yet recruiting,Interventional
1634,Twisted Pink Foundation,Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer,"September 2, 2021","July 1, 2031",Recruiting,Interventional
1635,18-195,Screening For BCRL In Targeted Therapy For Breast Cancer,"December 13, 2018","September 30, 2026",Recruiting,Observational
1636,SPY LNM 01,A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer,"January 4, 2019","September 28, 2020",Completed,Interventional
1637,HNCH-MBC12,Study of SHR-A1811 in HER2-positive Advanced Breast Cancer With Brain Metastases,"April 30, 2023","April 30, 2026",Not yet recruiting,Interventional
1638,1910208-9,Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer,"December 25, 2019","June 1, 2022",Recruiting,Interventional
1639,IKP275 / GBG91,Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients,"September 10, 2019","May 3, 2021",Completed,Interventional
1640,2021-0974,Time Restricted Eating During Chemotherapy for Breast Cancer,"August 1, 2022","March 1, 2026",Recruiting,Interventional
1641,1808189-7,Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer,"November 26, 2018","February 1, 2020",Unknown status,Interventional
1642,XJTU1AF-CRF-2020-006,Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer,"January 1, 2021","February 28, 2024",Recruiting,Interventional
1643,HORMONOVILLE,Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer,"June 25, 2019","August 27, 2021",Unknown status,Interventional
1644,ET17-057,Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer,"August 6, 2018",April 2024,Recruiting,Interventional
1645,60905722.0.0000.0072,Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy,"October 18, 2022","December 31, 2030",Recruiting,Interventional
1646,2022JC-55-1,Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.,"December 1, 2022","December 1, 2027",Not yet recruiting,Interventional
1647,1503144-7,"Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)","March 1, 2019","May 30, 2021",Unknown status,Interventional
1648,IRB00022667,Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening,May 2023,December 2025,Not yet recruiting,Interventional
1649,BOOG-2017-01,"Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.","June 15, 2019",August 2027,"Active, not recruiting",Interventional
1650,TOL2506A-EXT,"Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study","December 28, 2022",June 2028,Enrolling by invitation,Interventional
1651,GCC 1926,GammaPod Dose Escalation Radiation for Early Stage Breast Cancer,"September 15, 2021",December 2028,Recruiting,Interventional
1652,Pro00107615,TOPS for African American Breast Cancer Survivors,"June 11, 2021","August 30, 2022",Completed,Interventional
1653,Version 1.0_16.08.2021,TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes,"March 7, 2022",March 2032,Recruiting,Observational
1654,82071993,Assessment of Brain Cognitive Impairment in Breast Cancer,"May 31, 2022","May 30, 2027",Recruiting,Observational
1655,MUKDEN01,"Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial","July 27, 2020","December 30, 2026","Active, not recruiting",Interventional
1656,BO40747,A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer,"January 11, 2019","August 24, 2023","Active, not recruiting",Interventional
1657,2021-0532,Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy,"August 31, 2021","July 31, 2025",Recruiting,Observational
1658,BC-IIT-FMTN-SHR6390-ET,"Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer","December 8, 2021","January 30, 2026",Recruiting,Interventional
1659,QUILT-3.067,QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.,"March 16, 2018",January 2023,"Active, not recruiting",Interventional
1660,GO39869,"Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer","April 17, 2018","July 16, 2021",Completed,Interventional
1661,ShandongCHI-20,Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer,"August 1, 2021","July 31, 2024",Not yet recruiting,Interventional
1662,200218,Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design,"September 27, 2021",September 2024,Recruiting,Interventional
1663,P2100-SUR-S11,"Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer","September 10, 2021","June 1, 2026",Recruiting,Interventional
1664,FAVOR,"Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer","July 1, 2020","April 30, 2026",Not yet recruiting,Interventional
1665,2018-062,Reducing Metabolic Syndrome Among Breast Cancer Survivors,"November 6, 2018","September 13, 2020",Completed,Interventional
1666,TSL-CM-TSL1502-Ⅱ,A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations,"August 1, 2022","June 30, 2026",Not yet recruiting,Interventional
1667,17041,A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer,"November 28, 2018","September 20, 2023","Active, not recruiting",Interventional
1668,QL1701-002,"A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer","April 29, 2020",October 2023,"Active, not recruiting",Interventional
1669,R174-A11507-17-S52,Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression,March 2021,December 2022,Withdrawn,Interventional
1670,55516,Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety/Depression Levels in Breast Cancer,"January 5, 2022","July 29, 2022",Completed,Interventional
1671,21-018,A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer,"January 31, 2022",January 2024,Recruiting,Interventional
1672,2019-A02397-50,Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein),"February 22, 2021","August 22, 2023",Recruiting,Observational
1673,17249,A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body,"August 2, 2019","May 14, 2020",Completed,Interventional
1674,4-2018-0765,"Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients","June 10, 2019","October 30, 2023",Recruiting,Interventional
1675,Onkologikoa,PFMT Educational Intervention for Patients With Advancer Breast Cancer,"September 2, 2021","April 10, 2023",Recruiting,Interventional
1676,48347821.8.0000.5249,The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients,"June 2, 2022","December 2, 2023",Not yet recruiting,Interventional
1677,PRO00037175,Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer,"March 5, 2020","January 1, 2025",Recruiting,Interventional
1678,19-004343,"Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot","August 20, 2019","May 31, 2022",Enrolling by invitation,Interventional
1679,AL-2001,Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.,"March 1, 2021","November 1, 2025",Recruiting,Interventional
1680,YBCSG-22-08,Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions,"January 1, 2021","June 1, 2022",Completed,Observational
1681,GEICAM/2021-08,Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab,"July 1, 2023","March 1, 2029",Not yet recruiting,Interventional
1682,RSINETE,RWS of Inetetamab HER2 Positive Advanced Breast Cancer,July 2021,December 2021,Not yet recruiting,Observational
1683,kazuma,"To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study","July 1, 2021",September 2025,Recruiting,Interventional
1684,308-2017,Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer,"June 13, 2018",June 2028,Recruiting,Interventional
1685,AC682-002,A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer,"October 1, 2022",December 2024,Recruiting,Interventional
1686,MA-BC-II-007,Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer,January 2021,June 2025,Not yet recruiting,Interventional
1687,OBU-BC-II-086,"Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy",May 2023,December 2025,Not yet recruiting,Interventional
1688,D-FR-01070-003,Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer,"October 22, 2018","February 6, 2019",Terminated,Interventional
1689,MYBC,Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer,December 2021,December 2028,Not yet recruiting,Interventional
1690,1808189-8,Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer,"November 19, 2018","July 30, 2019",Unknown status,Interventional
1691,2017 0105,Health Benefits of HIT for Breast Cancer Patients,"May 1, 2019","December 31, 2019",Withdrawn,Interventional
1692,2022/0035983,The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa Project,"May 9, 2022",May 2024,Recruiting,Observational
1693,SCHBCC-NO27,Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients,"June 9, 2020","August 31, 2021",Unknown status,Interventional
1694,NCC-006461,Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer,"June 1, 2020","December 31, 2023",Recruiting,Interventional
1695,SCHBCC-N032,"Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer","October 15, 2021","October 15, 2024",Recruiting,Interventional
1696,OZM-103,A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer,February 2020,"June 9, 2020",Withdrawn,Interventional
1697,NCC2225,Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer,"September 23, 2020","July 11, 2023",Recruiting,Interventional
1698,UC-0109/1805,My Personalized Breast Screening,"July 18, 2019","December 31, 2025",Recruiting,Interventional
1699,Shandong CHI-11,Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer,January 2020,December 2024,Not yet recruiting,Interventional
1700,18-240,"Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer","July 13, 2018",July 2023,Recruiting,Observational
1701,BG01-2102,Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer,"January 15, 2023","December 31, 2025",Not yet recruiting,Interventional
1702,D8664R00002,Zoladex® 10.8 BC RWS,"January 6, 2022","February 28, 2024",Recruiting,Observational
1703,erector-spinae,Postoperative Analgesia in Breast Cancer Surgery: Safety and Efficiency of Ultrasound Guided Erector Spinae Plane Block,"December 17, 2018","June 30, 2019",Completed,Interventional
1704,000001,Reliability and Reproducibility of Bandaging in Breast Cancer,"January 1, 2020","December 30, 2021",Completed,Interventional
1705,IEO 0834/,CDH1 Germline Mutations in Lobular Breast Cancer,"December 1, 2018","June 30, 2023","Active, not recruiting",Observational
1706,OE861801,A Phase I Study of LX-039 Tablets,"January 7, 2020","July 19, 2023",Enrolling by invitation,Interventional
1707,ZDWY.XBZL.002,Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast Cancer,March 2022,September 2024,Not yet recruiting,Interventional
1708,19-886,RCT of CBD for Anxiety in Advanced Breast Cancer,"January 19, 2022","February 18, 2024",Recruiting,Interventional
1709,CIBI375Y008,"A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations","September 8, 2022","September 8, 2025",Recruiting,Interventional
1710,2020/482,"Supervised Exercise, Sleep in Patients With Non Metastatic Breast Cancer","April 8, 2021",August 2023,Recruiting,Interventional
1711,RP6530-2101,"Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients With Locally Advanced or Metastatic Breast Cancer","October 13, 2021",December 2022,"Active, not recruiting",Interventional
1712,TUXEDO-1,Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases,"July 28, 2020","July 28, 2023","Active, not recruiting",Interventional
1713,NL76658.029.21,Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer,"October 11, 2021",October 2023,Recruiting,Interventional
1714,2020/134,Analgesic Efficacy of Erector Spinae Plane Block After Breast Cancer Surgery,"September 1, 2018","March 3, 2021",Completed,Observational
1715,LB,Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer,"December 18, 2018","October 1, 2021",Unknown status,Interventional
1716,BO41843,"A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)","October 9, 2020","March 18, 2027",Recruiting,Interventional
1717,CSIIT-C34,Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer,"February 7, 2023","December 1, 2025",Recruiting,Interventional
1718,38406,Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery,"December 12, 2019","April 30, 2023",Recruiting,Observational
1719,OnkoFit I,Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer,"August 1, 2020","August 1, 2025",Recruiting,Interventional
1720,2017-IIT-HER2-Aspire,Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer,"October 15, 2018","October 15, 2025","Active, not recruiting",Interventional
1721,FACILE,FACILE: FeAsibility of First-line riboCIclib in oLdEr Patients With Advanced Breast Cancer,"December 27, 2018","November 27, 2025",Recruiting,Interventional
1722,270-2018,Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer,"August 30, 2018","August 30, 2024","Active, not recruiting",Observational
1723,SYHX2011-002,A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound),"May 1, 2023","September 1, 2024",Not yet recruiting,Interventional
1724,Shandong CHI-10,Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer,"October 25, 2019","December 31, 2024",Not yet recruiting,Interventional
1725,D967RC00001,"Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer","October 25, 2021","June 26, 2026",Recruiting,Interventional
1726,2020-0198,Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test,"August 18, 2022","December 31, 2028",Recruiting,Interventional
1727,0379520202023,Pain Neuroscience Education and Graded Exposure to Movement in Breast Cancer Survivors,"April 1, 2021","June 30, 2023",Recruiting,Interventional
1728,KM10B,Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physicians Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer,"December 15, 2018","June 30, 2022",Unknown status,Interventional
1729,HSEARS20180509004,Acupuncture for Joint Symptoms in Patients With Breast Cancer,"March 1, 2019","January 31, 2022",Terminated,Interventional
1730,SHR-1210-III-318,"A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.","July 14, 2020","January 1, 2024",Recruiting,Interventional
1731,CHD049-17,Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer,"February 20, 2018","May 15, 2020",Unknown status,Observational
1732,H21089,Breathing Exercise for Chronic Pain Management in Breast Cancer Survivors,"January 1, 2023","December 31, 2023",Not yet recruiting,Interventional
1733,IMMU-132-09,Study of Sacituzumab Govitecan-hziy Versus Treatment of Physicians Choice in Participants With HR+/HER2- Metastatic Breast Cancer,"May 8, 2019",October 2024,"Active, not recruiting",Interventional
1734,103089,"A ""Window Trial"" on Curcumin for Invasive Breast Cancer Primary Tumors","January 29, 2020","August 31, 2023","Active, not recruiting",Interventional
1735,SHR6390-III-301,A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer,"June 13, 2019","December 30, 2022",Unknown status,Interventional
1736,QL1209-301,Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.,November 2020,December 2022,Unknown status,Interventional
1737,17575,A Study of LY3484356 in Women With Breast Cancer Before Having Surgery,"April 21, 2021","November 11, 2022",Completed,Interventional
1738,SGNLVA-002,Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer,"February 27, 2018","December 31, 2024",Recruiting,Interventional
1739,19-486,A Study of the Bodys Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer,"March 4, 2020",March 2024,Recruiting,Interventional
1740,17395,"A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer","September 16, 2019","March 23, 2023",Withdrawn,Interventional
1741,2019-A01323-54,Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer,"May 14, 2021",October 2025,Recruiting,Interventional
1742,UPCC 10119,ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer,"November 1, 2021",December 2028,Recruiting,Interventional
1743,TriMix-Breast,Intratumoral TriMix Injections in Early Breast Cancer Patients,"November 12, 2018","December 30, 2024",Recruiting,Interventional
1744,WO41554,"A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer","January 29, 2020","September 19, 2025",Recruiting,Interventional
1745,I 72218,A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity,"January 16, 2019","February 5, 2021",Completed,Interventional
1746,CSPC-DMS-BC-11,Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer,"March 11, 2019","May 1, 2022",Unknown status,Interventional
1747,UC-GMP-2206,Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib,June 2023,June 2030,Not yet recruiting,Interventional
1748,RJBC2001,"A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.","January 15, 2020","December 31, 2022",Unknown status,Interventional
1749,CBYL719G12301,Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation,"July 16, 2020","April 2, 2024",Recruiting,Interventional
1750,SYSUCC-003,Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer,"April 20, 2021",February 2025,Recruiting,Interventional
1751,S63893,Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity,February 2021,"January 31, 2025",Withdrawn,Interventional
1752,GS-US-586-6144,Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer,"December 14, 2021",January 2025,Recruiting,Interventional
1753,soh-Med-21-10-17,Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer,"June 1, 2021","October 1, 2023",Recruiting,Observational
1754,MRG002-009,A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients,"March 23, 2022",October 2023,Recruiting,Interventional
1755,20150288,Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors,January 2019,January 2024,Withdrawn,Interventional
1756,PMC_TTAC-0001_05,TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer,"January 3, 2019","October 26, 2022","Active, not recruiting",Interventional
1757,2021-005,Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients,"November 22, 2021","April 28, 2022",Completed,Interventional
1758,TCF20-BRE-01,Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376,"December 23, 2020",November 2025,"Active, not recruiting",Interventional
1759,Pro2021000838,"Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care",December 2023,December 2025,Not yet recruiting,Interventional
1760,HR-BLTN-016,Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer,"February 28, 2020","November 15, 2023",Recruiting,Observational
1761,EOC103A3101,"Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer","May 15, 2018",March 2023,"Active, not recruiting",Interventional
1762,FCN-437c-III201,"This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.","March 2, 2022","March 2, 2025",Recruiting,Interventional
1763,CO41012,A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer,"November 15, 2019","September 30, 2023","Active, not recruiting",Interventional
1764,SHR6390-III-302,A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer,"July 19, 2019","December 30, 2023","Active, not recruiting",Interventional
1765,KSVGH20-CT7-26,Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution,"July 3, 2020","June 1, 2021",Unknown status,Observational
1766,MCC-20899,Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases,"November 30, 2021","December 31, 2024",Recruiting,Interventional
1767,CSPC-DMS-BC-K07,Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer,"December 20, 2021","January 31, 2028",Recruiting,Interventional
1768,SYM013,Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients,"January 8, 2021","December 31, 2023",Recruiting,Interventional
1769,FCN-437c-III202,"This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.","January 18, 2022","May 18, 2024",Recruiting,Interventional
1770,EMBRAVE-001,Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients,June 2021,June 2024,Not yet recruiting,Interventional
1771,WO43919,"A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy","March 17, 2023","March 30, 2029",Recruiting,Interventional
1772,IRB#18853,Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening,"September 19, 2019",June 2023,Recruiting,Interventional
1773,2021-TNBC-01,Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer,"September 20, 2021","November 1, 2024",Recruiting,Interventional
1774,breast-202204,Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer,"January 1, 2022","June 30, 2023",Recruiting,Interventional
1775,FDRT-BC015,The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients,"January 1, 2021","December 31, 2026",Recruiting,Observational
1776,206010,Vaccination of Triple Negative Breast Cancer Patients,"January 25, 2019","January 9, 2023",Completed,Interventional
1777,POL6326-009,"Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer","June 14, 2019",March 2022,Unknown status,Interventional
1778,2018-001705-91,Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer,"April 30, 2019","January 31, 2021",Completed,Interventional
1779,PCZCTP-220702-001,"Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer","February 1, 2023","June 1, 2024",Not yet recruiting,Interventional
1780,D9673R00005,Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer,"May 14, 2021","October 31, 2022",Completed,Observational
1781,ERC-260,Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer,"November 6, 2018","December 5, 2019",Withdrawn,Interventional
1782,NK/7784/Study/249,Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis,"August 31, 2021","August 31, 2026",Recruiting,Interventional
1783,HBBL-01,Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study,"April 30, 2019","April 30, 2022",Unknown status,Interventional
1784,P170927J,Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment,"February 1, 2021","February 1, 2024",Not yet recruiting,Interventional
1785,KA-20007,"The Effect of Oral Cryotherapy on Anticipatory, Acute and Late Nausea and Vomiting in Breast Cancer Patients","July 21, 2020","May 17, 2021",Completed,Interventional
1786,EAGER-001,Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer,"March 1, 2021",December 2022,Recruiting,Interventional
1787,Arise-FJ-B02,Apatinib Combined With Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer,"October 1, 2021","December 31, 2023",Not yet recruiting,Interventional
1788,911,"Effects of Green Coffee Extract Supplementation on Leptin, Ghrelin, Adiponectin,Anthropometric Measurements, Lipid Profile in Breast Cancer Survivors","March 12, 2018","August 12, 2019",Unknown status,Interventional
1789,17-428,Olaparib In Metastatic Breast Cancer,"April 1, 2018","December 30, 2022",Recruiting,Interventional
1790,UKFC-PU-2019-01-08,Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients,"September 7, 2021","December 30, 2023",Not yet recruiting,Interventional
1791,STUDY00019489,177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer,"September 1, 2022","December 20, 2023",Not yet recruiting,Interventional
1792,CTMX-2009-002,Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer,"December 29, 2020","April 30, 2023","Active, not recruiting",Interventional
1793,HNCH-BC011,Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer,"December 20, 2022","December 31, 2029",Recruiting,Interventional
1794,SHR-A1811-II-202,A Phase Ib/II Study of SHR-A1811 Injection in HER2 Positive Breast Cancer,"May 23, 2022","December 31, 2025",Recruiting,Interventional
1795,SYSU-2021,Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer,"June 25, 2021","July 1, 2025",Recruiting,Interventional
1796,SunYatsenU2H-LQ5,Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer,May 2021,September 2023,Not yet recruiting,Observational
1797,017-396,Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer,"February 8, 2018","December 31, 2020",Completed,Interventional
1798,2020-006106-23,Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva),"December 6, 2021",June 2025,Suspended,Interventional
1799,0000012,"Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient","December 1, 2020","February 1, 2021",Unknown status,Observational
1800,G1T28-213,Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer,"November 22, 2021",July 2024,"Active, not recruiting",Interventional
1801,REaCT-Algorithm,Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer,"March 6, 2020","May 18, 2022",Completed,Observational
1802,ZEN003694-004,A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer,"June 26, 2019",May 2024,Recruiting,Interventional
1803,UC-0140/1812,"Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.","August 26, 2019",August 2027,Recruiting,Interventional
1804,Shengjing-LCG012,A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer,"October 20, 2021","July 1, 2023",Recruiting,Interventional
1805,MAMA_MOVE_Gaia After Treatment,Effects of a Physical Exercise Program in Quality of Life of Breast Cancer Survivors,"July 1, 2018","January 1, 2022",Completed,Interventional
1806,IEO 1730,LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients,"May 16, 2022","May 16, 2027",Recruiting,Observational
1807,2019-A03112-55,Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study,"June 5, 2020",December 2022,"Active, not recruiting",Interventional
1808,GS-US-569-6172,Study of Sacituzumab Govitecan-hziy (SG) in Japanese Participants With Advanced Solid Tumors or Triple-negative Breast Cancer,"October 20, 2021",July 2024,"Active, not recruiting",Interventional
1809,2018.451,"FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET","November 13, 2018","January 29, 2023","Active, not recruiting",Interventional
1810,A5481159,Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone,"February 17, 2021","December 9, 2021",Completed,Observational
1811,s2192648,"""Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients""","October 3, 2021",April 2023,Recruiting,Interventional
1812,15.03.2023,Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.,"April 1, 2022","December 1, 2022",Completed,Observational
1813,CL0006,Intraoperative Detection of Residual Cancer in Breast Cancer,"February 6, 2018","April 10, 2020",Completed,Interventional
1814,SDX-0103,Evexomostat Plus Alpelisib and Fulvestrant in Postmenopausal Women at Risk for Hyperglycemia With Breast Cancer,"August 26, 2022",September 2026,Recruiting,Interventional
1815,NCC3397,Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer,"March 24, 2022","March 24, 2027",Recruiting,Interventional
1816,TED15954,Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer,"March 25, 2019","May 31, 2023","Active, not recruiting",Interventional
1817,202103030005,Evaluation and Re-evaluation of Post-mastectomy Pain Syndrome by Breast Cancer EDGE Task Force Outcomes,"March 3, 2021","April 4, 2022",Completed,Interventional
1818,IC 2020-10,Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer,"March 23, 2021",June 2025,Recruiting,Interventional
1819,HR-NeoBC-HN003,Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.,"June 1, 2019","December 30, 2020",Unknown status,Interventional
1820,D8530C00002,A Comparative Study of AZD9833 Versus Fulvestrant in Women With Advanced ER-Positive HER2-Negative Breast Cancer,"April 22, 2020","May 31, 2023","Active, not recruiting",Interventional
1821,PR351/20,TAD After Chemotherapy in Locally Advanced Breast Cancer,"February 1, 2021","February 1, 2024",Recruiting,Observational
1822,2021-SR-592,Anlotinib Combined With Chemotherapy for the Treatment of HER2 Negative Advanced Breast Cancer,"April 15, 2022","September 1, 2025",Not yet recruiting,Observational
1823,DOUBLE,Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer,"June 10, 2022","March 9, 2025",Not yet recruiting,Interventional
1824,17320,"A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer","August 14, 2019","August 11, 2020",Terminated,Interventional
1825,202007016,Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer,"November 19, 2020","May 31, 2026","Active, not recruiting",Interventional
1826,PALBOBIN,Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer,"November 18, 2020","August 1, 2023","Active, not recruiting",Interventional
1827,2017-A03413-50,Metastatic Breast Carcinoma and Women Sexual Quality of Life,"March 12, 2018","April 4, 2018",Completed,Observational
1828,GIM23-POSTER,Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients,"October 24, 2019","July 31, 2032","Active, not recruiting",Observational
1829,AK117-203,A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer,"March 23, 2022","October 30, 2023",Recruiting,Interventional
1830,MA-BC-II-033,The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis,June 2022,December 2027,Not yet recruiting,Interventional
1831,CO42177,"A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer","September 28, 2020","March 8, 2023",Completed,Interventional
1832,2021-0491,Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen,"October 1, 2021","October 31, 2023",Recruiting,Observational
1833,MO39874,A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer,"December 17, 2019","December 15, 2024","Active, not recruiting",Interventional
1834,AH150201,"Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c","February 14, 2019","June 30, 2022",Unknown status,Interventional
1835,BAC,Satisfaction Survey for the Outpatient Unit Dedicated to Post-cancer Treatment,"July 18, 2022","March 6, 2023",Completed,Observational
1836,20200225,Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI),"October 8, 2021","December 30, 2023",Recruiting,Interventional
1837,BOOG-2017-02,Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer,February 2018,June 2023,Withdrawn,Interventional
1838,NL81896.078.22,Tamoxifen Prediction Study in Patients With ER+ Breast Cancer,September 2022,July 2023,Not yet recruiting,Interventional
1839,B003-101,B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer,"April 1, 2019","July 31, 2023","Active, not recruiting",Interventional
1840,TQB2450-Ib-07,A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC),"May 9, 2019","December 30, 2020",Unknown status,Interventional
1841,CO40151,A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer,"February 13, 2018","March 15, 2022",Completed,Interventional
1842,REaCT-5G,"A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy","June 9, 2021",December 2023,"Active, not recruiting",Interventional
1843,2021/609,Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer,December 2021,March 2024,Not yet recruiting,Interventional
1844,R19-149,Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging,"March 1, 2024","June 30, 2028",Recruiting,Interventional
1845,HR-NeoBC-HN002,Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.,"November 20, 2018","October 20, 2020",Completed,Interventional
1846,14/2021,Efficacy of Expressive Writing on Quality of Life Among Breast Cancer Survivors in Oman: A Double Blind Randomized Controlled Trial,"January 1, 2022","December 30, 2024",Not yet recruiting,Interventional
1847,SI 475/2019,Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer Surgery,"August 1, 2019","March 1, 2022",Recruiting,Interventional
1848,99mTc-ADAPT6 in breast cancer,99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes,"May 1, 2022","December 30, 2023",Recruiting,Interventional
1849,2021-A02007-34,"Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients With HER2+ Breast Cancer","December 14, 2021",July 2024,"Active, not recruiting",Observational
1850,AND019-MN-101,A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer,"October 5, 2022",May 2025,Recruiting,Interventional
1851,SKB264-Ⅲ-03,"SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer","June 10, 2022","December 31, 2024",Not yet recruiting,Interventional
1852,ESPB in breast cancer surgery,Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery,"August 1, 2020",April 2022,"Active, not recruiting",Interventional
1853,JS001-026-III-TNBC,Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment,"December 21, 2018","December 31, 2024","Active, not recruiting",Interventional
1854,NCR191600,Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer,September 2022,August 2023,Withdrawn,Observational
1855,WO43571,"A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)","July 4, 2022","September 30, 2032",Recruiting,Interventional
1856,495573096,Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer,"March 1, 2019","February 28, 2021",Unknown status,Interventional
1857,GIM26-TRASTHER,Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy,"July 27, 2021","May 2, 2025",Recruiting,Observational
1858,2020-0232,Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC),"July 9, 2020",July 2026,Recruiting,Interventional
1859,TQB2450-III-06,A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC),"June 1, 2020","July 1, 2022",Unknown status,Interventional
1860,CBYL719CIN01,"Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment","August 10, 2022","November 15, 2024",Recruiting,Interventional
1861,CASE5119,Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer,"August 12, 2021","June 1, 2023",Recruiting,Interventional
1862,SPORT-DS,Single Pre-Operative Radiation Therapy - With Delayed Surgery for Low Risk Breast Cancer,"April 1, 2018","December 31, 2022","Active, not recruiting",Interventional
1863,EVER-132-001,Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments,"October 23, 2020",May 2023,"Active, not recruiting",Interventional
1864,TBDBreast50,Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer,"May 1, 2018","May 1, 2018",Withdrawn,Interventional
1865,STUDY00004350,A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy,"April 3, 2023","March 30, 2025",Not yet recruiting,Interventional
1866,MOST Pain Pilot,Optimizing Psychological Treatment for Pain After Breast Cancer: A Pilot Study,"March 1, 2021","August 1, 2021",Completed,Interventional
1867,275142,An EORTC Study Updating the QLQ-BR23 to BR45,"November 2, 2020","December 31, 2022",Recruiting,Observational
1868,RG1006427,Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors,"February 21, 2020","October 28, 2021",Completed,Interventional
1869,BC-Fluzoparib,Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer,"February 8, 2021","December 31, 2024",Recruiting,Interventional
1870,QUILT-3.058,A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies,"September 27, 2021","January 4, 2023",Terminated,Interventional
1871,214-2018,Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI,"October 1, 2018","January 1, 2021",Completed,Observational
1872,SCCC-03121; STU-2021-0657,"CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer","April 20, 2022",April 2026,Recruiting,Interventional
1873,I237,CFI-400945 in Patients With Advanced/Metastatic Breast Cancer,"December 21, 2018","June 30, 2023","Active, not recruiting",Interventional
1874,KarolinskaUD,"OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery","May 20, 2019","May 30, 2020",Unknown status,Interventional
1875,NCC1969,Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer,"April 11, 2019","December 31, 2022",Recruiting,Interventional
1876,SYSU-2022-UCAN,Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer,"June 21, 2022","June 1, 2027",Recruiting,Interventional
1877,HX008-Ib/II-TNBC-01,A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer,"July 15, 2019","December 1, 2021",Unknown status,Interventional
1878,21030,Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast Cancer,"December 14, 2022","November 14, 2023",Withdrawn,Interventional
1879,HNCH-MBC07,Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure,"May 13, 2022","November 1, 2025",Recruiting,Interventional
1880,BC- T-DM1,Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy,"September 30, 2022","August 23, 2025",Not yet recruiting,Interventional
1881,A5481123,RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.,"January 4, 2019","June 24, 2019",Completed,Observational
1882,B013-301,Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer,"December 6, 2022","December 31, 2026",Recruiting,Interventional
1883,HR-BLTN-III-NeoBC,Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer,"July 24, 2018",June 2022,"Active, not recruiting",Interventional
1884,IIT2022-07-YUAN-IB-TNBC,Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer,April 2023,October 2026,Not yet recruiting,Interventional
1885,19-113,Exercise Treatment With Standard Therapy for Metastatic Breast Cancer,"June 12, 2019","August 1, 2023",Recruiting,Interventional
1886,4CAST,Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer,"November 1, 2021",December 2024,Not yet recruiting,Interventional
1887,SHR1210-III-322,A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC),"December 9, 2020","January 30, 2024",Recruiting,Interventional
1888,222.20,SBRT in Early Breast Cancer in Elderly Women,"January 1, 2021",November 2023,Recruiting,Interventional
1889,MedOPP190,"Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)","June 15, 2020","December 31, 2022",Terminated,Interventional
1890,CBYL719A0US03T,"Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer","August 25, 2021",July 2023,Recruiting,Interventional
1891,HERMIONE-7,"Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)","January 7, 2020",December 2023,"Active, not recruiting",Interventional
1892,811,"Effects of Green Coffee Extract Supplementation on Adropin, Irisin, Vaspine,Systemic Inflammation and Oxidative Stress in Breast Cancer Survivors","February 11, 2018","October 11, 2019",Unknown status,Interventional
1893,22-x354,ATI-2231 With in Advanced Solid Tumor Malignancies Followed by ATI-2231 in Combination With Capecitabine in Patients With Hormone Receptor-positive and HER2 Negative Metastatic Breast Cancer,"June 1, 2023","October 1, 2030",Not yet recruiting,Interventional
1894,MK 3475-318,Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.,"January 18, 2018","March 31, 2020",Completed,Interventional
1895,2019-0634,Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women,"November 22, 2021","December 31, 2022",Recruiting,Interventional
1896,IJB-LOB-2019,Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE),"January 14, 2021",March 2023,Recruiting,Interventional
1897,BAT-8001-002-CR,The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer,"July 1, 2018","December 31, 2021",Unknown status,Interventional
1898,CO41863,A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer,"September 23, 2020","February 4, 2021",Terminated,Interventional
1899,EH20-251,Advanced Diffusion Tensor MRI for Breast Cancer,"February 3, 2021",February 2024,Recruiting,Observational
1900,A5481095,TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.,"March 1, 2018","July 1, 2018",Completed,Observational
1901,Combined CTH and HT in MBC,"Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study","August 30, 2018",February 2021,Unknown status,Interventional
1902,KN046-203,A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer,"May 30, 2019","September 15, 2023","Active, not recruiting",Interventional
1903,DZ2019HE001,"DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer","September 21, 2020",May 2024,"Active, not recruiting",Interventional
1904,SHR6390-SHR1020-I-101-BC,A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast Cancer,"October 25, 2021","October 31, 2023",Recruiting,Interventional
1905,2022-A01192-41,SexoMBC2 Non Interventional Study,"December 5, 2022",June 2023,Recruiting,Observational
1906,U025,Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer,"June 6, 2018","May 4, 2022",Completed,Interventional
1907,NCC2474,Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer,September 2020,December 2022,Unknown status,Interventional
1908,MA-BC-II-047,Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study,"November 1, 2022","November 30, 2025",Not yet recruiting,Interventional
1909,NCI-2021-08921,Metformin and Nightly Fasting in Women With Early Breast Cancer,"January 30, 2023","November 30, 2024",Not yet recruiting,Interventional
1910,FUSCC,Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA),"February 1, 2022","August 1, 2026",Not yet recruiting,Interventional
1911,ShandongCHI-06,Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy,October 2018,December 2025,Not yet recruiting,Interventional
1912,NCC201711008,Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer,"February 20, 2018","June 25, 2019",Unknown status,Interventional
1913,S62794,"Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast Cancer","June 20, 2019","November 20, 2020",Completed,Interventional
1914,Bioscore in breast cancer,Prognostic Significance of Bioscore in Nonmetastatic Breast Cancer,"January 1, 2018","October 16, 2020",Completed,Observational
1915,MORE-T trial,Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients,"October 21, 2021","December 31, 2028",Recruiting,Interventional
1916,Soh-Med-21_10_18,One Week Adjuvant Radiotherapy for Breast Cancer,"October 1, 2021","October 1, 2023",Recruiting,Interventional
1917,Medical Research Institute,"US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation","November 25, 2020","January 21, 2022",Completed,Interventional
1918,Cardiotoxicity study,Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients,"January 8, 2021","December 30, 2021",Unknown status,Observational
1919,20-068,MARGetuximab Or Trastuzumab (MARGOT),"July 13, 2020","July 1, 2027",Recruiting,Interventional
1920,262840,CIPN in Early Stage Breast Cancer Patients,"May 26, 2022","January 1, 2024",Recruiting,Interventional
1921,2021P002943,Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda,"September 15, 2022","December 31, 2023",Not yet recruiting,Observational
1922,MS200647_0020,Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer,"October 12, 2020","July 8, 2022",Terminated,Interventional
1923,HNCH-HER2-MBC001,Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.,"April 23, 2021","October 30, 2022",Recruiting,Interventional
1924,GB491-004,GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer,"September 10, 2021","January 31, 2024",Recruiting,Interventional
1925,P170929J,PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers,May 2022,May 2030,Not yet recruiting,Interventional
1926,19-002448,Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer,"August 20, 2020","November 25, 2023","Active, not recruiting",Interventional
1927,MCLA-128-CL02,MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer,"January 15, 2018","February 15, 2024","Active, not recruiting",Interventional
1928,2019-185-AGH,Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer,"January 15, 2020",December 2023,Recruiting,Interventional
1929,KN026-205,Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer,"May 25, 2022","December 30, 2024",Recruiting,Observational
1930,SPH4336-301,Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer,"April 30, 2023","December 16, 2024",Not yet recruiting,Interventional
1931,HCB/2019/0786,Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy,"October 30, 2020","August 30, 2022","Active, not recruiting",Interventional
1932,AIs with chemotherapy in MBC,Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer,"August 30, 2023","May 31, 2025",Not yet recruiting,Interventional
1933,SIBP-01-3,A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer,"June 30, 2019","July 30, 2021",Unknown status,Interventional
1934,REaCT-OGF,Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy,April 2023,October 2025,Not yet recruiting,Interventional
1935,CTRIAL-IE 22-01,Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study),"March 30, 2023","March 30, 2028",Not yet recruiting,Interventional
1936,CO42867,A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer,"June 20, 2021","October 31, 2026",Recruiting,Interventional
1937,EC2019/0127,Hyperventilation and Oxygenation to Prolong Breath Hold in Breast Cancer Irradiation Treatment,"March 15, 2019","February 22, 2021",Completed,Interventional
1938,UC Laser,Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors,"March 20, 2018","June 1, 2022",Recruiting,Interventional
1939,2022-09/2057,The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery,"October 16, 2022","January 30, 2023",Recruiting,Observational
1940,TEMPLATE,Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study,"May 27, 2021","June 1, 2023",Not yet recruiting,Interventional
1941,M19-992,"A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy","May 21, 2020","October 8, 2020",Terminated,Interventional
1942,2021-1122,"AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer","May 1, 2022","December 30, 2024",Recruiting,Interventional
1943,IJB-LBC-NEOCHECKRAY-2018,"Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:","November 6, 2019","January 15, 2026",Recruiting,Interventional
1944,CBYL719CIN02,Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world,"October 27, 2021","September 30, 2025",Recruiting,Observational
1945,2022-0500,Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors or Chemotherapy in Luminal B/HER2-negative Breast Cancer (DAPATH),"October 1, 2022","October 31, 2025",Recruiting,Interventional
1946,Labra-001,Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy,"July 1, 2020","June 1, 2021",Completed,Interventional
1947,GBG 93,"A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).","March 1, 2018","March 31, 2023",Recruiting,Interventional
1948,HR-MBC-HN001,A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer,"November 20, 2018","December 30, 2022","Active, not recruiting",Interventional
1949,CS2-19004,Chemotherapy - Induced Peripheral Neuropathy,"October 1, 2019","October 15, 2020",Completed,Interventional
1950,20-130,Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer,"October 8, 2020",July 2025,Recruiting,Interventional
1951,MCC-19803,Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer,"April 26, 2019","January 6, 2021",Terminated,Interventional
1952,SYSU-2021-UCAN,Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer,"March 1, 2022","March 1, 2030",Not yet recruiting,Interventional
1953,ROGABREAST,"Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.","November 25, 2020","April 4, 2023",Completed,Interventional
1954,18040334,Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer,"January 15, 2018","September 5, 2019",Completed,Interventional
1955,BG01-2001,PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer,"October 15, 2020","February 19, 2021",Completed,Interventional
1956,ZhejiangCH-0709,RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer,July 2021,November 2025,Not yet recruiting,Observational
1957,CBYL719C2404,"A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting","April 28, 2023","December 19, 2025",Recruiting,Observational
1958,SYSKY-2022-105-01,Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer,"August 1, 2022","December 1, 2024",Recruiting,Interventional
1959,IRB18-1178,Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer,"November 25, 2019","April 10, 2024",Recruiting,Interventional
1960,I2I1,Connecting Breast Cancer Survivors for Exercise,"May 10, 2021","January 30, 2022",Completed,Interventional
1961,MO43110,A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer,"July 5, 2022","September 25, 2025",Recruiting,Interventional
1962,MC1831,"Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer","August 28, 2019","April 30, 2024",Recruiting,Interventional
1963,UC-BCG-2011,Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer,"December 17, 2021","June 30, 2025",Recruiting,Interventional
1964,FOENIX-MBC2 TAS-120-201,A Study of TAS-120 in Patients With Metastatic Breast Cancer,"August 30, 2019","June 30, 2023","Active, not recruiting",Interventional
1965,2019-01-064,TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery,"May 27, 2019","October 31, 2022",Unknown status,Interventional
1966,ML43171,"A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physicians Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)","August 3, 2022","March 31, 2026",Recruiting,Interventional
1967,SHR-A1811-206,A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.,April 2023,"February 27, 2025",Not yet recruiting,Interventional
1968,OSU-20380,Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer,"December 9, 2020","October 30, 2022",Completed,Observational
1969,EOC202A2102,"HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy",April 2022,May 2025,Not yet recruiting,Interventional
1970,IEO 675,Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer,"July 1, 2020","December 1, 2021",Unknown status,Interventional
1971,7339-009,Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009),"December 19, 2019","January 26, 2026","Active, not recruiting",Interventional
1972,CSIIT-C41,Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy,"May 1, 2023","November 1, 2024",Not yet recruiting,Interventional
1973,MP-05-2021-2605,Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer,"March 30, 2021",February 2023,Recruiting,Interventional
1974,EUBREAST 3,AXillary Surgery After NeoAdjuvant Treatment,"April 28, 2020",April 2030,Recruiting,Observational
1975,2020-1190,Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer,"May 21, 2021","November 30, 2023",Recruiting,Interventional
1976,D933LC00001,A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer,"December 21, 2018","June 30, 2023","Active, not recruiting",Interventional
1977,BreCLIM-2018-116-31M,BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases,"January 1, 2020","December 31, 2029",Recruiting,Interventional
1978,I 73718,Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer,"December 6, 2019","February 27, 2024","Active, not recruiting",Interventional
1979,SHR-1210-III-327,A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer,"November 30, 2021","April 30, 2023",Not yet recruiting,Interventional
1980,IRB18-00912,Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery,"February 4, 2020","April 30, 2024",Recruiting,Interventional
1981,Shengjing-LJY03,CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer,"November 1, 2019","August 31, 2024",Recruiting,Observational
1982,MA-BC-II-042,Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer,"November 23, 2022","December 31, 2026",Recruiting,Interventional
1983,HCB/2020/0971,Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors,"December 1, 2020","June 30, 2023",Recruiting,Interventional
1984,2019-00673; sp19Kurzeder,Digoxin Induced Dissolution of CTC Clusters,"July 8, 2020",June 2022,Recruiting,Interventional
1985,HKUCTR-2709,Use of Superparamagnetic Iron Oxide (SPIO) in Sentinel Lymph Node Detection for Breast Cancer,"July 24, 2018","June 30, 2024",Recruiting,Interventional
1986,Prevention of neuropathy,Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer,"January 10, 2023","December 30, 2024",Not yet recruiting,Interventional
1987,HRS8807-I-101,"A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer","October 26, 2021","December 31, 2024",Recruiting,Interventional
1988,MUKDEN5,Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer,"February 25, 2022","January 31, 2025",Not yet recruiting,Interventional
1989,s17-00995,MBSR During AI Therapy for Breast Cancer,"April 23, 2018","September 8, 2020",Completed,Interventional
1990,18/0059,Health Status of Women With Breast Cancer,"March 14, 2019","November 30, 2019",Unknown status,Observational
1991,UW19046,FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer,"October 20, 2020",December 2023,Recruiting,Interventional
1992,2018-1133,Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer,"August 23, 2019","January 31, 2024","Active, not recruiting",Observational
1993,TQ-B3525-I-02,"A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer",July 2020,September 2021,Unknown status,Interventional
1994,MC01/05/20; IST-325 (KPT),Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START),"March 1, 2021",November 2025,Recruiting,Interventional
1995,TQB3616-II-01,A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer,"February 4, 2021","January 31, 2023",Unknown status,Interventional
1996,2020-1267,Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion,"March 19, 2021","December 31, 2024","Active, not recruiting",Interventional
1997,s61033,A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer,"December 11, 2018",December 2023,"Active, not recruiting",Observational
1998,SHR9549-I-101,SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer,"July 25, 2018","October 14, 2019",Terminated,Interventional
1999,IRB00109957,THRIVE Breast Cancer App Study,"November 15, 2018","June 30, 2022",Completed,Interventional
2000,21/079,Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients,"May 9, 2022","December 31, 2024",Recruiting,Observational
2001,3-2019-0140,Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients,August 2019,August 2021,Unknown status,Interventional
2002,0392-18-HMO,CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer,"February 1, 2019",August 2023,"Active, not recruiting",Interventional
2003,22012020,Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer,"February 1, 2018","February 28, 2019",Completed,Interventional
2004,FJD-LCO2-19-01,A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.,December 2022,January 2026,Not yet recruiting,Interventional
2005,ARIANNA (SOLTI-1502),Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BC,"June 1, 2020","October 10, 2022",Terminated,Interventional
2006,KROG 21-07,Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients,"April 1, 2022","December 31, 2032",Not yet recruiting,Interventional
2007,18291,A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer,"October 9, 2022","January 30, 2025",Recruiting,Interventional
2008,HER2BAT,A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone,"May 10, 2020","March 31, 2024",Recruiting,Interventional
2009,Regina Elena,Endometrial Changes in Breast Cancer Women.,"January 26, 2023","January 26, 2024","Active, not recruiting",Observational
2010,Geriatric-CDK4/6,Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?,"October 1, 2021","December 15, 2021",Not yet recruiting,Observational
2011,CLEAR,Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer,"August 1, 2018","July 31, 2025",Recruiting,Interventional
2012,PROICM 2019-05 MAC,Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery,"May 18, 2021",July 2024,Recruiting,Interventional
2013,2.777.676,Photobiomodulation for Breast Cancer Radiodermatitis,"September 26, 2018","July 20, 2021",Completed,Interventional
2014,BLI-1401-2-01,"Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.","September 1, 2023","February 28, 2025",Not yet recruiting,Interventional
2015,R018-SABI-00193,Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica,"January 7, 2019","November 30, 2020",Unknown status,Observational
2016,2018-0287,"Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study","May 31, 2019","April 26, 2024",Recruiting,Interventional
2017,Pro00087654,Family History in a Singapore Oncology Population,"January 7, 2019","August 31, 2019",Completed,Observational
2018,20221120,A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause,"June 1, 2023","June 1, 2026",Not yet recruiting,Interventional
2019,PMCT-IMSLNB-MIT,Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique,"July 1, 2018","December 31, 2020",Unknown status,Interventional
2020,IC 2017-06,Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer,"October 5, 2020","April 5, 2024",Recruiting,Interventional
2021,2020-2-4023,Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer,"September 1, 2021","June 30, 2023",Recruiting,Observational
2022,CO40115,A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Advanced Triple-Negative Breast Cancer,"April 2, 2018","May 3, 2024","Active, not recruiting",Interventional
2023,1605576856,Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients,"May 3, 2021","May 1, 2023",Recruiting,Interventional
2024,111-009-F,A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients,"April 8, 2022","April 7, 2023",Recruiting,Interventional
2025,V2000701,Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer,"April 11, 2022","January 30, 2024",Recruiting,Interventional
2026,21129002,Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer,"July 1, 2022","April 1, 2023",Completed,Interventional
2027,IRMA,Impact of Recurrence Score on Adjuvant Treatment Decisions in Breast Cancer Patients,"March 1, 2019","June 30, 2023",Recruiting,Observational
2028,MCC-20915,"Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab","October 28, 2021",October 2025,Recruiting,Interventional
2029,ZJCH-CK19B,A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer,"October 15, 2018",June 2020,Unknown status,Interventional
2030,69HCL21_0145,Immediate Breast Reconstructions Increasing,"January 1, 2021",June 2021,Unknown status,Observational
2031,2017-0500,M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer,"May 30, 2018","September 21, 2022",Terminated,Interventional
2032,3475-B49,Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49),"June 18, 2021","July 21, 2028",Recruiting,Interventional
2033,UW20037,Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study),"October 5, 2021",March 2025,Recruiting,Interventional
2034,University Brunswick,Physical Activity Levels and Functional Improvement in Breast Cancer Survivors,"September 11, 2018",April 2021,Unknown status,Interventional
2035,22-259,A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer,"September 6, 2022","September 6, 2025",Recruiting,Interventional
2036,BLTN-NeoBC1115,Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer,November 2019,April 2021,Unknown status,Interventional
2037,4-2022-0600,Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction,October 2022,June 2030,Not yet recruiting,Interventional
2038,SABO 21-01,Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer,"September 19, 2022","December 31, 2027",Recruiting,Interventional
2039,IPI-549-03,Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma (MARIO-3),"December 17, 2019","August 1, 2022","Active, not recruiting",Interventional
2040,20201101,Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study),"April 30, 2021","April 30, 2025",Not yet recruiting,Interventional
2041,17384,A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer,"May 10, 2021","February 9, 2024","Active, not recruiting",Interventional
2042,NNG17.2,Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients,"February 2, 2018","February 19, 2021",Completed,Interventional
2043,UW18099,Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer,"May 16, 2022",January 2031,Recruiting,Interventional
2044,22239,Treatment of Frailty With Fisetin (TROFFi) in Breast Cancer Survivors,"March 15, 2023","May 15, 2025",Recruiting,Interventional
2045,I 571719,Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors,"July 3, 2020","July 3, 2025",Recruiting,Observational
2046,APG2575XU103,"A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer","August 13, 2021","October 1, 2023",Recruiting,Interventional
2047,M21CSM,COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study,"September 1, 2022","April 1, 2040","Active, not recruiting",Interventional
2048,20171,Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer,"July 27, 2021","December 12, 2023",Recruiting,Interventional
2049,BL-B01D1-104,A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors,"August 11, 2022",August 2024,Recruiting,Interventional
2050,202107015,"Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing","March 7, 2022","March 31, 2027",Recruiting,Interventional
2051,IRB-52869,Umbrella Trial Testing Integrative Subtype-Targeted Therapeutics in HR+ /HER2-Negative Breast Cancer,"March 20, 2023",December 2026,Recruiting,Interventional
2052,ICRG0201,"Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.","December 20, 2022",June 2026,Recruiting,Interventional
2053,2019-40016-06,Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy,"May 10, 2019","December 10, 2020",Unknown status,Interventional
2054,UPCC 17119,Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Ancillary Study,"August 1, 2020",December 2024,Enrolling by invitation,Observational
2055,D9266C00001,"A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)","July 11, 2022","June 23, 2024",Recruiting,Interventional
2056,XJTU1AF-CRF-2018-001,Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients,"April 1, 2019","December 31, 2024",Recruiting,Observational
2057,CHANGEABLE,Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer,"September 14, 2020","December 28, 2022",Recruiting,Interventional
2058,U21-02-4401,Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition,"August 8, 2021",July 2025,Recruiting,Interventional
2059,HS-10352-101,Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer,"September 8, 2020","August 31, 2023",Recruiting,Interventional
2060,1B-21-6,Breast Cancer Survivorship Biorepository,"April 11, 2022","April 11, 2028",Recruiting,Observational
2061,Pro00100408,Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer,"June 19, 2019","January 1, 2024",Recruiting,Observational
2062,2017/78,"Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)",March 2023,March 2032,Not yet recruiting,Interventional
2063,NNG17.1,Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.,"May 27, 2019","February 19, 2021",Completed,Interventional
2064,Polarhis,Assessment of Lumpectomy Margins With the Histolog Scanner in Comparison With Intraoperative Imaging Techniques,"October 1, 2020","May 31, 2022",Completed,Observational
2065,SHR-A1811-III-301,"A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane","July 29, 2022","December 31, 2024",Recruiting,Interventional
2066,IRB-63041,Study Assessing QBS72S For Treating Brain Metastases of Breast Cancer,"August 16, 2022",August 2026,Recruiting,Interventional
2067,GS-US-592-6173,"Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physicians Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer","July 25, 2022",February 2027,Recruiting,Interventional
2068,SCO-120-19-22,A Study in Patients With Advanced Breast Cancer,"May 20, 2022",January 2024,Recruiting,Interventional
2069,AssiutU AAHelmy,Multimodal Ultrasonographic Assessment of Ipsilateral Axillary Lymph Nodes in Patients With Breast Cancer: A STARD Study,"May 15, 2022","June 15, 2023",Not yet recruiting,Observational
2070,GS-US-592-6238,Study of Sacituzumab Govitecan-hziy Versus Treatment of Physicians Choice in Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer,"July 20, 2022",May 2027,Recruiting,Interventional
2071,CBYL719C2201,Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer,"January 20, 2021","July 31, 2025",Recruiting,Interventional
2072,NCI-2022-00004,Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body,"March 25, 2022","June 30, 2026",Recruiting,Interventional
2073,19/218,Increasing Access to Breast Cancer Screening Among Immigrants,"April 15, 2021","December 31, 2030","Active, not recruiting",Interventional
2074,AIPAC-003,Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy,"March 20, 2023","July 31, 2027",Recruiting,Interventional
2075,STUDY00004618,A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening,"September 5, 2022","March 31, 2023","Active, not recruiting",Interventional
2076,2019-00174 Neoadj Breast Pilot,"Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer","October 1, 2019","December 31, 2020",Withdrawn,Interventional
2077,INT/2020/VOICE,"Implementation, Effectiveness and Impact of a Value Based Intervention for Patients With Breast or Lung Cancer","January 1, 2019","June 30, 2023","Active, not recruiting",Interventional
2078,SCT200IITNBC,Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer,"July 20, 2018","December 31, 2019",Unknown status,Interventional
2079,SuleymanDU-SALMAN-F-001,The Effect of Mobile Application-based Information About Before and After Surgery,"April 1, 2021","August 30, 2021",Completed,Interventional
2080,TQB3616-III-01,TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail,"March 18, 2022",December 2023,Recruiting,Interventional
2081,19-3032.cc,Combined Modality Exercise and Appetite in Breast Cancer Survivors,"June 5, 2020","September 20, 2021",Terminated,Interventional
2082,H3B-6545-J081-103,"Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer","September 30, 2020","November 30, 2023","Active, not recruiting",Interventional
2083,UPNA-CUMACA-B2022,Web-based Intervention for Long-term Breast Cancer Survivors,January 2023,June 2024,Not yet recruiting,Interventional
2084,MO40628,A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer,"December 19, 2018","October 12, 2022",Completed,Interventional
2085,IIBSP-SIL-2017-70,Evaluation of a New Technique to Fill the Defect Generated After Conservative Surgery in Breast Cancer,"September 18, 2019","March 1, 2022",Completed,Interventional
2086,18-1068,Clinician Communication About Sexual Health,"February 7, 2020","October 12, 2020",Completed,Interventional
2087,19959,Effects of Computer-Assisted Cognitive Rehabilitation Programs With Breast Cancer Survivors,"February 26, 2018","February 26, 2020",Unknown status,Interventional
2088,651,Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.,"June 21, 2019","June 21, 2027",Recruiting,Interventional
2089,2021SQGH00743,The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer,"September 1, 2021","August 31, 2026",Recruiting,Interventional
2090,213831,Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease,"June 28, 2021","August 28, 2029",Recruiting,Interventional
2091,Shoulder exercise cancer,Limited Versus No-limited Shoulder Movement in Breast Cancer Surgery,"February 1, 2019","December 20, 2019",Completed,Interventional
2092,LCCC 2104,Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN),"May 17, 2022","May 17, 2025",Recruiting,Interventional
2093,N assisted,A Clinical Study on Hormone Receptor Positive HER2 Positive Breast Cancer of RCB1-2 After Neoadjuvant Treatment With Trastuzumab Combined With Parezumab,"February 16, 2023","November 1, 2028",Recruiting,Interventional
2094,32158620.0.0000.0072,Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia,"August 5, 2020","February 28, 2022","Active, not recruiting",Observational
2095,GC-627-05,Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy,"April 12, 2018","March 5, 2020",Completed,Interventional
2096,PI2018_843_0061,Feasibility of Total Mastectomy in Ambulatory Care,"January 1, 2021",March 2024,Recruiting,Interventional
2097,LightCT-PKUPH,Light-CT in the Diagnosis of Breast Tumor and Lymph Node,"April 1, 2018","December 31, 2023",Recruiting,Observational
2098,SYSKY-2022-024-01,Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients,"June 24, 2022","July 30, 2024",Recruiting,Interventional
2099,rosuva2020,Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients,"September 15, 2020","September 15, 2023",Recruiting,Interventional
2100,GCO 17-2320,Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer,"May 17, 2018","February 10, 2020",Completed,Interventional
2101,NL62441.068.17,PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients,"February 22, 2018",December 2023,Recruiting,Interventional
2102,2110244-11,Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery,"November 1, 2021","May 2, 2023",Recruiting,Interventional
2103,N21CPB-IRBd22-103,Communication in Breast Cancer Care,"June 5, 2022","December 31, 2022",Recruiting,Interventional
2104,Pro00109917,Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors,"May 26, 2022",August 2023,Recruiting,Interventional
2105,SUGBG-2021001,Sentinel Node Localization and Staging With Low Dose Superparamagnetic Iron Oxide,"November 1, 2021","April 30, 2024","Active, not recruiting",Interventional
2106,EP0062-101,Phase 1/2 Study to Evaluate EP0062 in Patients With Relapsed Locally Advanced or Metastatic Androgen Receptor Positive (AR+)/HER2-/ER+ Breast Cancer,December 2022,March 2025,Not yet recruiting,Interventional
2107,MA-BC-II-025,Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer,"July 2, 2021","December 31, 2027",Recruiting,Interventional
2108,"S-20200021, 19-16321",An Individualised Treatment vs. a Minimal Program in Women With Late-term Shoulder Impairments After Breast Cancer.,"April 4, 2022","October 10, 2022",Completed,Interventional
2109,CPO-NBP-2002,NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy,"June 30, 2023","January 30, 2025",Not yet recruiting,Interventional
2110,MCC-19220,PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient,December 2020,December 2022,Withdrawn,Interventional
2111,PROSOM-K,Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep,"January 5, 2018","March 6, 2020",Completed,Interventional
2112,HSM/VGH-2019-12-009CC,Web-based Oncofertility Support Tool for Reproductive-age Women With Breast Cancer,"January 1, 2020","August 5, 2021",Completed,Interventional
2113,BR-003,Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors,"April 30, 2023","March 31, 2025",Not yet recruiting,Interventional
2114,2021/156064(REK),Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients,"March 16, 2023","September 30, 2035",Recruiting,Interventional
2115,StrataXRT,A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients,"October 13, 2022","June 30, 2023",Recruiting,Interventional
2116,KY2022-044-B,"CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial","September 14, 2022",June 2029,Recruiting,Interventional
2117,2018-09-20 Version 1.2,Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer,"March 1, 2019","September 30, 2023",Recruiting,Observational
2118,events in breast cancer,Skeletal Events of Hormonal Treatment and Radiotherapy in Patient With Breast Cacer,"December 1, 2021",December 2021,Unknown status,Observational
2119,2021-A01550-41,Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer,"September 27, 2022",September 2025,Recruiting,Interventional
2120,20220430GD,Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation,"May 6, 2022","December 31, 2028",Recruiting,Interventional
2121,MC220902,Evaluation of Endocrine Therapy-Induced Alopecia Among Postmenopausal and Premenopausal Female Patients With Breast Cancer,"December 12, 2022","August 1, 2024",Recruiting,Observational
2122,ShengjingH 3,"Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy","July 19, 2021","December 31, 2026",Recruiting,Observational
2123,2449PT,Effect of Exercise Mode in Breast Cancer-Related Lymphedema,"January 15, 2019","May 5, 2020",Completed,Interventional
2124,MedOPP199,"Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -","May 7, 2019","December 31, 2019",Completed,Interventional
2125,Exo-LCR-1807,Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.,July 2019,October 2023,Withdrawn,Interventional
2126,ILLUMINE,Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer,"January 1, 2020","March 31, 2024",Recruiting,Observational
2127,C4891016,A Study to Learn About the ARV-471 (PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC),"August 16, 2022","April 19, 2023","Active, not recruiting",Interventional
2128,TQB3909-Ib/II-01,A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer,"March 2, 2023",December 2023,Recruiting,Interventional
2129,UCI 19-145 [HS# 1459],"Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer","August 31, 2022","December 31, 2028",Recruiting,Interventional
2130,AGO/2019/003,Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer,"November 24, 2020","May 1, 2021",Withdrawn,Interventional
2131,2020-A01916-33,Adapted Fencing in Breast Cancer: a Pilot Study,"November 10, 2021",November 2022,Recruiting,Interventional
2132,NBK 171/1/2021,"Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a ""Window of Opportunity"" Study","January 1, 2022","December 6, 2026",Not yet recruiting,Interventional
2133,18496,"Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer","March 4, 2019","December 21, 2023","Active, not recruiting",Interventional
2134,18459,A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer,"October 4, 2022","March 15, 2032",Recruiting,Interventional
2135,NCC1787,Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer,"December 1, 2018","December 31, 2021",Unknown status,Interventional
2136,DBCG RT SDM,Shared Decision Making With Breast Cancer Patients,"March 4, 2020","July 31, 2023","Active, not recruiting",Interventional
2137,20923,"Impact of Breast Cancer Treatment on Joint Health, Cartilage Composition, and Bone Structure in the Knee and Hand","May 18, 2020","May 24, 2022",Terminated,Observational
2138,PRO00030295,Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivors,"November 1, 2019","July 30, 2022",Completed,Interventional
2139,SUN-2252,Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients,"July 21, 2021",December 2023,Recruiting,Observational
2140,RECHMPL21_0680,Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery,"June 22, 2022","April 1, 2025",Recruiting,Interventional
2141,RIBBS 2019/37,Risk-Based Breast Screening in Young Women,"January 20, 2020","January 31, 2026","Active, not recruiting",Interventional
2142,INT214/22,Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial,"March 1, 2023","March 1, 2025",Not yet recruiting,Interventional
2143,Folio No.03-2022,Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae,"September 5, 2022","January 9, 2023",Completed,Interventional
2144,22-250,TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients,"March 20, 2023","February 1, 2027",Recruiting,Interventional
2145,201906,Psychological Interventions to Prevent Late Effects in Breast Cancer,"October 1, 2020","January 1, 2025",Recruiting,Interventional
2146,HCI130492,Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics,"May 3, 2021",August 2025,Recruiting,Interventional
2147,A171601,"Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer","August 15, 2018",August 2024,"Active, not recruiting",Interventional
2148,2021-0669,Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer,"December 31, 2022","December 31, 2023",Not yet recruiting,Observational
2149,BL-M07D1-101,A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors,"August 9, 2022",August 2024,Recruiting,Interventional
2150,S63330,FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.,"September 1, 2020","October 31, 2024",Recruiting,Interventional
2151,CA209-8H3,"Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients","April 3, 2019",April 2025,Recruiting,Interventional
2152,CARDIEJERCAN,Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients,"September 13, 2021","September 20, 2022",Not yet recruiting,Interventional
2153,E7090-J081-102,A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer,"October 9, 2020","April 30, 2024","Active, not recruiting",Interventional
2154,2574,Prospective Thinking in Hormone-Responsive Breast Cancer,"August 1, 2018","September 20, 2019",Completed,Interventional
2155,A5481122,Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy,"January 25, 2019","December 1, 2022","Active, not recruiting",Observational
2156,21-091,A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer,"December 15, 2021","December 15, 2023",Recruiting,Interventional
2157,VHIO20002,A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020,"May 11, 2022","April 11, 2025",Recruiting,Interventional
2158,439-21,High-intensity Exercise After Treatment,"March 28, 2022","July 30, 2023","Active, not recruiting",Interventional
2159,OP-1250-001,"A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer","August 13, 2020",December 2023,Recruiting,Interventional
2160,MC1835-ACCRU-BR-1701,"TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery","February 20, 2020","January 15, 2025",Recruiting,Interventional
2161,FDRT-BC010,Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases,"January 2, 2020","August 12, 2023","Active, not recruiting",Interventional
2162,H-45698,Topical Dermaprazole for Radiation Dermatitis in Breast Cancer and Head and Neck Cancer Patients (TOPAZ),April 2023,January 2027,Not yet recruiting,Interventional
2163,CCR5234,Digital Delivery of Information About Genetic Testing for Breast Cancer,"July 5, 2021",December 2022,"Active, not recruiting",Interventional
2164,1890-1-2019,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,"January 14, 2019","August 13, 2019",Completed,Observational
2165,IFG-06-2019,Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer,"March 11, 2021","March 15, 2023",Recruiting,Interventional
2166,11066,Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors,"July 17, 2021","January 1, 2025",Recruiting,Interventional
2167,PHDW-006,Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer,December 2020,December 2021,Unknown status,Observational
2168,OTT 17-02,Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients,"February 28, 2018","April 2, 2019",Completed,Interventional
2169,21094,CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer,"October 18, 2021","December 1, 2023",Recruiting,Interventional
2170,IEO 0837/,Patients Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer,"June 5, 2018","December 31, 2021",Unknown status,Observational
2171,CCR4772,PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related Lymphoedema,"October 13, 2021",April 2024,Recruiting,Interventional
2172,PECP,The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer,"December 1, 2018","November 30, 2020",Unknown status,Interventional
2173,UC-BCG-2205,Treatment for Breast Cancer Patients With Meninges Invaded by Tumor Cells,September 2023,March 2027,Not yet recruiting,Interventional
2174,UPCC 11121,"Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer","October 21, 2021",October 2039,Recruiting,Observational
2175,22-655,STOP-HER2: Stopping Trastuzumab in HER2+ MBC,June 2023,February 2036,Not yet recruiting,Interventional
2176,D8666C00004,To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.,"March 31, 2020","November 4, 2021",Withdrawn,Interventional
2177,AnhuiPH,A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2,"April 10, 2019","October 10, 2020",Unknown status,Observational
2178,NL67422.041.18,Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer,March 2021,November 2022,Unknown status,Interventional
2179,S-64813,"Clinical, Histological and In-depth Molecular Characterization as Well as Experimental Models of Liver Metastasis From Patients With Breast Cancer in Order to Identify New Potential Treatment Avenues.",March 2023,March 2025,Not yet recruiting,Observational
2180,17-0310,Narrative Visualization for Breast Cancer Survivors Physical Activity,"September 1, 2018","March 31, 2022",Completed,Interventional
2181,VICC BRE 20104,Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment,"August 9, 2021",December 2024,Recruiting,Observational
2182,2020-0831,Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment,"November 29, 2021","November 29, 2021",Withdrawn,Observational
2183,SDO-006-20-01,To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer,"April 27, 2020","January 28, 2021",Withdrawn,Interventional
2184,CBYL719A03201,Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant,"March 8, 2022","September 19, 2022",Terminated,Interventional
2185,ASSOCIHER,Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy,"May 1, 2022","October 1, 2022",Completed,Observational
2186,2021-40-2343,RWE About QOL and Compliance of Patients With OFS in China,November 2021,April 2024,Not yet recruiting,Observational
2187,CL0007,Investigation of Novel Surgical Imaging for Tumor Excision,"November 4, 2019","May 4, 2022",Completed,Interventional
2188,HSR210410,Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer,May 2022,October 2026,Not yet recruiting,Interventional
2189,MO39193,A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer,"January 11, 2018","September 30, 2024",Recruiting,Interventional
2190,"CD133, Breast Cancer",CD133 Expression in Mammary Invasive Ductal Carcinoma,"May 1, 2021","December 1, 2021",Recruiting,Observational
2191,NCI-2018-01581,"Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer","December 14, 2018","December 31, 2024",Recruiting,Interventional
2192,EPTTCSM (239BRC18.0129),Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer,"January 22, 2019","July 22, 2019",Unknown status,Observational
2193,ALTER-BC-003,AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer,July 2022,March 2024,Not yet recruiting,Interventional
2194,2021-0261,Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer,"April 23, 2021","May 9, 2022",Completed,Interventional
2195,H3B-6545-G000-102,A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer,"April 1, 2020","March 31, 2024","Active, not recruiting",Interventional
2196,SIB16134,Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer,"May 22, 2018","August 1, 2019",Withdrawn,Interventional
2197,QUILT-3.057,QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine,September 2018,December 2021,Withdrawn,Interventional
2198,AL-TNBC-01,A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer,"August 14, 2020",December 2023,"Active, not recruiting",Interventional
2199,CAR202,A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC,"November 5, 2021","August 9, 2024",Recruiting,Interventional
2200,69HCL19_0593,"PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study",December 2020,June 2023,Not yet recruiting,Observational
2201,41494,Feasibility of a Remotely-Delivered Yoga Intervention on Cognitive Function in Breast Cancer Survivors,"December 13, 2021","July 27, 2022",Completed,Interventional
2202,300007016,"Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations","September 1, 2021",December 2023,Recruiting,Interventional
2203,HSaleem,Kinesiology Taping Technique in Post-mastectomy Breast Cancer Related Lymphedema,"April 4, 2021","February 28, 2022",Recruiting,Interventional
2204,20D.876,SABR-CaRe in Early Stage Breast Cancer,"August 23, 2021","January 1, 2026",Recruiting,Interventional
2205,19D.799,A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer,"November 18, 2022",April 2023,Recruiting,Interventional
2206,112626,Three Fraction Radiation to Induce Immuno-Oncologic Response,"September 2, 2020",November 2024,Recruiting,Interventional
2207,220493,Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment,September 2018,August 2019,Unknown status,Interventional
2208,2020-q12,Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer,"June 22, 2021","July 31, 2025",Recruiting,Interventional
2209,2020-11/15,"The Effect of Art Therapy on Pain, Emesis, Anxiety and Quality of Life, Breast Cancer","September 1, 2021","October 7, 2022",Completed,Interventional
2210,22-225,ETHAN - ET for Male BC,February 2023,"April 1, 2036",Not yet recruiting,Interventional
2211,GM1-CIPN-202,"A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer","April 20, 2023","December 31, 2025",Not yet recruiting,Interventional
2212,21-110,Anti-anxiety Biotics for Breast Cancer Survivors,"July 20, 2021","May 1, 2022",Completed,Interventional
2213,21050,An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis,"December 21, 2022","February 25, 2025",Recruiting,Interventional
2214,1280-0022,The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread,"November 28, 2018","May 11, 2022",Completed,Interventional
2215,MC1733,A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer,"September 23, 2020","August 15, 2024",Recruiting,Interventional
2216,RLY-2608-101,"First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer","December 8, 2021","August 31, 2025",Recruiting,Interventional
2217,BL2014084,"This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment","September 1, 2018","December 31, 2019",Unknown status,Interventional
2218,ShandongCHI-04,The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy,"February 8, 2018","February 8, 2020",Unknown status,Interventional
2219,0124-18-TLV,Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor,January 2019,June 2021,Unknown status,Interventional
2220,20160504,Impact of Intensive Follow-up for Bone Metastasis on Characteristics and Prognosis of Chinese Breast Cancer Patients,"March 1, 2018","March 31, 2019",Completed,Observational
2221,55054,Inspiratory Muscle Training in Obese Breast Cancer Survivors,"July 1, 2023","June 30, 2029",Not yet recruiting,Interventional
2222,PILOT 171548,RISE - Reduce Sitting Time Among Breast Cancer Survivors,"March 29, 2022","February 7, 2023","Active, not recruiting",Interventional
2223,CLEE011A2207,"Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer","June 11, 2019","December 30, 2025","Active, not recruiting",Interventional
2224,IFG-NIB-01,Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC,"March 23, 2018","January 22, 2021",Completed,Interventional
2225,VICC BRE 17107,Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer,"July 10, 2018","December 10, 2020",Terminated,Interventional
2226,1710018694,Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients,"November 15, 2018","December 30, 2026",Recruiting,Interventional
2227,29747,T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer,"December 6, 2018","December 22, 2022",Completed,Interventional
2228,YWBC-001,"A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer","April 1, 2020","March 31, 2025",Recruiting,Observational
2229,294-2018,Efficacy Study of Mepitel Film the Prophylaxis of Radiation-Induced Skin Reactions in Breast Cancer Patients,"March 14, 2019","September 8, 2020",Completed,Interventional
2230,2022/005-OST,Exploratory Evaluation of the Functional/Emotional Life Characteristics During the First Year of Ongoing Endocrine Adjuvant Treatment With Aromatase Inhibitors in Breast Cancer Patients With Reduced Bone Mineral Density,"January 9, 2023","June 30, 2024",Recruiting,Observational
2231,WSG-AM08,"Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC","July 2, 2019","July 31, 2027",Recruiting,Interventional
2232,PRESSODOU-1809,Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer Surgery,"May 27, 2020",November 2023,Recruiting,Interventional
2233,IRB-53650,"Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer","October 13, 2020","October 22, 2021",Terminated,Interventional
2234,NCI-2018-01519,Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer,"September 12, 2018","June 1, 2027",Recruiting,Interventional
2235,NCI-2022-07265,"Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer, A ComboMATCH Treatment Trial","March 6, 2023","November 1, 2026",Recruiting,Interventional
2236,HLX10-013-TNBCneo,to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC),"April 17, 2020","April 9, 2027",Not yet recruiting,Interventional
2237,Pro00103625,Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer,"September 14, 2020","December 30, 2023","Active, not recruiting",Interventional
2238,MRG002-005,A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC),"May 13, 2021",February 2023,Recruiting,Interventional
2239,INT 192/19,Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer,"May 5, 2020","May 1, 2024","Active, not recruiting",Interventional
2240,AURORA US,Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer,"September 16, 2019","November 15, 2023",Recruiting,Observational
2241,G1T28-208,"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)","April 15, 2021","October 25, 2024","Active, not recruiting",Interventional
2242,2017/01,Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients,"January 10, 2018",January 2021,Unknown status,Interventional
2243,2017-004938-28,Satisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal Cure,"August 3, 2018","November 30, 2020",Completed,Interventional
2244,2020-001,"Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer","April 30, 2022","April 1, 2025",Not yet recruiting,Interventional
2245,G0F9119N,CoMoon for Supporting Breast Cancer Patients on Adjuvant Endocrine Therapy,"December 1, 2020","December 31, 2022",Completed,Interventional
2246,I-3010822,"Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer","May 1, 2023","April 1, 2027",Not yet recruiting,Interventional
2247,OP_1413,Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer,"October 1, 2021","September 1, 2025",Recruiting,Interventional
2248,18HH4880,D4 Choline Breast PET/CT,"February 24, 2022","November 3, 2024",Recruiting,Observational
2249,ZZBGCART-016,EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer,"May 1, 2022","May 1, 2025",Recruiting,Interventional
2250,STUDY00004257,"Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer","September 2, 2022","April 15, 2025",Recruiting,Interventional
2251,HYPART,HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).,"March 30, 2021","August 20, 2028",Recruiting,Interventional
2252,PALBO01/2021,Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period,"December 15, 2021","November 15, 2023",Recruiting,Observational
2253,21-038,Fulvestrant + Neratinib In Breast Cancer,December 2021,"December 1, 2024",Not yet recruiting,Interventional
2254,IUSCC-0647,Effects of Aromatase Inhibitor Therapy on Muscle Function,"July 26, 2018","February 7, 2020",Completed,Observational
2255,09.2019.865,Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema,"October 19, 2019","May 30, 2020",Unknown status,Interventional
2256,2022-A00171-42,Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment,"June 27, 2022","November 30, 2026",Recruiting,Observational
2257,AZV2022,The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors,"June 6, 2022",June 2025,Recruiting,Interventional
2258,UMCC 2021.056,An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors,"October 26, 2021","May 16, 2022",Completed,Interventional
2259,UC-0140/1814,"Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients","October 23, 2019","October 23, 2027",Recruiting,Interventional
2260,SL-2020076,Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude,October 2021,December 2024,Not yet recruiting,Observational
2261,IC 2020-15,Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer,"March 23, 2021","April 11, 2022",Completed,Observational
2262,BOOG 2019-01,"TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer","September 25, 2020",July 2024,Recruiting,Interventional
2263,NBG-19-01; SWEBCG 19-01,"NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC","December 20, 2019","June 30, 2035",Recruiting,Interventional
2264,RF-2016-02362383,Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer,"June 18, 2019",September 2023,Recruiting,Interventional
2265,2018/14-01,A New Mindfulness Intervention Called Mindfulness Based Swinging Technique (MBST) for Women With Breast Cancer,"November 29, 2018","October 20, 2022",Completed,Interventional
2266,UTD-1-BM-II,"The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.","July 20, 2022","July 20, 2025",Recruiting,Interventional
2267,3-2020-0448,Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence,"March 1, 2020","January 31, 2029",Recruiting,Interventional
2268,9764,"Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer","September 1, 2018","March 14, 2025",Withdrawn,Interventional
2269,CLEE011AUS65,Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors,"May 8, 2020","July 31, 2020",Completed,Observational
2270,LCCC1934,Reverse Axillary Mapping in Breast Radiation Treatment Planning,May 2021,January 2027,Withdrawn,Observational
2271,Lymphedema Rehabilitation,New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA),"March 1, 2019",September 2021,Unknown status,Interventional
2272,bakircaymzeren07,Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema,"March 20, 2023","September 1, 2023",Recruiting,Interventional
2273,EA1211,"Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial","May 11, 2023","March 31, 2025",Not yet recruiting,Interventional
2274,Pro2020001306,Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer,"May 18, 2021","January 31, 2024",Recruiting,Interventional
2275,IRB-30000320,"Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors","January 17, 2020","August 31, 2025",Recruiting,Interventional
2276,11B1920N_BCS-PAIN,The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors,"October 12, 2020",April 2024,Recruiting,Interventional
2277,17502,A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer,"December 10, 2019","December 31, 2024","Active, not recruiting",Interventional
2278,ShandongCHI-13,Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer,"November 1, 2020","June 1, 2021",Unknown status,Interventional
2279,2021SCR,Cone Beam Breast CT for Breast Cancer Screening,"October 30, 2021","October 30, 2023","Active, not recruiting",Interventional
2280,Pro00109777,Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib,"September 1, 2022",April 2025,Recruiting,Interventional
2281,MIMIR-mTNBC,Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer,"March 1, 2023","May 20, 2027",Not yet recruiting,Observational
2282,2861/20,Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer,"March 1, 2021","April 30, 2028",Recruiting,Interventional
2283,STUDY00146320,Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens,"December 14, 2021","January 31, 2026",Recruiting,Interventional
2284,2-114-18,Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer?,"May 13, 2019","June 30, 2020",Unknown status,Interventional
2285,VMA-253-18,Fish Oil and EPO in Breast Cancer,"February 20, 2019","June 20, 2024",Recruiting,Interventional
2286,2018-01-054,Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy,"March 1, 2018","August 31, 2023","Active, not recruiting",Observational
2287,2.073.549,Pilates and Dance to Breast Cancer Patients Undergoing Treatment,"January 1, 2018","December 30, 2020",Completed,Interventional
2288,2020-12518,Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer,"July 16, 2020","July 1, 2027",Recruiting,Observational
2289,NCI-2020-02319,Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer,"August 10, 2020","December 31, 2023",Recruiting,Interventional
2290,2022-A00437-36,Impact of Sleep Disturbance on Cognition and Quality of Life in Breast Cancer,October 2022,June 2027,Not yet recruiting,Interventional
2291,BMTN,Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer,"July 1, 2018","February 15, 2021",Completed,Interventional
2292,30388,"Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors","April 19, 2019","November 30, 2024","Active, not recruiting",Interventional
2293,WO40181,"A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy","September 6, 2018","May 6, 2021",Terminated,Interventional
2294,SM-88-001,Study of SM-88 in Advanced Cancers,October 2022,October 2023,Withdrawn,Interventional
2295,GY202201,Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia,"October 20, 2022",June 2025,Recruiting,Interventional
2296,NL76792.091.21,DLSCT for Breast Cancer Detection in Women With Dense Breasts,"January 1, 2022","January 1, 2023",Recruiting,Observational
2297,UKT HT03_1,Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy,"August 1, 2020","December 31, 2026",Recruiting,Observational
2298,P170407J,Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer,"November 28, 2019","August 30, 2022",Completed,Interventional
2299,BRAVE,QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.,"July 14, 2021","July 30, 2022",Enrolling by invitation,Observational
2300,20190304-01H,"Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic Arm and Chest Pain","September 1, 2022","December 31, 2023",Not yet recruiting,Interventional
2301,QF-SC10914-203,A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients,"August 12, 2020","August 30, 2022",Unknown status,Interventional
2302,A011801,"T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial","January 6, 2021",May 2035,Recruiting,Interventional
2303,H19-02480,BREast Cancer And Sexuality Treatment,"January 6, 2020",December 2023,"Active, not recruiting",Interventional
2304,190025,Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies,"January 4, 2022","December 29, 2023",Enrolling by invitation,Observational
2305,ICS Maugeri - CE 2202,Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer,"June 1, 2018","June 30, 2021",Completed,Interventional
2306,CBCSG041,Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction,"September 1, 2022","October 1, 2027",Not yet recruiting,Interventional
2307,IRB202000746,"A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)","September 26, 2020","September 26, 2029","Active, not recruiting",Interventional
2308,D926PC00001,"A Study of Dato-DXd Versus Investigators Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)","May 16, 2022","December 3, 2025",Recruiting,Interventional
2309,IRB00376235,The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer,"November 1, 2023","December 31, 2028",Not yet recruiting,Interventional
2310,PILHLE-001,"Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial","May 19, 2021","May 19, 2028",Recruiting,Interventional
2311,HCRN BRE18-360,Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physicians Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases,"March 9, 2022",September 2026,Recruiting,Interventional
2312,19-1974.cc,Appetite and Exercise in Breast Cancer Survivors,"February 7, 2020","February 5, 2022",Completed,Interventional
2313,21-579,Low-field MRI for Breast Cancer Screening,September 2022,"September 1, 2024",Not yet recruiting,Interventional
2314,A5481151,Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor,"September 1, 2021","September 1, 2021",Completed,Observational
2315,HS-10342-201,A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer,"September 30, 2021","December 31, 2023",Not yet recruiting,Interventional
2316,WEBAPPAC,Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer,"September 3, 2020","March 3, 2025",Recruiting,Interventional
2317,108818,Early Detection of Cardiac Damage With CMR in Women With Breast Cancer,"March 1, 2020","March 31, 2021",Unknown status,Observational
2318,2020-01-mp-BUS,Multi-parametric Breast Ultrasound Imaging as a Potential Biomarker for Breast Cancer,"November 15, 2020","December 13, 2021",Completed,Interventional
2319,NCI-2019-00048,"A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer","February 13, 2019","February 19, 2022",Withdrawn,Interventional
2320,Maple Tree Exercise,Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients,"August 23, 2019",December 2021,Unknown status,Interventional
2321,22145,Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer,"June 15, 2020","October 5, 2020",Completed,Interventional
2322,ERC/2019/10/05,Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria,"October 5, 2019","June 30, 2023",Recruiting,Interventional
2323,19-001881,Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors,"September 29, 2021","November 1, 2024",Recruiting,Interventional
2324,OSU-21185,Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors,"November 14, 2022","December 31, 2023",Recruiting,Interventional
2325,I 60517,Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice,"February 6, 2019","August 30, 2022",Completed,Interventional
2326,MC220303,Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women,"March 10, 2023","January 15, 2033",Not yet recruiting,Observational
2327,STU-2020-1043,Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib,"April 15, 2021","December 22, 2024",Recruiting,Interventional
2328,TCHP,Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer,"August 1, 2019","July 31, 2021",Unknown status,Interventional
2329,IndonesiaU2022,The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer,"August 19, 2022",February 2025,Recruiting,Interventional
2330,STUDY00003100,Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts,"May 20, 2021",July 2024,Recruiting,Interventional
2331,041-2018,Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer,"July 18, 2018","March 31, 2023",Completed,Interventional
2332,RESCREEN,Optimized Rehabilitation Following Primary Breast Cancer Surgery,"November 15, 2018",November 2025,Recruiting,Interventional
2333,20-009279,Evaluating the Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Women Receiving Chemotherapy for Stage I-III Breast Cancer,"April 14, 2021","April 15, 2024",Recruiting,Observational
2334,IRB-57111,Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients,"March 15, 2021","October 31, 2026","Active, not recruiting",Interventional
2335,A221803,Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy,"June 15, 2022","December 31, 2025",Recruiting,Interventional
2336,PUMCH-2020-EBC,A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients,June 2020,June 2027,Not yet recruiting,Observational
2337,Organoids Breast,Developing Breast (Cancer) Organoids,"September 1, 2022","May 1, 2028",Recruiting,Observational
2338,KKKR-Neulasta OS-01,An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®),"January 18, 2018","June 30, 2021",Completed,Observational
2339,H19094,Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer Patients,"May 4, 2020","April 6, 2021",Completed,Interventional
2340,BYEC20211201,Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC,"January 14, 2022","June 1, 2024",Recruiting,Interventional
2341,D0819C00005,Lynparza Breast Cancer Clinical Experience Investigation,"August 14, 2018","March 24, 2022",Completed,Observational
2342,18-140,Sexual Health and Rehabilitation After Ovarian Suppression Treatment,"December 1, 2018","December 1, 2019",Completed,Interventional
2343,2022-0959,Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery,"August 31, 2023","December 31, 2028",Not yet recruiting,Interventional
2344,20-133,A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer,"June 23, 2020",June 2024,"Active, not recruiting",Interventional
2345,16-185671,Integrative Approaches to Cancer Survivorship: Project 3,"April 17, 2018","January 30, 2020",Completed,Interventional
2346,FM-17-B01,Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer,"September 7, 2018","June 15, 2027","Active, not recruiting",Interventional
2347,SunYatsenU2H-LQ3,"A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC","August 3, 2020",August 2032,Recruiting,Interventional
2348,STUDY00001007,Peer Support For Young Adult Women With High Breast Cancer Risk,"July 15, 2020",June 2025,Recruiting,Interventional
2349,HCC 20-243,Apollo Device for Metastatic Breast Cancer (MBC),"February 1, 2021",March 2026,Recruiting,Interventional
2350,Alaa_Negm_MSc_2023,"Effect of Kinesiotaping Augmented By Resistive Exercise on Fatigue, Physical Strength, Quality of Life in Breast Cancer Survivors","February 20, 2023","June 20, 2023",Not yet recruiting,Interventional
2351,21656,"A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer","October 14, 2022","December 7, 2024",Recruiting,Interventional
2352,STUDY00007842,Music as a Perioperative Therapy in Breast Cancer Patients,"July 10, 2019","October 27, 2021",Withdrawn,Interventional
2353,20-221,Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity,"August 12, 2021","June 15, 2026",Recruiting,Interventional
2354,E-HHC-2016-0245,Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer,"April 11, 2018","March 25, 2022",Suspended,Interventional
2355,I 1680021,Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer,"April 7, 2023","December 7, 2025",Not yet recruiting,Interventional
2356,ACCRU-BR-1801,T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer,"November 11, 2020","February 16, 2022",Withdrawn,Interventional
2357,HE072-CSP-002,Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance,April 2021,April 2024,Not yet recruiting,Interventional
2358,M18BEL,Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO,"October 4, 2019","January 7, 2027",Recruiting,Interventional
2359,"UPCC# 15122, IRB # 852205",CAR T Cells in Mesothelin-Expressing Breast Cancer,"February 6, 2023",February 2038,Recruiting,Interventional
2360,2020-01,Exercise Therapy During Radiotherapy,"October 10, 2020","April 10, 2021",Unknown status,Interventional
2361,LCCC1745,"ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer","May 10, 2018","July 15, 2021",Completed,Observational
2362,BPI-1178-2019-001,A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer,"June 15, 2020","March 15, 2024",Recruiting,Interventional
2363,UC-0140/1901,Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer,"June 11, 2020",June 2028,Recruiting,Interventional
2364,HMCC-BR22-001,Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC),"January 12, 2023","December 2, 2028",Recruiting,Interventional
2365,2022-0378,Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care,April 2023,September 2028,Recruiting,Interventional
2366,IRB-58571,Analysis of Patient Understanding of Radiation Therapy Among Patients With Breast Cancer,"January 20, 2021","October 12, 2021",Completed,Interventional
2367,TransRosaLEE-IPC 2021-075,"Trans-RosaLEE Study: a Biomarker-directed, Translational Study","January 1, 2023","October 1, 2027",Not yet recruiting,Interventional
2368,2000024495,Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer,"July 22, 2019","August 30, 2023","Active, not recruiting",Interventional
2369,NCC1692,Anlotinib in Metastatic HER2 Negative Breast Cancer,"July 12, 2018","March 15, 2020",Completed,Interventional
2370,NCI-2019-06461,"Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer","December 6, 2019","June 30, 2023",Recruiting,Interventional
2371,CIH-TZS-20190912,Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China,"September 13, 2019","May 31, 2023",Recruiting,Observational
2372,TROIKA,"A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients","February 19, 2018","January 13, 2022",Completed,Interventional
2373,19/002,"Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer","March 1, 2021","September 30, 2025",Recruiting,Interventional
2374,17-00890,Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC),"May 2, 2019",May 2023,"Active, not recruiting",Interventional
2375,UMCC 2021.109,Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer,"March 28, 2022",October 2023,Recruiting,Interventional
2376,249571,Mini-AFTERc Intervention for Fear of Cancer Recurrence,"June 13, 2019","September 1, 2020",Unknown status,Interventional
2377,HNCH-BC001,The TP Regimen in the Treatment of Early Triple Negative Breast Cancer,"November 23, 2018","November 26, 2022",Completed,Interventional
2378,17782,A Study of Abemaciclib in Indian Women With Advanced Breast Cancer,"February 22, 2021","March 3, 2023",Recruiting,Interventional
2379,0201-21,Implantation of CEST and CESL MRI Methods for Detection of Breast Tumors,May 2022,"May 31, 2025",Not yet recruiting,Interventional
2380,0201263,Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer,"June 28, 2019","June 28, 2021",Unknown status,Interventional
2381,HCI103657,Merestinib on Bone Metastases in Subjects With Breast Cancer,"January 11, 2018","June 24, 2019",Terminated,Interventional
2382,KutahyaMSUcancer,Clinical Classification of Pain in Breast Cancer Survivors,"July 1, 2023","October 1, 2023",Recruiting,Observational
2383,AAAS9859,Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI),"January 19, 2022",May 2025,Recruiting,Interventional
2384,ExtremeHypofractionationBreast,Postoperative Radiation of Patients With Breast Cancer in Extreme Hypofractionation.,"August 1, 2022","July 30, 2035",Not yet recruiting,Observational
2385,S-169,Complementary and Alternative Medicine on Mental Health in Breast Cancer Patients,"July 1, 2020","October 30, 2021",Unknown status,Interventional
2386,NCI-2022-10810,"Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer","March 2, 2023","February 23, 2027",Recruiting,Interventional
2387,LQ004,Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer,"November 1, 2018","June 1, 2020",Unknown status,Interventional
2388,HS627-III,Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel,"June 30, 2020","November 20, 2021",Unknown status,Interventional
2389,RG1004302,Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer,"April 8, 2020","February 1, 2025",Recruiting,Interventional
2390,CORE,Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity,"April 1, 2018","May 1, 2018",Terminated,Interventional
2391,001,The Efficacy of Acupuncture as a Complementary Treatment for Pain and Anxiety After Breast Cancer Surgery,November 2020,March 2023,Unknown status,Interventional
2392,ENZENO-C-101,ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study),"July 26, 2021","January 31, 2024",Recruiting,Interventional
2393,UMCC 2020.122,"Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer","March 4, 2021",July 2023,Recruiting,Interventional
2394,2022/050,Telerehabilitation in Survival Breast Cancer Patients,"October 20, 2022","December 30, 2023",Recruiting,Interventional
2395,BR01/01/22,Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer,"December 31, 2022","December 31, 2026",Not yet recruiting,Interventional
2396,2021-A03166-35,Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.,"July 1, 2022","January 1, 2025",Not yet recruiting,Interventional
2397,ATENTO19,Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO),"September 30, 2021","September 30, 2023",Recruiting,Interventional
2398,Pro00100093,A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer,"March 1, 2019",December 2024,Recruiting,Interventional
2399,19206,Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.,"March 25, 2020","December 15, 2023",Recruiting,Interventional
2400,POLAR-01,Treatment With Pyrotinib-Based Therapy in Lapatinib Resistant HER2-Positive Metastatic Breast Cancer,"August 1, 2018",June 2021,"Active, not recruiting",Observational
2401,STUDY00002373,Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy,"December 1, 2022","July 31, 2025",Not yet recruiting,Interventional
2402,09.2018.,Diagnostic Accuracy of Dermal Thickness in Lymphedema,"September 28, 2018","December 19, 2018",Completed,Observational
2403,SCHBCC-N048,Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.,"March 17, 2023","January 1, 2027",Recruiting,Interventional
2404,S2020-09,Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor,"September 18, 2020","May 30, 2023",Recruiting,Interventional
2405,CA048-001,A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread,"September 22, 2020","August 15, 2022",Completed,Interventional
2406,S00748-NIM,Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial,"March 1, 2023","February 28, 2024",Not yet recruiting,Interventional
2407,NEO-R-IPC 2019-041,Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy,"November 3, 2022",January 2030,Recruiting,Observational
2408,22-074,A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer,"October 3, 2022",October 2027,Recruiting,Interventional
2409,UW 19-045,Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy,"November 18, 2019",April 2022,Unknown status,Interventional
2410,3-2020-0343,Primary Surgical Prevention of Breast Cancer-related Lymphedema,"January 1, 2021","December 31, 2027",Not yet recruiting,Interventional
2411,18549,Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema,"April 19, 2019","March 31, 2024","Active, not recruiting",Interventional
2412,2017-073,The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer,"March 9, 2018","May 31, 2023","Active, not recruiting",Interventional
2413,201710109,Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy,"August 8, 2019","February 25, 2023","Active, not recruiting",Interventional
2414,lithium and breast cancer,Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients,"August 1, 2020","June 1, 2022",Completed,Interventional
2415,KSF2-1707,Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer,"March 23, 2018",January 2028,"Active, not recruiting",Interventional
2416,RG1718047,"Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer","April 1, 2019","October 30, 2022",Withdrawn,Interventional
2417,19-0448,Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer,"September 10, 2019","September 10, 2027",Recruiting,Observational
2418,Multimodal Project,Multimodal Project,January 2023,September 2023,Not yet recruiting,Interventional
2419,22-490,VS-6766+Abema+Fulv in Met HR+/HER- BC,"March 27, 2023","December 31, 2028",Recruiting,Interventional
2420,C-MOT,Copenhagen Master Observational Trial,"August 1, 2021","December 31, 2023",Recruiting,Observational
2421,EGC002,Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer,"October 16, 2018","January 20, 2022",Completed,Interventional
2422,2016-003518-28,Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer,December 2018,December 2021,Unknown status,Interventional
2423,ZLiu,Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer,"July 18, 2018","June 1, 2022",Unknown status,Observational
2424,XJLL-KY20212136,RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer,"November 26, 2021","September 30, 2025",Not yet recruiting,Interventional
2425,SYSKY-2022-445-01,"Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study","April 1, 2023","December 30, 2023",Not yet recruiting,Observational
2426,CGAprediting,The Value of Geriatric Assessments in Older Patients With Breast Cancer,"April 1, 2018","May 1, 2025",Recruiting,Observational
2427,CMUH107-REC3-102,Yoga for Aromatase Inhibitor-related Knee Pain Relief in Breast Cancer Patients,"March 10, 2019","September 5, 2019",Completed,Interventional
2428,J17118,Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC,"July 20, 2018","July 1, 2024",Recruiting,Interventional
2429,19P.117,Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences,"May 20, 2019",October 2023,"Active, not recruiting",Interventional
2430,TX05-03,"Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer","June 28, 2018","February 4, 2021",Completed,Interventional
2431,BR01/02/19,Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA),"August 14, 2019",October 2024,Recruiting,Interventional
2432,HCRN BRE19-433,"A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer","April 1, 2021",July 2024,"Active, not recruiting",Interventional
2433,BC-P32,Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer,"March 6, 2023","March 6, 2025",Not yet recruiting,Observational
2434,THALIA-01,Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study,"August 1, 2019",December 2022,Recruiting,Observational
2435,HBO001,Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy,"July 1, 2019","May 1, 2024","Active, not recruiting",Interventional
2436,2023-3181,Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery,"November 4, 2022","December 1, 2023",Recruiting,Interventional
2437,CH-BC-086,Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC,"September 1, 2021","September 1, 2022",Recruiting,Observational
2438,2016/65,Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer,"October 25, 2018","October 24, 2025","Active, not recruiting",Interventional
2439,UW21062,Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals,"August 24, 2021","July 28, 2022",Completed,Interventional
2440,2020-006,Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients,"September 16, 2020","May 20, 2021",Completed,Interventional
2441,2018/8361/I,MUltimodal Targeted Axillary Surgery,"October 23, 2019","November 15, 2022",Recruiting,Interventional
2442,20210901-jiangchunling,A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases,"March 1, 2022","September 30, 2024",Recruiting,Interventional
2443,01,Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer,"June 5, 2021","March 29, 2022",Recruiting,Interventional
2444,2020KT151,Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab,"May 10, 2021","December 10, 2023",Recruiting,Observational
2445,NCC3222,Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- ABC,"December 1, 2021","June 1, 2024",Recruiting,Observational
2446,427 BC SDM,Enhancing Shared Decision-Making in Breast Cancer,"December 11, 2018","December 31, 2022",Completed,Interventional
2447,STUDY00018239,Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer,"May 3, 2018","November 18, 2020",Completed,Interventional
2448,IJB-EBC-Decrescendo-2020,De-escalation Adjuvant Chemo in HER2+/ER-/Node-neg Early BC Patients Who Achieved pCR After Neoadjuvant Chemo & Dual HER2 Blockade,"January 17, 2022",March 2029,Recruiting,Interventional
2449,170115,T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery,"April 18, 2018","June 30, 2023","Active, not recruiting",Interventional
2450,EQ132-201,A Study of Lerociclib in Participants With Advanced Breast Cancer,"December 21, 2021",May 2026,Recruiting,Interventional
2451,NCO-21001,Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma,"February 4, 2021",December 2022,Recruiting,Interventional
2452,ACT16106,"Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer","February 4, 2020","May 28, 2021",Terminated,Interventional
2453,FASCINATE-N,Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy,"November 1, 2022",September 2025,Recruiting,Interventional
2454,IRB00154162,Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection,"March 1, 2022","February 2, 2024",Recruiting,Observational
2455,CHUV-DO-0009-CyberImmunoBreast,CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC),"April 8, 2021",December 2025,Recruiting,Interventional
2456,ANG1005-CLN-07,ANG1005 in Leptomeningeal Disease From Breast Cancer,September 2022,December 2024,Not yet recruiting,Interventional
2457,17471,Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer,"June 14, 2018","December 29, 2023","Active, not recruiting",Interventional
2458,BAIBU-FTR-ED-001,Effect of Different Bandage Interface Pressures on Breast Cancer Related Lymphedema,"June 1, 2019","May 18, 2022",Completed,Interventional
2459,Shengjing-LJY02,DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast,"October 1, 2019","September 1, 2026",Recruiting,Interventional
2460,PEMBRACA,Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA),"December 12, 2018","January 30, 2023",Completed,Interventional
2461,KaratayUHaticeTEZ,The Effect of Training Given by Mobile Application to Women Undergoing Breast Surgery,"June 1, 2022","December 1, 2022",Completed,Interventional
2462,22-10590-BO,Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients,April 2022,December 2023,Not yet recruiting,Observational
2463,Manual Therapy BCS,Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer Survivors,"November 1, 2019","February 27, 2020",Terminated,Interventional
2464,KUH5101090,"The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients","March 21, 2018","March 21, 2018",Withdrawn,Interventional
2465,16-015,Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib,"April 24, 2018","October 28, 2021","Active, not recruiting",Interventional
2466,IIT-2017-MM-BRST-Her2noRT,Omission of Radiation in Patients With Her-2 Positive Breast Cancer,"February 23, 2018","December 31, 2026",Recruiting,Interventional
2467,YBCSG-21-01,Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab,"September 15, 2021","October 31, 2024",Recruiting,Interventional
2468,GBG 97,Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer,"March 15, 2018","July 31, 2022","Active, not recruiting",Interventional
2469,DOT-1871-KIE-0120-I,Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW,June 2021,March 2023,Withdrawn,Interventional
2470,PROICM 2018-02 SKY,Feasibility Study: Yoga Educational Project,"August 31, 2018","July 30, 2019",Completed,Interventional
2471,2016-6346,Comparison of Healthy Diets on Breast Cancer Markers,"June 22, 2018","August 25, 2020",Completed,Interventional
2472,UniUrb_21/10.07.2019,Movement and Health Beyond Care (MoviS),"January 7, 2020","November 30, 2025",Recruiting,Interventional
2473,NCI-2016-01293,Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer,"March 16, 2018","June 3, 2023","Active, not recruiting",Interventional
2474,BOOG 2021-01 SEQUEL-Breast,SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast),"June 2, 2022",March 2028,Recruiting,Interventional
2475,GRASPA-TNBC-2018-02,Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2),"June 13, 2019","March 31, 2022",Terminated,Interventional
2476,4-2017-1108,"Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy","February 1, 2018","February 1, 2024",Recruiting,Observational
2477,SIMR_onc19_IIS_DAndre_Ashwaga,Ashwagandha for Cognitive Dysfunction,"January 1, 2020","November 1, 2022",Unknown status,Interventional
2478,RI-002,Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring),"June 1, 2018","November 1, 2018",Completed,Observational
2479,N19TON,Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients,"February 21, 2020","December 15, 2026",Recruiting,Interventional
2480,20170770,"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer","February 26, 2020","January 14, 2027",Recruiting,Interventional
2481,1070741-1,Subclinical Lymphedema Treatment Study,"April 1, 2018",December 2025,"Active, not recruiting",Interventional
2482,GATTUM -1,Gated Radiotherapy in Left Sided Breast Cancer Patients,May 2018,December 2019,Unknown status,Observational
2483,Soh-Med-23-02-16,Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients,"April 1, 2023","August 1, 2025",Not yet recruiting,Interventional
2484,MCC-19337,HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer,"June 6, 2018",August 2024,Recruiting,Interventional
2485,YX2021-070(F1),Effect of Intravenous S-ketamine on Opioid Consumption,"October 7, 2021","July 7, 2023",Recruiting,Interventional
2486,2020-1138,A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer Patients,"February 1, 2021","March 31, 2022",Completed,Interventional
2487,1B-16-11,Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer,"July 29, 2019","July 29, 2025",Withdrawn,Interventional
2488,7119-001,A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001),"April 8, 2021","December 6, 2028","Active, not recruiting",Interventional
2489,LCI-BRE-MTN-NIR-001,LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer,"April 1, 2021",January 2026,Withdrawn,Interventional
2490,CDX-ONC-101,"A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer","January 15, 2023","January 30, 2025",Not yet recruiting,Interventional
2491,18175,"A Study of Imlunestrant, Investigators Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer","October 4, 2021","August 31, 2027",Recruiting,Interventional
2492,432-17,Facilitating Oncology Patient-Clinician Communication Via E-health Innovations,"January 31, 2018","December 20, 2019",Completed,Interventional
2493,2021332GD,Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy,"June 15, 2021","August 15, 2023",Not yet recruiting,Interventional
2494,2021-1031,"A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer","October 28, 2022","January 1, 2025",Recruiting,Interventional
2495,PRO2,Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer During Chemotherapy in Combination With HER2-targeted Therapy or Antibody-drug Conjugate Therapy.,"August 29, 2022","March 29, 2024",Recruiting,Interventional
2496,KTI-21-01,Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC),"July 1, 2023","December 31, 2024",Not yet recruiting,Interventional
2497,MO42319,A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC),"June 7, 2021","December 31, 2029","Active, not recruiting",Interventional
2498,I 62218,Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer,"January 9, 2019","June 2, 2023","Active, not recruiting",Interventional
2499,ICL-2022-1,Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog),July 2023,September 2025,Not yet recruiting,Interventional
2500,21152,Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer,"June 21, 2022","September 7, 2023",Recruiting,Interventional
2501,22-364,Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer,"January 30, 2023","January 30, 2028",Recruiting,Interventional
2502,18238,Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer,"March 11, 2022","February 16, 2026",Recruiting,Interventional
2503,NCI-2019-02752,Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer,"October 21, 2019","November 1, 2023",Recruiting,Interventional
2504,4090,Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.,"August 13, 2020","November 19, 2021",Completed,Interventional
2505,E2019316,A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer,"May 1, 2020",June 2022,Unknown status,Interventional
2506,BLTN-Ig,Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer,"July 7, 2020","December 30, 2023","Active, not recruiting",Interventional
2507,Pro00080769,Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA),"October 4, 2018","June 30, 2022",Completed,Interventional
2508,ISK-N103,"Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer","September 6, 2018","April 21, 2020",Withdrawn,Interventional
2509,BCIG,Clinical Study of Imaging Genomics Based on Machine Learning for BCIG,"December 1, 2020","December 30, 2023",Not yet recruiting,Observational
2510,RECHMPL20_0130,Contraception and Cervical and Breast Cancer Screening in Obese Versus Non-obese Women,"June 1, 2020","September 1, 2021",Completed,Observational
2511,OSU-17122,Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors,"March 6, 2019","December 31, 2023",Recruiting,Interventional
2512,STao-003,Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer,"June 24, 2019","June 26, 2023",Not yet recruiting,Interventional
2513,2018-0473,Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer,"July 31, 2019","February 28, 2024",Recruiting,Interventional
2514,MCC-21-18633,Entertainment Media to Deliver Educational Messages About Mammography in Saudi Arabia,"February 10, 2022","March 14, 2022",Completed,Interventional
2515,SKB264-Ⅱ-07,SKB264 +/- KL-A167 in Recurrent or Metastatic Triple-negative Breast Cancer,July 2022,July 2024,Not yet recruiting,Interventional
2516,PTC-breastNAT,PTC Guiding Neoadjuvant Treatment in Breast Cancer,"November 1, 2021","December 31, 2023",Not yet recruiting,Interventional
2517,LonghuaH,Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women,"January 4, 2019","December 1, 2019",Unknown status,Interventional
2518,ZL-1302-002,A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC,"January 13, 2020",September 2021,Unknown status,Interventional
2519,2019-0638,Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer,"December 3, 2020","December 31, 2023",Recruiting,Interventional
2520,Fudan-P1-201701,PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients,"May 15, 2019","December 30, 2022","Active, not recruiting",Interventional
2521,OTT 18-01,Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL),"October 31, 2018",December 2023,"Active, not recruiting",Interventional
2522,NU 19B07,"SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer","November 10, 2022","November 10, 2022",Withdrawn,Interventional
2523,MEDOPP445,Preventive stRategy for IMMU132-relatED AEs in TNBC - PRIMED,"February 7, 2023","December 14, 2025",Recruiting,Interventional
2524,OSU-21035,Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors,"June 28, 2021","August 31, 2025",Recruiting,Interventional
2525,NCC1786,Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer,"January 1, 2019","March 1, 2025",Recruiting,Interventional
2526,CBYL719C2005,Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib,"February 28, 2022","June 30, 2023",Recruiting,Observational
2527,69HCL21_0552,NEOZOL_Follow-up Study,May 2021,"December 31, 2021",Not yet recruiting,Observational
2528,ICR-CTSU/2017/10065,PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer,"October 15, 2019",December 2025,Recruiting,Interventional
2529,Neo-RT,Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible,"March 26, 2018","December 31, 2022",Recruiting,Observational
2530,ZG-2021-002,ZetaFuse™ Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body,"September 1, 2022",September 2023,Recruiting,Interventional
2531,LUT-RD-02-01,LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients,"January 30, 2021","July 15, 2022",Completed,Interventional
2532,OSU-18174,A QoL Intervention for Young African American Breast Cancer Survivors,"August 1, 2022","September 30, 2023",Recruiting,Interventional
2533,20-166,Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC,"July 20, 2020","April 1, 2027",Recruiting,Interventional
2534,OSU-20101,A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer,"June 1, 2022","December 31, 2024",Recruiting,Interventional
2535,DR210090_SILENCE,Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea,"June 1, 2022","May 1, 2024",Not yet recruiting,Interventional
2536,VICC BRE 18108,A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer,"July 8, 2019",May 2025,Recruiting,Interventional
2537,RIGAIN,RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer,"August 20, 2019","December 31, 2030",Recruiting,Interventional
2538,Survey_App,Anonymous Survey of Breast Cancer Patients Concerning Their Use of Medical Apps,"September 1, 2022",August 2023,Recruiting,Interventional
2539,ML42876,The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy,"April 29, 2021","November 15, 2021",Recruiting,Observational
2540,N201912134,A Patient-centered Continuous and Interdisciplinary Shared Decision Making Approach for Breast Cancer Rehabilitation,"May 5, 2020","May 5, 2021",Unknown status,Interventional
2541,INCMNSZ REF 1239,Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients,"February 1, 2018",November 2021,Unknown status,Interventional
2542,19-031,ADVANCE (A Pilot Trial),"March 21, 2019","March 21, 2023","Active, not recruiting",Interventional
2543,OSU-18201,Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer,"January 9, 2019","December 31, 2023","Active, not recruiting",Interventional
2544,UW18063,Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS,"January 3, 2019","December 31, 2024",Recruiting,Interventional
2545,IRST174.21,"Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy","August 2, 2019","April 4, 2022",Unknown status,Interventional
2546,PEAR-TNBC_ Protocol_v2.0,Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment,"June 6, 2022","December 31, 2024",Recruiting,Observational
2547,SAHZhejiangU---Breast,Application of Radiomics in Breast Cancer,"January 1, 2018",December 2028,Recruiting,Observational
2548,I 2612022,Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer,"May 1, 2023",May 2027,Not yet recruiting,Interventional
2549,IRB00049171,Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer,"June 21, 2018","March 5, 2020",Completed,Observational
2550,MA-BC-II-002,Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer,"May 22, 2020","December 1, 2023",Recruiting,Interventional
2551,UPCC 21118,"HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer","October 15, 2020",April 2024,Recruiting,Interventional
2552,RG1122380,STEMVAC in Patients With Early Stage Triple Negative Breast Cancer,"November 17, 2022","April 30, 2024",Recruiting,Interventional
2553,M21CAR,DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy,July 2022,May 2037,Not yet recruiting,Interventional
2554,MHICC-2018-003,"Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia","December 2, 2021",January 2026,Recruiting,Observational
2555,H-1912-010-086,To Assess the Efficacy of the LYMPHA in the Prevention of Lymphedema Following Axillary Dissection for Breast Cancer,"March 5, 2020","February 28, 2022",Unknown status,Interventional
2556,DAN-22220205,A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer,"February 2, 2022","April 30, 2024",Recruiting,Interventional
2557,RG1003977,Acute Exercise Intervention in Reducing Breast Cancer Risk in Healthy Participants,"March 25, 2019","June 30, 2022",Completed,Interventional
2558,IFOM-CPT008/2022/PO007,Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel,"December 15, 2022",November 2025,Recruiting,Interventional
2559,BabesBolyaiOncovox,A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial,"November 15, 2021",May 2022,Recruiting,Interventional
2560,R21052,Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO),"May 28, 2022","April 1, 2025",Recruiting,Observational
2561,V2011801,P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .,"December 30, 2021","June 30, 2023",Withdrawn,Interventional
2562,20190812,Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy,"September 1, 2019","September 30, 2020",Completed,Interventional
2563,2022-0239,Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen,"May 1, 2022",October 2032,Recruiting,Observational
2564,4070,A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients,"January 23, 2020","February 8, 2020",Terminated,Interventional
2565,MCC-19-14621,Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx,"May 10, 2019","April 18, 2022",Completed,Interventional
2566,I-19-04120,Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer,"April 7, 2022","April 15, 2025",Recruiting,Interventional
2567,042001,"INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study","July 13, 2020","September 30, 2023",Recruiting,Interventional
2568,R.18.02.33,Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy,"August 1, 2019","August 1, 2026",Recruiting,Interventional
2569,i 67518,Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors,"March 25, 2019","May 21, 2021",Terminated,Interventional
2570,268-2017,Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control,"May 19, 2018","January 30, 2022",Completed,Interventional
2571,CADPT01A12101C,Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).,"January 31, 2019","February 6, 2023",Terminated,Interventional
2572,Exactis-05,RWD Study in HER2+ mBC Patients in Third-Line Therapy,"October 1, 2020","May 30, 2021",Completed,Observational
2573,GIM25-CAPT,Atezolizumab Plus CArboplatin Plus Nab-paclitaxel,"July 3, 2020","July 3, 2024",Recruiting,Interventional
2574,STUDY00002985,Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer,"October 22, 2021","December 31, 2024",Recruiting,Interventional
2575,767/29-09-2017,Vaginal Laser Therapy in Breast Cancer Survivors,"December 1, 2018",August 2020,Unknown status,Interventional
2576,HCI153239,"Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC","January 6, 2023","September 30, 2027",Suspended,Interventional
2577,2022-191,Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients,April 2023,July 2027,Not yet recruiting,Interventional
2578,WSG-AM12,NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer,March 2023,June 2028,Not yet recruiting,Interventional
2579,CSIIT-C37,Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer,"May 1, 2023","September 1, 2024",Not yet recruiting,Interventional
2580,16-304,Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma,"April 1, 2018","April 1, 2030","Active, not recruiting",Interventional
2581,ELA-0121,Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer,"August 31, 2022",December 2025,Recruiting,Interventional
2582,NCI-2017-02320,"Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer","August 7, 2018","August 7, 2018",Withdrawn,Interventional
2583,S2020-300,Prospective Multicenter Study on Clinical Application of Sonazoid in Breast Tumor,"August 15, 2020",October 2021,Recruiting,Observational
2584,844978,Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts,"September 23, 2021","July 13, 2025",Recruiting,Observational
2585,ERC/2018/06/01,Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria,"April 12, 2021",April 2024,Recruiting,Observational
2586,187519,"Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer","July 8, 2019","July 30, 2023",Recruiting,Interventional
2587,2019-A02374-53,"Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer","June 17, 2020",March 2023,Unknown status,Interventional
2588,APPI2-PT-2020-AIMSS,Targeted Physiotherapeutic Treatment for Aromatase Inhibitor-associated Musculoskeletal Pain in Breast Cancer Survivors,"October 14, 2020","November 30, 2023",Recruiting,Interventional
2589,OnerCengiz,The Effect of Mindfulness Program on Spiritual Well-BeingBreast Cancer Patients,"September 29, 2021","June 30, 2022",Completed,Interventional
2590,EDP1503-101,"A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors","December 19, 2018","October 31, 2021",Completed,Interventional
2591,PH-CP026,PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy,"March 1, 2018","August 27, 2021",Completed,Interventional
2592,B1432020000025,"Pain, Nutrition and Glycemic Response in Chronic Low Back Pain and Breast Cancer Survivors","September 21, 2020","December 19, 2022",Completed,Interventional
2593,50619,Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening,"October 1, 2018","December 30, 2023",Enrolling by invitation,Observational
2594,CTP-BRST-01,Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases,"November 28, 2019",October 2027,Recruiting,Interventional
2595,2016-0538,Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer,"June 7, 2019","December 31, 2023",Recruiting,Interventional
2596,TN.32.1.17.SATF,Pilot Clinical Study on a Low-power Electromagnetic Wave Breast Imaging Device for Cancer Screening Purposes.,"October 10, 2018","May 7, 2020",Completed,Interventional
2597,A221801,"Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial",September 2022,May 2027,Not yet recruiting,Interventional
2598,ANI251_BCS-PI,PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS,"April 1, 2021",April 2024,Recruiting,Interventional
2599,IFG-05-2019,Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO,"July 30, 2022",February 2026,Recruiting,Interventional
2600,PHRI.SCHOLAR-2,Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction,"July 1, 2021","December 1, 2025",Recruiting,Interventional
2601,MC1931,Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer,"April 28, 2020","June 1, 2024",Recruiting,Interventional
2602,MC2031,"Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer","January 23, 2020","November 17, 2021",Withdrawn,Interventional
2603,CBTMMUH,Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients,"May 31, 2021","March 2, 2023",Completed,Interventional
2604,2018/455,Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy,"July 4, 2019","October 31, 2020",Unknown status,Interventional
2605,2019-1237,Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy,"August 15, 2022","December 31, 2026",Recruiting,Observational
2606,9988,Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors,"April 18, 2018","July 15, 2019",Completed,Interventional
2607,OSU-18317,Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer,"December 11, 2020","January 2, 2024",Recruiting,Interventional
2608,e-OTCAT20,Telehealth Program to Prevent Cancer and Chemotherapy-related Cognitive Impairment.,"October 31, 2020","October 30, 2023",Enrolling by invitation,Interventional
2609,19447,Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors,"June 15, 2022","June 15, 2023",Withdrawn,Interventional
2610,KN026-US-I-001,KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer,"June 18, 2019","December 31, 2022","Active, not recruiting",Interventional
2611,ACT-MBC,ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC),"December 12, 2022","December 31, 2024",Recruiting,Observational
2612,2017-0502,M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer,"August 3, 2018","December 31, 2024","Active, not recruiting",Interventional
2613,20180259-01H,Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial,"January 1, 2020","December 31, 2023",Recruiting,Interventional
2614,NCI-2019-05187,"Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer","November 20, 2019","November 20, 2023",Recruiting,Interventional
2615,23-050,A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction,April 2023,April 2028,Not yet recruiting,Interventional
2616,20G.093,"Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial","March 11, 2020","December 23, 2021",Completed,Interventional
2617,OUMK59829,Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer,"October 1, 2022","September 30, 2027",Not yet recruiting,Interventional
2618,STUDY00000057,"WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor","April 1, 2019",December 2023,"Active, not recruiting",Interventional
2619,55457122.3.0000.5330,Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System,"November 9, 2022","December 31, 2023",Recruiting,Observational
2620,239531,Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors,"June 7, 2021",June 2024,Recruiting,Interventional
2621,Castle06(BC),Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy,"May 1, 2022","April 1, 2024",Recruiting,Interventional
2622,IFG-01-2022,"Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients","October 12, 2022",October 2026,Recruiting,Interventional
2623,LACOG 0122,Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study,May 2023,July 2024,Not yet recruiting,Observational
2624,STUDY02000934_1,A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation,"August 10, 2021","June 13, 2022",Completed,Interventional
2625,RG1718049,Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy,"October 25, 2018","September 22, 2020",Terminated,Interventional
2626,PI-0171-2020,Pain Treatment in a Breast Cancer Population. PaiNEd Study.,"April 4, 2022",September 2023,Recruiting,Interventional
2627,OSU-19152,EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer,"October 7, 2020","December 31, 2021",Recruiting,Interventional
2628,STU-2019-0529,Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM),"January 22, 2020","June 15, 2022",Terminated,Interventional
2629,NBC Sur001,Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for cN+ Breast Cancer,"September 24, 2020","April 30, 2024",Recruiting,Interventional
2630,OSU-20340,Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer,"March 1, 2023","December 31, 2024",Recruiting,Interventional
2631,NCI-2022-04956,"Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer","September 30, 2022","September 30, 2025",Recruiting,Interventional
2632,PAXMAN,Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients,"December 23, 2020","August 30, 2022",Completed,Interventional
2633,S1703,S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer,"July 16, 2018","January 1, 2038",Recruiting,Interventional
2634,2020-A02045-34,The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.,"December 24, 2020","November 16, 2022",Completed,Observational
2635,ESPvsPECS/AOP,Comparison of Erector Spinae Plane Block With PECS II Block in Patients Undergoing Breast Cancer Surgery,"January 1, 2022",January 2023,Withdrawn,Interventional
2636,MP-12-2021-2565,Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS),"October 8, 2021","December 31, 2028",Recruiting,Interventional
2637,NL80749.058.22 DIRECT 2,"Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer","May 1, 2023","May 1, 2032",Recruiting,Interventional
2638,2020-01097,Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes,"December 5, 2018","January 1, 2023","Active, not recruiting",Interventional
2639,IRB-2022-329,Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency,"September 1, 2022","June 30, 2025",Not yet recruiting,Interventional
2640,MC210303,Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer,"March 10, 2023","March 1, 2027",Not yet recruiting,Interventional
2641,UZBRU_VHH1_3,Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients,"April 1, 2019",December 2024,Recruiting,Interventional
2642,2018-11-128,Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer,"July 19, 2019","July 18, 2023",Recruiting,Interventional
2643,17753,T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer,"February 5, 2020","April 30, 2024",Recruiting,Interventional
2644,2019-5382,Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk,"October 24, 2019","April 1, 2024",Recruiting,Interventional
2645,N20ESP,Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial,"June 1, 2021","December 31, 2022",Recruiting,Interventional
2646,SMC2018-09-029-003,The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery,"December 31, 2018","December 30, 2019",Completed,Observational
2647,IRB00105944,"Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis","February 8, 2019","August 10, 2023","Active, not recruiting",Interventional
2648,35945/10/22,Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients,"October 28, 2022","October 28, 2024",Enrolling by invitation,Interventional
2649,2022-376,Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors,April 2023,August 2025,Not yet recruiting,Interventional
2650,20-002712,Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer,"September 23, 2020","December 31, 2024",Recruiting,Interventional
2651,MC18C3,Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer,"September 18, 2020","March 1, 2023",Recruiting,Interventional
2652,IRB202201483,Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors,"November 8, 2022","May 31, 2023",Recruiting,Interventional
2653,2019-1042,Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer,"May 3, 2021","December 9, 2029",Recruiting,Observational
2654,167514,Incidence and Severity of Diarrhea in Patients With Stage II-IIIC HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib,"October 9, 2018","October 31, 2022",Completed,Interventional
2655,ReMig,Rehabilitation on Equal Terms - The ReMig Study,"January 10, 2023","May 15, 2025",Recruiting,Observational
2656,Gabapentin RCT,Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy,"July 2, 2018","June 30, 2020",Unknown status,Interventional
2657,G1T48-01,"G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer","May 9, 2018","September 29, 2022",Completed,Interventional
2658,2018-0550,Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy,"January 14, 2019","December 31, 2023","Active, not recruiting",Interventional
2659,EVE-CWM-01,Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study,"May 1, 2021","August 30, 2021",Completed,Observational
2660,2018-0062,Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer,"July 28, 2020","March 31, 2025",Recruiting,Interventional
2661,PH-CP032,PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients,"June 15, 2022",December 2022,Recruiting,Interventional
2662,SAFE-FORWARD,Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery,"November 30, 2021",December 2022,Recruiting,Observational
2663,EstroTEP COMPARE,Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES,January 2020,February 2021,Unknown status,Interventional
2664,FS-CY1502-Ph1-01,Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.,"October 11, 2019",June 2025,Recruiting,Interventional
2665,URomLS-2019a,The Recovery of Reaching Movement in Breast Cancer Survivors: Two Different Rehabilitative Protocols in Comparison,"January 8, 2018","July 19, 2019",Completed,Interventional
2666,CF22200A,Effects of an Exercise Intervention on Taxane-induced Peripheral Neuropathy in Breast Cancer Survivors,"December 1, 2022","December 31, 2023",Not yet recruiting,Interventional
2667,2020-0715,Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer,"March 11, 2022","December 31, 2028",Recruiting,Interventional
2668,3543,Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery.,"January 1, 2022","August 30, 2023",Recruiting,Interventional
2669,20-001275,"Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer","October 9, 2020","September 30, 2025",Recruiting,Interventional
2670,230/HĐĐĐ-ĐHYD,2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors,"September 15, 2020","June 30, 2023",Recruiting,Observational
2671,20-222,Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy,"July 14, 2021","June 15, 2023",Recruiting,Interventional
2672,NCI-2019-06088,Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones,"December 27, 2019","June 30, 2023",Recruiting,Interventional
2673,OSU-22083,Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer,"December 14, 2022","December 31, 2024",Recruiting,Interventional
2674,ODO-TE-B201,"Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC","February 5, 2019","June 11, 2021",Terminated,Interventional
2675,LCZ696ABM001.001,Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM),February 2023,February 2028,Not yet recruiting,Interventional
2676,2018-8984,Low Energy Dissection Vs. Electrocautery in Lumpectomy Shaved Surgical Margins,"March 15, 2019","June 15, 2020",Unknown status,Observational
2677,MAMMoutreach,Opt-in vs. Opt-out for Breast Cancer Screening,"April 18, 2022","August 31, 2022",Not yet recruiting,Interventional
2678,MC1635,Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery,"February 7, 2018","June 30, 2023","Active, not recruiting",Interventional
2679,115300-20-52703,Early Rehabilitation for Breast Cancer - A Randomized Control Trial,"April 1, 2021","December 31, 2022",Unknown status,Interventional
2680,A5481152,First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.,"October 13, 2020","April 3, 2028",Recruiting,Observational
2681,MA-BC-II-037,Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02),"May 20, 2022","January 1, 2026",Recruiting,Interventional
2682,2018-0127,Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer,"August 14, 2018","December 31, 2020",Unknown status,Interventional
2683,ANG-002,Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System,"March 29, 2018","December 31, 2019",Completed,Observational
2684,S2007,Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases,"December 15, 2020",December 2026,Recruiting,Interventional
2685,IIT2019-21-Basho-TOPAZ,TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases,"June 1, 2022","June 1, 2024",Withdrawn,Interventional
2686,19-004024,RBX7455 Before Surgery for the Treatment of Operable Breast Cancer,"August 31, 2020","December 17, 2025",Recruiting,Interventional
2687,BTCRC BRE15-024,Ribociclib and Bicalutamide in AR+ TNBC,"May 7, 2018",September 2024,Recruiting,Interventional
2688,18-000427,"Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted","July 10, 2019","July 1, 2024","Active, not recruiting",Interventional
2689,REaCT-CHRONO,Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance,"June 30, 2021",August 2023,"Active, not recruiting",Interventional
2690,81603703,Effects of Infrared Laser Moxibustion on Cancer-related Fatigue in Breast Cancer Patients,"June 20, 2018","July 27, 2021",Completed,Interventional
2691,19.07,ImmunoBreast - A Phase Ib Study,"April 21, 2020","May 21, 2023",Recruiting,Interventional
2692,3474028/2019,Effects of the Anchor System in the Postural Stability,"March 1, 2020","March 1, 2024",Recruiting,Interventional
2693,2020-0245,"Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial","March 7, 2021","February 16, 2022",Withdrawn,Interventional
2694,CASE11119,Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program,"January 6, 2021",December 2023,Recruiting,Interventional
2695,38RC20.120,"Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care","June 1, 2021","January 28, 2022",Completed,Observational
2696,2021-375,Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients,"April 12, 2022","October 30, 2022",Completed,Interventional
2697,202104085,Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma,"August 12, 2021","June 30, 2029",Recruiting,Interventional
2698,D19160,Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging,"February 6, 2020","March 16, 2022",Completed,Observational
2699,ZLYNXM202014,Identification and Preservation of Arm Lymphatics,"June 20, 2020","September 30, 2025",Recruiting,Interventional
2700,MedOPP150,"First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC","October 5, 2020",December 2023,Recruiting,Interventional
2701,ZL-MG-BC-001,A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC,"August 25, 2020","April 27, 2021",Completed,Interventional
2702,PRO00035701,"Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer","October 21, 2021",January 2028,Withdrawn,Interventional
2703,REaCT-Low Risk HER-2,A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer,"May 1, 2019","May 11, 2022",Completed,Interventional
2704,I 60217,Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects,"October 18, 2018","June 18, 2023",Recruiting,Interventional
2705,P170104J,"A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer","June 27, 2018","June 1, 2022",Unknown status,Interventional
2706,Acu-CIPN,Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer,"September 1, 2020",December 2023,Recruiting,Interventional
2707,IO Panel,Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer,"May 1, 2020","December 31, 2021",Unknown status,Observational
2708,Pro00104214,Well-Being After Breast Cancer Surgery,"June 8, 2021","April 30, 2025",Recruiting,Interventional
2709,CLEE011AIT01,"Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant","February 2, 2018","July 1, 2024","Active, not recruiting",Interventional
2710,17-546,Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC,"May 21, 2018",December 2025,"Active, not recruiting",Interventional
2711,RIPH2_BREYSSE_ETAPH,"Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer","August 9, 2021",August 2024,Recruiting,Interventional
2712,ODO-TE-B202,Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC,"July 9, 2019","June 23, 2021",Terminated,Interventional
2713,21-001819,"Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer","April 7, 2022","April 1, 2025",Recruiting,Interventional
2714,PA18-1077,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery","May 21, 2019","March 31, 2023",Recruiting,Observational
2715,ARC-2 (AB928CSP0002),A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies,"October 15, 2018","July 2, 2021",Completed,Interventional
2716,Study00146761,Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers,"December 2, 2021","December 31, 2023",Recruiting,Interventional
2717,DRACARYS,Dragonboat Activity for Breast Cancer,"May 15, 2021","September 30, 2021",Completed,Interventional
2718,OSU-20408,An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors,"November 1, 2021","December 31, 2024",Recruiting,Interventional
2719,IRB00076577,Oral Aromatase Inhibitors Modify the Gut Microbiome,"March 29, 2022",September 2023,Recruiting,Observational
2720,RJ-101-RCT-001,Study to Investigate the Effect of AB-101 in Breast Cancer Survivors,"July 9, 2018","October 12, 2019",Completed,Interventional
2721,2021-1151-002,OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk,"February 6, 2023",January 2033,Recruiting,Interventional
2722,SCHBCC-N046,FUSCC Refractory TNBC Platform Study (FUTURE2.0),March 2023,June 2026,Not yet recruiting,Interventional
2723,21D.625,Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery,"July 28, 2022","May 1, 2024",Suspended,Interventional
2724,KEK 2021-D0051,HER2-directed Biosimilar in Breast Cancer: Real World ePRO,"December 14, 2021","June 30, 2023",Recruiting,Observational
2725,RD19/125787,Guide for Prioritisation of Patients for Referral to Breast Clinics,"February 12, 2020","February 11, 2023",Suspended,Observational
2726,TNBC-NEO,Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC,"May 10, 2019",May 2026,Withdrawn,Interventional
2727,Aqua POLO-IPC 2019-028,Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer Remission,"March 15, 2021","December 31, 2021",Unknown status,Interventional
2728,NCI-2017-01960,Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer,"June 15, 2018","March 25, 2022",Completed,Interventional
2729,CSIIT-C25,Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC,"May 23, 2022","May 23, 2024",Recruiting,Interventional
2730,13/21,Continuous Pectoral Nerve Block in Breast Cancer Surgery,"July 30, 2019","November 15, 2019",Completed,Interventional
2731,CE 193/17,"Oxidative Stress, Anxiety and Depression in Breast Cancer Patients: Impact of Music Therapy","February 1, 2018","December 31, 2019",Completed,Interventional
2732,USB_22 Trial,Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer,"August 1, 2022","July 31, 2023",Recruiting,Interventional
2733,SAKK 95/17,Activity Program During Aromatase Inhibitor Therapy,"March 28, 2019",December 2025,"Active, not recruiting",Interventional
2734,Fisioterapia en Linfedema,Effects of Physiotherapy in the Treatment of Lymphedema After Breast Cancer,"March 1, 2022","October 27, 2022",Completed,Interventional
2735,2020-01,Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy,"March 19, 2020","July 16, 2020",Completed,Interventional
2736,2019-0752,Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations,"February 5, 2020","December 31, 2023","Active, not recruiting",Interventional
2737,YOUNGBC-12,Eribulin in mTNBC Patients,"December 15, 2019","December 20, 2020",Completed,Observational
2738,STUDY00003705,Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer,"October 19, 2022","March 31, 2023",Recruiting,Interventional
2739,X9001194,UK Ibrance Patient Program (IPP) Study,"March 1, 2019","March 4, 2021",Completed,Observational
2740,2018-A01019-46,Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer,"September 13, 2018","March 23, 2022",Completed,Interventional
2741,D5336C00001,To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.,"March 7, 2018","September 29, 2023","Active, not recruiting",Interventional
2742,CL 2775,Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients,"November 4, 2021",June 2023,Recruiting,Interventional
2743,MUST-02-001,Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening,"January 14, 2020",November 2021,Unknown status,Interventional
2744,UEM Quirón,Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer,"November 1, 2019","January 1, 2022",Unknown status,Interventional
2745,STUDY00003782,RAGE Inhibition to Decrease Therapy Cardiotoxicity in Women With Early Breast Cancer,May 2023,November 2024,Recruiting,Interventional
2746,IB2022-04,Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.,"February 1, 2023","December 1, 2024",Recruiting,Interventional
2747,LCCC 1716,PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo,"December 5, 2018","February 17, 2020",Terminated,Interventional
2748,IRAS 314460,CLI and FAR for Intraoperative Margin Assessment,"October 30, 2022","December 31, 2024",Not yet recruiting,Interventional
2749,UPCC12118,Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab,"August 9, 2019","December 31, 2024","Active, not recruiting",Interventional
2750,227/KEPK/IX/2022,The Effectiveness of Lymphatic Bypass Supermicrosurgery,"October 6, 2022",July 2024,Recruiting,Interventional
2751,EXERT-BC,"EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA","October 1, 2022",August 2023,Recruiting,Observational
2752,D3614C00001,Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC,"June 25, 2019","October 6, 2023",Recruiting,Interventional
2753,AH150202-1,"Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin","June 30, 2020","June 30, 2023",Recruiting,Interventional
2754,YL202-INT-101-01,A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer,"December 20, 2022",December 2025,Recruiting,Interventional
2755,STUDY00021243,Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer,"June 7, 2021","June 30, 2024",Recruiting,Interventional
2756,OFA,Opioid Free Anesthesia in Breast Cancer Surgery,"July 1, 2020","March 15, 2022",Completed,Interventional
2757,Prevention of radiodermatitis,Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy,"February 6, 2023","February 6, 2025",Not yet recruiting,Interventional
2758,HNCH-2022KY59,UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases,"August 1, 2022",July 2025,Recruiting,Interventional
2759,yifeng,Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors,"December 30, 2022","April 20, 2023",Recruiting,Observational
2760,MEC-2021-0829,An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study),"April 11, 2022",September 2025,Recruiting,Observational
2761,D8530C00007,AZD9833 China PK Study,"November 12, 2021","November 13, 2023",Recruiting,Interventional
2762,21-194,"A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer","September 9, 2021","September 9, 2023",Recruiting,Interventional
2763,SYSU003-2020,Nail Changes Associated With Chemotherapy and Prevention of Nail Pigmentation by Ice Water Immersion,February 2020,December 2022,Unknown status,Interventional
2764,Exactis-03,Combination of Olaparib and Navitoclax in Women With HGSC and TNBC,"November 9, 2022","April 28, 2025",Recruiting,Interventional
2765,NEODOC-2021668610-165,Evaluation of NeoNavia® Biopsy System in Axillary Lymph Nodes,"February 14, 2019","June 30, 2021",Unknown status,Observational
2766,MedOPP100,A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent,"April 17, 2018","December 31, 2021",Terminated,Interventional
2767,YOUNGBC-23,The Rechallenge of ADCs in MBC Patients,"September 1, 2022","September 1, 2024","Active, not recruiting",Observational
2768,MS201922_0010,Study of M4344 in Combination With Niraparib,"December 1, 2020","September 1, 2023",Withdrawn,Interventional
2769,202207200MIPB,"A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC","September 16, 2022","September 30, 2026",Recruiting,Interventional
2770,MC1892,Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy,"September 10, 2018","September 10, 2021",Withdrawn,Interventional
2771,C4391002,A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors,"March 14, 2022","December 30, 2027",Recruiting,Interventional
2772,ZWI-ZW25-202,A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer,"June 10, 2020","June 30, 2023","Active, not recruiting",Interventional
2773,HR-BLTN-III-MBC-C,A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer,"April 22, 2019","July 30, 2024","Active, not recruiting",Interventional
2774,DokuzEUBanuNihan,Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema,"January 2, 2020","January 31, 2020",Completed,Interventional
2775,UW20058,Intraoperative Evaluation of Axillary Lymphatics,"May 5, 2022",June 2023,Recruiting,Interventional
2776,MC1734,"Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer","January 10, 2020","July 31, 2023",Recruiting,Interventional
2777,TADANAC,Targeted Axillary Dissection After Neo-adjuvant Chemotherapy,"April 21, 2021",June 2024,Recruiting,Observational
2778,20-153,Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC,"September 23, 2020","June 1, 2027",Recruiting,Interventional
2779,MC1935,Assessing the Rate of Complications in X-Ray Therapy Versus Proton Beam Radiation Therapy After Breast Conserving Surgery or Mastectomy in Treating Patients With Breast Cancer,"June 1, 2020","June 1, 2024",Recruiting,Interventional
2780,00055029,Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer,"July 5, 2021","August 12, 2021",Completed,Observational
2781,HCRN BRE17-141,Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers,"July 21, 2022",February 2024,Recruiting,Interventional
2782,C4891018,A Study to Learn About the Study Medicine (Called ARV-471) in People With ER+/HER2- Advanced BC in China,"February 20, 2023","December 3, 2024",Recruiting,Interventional
2783,2021-5644,App for Adverse Events to Oral Chemotherapy - Pilot Study,"January 16, 2023","December 31, 2023",Recruiting,Interventional
2784,CPH-2022-10-MHS-2,Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine,"December 8, 2022",November 2023,Recruiting,Interventional
2785,19F.265,A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer,"November 7, 2018","May 31, 2024",Recruiting,Interventional
2786,2019COIMBRA001,Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer,"November 1, 2020","December 31, 2021",Unknown status,Interventional
2787,SHR-1210-APTN-IIT-TNBC,A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC,"January 10, 2018","September 30, 2020",Completed,Interventional
2788,FMUUH-BC-2201,PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients,"January 27, 2023","May 31, 2024",Not yet recruiting,Interventional
2789,2066383,Metacognitive Strategy Training in Cancer-related Cognitive Impairment,"August 9, 2022",June 2024,Recruiting,Interventional
2790,YOUNGBC-11,First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients,"August 25, 2020","October 15, 2023",Recruiting,Interventional
2791,P-2020-246,Stick Together - Pilot Intervention Study,"February 1, 2023","May 31, 2024",Enrolling by invitation,Interventional
2792,YOUNGBC-18,Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC,"June 15, 2022","March 15, 2025",Recruiting,Interventional
2793,201901698B0,Music Therapy in Patients With Breast Cancer- a Randomized Controlled Trial,"September 1, 2020","December 31, 2020",Unknown status,Interventional
2794,OBU-BC-II-024,Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer,July 2020,December 2026,Recruiting,Interventional
2795,328717,Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing Chemotherapy,"March 1, 2019","January 31, 2023",Unknown status,Interventional
2796,PF008,Treatment Patterns of Neratinib in HER2+ EBC in China,"September 30, 2022","June 30, 2026",Not yet recruiting,Observational
2797,2,A Feasibility Study of the Bone@BC App Version 3.0,"December 1, 2022","October 30, 2024",Not yet recruiting,Interventional
2798,BZ01/17,Effect of Quilting Sutures on Post-operative Drainage After Mastectomy and/or Axillary Lymph Node Dissection,"February 19, 2019","October 1, 2020",Terminated,Interventional
2799,2018-0477,Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer,"April 1, 2019","August 1, 2023",Recruiting,Observational
2800,712,Effects of Interpectoral-Pectoserratus Plane Block After Breast Cancer Surgery,"October 6, 2022","April 6, 2023",Not yet recruiting,Observational
2801,KGYY-001,Plasmodium Immunotherapy for Breast and Liver Cancers,"August 10, 2018","December 31, 2021",Unknown status,Interventional
2802,MedOPP253,Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer,"October 8, 2020","January 31, 2024","Active, not recruiting",Interventional
2803,RC48-C006,A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases,"April 24, 2018","December 31, 2023",Recruiting,Interventional
2804,S-20180117,Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting,"December 18, 2018","June 1, 2021",Completed,Interventional
2805,UHaiArtBC,The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer Patients,"June 11, 2019","June 10, 2022",Completed,Interventional
2806,1808852902,"Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets","December 19, 2018","April 26, 2021",Completed,Interventional
2807,NL67059.068.18,Microsurgical Treatment of Breast Cancer-related Lymphedema by Lymphaticovenous Anastomosis,"January 1, 2019","August 1, 2022",Recruiting,Interventional
2808,16381,Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial,"October 15, 2018","February 28, 2019",Completed,Interventional
2809,IRB00223131,Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study,"February 8, 2021","December 31, 2023","Active, not recruiting",Interventional
2810,202301160RINA,Novel MRI Techniques on Evaluation of Lymphedema,"March 30, 2023","December 31, 2026",Not yet recruiting,Observational
2811,VSN-18-199,The Effects of Light Therapy to Treat Cancer-related Side Effects,"June 8, 2020",July 2024,Recruiting,Interventional
2812,ALRN-6924-1-05,A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer,"January 9, 2023","February 22, 2023",Terminated,Interventional
2813,WHUH-BC-001,Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy,October 2021,October 2024,Not yet recruiting,Interventional
2814,22-544,TRUDI: TDXD+Durva in HER2+/Low IBC,June 2023,"December 1, 2032",Not yet recruiting,Interventional
2815,202111198,Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM),"April 30, 2023","October 31, 2029",Not yet recruiting,Interventional
2816,Shengjing-LCG003,Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy,"July 19, 2021","May 31, 2026",Not yet recruiting,Interventional
2817,STU00201961B,A Research Study for Latina Women With Breast Cancer,"April 1, 2021","April 25, 2023","Active, not recruiting",Interventional
2818,2-107-05-079,Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery,"August 3, 2018","December 27, 2018",Completed,Interventional
2819,AHQU-2022002,Personalized Electroacupuncture Treatment for Chemotherapy-induced Nausea and Vomiting in Breast Cancer (PET),"March 15, 2022","December 31, 2024",Recruiting,Interventional
2820,2001272738,Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women,"August 30, 2022","August 30, 2025",Withdrawn,Observational
2821,IC 2019-04,MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery,"August 4, 2020","January 28, 2022",Completed,Interventional
2822,IRB00054587,Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases,"March 13, 2019",August 2023,Recruiting,Interventional
2823,2012-090-1182,Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer,"July 6, 2021","January 31, 2024",Enrolling by invitation,Interventional
2824,2018/781,Pre-operative Hypnosis to Prevent Side Effects After Surgery,"May 1, 2018","December 31, 2020",Completed,Interventional
2825,GCO 15-1783,Systematic Light Exposure for Fatigue in Breast Cancer Patients,"January 25, 2018","April 30, 2022",Recruiting,Interventional
2826,2022YF035-01,Dalpiciclib Plus Letrozole and Capecitabine,"August 10, 2022",August 2024,Not yet recruiting,Interventional
2827,METIS,ACH-TH vs EC-TH as Neoadjuvant Therapy for HER2-positive EBC,"January 10, 2019","January 1, 2022",Unknown status,Interventional
2828,2019-06-027,Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation,"October 17, 2019","December 31, 2021",Unknown status,Observational
2829,NCI-2017-01119,Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer,"March 12, 2019","April 30, 2024","Active, not recruiting",Interventional
2830,MRI in response assesment,Functional MRI in Predicting Response to Chemotherapy,"June 15, 2019","December 30, 2023",Recruiting,Observational
2831,1191/2018,"Exercise, Cancer and Cognition: The ECCO-Study","December 1, 2019","December 1, 2025",Recruiting,Interventional
2832,021-013772,Marker Technique Comparison in Targeted Axillary Dissection,July 2023,January 2025,Not yet recruiting,Interventional
2833,UAB 1794,"Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD","February 20, 2019","July 22, 2024","Active, not recruiting",Interventional
2834,CRM-BRE-002,The Malaysian Soy and Mammographic Density Study,"November 19, 2018",June 2020,Unknown status,Interventional
2835,H1901940,IORT-Breast at Medical Center Navicent Health,"March 19, 2019","December 31, 2029",Recruiting,Observational
2836,IUSCC-0616 (1709077419),Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy,"February 8, 2018","October 15, 2018",Terminated,Interventional
2837,19-5080,Cardio-Oncology Rehabilitation Exercise,"March 14, 2022",December 2023,Recruiting,Observational
2838,HSM/VGH-2017-01-011AC,Effects of Naturalistic Decision-Making Model-based Oncofertility Care Education,"May 1, 2018","August 30, 2020",Completed,Interventional
2839,APA-PG1,Adapted Physical Activity (APA) in a Breast Cancer Population.,"January 1, 2019","December 31, 2022","Active, not recruiting",Interventional
2840,26778919.3.0000.0072,Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer,"January 30, 2020","February 28, 2022",Unknown status,Interventional
2841,ICO-N-2018-03,Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma,"January 8, 2019",October 2023,Recruiting,Interventional
2842,RG1121659,Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer,"January 23, 2022","September 30, 2023",Recruiting,Interventional
2843,CETC 002,Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.,"July 1, 2021","December 31, 2026",Recruiting,Observational
2844,H2207-207-1346,Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor,"December 31, 2022","December 31, 2025",Not yet recruiting,Interventional
2845,BC-TATOO-2020,Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy,"March 1, 2020","March 31, 2023",Recruiting,Interventional
2846,20190511,Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node Biopsy,"December 1, 2019","June 1, 2021",Completed,Interventional
2847,BGB-A317-ZW25-101,Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab,"March 26, 2020","December 31, 2026","Active, not recruiting",Interventional
2848,17-AKD-186,Erector Spinae Block in Segmental Mastectomy.,"April 3, 2018",May 2019,Unknown status,Interventional
2849,Immuno2020-01,A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC,"March 25, 2020","August 31, 2023","Active, not recruiting",Interventional
2850,ATOX-2018,Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer,"January 15, 2019","January 31, 2027",Recruiting,Interventional
2851,TQB3616-Ⅲ-02,"To Evaluate the Efficacy and Safety of TQB3616 in Combination With Flulvesant Versus Placebo in Combination With Flulvesant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer",June 2022,June 2026,Not yet recruiting,Interventional
2852,STUDY00011444,Nurse AMIE: Addressing Metastatic Individuals Everyday,"March 1, 2019","September 1, 2020",Completed,Interventional
2853,SHAW001,Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients,"January 1, 2023","December 31, 2026",Not yet recruiting,Interventional
2854,A5481150,Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC,"July 15, 2021","April 30, 2025",Recruiting,Observational
2855,71306642-5/24,Serratus Plane Plus Pectoral I Block Versus Serratus Plane Block for Perioperative Analgesia in Breast Cancer Surgery,"April 6, 2019","September 20, 2019",Completed,Interventional
2856,2021-0077,Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer,"November 4, 2021","December 31, 2025",Recruiting,Interventional
2857,CTPR-0015,"An Efficacy Study of the Xoft® Axxent® eBx® IORT System® ""Lite""","June 30, 2022","June 30, 2034",Withdrawn,Interventional
2858,QoLMa,Quality of Life Improvement During Chemotherapy,"July 31, 2021","December 30, 2024",Recruiting,Interventional
2859,TDM of TAM,Therapeutic Dose Monitoring (TDM) of Tamoxifen,"April 4, 2022","March 1, 2023","Active, not recruiting",Interventional
2860,SYSA1501-CSP-005,"DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer","May 1, 2022","December 31, 2023",Not yet recruiting,Interventional
2861,1028595,Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention,"June 25, 2018","December 30, 2019",Completed,Interventional
2862,ECP 250 - 15/16,Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer,"October 1, 2018","September 30, 2020",Unknown status,Interventional
2863,STUDY20110029,Screening Contrast-Enhanced Mammography as an Alternative to MRI,"February 15, 2021","January 31, 2024","Active, not recruiting",Interventional
2864,00031569,Photoacoustic Lymph Node Imaging,"November 1, 2019","December 31, 2025",Suspended,Observational
2865,FZPL-Ib-105,A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC,"June 4, 2019","February 9, 2021",Completed,Interventional
2866,OSU-16288,Nipple Aspirate Fluid in Detecting Breast Cancer,"July 25, 2019","December 31, 2023",Recruiting,Interventional
2867,CTR20220630,Mindfulness Yoga and Sexual Functioning,"August 1, 2022","August 1, 2024",Not yet recruiting,Interventional
2868,20.478.486,Is Breast Massage Necessary to Find Sentinel Lymph Node?,"December 6, 2021","August 1, 2023",Recruiting,Interventional
2869,2022-001,Deformable Image Registration for Breast Adaptive Tomotherapy,"June 27, 2022","April 4, 2023",Completed,Observational
2870,REC 22/WA/0164,Acceptance and Usability of an App Promoting Healthy Behaviours Amongst Young Women at Increased Risk of Breast Cancer,"November 3, 2022","March 10, 2023",Completed,Interventional
2871,829400,Abbreviated Breast MRI After Cancer Treatment,"September 7, 2018","September 30, 2024","Active, not recruiting",Observational
2872,2019DEPO-TRIGGER001,DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation,"November 1, 2020","December 31, 2021",Unknown status,Interventional
2873,STUDY00001721,Evaluation of Hydroxychloroquine to Prevent CIPN,June 2023,"December 1, 2024",Not yet recruiting,Interventional
2874,J16146,Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins,"January 26, 2018",July 2023,Recruiting,Interventional
2875,46.20 PAR ComEt CBM,Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients,"July 10, 2020","April 10, 2023",Recruiting,Interventional
2876,2022-A02337-36,4D CT Scan With Respiratory Gating Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy.,February 2023,June 2023,Not yet recruiting,Interventional
2877,1100903,Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer,"May 5, 2022","March 3, 2023",Recruiting,Interventional
2878,H19017,Somatic Acupressure for Symptom Cluster Management in Breast Cancer Patients,"March 15, 2021","July 20, 2022",Completed,Interventional
2879,BXu-1839,The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency,"February 22, 2019",December 2024,Recruiting,Interventional
2880,NABP201801,A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC,"December 21, 2018","July 30, 2020",Suspended,Interventional
2881,LAAVA2,Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients,"July 24, 2018","October 1, 2021",Unknown status,Interventional
2882,RG1121642,Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer,"June 9, 2022","November 1, 2024",Recruiting,Interventional
2883,16-0040-02,Pink Warrior 2: Teleconference-based Gaming Support,"May 11, 2020","March 29, 2022",Completed,Interventional
2884,2021-0031,"An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer","April 8, 2021","March 1, 2024",Recruiting,Interventional
2885,C-plus-Pairs,"A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.","March 1, 2023","September 1, 2023",Recruiting,Interventional
2886,URomLS_4,Metabolomic Evaluation of Psycho-surgical Synergy on Body Image Restoration After Breast Cancer,"October 26, 2022","January 30, 2024",Recruiting,Interventional
2887,012418QM,Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC,"December 19, 2018","January 30, 2026","Active, not recruiting",Interventional
2888,R_ReLoCC,Registry of Local Recurrences After Breast-conserving Surgery,January 2023,June 2026,Not yet recruiting,Observational
2889,2022-008,Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C),"December 15, 2022","December 15, 2030",Not yet recruiting,Interventional
2890,2020466,PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC,March 2021,March 2024,Not yet recruiting,Interventional
2891,736-19,The Patterns of Activity and Cognition During Treatment (PACT) Study,"January 15, 2021","October 31, 2022","Active, not recruiting",Interventional
2892,2017-0479,Comprehensive Lifestyle Change To Prevent Breast Cancer,"April 4, 2019","September 1, 2022",Recruiting,Interventional
2893,SYM011,AKY15-HK-301_NEPA Study,"February 27, 2018","December 31, 2025",Recruiting,Interventional
2894,X4P-001-201,"A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC","July 21, 2021","May 21, 2023",Enrolling by invitation,Interventional
2895,2018/827,Aspects of Breast-conserving Surgery,"January 1, 2019","June 30, 2022",Completed,Observational
2896,HelouEl,Factor Influencing Breast Surgery Type Decision-Making,"June 15, 2022","August 19, 2022",Completed,Observational
2897,SYSU-2022-01,Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure),"April 12, 2023",August 2024,Recruiting,Interventional
2898,SAKK 21/18,Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC,"June 25, 2019","April 15, 2021",Terminated,Interventional
2899,AP1907-50101,Perioperative Analgesic Modalities for Breast Cancer Surgeries,"January 28, 2020","July 1, 2020",Completed,Interventional
2900,RWS-PEGCSF,Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer,"January 20, 2019","December 31, 2021",Unknown status,Observational
2901,198411013011,The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast Cancer,"July 20, 2022","October 6, 2023",Recruiting,Interventional
2902,A5481170,European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies,"February 8, 2022","March 30, 2023",Recruiting,Observational
2903,YOUNGBC-13,18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response,"September 1, 2018","July 24, 2020",Completed,Observational
2904,2021-19,The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC,"September 15, 2021","December 31, 2025",Recruiting,Interventional
2905,BRI-ROL-001,Combination Study of SV-BR-1-GM With Retifanlimab,"March 16, 2018","June 30, 2023",Recruiting,Interventional
2906,RLY-5836-101,First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors,"March 29, 2023","January 13, 2026",Recruiting,Interventional
2907,RP-PG-1214-20016,What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol,"August 1, 2019","June 30, 2022",Completed,Interventional
2908,BCP-25,Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study),"March 7, 2019","December 31, 2023",Recruiting,Interventional
2909,PI17/01687,Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity,"August 1, 2018","March 1, 2022","Active, not recruiting",Interventional
2910,220287,The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies,"April 1, 2023","March 15, 2025",Not yet recruiting,Interventional
2911,EUBREAST-4,MEthods for LOcalization of Different Types of Breast Lesions,"January 1, 2023",December 2026,Recruiting,Observational
2912,2018-1518,"Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic Pain","July 31, 2019","February 3, 2020",Completed,Interventional
2913,URCC16070,Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer,"April 19, 2018","June 30, 2025",Recruiting,Interventional
2914,20210312/2,Neoadjuvant Chemotherapy in Breast Cancer,"March 12, 2021","March 30, 2024",Recruiting,Interventional
2915,UCI 18-79 [HS# 2020-5660],Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer,"July 23, 2020","February 16, 2022",Terminated,Interventional
2916,Shengjing-LJY06,Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy,"November 1, 2021","October 31, 2028",Recruiting,Interventional
2917,ePOST,Efficacy of Point Of Service Testing in MBC,"June 11, 2019",August 2024,Recruiting,Interventional
2918,202210064DIPD,"LLLT for BCRL: a Randomized, Placebo-controlled Study","February 15, 2023","October 31, 2024",Not yet recruiting,Interventional
2919,69HCL17_0480,Collaborative Self-Management Support in Chronic Conditions - Qualitative Study,"April 14, 2018","June 27, 2019",Completed,Observational
2920,Pro00105104,Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477),"November 13, 2020","May 5, 2021",Terminated,Interventional
2921,MedOPP068,PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA),"April 5, 2019","November 30, 2022",Completed,Interventional
2922,HCI140278,[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial,"March 31, 2021","April 30, 2025",Recruiting,Interventional
2923,PERT.21.001,"A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)","September 17, 2022","December 31, 2024",Not yet recruiting,Interventional
2924,SILMET_0107665,SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET),"January 2, 2023","January 1, 2027",Recruiting,Interventional
2925,2021/270,Effect of Nurse-led Supportive Care on Quality of Life,"January 3, 2022","June 10, 2022",Completed,Interventional
2926,KCT003,A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema,"June 1, 2021","December 31, 2021",Recruiting,Interventional
2927,202109031MIPD,"Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC","January 17, 2023","December 31, 2025",Recruiting,Interventional
2928,241379,Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer,"April 27, 2018","July 31, 2019",Completed,Interventional
2929,S-20180134,Prevention of Breast Cancer-related Lymphedma With Tacrolimus,"February 26, 2020",September 2022,"Active, not recruiting",Interventional
2930,A5481158,Swedish Ibrance Registries Insights (SIRI),"December 15, 2020","December 31, 2022",Recruiting,Observational
2931,SCHBCC-N023,Patient Report Outcome-Reconstruction and Oncoplastic Cohort,"July 1, 2019","December 30, 2024",Recruiting,Observational
2932,00048814,Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors,"March 24, 2021","October 1, 2021",Completed,Interventional
2933,2018-A03054-51,Loreline Study: Characterization of Long Responders Under Eribuline,"August 23, 2019","February 28, 2021",Completed,Observational
2934,2017/12-SBO-GHMG,Autohypnosis and Cancerology,"May 23, 2018","July 1, 2022",Completed,Interventional
2935,LYT-100-2020-01,LYT-100 in Healthy Volunteers and BCRL,"March 1, 2020","September 9, 2022",Completed,Interventional
2936,Pro00117242,Moving Forward Together 4,"November 1, 2022",January 2025,Recruiting,Interventional
2937,MC1937,Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer,"July 27, 2020","July 27, 2028",Recruiting,Observational
2938,JD-LK-2022-136-01,"Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)","October 30, 2022","October 17, 2024",Not yet recruiting,Interventional
2939,2179 CE,Music Listening in Radiotherapy Treatment,"March 5, 2018","September 30, 2020",Completed,Interventional
2940,2017-0328,Development of Exercise Promotion Program Using a Mobile Community,"January 30, 2018","December 31, 2018",Completed,Interventional
2941,WSG-NIS04 / PROOFS,PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS,"December 7, 2022",June 2035,Recruiting,Observational
2942,2018-002,Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast,"June 21, 2019","April 15, 2023",Recruiting,Interventional
2943,CAPRICE,Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study,"May 1, 2019","January 31, 2023",Terminated,Interventional
2944,7119-002,Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002),"June 29, 2022","December 29, 2025","Active, not recruiting",Interventional
2945,mavis20023,Application-Enabled Shared Decision-Making,"August 1, 2019","July 31, 2020",Completed,Interventional
2946,US-003,Magseed Enabled Long-Term Localization of Axillary Lymph Nodes,"June 13, 2019",April 2024,Recruiting,Interventional
2947,12345,The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer,"January 28, 2021","January 28, 2024","Active, not recruiting",Interventional
2948,21-169,Scalp Cooling in MBC,"October 7, 2021","June 1, 2026",Recruiting,Interventional
2949,A221702,Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection,"May 31, 2019",January 2024,Recruiting,Interventional
2950,CT/2019/CANFLAX,Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?,"October 21, 2020","December 31, 2022",Unknown status,Interventional
2951,22-006606,3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer,"February 14, 2023","April 1, 2025",Recruiting,Interventional
2952,GN19ON381,Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy,"March 15, 2021","November 25, 2022",Recruiting,Observational
2953,IJB-BC-TDM1BM-2016,Kadcyla In pAtients With bRAin Metastasis,"February 23, 2018","August 27, 2018",Withdrawn,Interventional
2954,Self-compassion FCR,Fear-focused Self-Compassion Therapy for Young Breast Cancer Patients Fear of Cancer Recurrence,"September 15, 2021",December 2023,Recruiting,Interventional
2955,GLSI-21-01,Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects,"August 11, 2022",December 2026,Recruiting,Interventional
2956,1024489,Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2),"April 29, 2019","December 31, 2023",Recruiting,Interventional
2957,20-754,Axillary Lymph Node Tattoo Marking Study,"December 29, 2021","June 30, 2025",Recruiting,Interventional
2958,1B-15-6,Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors,"March 8, 2019","July 31, 2019",Withdrawn,Interventional
2959,HiFi-APBI,High Five (HiFi) Accelerated Partial Breast Irradiation Study,"October 1, 2021","December 31, 2025",Recruiting,Interventional
2960,CBYL719H12301,Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss,"June 8, 2020","June 19, 2024","Active, not recruiting",Interventional
2961,20-010751,3D Ultrasound Breast Imaging,"November 19, 2021","December 31, 2025",Recruiting,Interventional
2962,2021-01-075,PALbociclib Endocrine Therapy Followed by Talazo vs. Talazoz-Atezo Study,"September 1, 2021","December 31, 2027",Not yet recruiting,Interventional
2963,URomLS-2019,The Sequelae of Mastectomy and Quadrantectomy Respect to the Reaching Movement in Breast Cancer Survivors,"April 23, 2018","April 15, 2019",Completed,Interventional
2964,WSG-AM11,"Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC","September 2, 2020",December 2027,Recruiting,Interventional
2965,2020-10/850,Correlation of Preoperative Anxiety With Early Postoperative Cognitive Dysfunction in Breast Cancer Patients,"October 21, 2020","July 13, 2021",Completed,Observational
2966,P018,"A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel",June 2023,February 2026,Withdrawn,Interventional
2967,IEO 0758/,Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial),"June 1, 2018","December 31, 2021","Active, not recruiting",Observational
2968,2018-0528,An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction,"May 24, 2019","December 31, 2022",Recruiting,Interventional
2969,2021/03,A Deep Learning Method to Evaluate QT on Ribociclib,"December 1, 2022","December 1, 2024",Not yet recruiting,Observational
2970,CCR 5006,Exploring the Link Between Cancer Genetics and PPSP,July 2019,December 2019,Unknown status,Observational
2971,QUILT 2021-1,The QUILT Study: Quilting Sutures in Patients Undergoing Breast Cancer Surgery,"August 1, 2022","July 1, 2023",Not yet recruiting,Interventional
2972,MC18C1,Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer,"May 24, 2019","June 1, 2023","Active, not recruiting",Interventional
2973,20180349,Health Economy Register,"July 5, 2019","December 31, 2020",Completed,Observational
2974,OBI-822-011,Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC,"December 5, 2018","December 30, 2027",Recruiting,Interventional
2975,ICO-N-2018-12,Intravenous Chemotherapy and Plant-based Dietary Supplements,"April 2, 2019","May 13, 2020",Completed,Observational
2976,H-18016600,Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer,"December 17, 2018",November 2026,Recruiting,Observational
2977,MSCW2019,Mindfulness and Self-compassion Focussed Walking,"August 8, 2019","December 31, 2022",Recruiting,Interventional
2978,NIS07075,Real-life Pan-HER-blockade With Neratinib,"July 2, 2020",January 2025,Recruiting,Observational
2979,IJB-PRINTEMPS-2022,Multidisciplinary Approach to Fatigue,"August 19, 2022",September 2027,Recruiting,Interventional
2980,2020-12-044-012,Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves,"October 1, 2020",June 2023,Recruiting,Interventional
2981,c5ZTCN100,A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS,"May 31, 2021","June 23, 2022",Completed,Interventional
2982,Ref. 070/2018,Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery,"June 1, 2018","June 30, 2020",Completed,Interventional
2983,HNCH-BC009,"Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer","January 1, 2022","June 1, 2024",Recruiting,Interventional
2984,ICO_UCC_202001,SMS Messaging as a Tool to Improve Cancer Screening Programs,"September 15, 2020","December 31, 2022",Unknown status,Interventional
2985,CRO-2019-26,Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?,"October 31, 2019",November 2021,Unknown status,Interventional
2986,19-578,Sacituzumab Govitecan In TNBC,"July 7, 2020",October 2026,"Active, not recruiting",Interventional
2987,A211601,Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502,"August 1, 2018","July 18, 2022",Terminated,Observational
2988,LCCC1921,Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer,"September 25, 2019","April 4, 2022",Completed,Interventional
2989,182113,Improving Cognition After Cancer,"September 9, 2019","February 1, 2024",Recruiting,Interventional
2990,AP2205-5015,Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries,"June 27, 2022","April 10, 2023",Recruiting,Interventional
2991,YM111146EF,Effects of Kombucha Intervention on Emotional Distress and Sleep Quality in Breast Cancer Survivors,"December 12, 2022","December 12, 2025",Recruiting,Interventional
2992,2018-172,The Effects of Wheat Sprouts Supplements on the Key Health Indicators of the Patients With Breast Cancer After Chemotherapy,"April 22, 2019","October 1, 2020",Completed,Observational
2993,EC /2018/0996,Pre- or Postoperative Accelerated Radiotherapy,"September 17, 2018","November 19, 2021",Completed,Interventional
2994,19-008929,Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients,"January 23, 2020","December 31, 2024","Active, not recruiting",Interventional
2995,22-4004,African Cancer Genome: GMD,"November 28, 2022","July 1, 2024",Recruiting,Observational
2996,CD07_TNBC,Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC,"April 22, 2019","September 16, 2022","Active, not recruiting",Interventional
2997,2021-04031,Supporting Women With Breast Cancer to Practice DIBH at Home Before Radiation Therapy,"September 1, 2023","March 30, 2029",Not yet recruiting,Interventional
2998,STU-2019-0769,PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer,"July 23, 2019","June 15, 2021",Completed,Interventional
2999,F16J16000620002,Innovation in Mammography: Tomosynthesis Pathways,"September 3, 2018","September 1, 2021",Unknown status,Interventional
3000,PSCI 21-045,Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer Survivors,"November 22, 2021",November 2023,Recruiting,Interventional
3001,CD07_TNBC,Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC,"April 22, 2019","September 16, 2022","Active, not recruiting",Interventional
3002,F16J16000620002,Innovation in Mammography: Tomosynthesis Pathways,"September 3, 2018","September 1, 2021",Unknown status,Interventional
3003,NUR20-0124CRYO,The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer,"August 4, 2020","February 3, 2021",Terminated,Interventional
3004,32551/09/2018,Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy,"September 10, 2018","December 10, 2019",Completed,Interventional
3005,AAAS3402,Glucose Monitoring During Chemotherapy,"October 31, 2019",December 2023,"Active, not recruiting",Observational
3006,2017-1535,OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease,"May 21, 2018",December 2022,"Active, not recruiting",Interventional
3007,HUM00208684,Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging,"July 25, 2022",July 2026,Recruiting,Observational
3008,12341234,Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy,"October 1, 2022","October 1, 2023",Not yet recruiting,Interventional
3009,Mepitel RCT,Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients,"January 30, 2020",December 2024,"Active, not recruiting",Interventional
3010,ShandongCHI-07,Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy,November 2018,November 2025,Not yet recruiting,Interventional
3011,D8532C00005,"A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833","May 10, 2022","June 20, 2022",Completed,Interventional
3012,CADEX-0001,Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer,"March 1, 2019","October 1, 2023",Suspended,Observational
3013,ELIPSE (SOLTI-1905),"Elacestrant in Preoperative Setting, a Window of Opportunity Study","February 9, 2021","February 25, 2022",Completed,Interventional
3014,VI-ISRP-026,A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes,"August 1, 2018","March 1, 2020",Suspended,Interventional
3015,5652-18-SMC,Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients,"March 25, 2019","May 3, 2020",Completed,Interventional
3016,İboelif22,"The Relationships Between Physical Activity Level, Quality of Life and Cognitive Level in Breast Cancer Patients","January 5, 2022","September 5, 2022",Recruiting,Observational
3017,FEMAL,Comparison of the Efficacy and Tolerability of Femal Versus Placebo,"May 10, 2019","April 1, 2022",Completed,Interventional
3018,20-30638,Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP),"February 1, 2022",September 2023,Recruiting,Interventional
3019,R.20.11.1099,Ultrasonographic Axillary Localization,"December 15, 2020",April 2022,Unknown status,Interventional
3020,IRB00074154,Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients,"October 22, 2021",July 2024,Recruiting,Interventional
3021,SMC 2021-05-045,SMC Radiation Oncology Breast Cancer Cohort Study,"January 1, 2021","December 31, 2030",Recruiting,Observational
3022,SamsunU,Combination of Serratus Anterior and Pectoral Nerve Blocks (PECS II) as Main Anesthetic Method in Breast Cancer Surgery,"July 7, 2022","July 20, 2023",Recruiting,Observational
3023,ShandongCHI-18,Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort,"October 1, 2021","December 30, 2024",Not yet recruiting,Observational
3024,JWCI OBCS WITH IORT,Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.,"December 16, 2021",February 2026,Recruiting,Interventional
3025,AAAT8915,Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia,"August 3, 2022","February 29, 2024",Recruiting,Interventional
3026,20-513,Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer,"November 24, 2020",November 2024,Recruiting,Interventional
3027,IRB00313835,Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic,"July 18, 2022",June 2024,Recruiting,Interventional
3028,HE-202012,Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer,"June 18, 2021","July 28, 2028",Recruiting,Interventional
3029,NCC201804007,Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model,"January 1, 2019","July 1, 2020",Unknown status,Interventional
3030,110.01-2016-GES-0001,Automated Breast Ultrasound Case Collection Registry,"July 12, 2018","January 25, 2019",Terminated,Observational
3031,PREVENT,"Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery","January 9, 2018","January 1, 2024",Recruiting,Interventional
3032,QL-KPTB-150,Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer,"December 10, 2018","January 26, 2019",Completed,Interventional
3033,REaCT-Hot Flashes Pilot,Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study,"February 25, 2022","September 22, 2022",Completed,Interventional
3034,IRB00081356,Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer,"December 17, 2019",January 2041,Recruiting,Observational
3035,VIL-HEQ-17-014,Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population,"July 26, 2018","October 26, 2021",Unknown status,Observational
3036,COMPLEMENT,Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients,"June 1, 2022","March 1, 2025",Not yet recruiting,Interventional
3037,DHLI-BC/OC-BE-001,Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients,"July 28, 2021","April 30, 2022",Recruiting,Interventional
3038,GS18/107321,ePainQ - Feasibility Study,"August 6, 2018","March 30, 2020",Unknown status,Interventional
3039,2019-003825-56,"Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer",March 2020,August 2021,Unknown status,Interventional
3040,80252,Breast Reconstruction and Neoadjuvant Radiotherapy,"May 1, 2022","March 1, 2024",Not yet recruiting,Interventional
3041,Exo-LCR,Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (Exo-LCR),"January 4, 2023",December 2026,Recruiting,Interventional
3042,MCC-19117,Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer,"February 19, 2018",December 2026,"Active, not recruiting",Interventional
3043,EA1181,CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy,"February 11, 2020","December 31, 2038",Recruiting,Interventional
3044,PAL-ZJCC-02,Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients,"April 22, 2021","June 30, 2023",Recruiting,Interventional
3045,GCO 18-1832,Leflunomide in Previously Treated Metastatic Triple Negative Cancers,"April 16, 2019",October 2025,Recruiting,Interventional
3046,DS_v01,A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations,"April 28, 2020","September 1, 2023",Recruiting,Observational
3047,T06/024/21,Exercise and Tumor Blood Flow in Lymphoma And Breast Cancer Patients (EXETUMOR 3),"August 10, 2021","December 31, 2022",Recruiting,Interventional
3048,ES,Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer,"February 10, 2021","May 10, 2022",Completed,Interventional
3049,Study00145121,Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms,"June 1, 2020","July 31, 2021",Terminated,Interventional
3050,STU 042018-083,Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod,"April 22, 2019","June 28, 2030","Active, not recruiting",Interventional
3051,AcuBreast 2020,Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?,"September 1, 2021","July 1, 2023",Recruiting,Interventional
3052,4-2020-1093,Radiotherapy for Thoracic and Breast Cancer and the Related Cardiotoxicity Following Treatment (RACCOON),"December 22, 2020",December 2022,Unknown status,Observational
3053,A012103,Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab,"May 10, 2023","May 31, 2033",Not yet recruiting,Interventional
3054,HREBA.CC-22-0128,Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women,"June 5, 2023",June 2027,Not yet recruiting,Interventional
3055,A191901,Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy,"February 15, 2021",October 2025,Suspended,Interventional
3056,VICCBRE2257,Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy,"April 30, 2023","May 1, 2028",Not yet recruiting,Interventional
3057,HCI69515,Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment,"January 31, 2018",January 2026,Recruiting,Interventional
3058,TX05-03E,Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03,"August 20, 2019","March 8, 2022",Completed,Interventional
3059,2019/639,Effect of Nurse-led Supportive Care on Caregiver Burden and Well-being,"April 18, 2022","January 13, 2023",Completed,Interventional
3060,GBG 107,Long-term Safety and Efficacy of GBG Study Participants,"October 12, 2022","May 19, 2030",Recruiting,Observational
3061,CE-MRI&CESM in breast lesions,CE-MRI&CESM in Solid Breast Lesions,"April 1, 2021","May 1, 2023",Not yet recruiting,Observational
3062,PBCST,Precision Breast Conserving Surgery With Guidance.,"August 1, 2021","January 1, 2023",Completed,Interventional
3063,NEODOC- 2021668610-221,Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes,"July 13, 2020","December 31, 2021",Unknown status,Interventional
3064,9785-CL-0018,A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer,"January 27, 2020","December 27, 2020",Completed,Interventional
3065,2021-03165,Validation of Scales in Reconstructive Breast Surgery,"June 21, 2021","December 21, 2027",Recruiting,Observational
3066,IRB202202679,Exercise to ReGain Stamina and Energy (The EXERGISE Study),March 2023,March 2024,Not yet recruiting,Interventional
3067,Arise-FJ-B102,Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer,November 2019,November 2023,Not yet recruiting,Interventional
3068,453190,Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52,"July 22, 2020","May 1, 2022",Unknown status,Interventional
3069,RenJiH-2018-038,"CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial","August 24, 2018","June 30, 2019",Completed,Interventional
3070,202110124,Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women,"March 18, 2022","June 30, 2022",Completed,Interventional
3071,18-003544,Comparison of Three Methods for Early Detection of Breast Cancer,"October 15, 2019","October 5, 2021",Completed,Interventional
3072,MCC-21262,A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV),"March 28, 2023",March 2026,Recruiting,Interventional
3073,CKRC2021-CCV,Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups,"March 1, 2021","February 17, 2024",Enrolling by invitation,Interventional
3074,BEXMET,The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC,"October 1, 2020","June 30, 2023",Recruiting,Interventional
3075,PICC One Day 01 (ET15-123),Iterative PICC Placement Versus Long Term Device,"January 10, 2018","January 10, 2018",Withdrawn,Interventional
3076,IRB00049061,Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer,"August 3, 2018","February 21, 2021",Completed,Interventional
3077,CP-13-001,MarginProbe 2.0 Data Collection Protocol,"December 15, 2021","December 31, 2023",Recruiting,Observational
3078,SOLTI-1710,Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy,"November 21, 2019","February 24, 2022",Completed,Interventional
3079,IJB-SYNERGY-012017,Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC,"December 28, 2018",October 2023,"Active, not recruiting",Interventional
3080,IRB00046759,Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer,"March 26, 2018","November 1, 2018",Completed,Interventional
3081,18947,Sentinel Lymph Node Mapping With Near Infrared Fluorescent Markers,"July 20, 2018","May 25, 2022",Completed,Interventional
3082,2021-A03027-34,Shared Decision Making on Care Pathways and CAMs: A Pilot Study,September 2022,August 2023,Not yet recruiting,Interventional
3083,IRB-44367,Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy,"August 1, 2018",December 2022,Recruiting,Interventional
3084,NEPA-17-05,A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer,"March 16, 2018","September 19, 2018",Completed,Interventional
3085,I3Y-MC-B009,A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemaciclib) Among Breast Cancer Patients in China Verzenios® (Abemaciclib) Among Breast,March 2022,May 2026,Not yet recruiting,Observational
3086,SHR6390-III-303,"Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative","April 30, 2021","October 31, 2031",Enrolling by invitation,Interventional
3087,17/222,Under- and Overdiagnosis in BreastScreen Norway,"July 1, 2018","June 8, 2020",Completed,Observational
3088,2022-761,Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality,February 2023,July 2024,Not yet recruiting,Interventional
3089,JCL2020,A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast,"July 14, 2020","October 1, 2026",Recruiting,Interventional
3090,19-302,"Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer","January 29, 2021",January 2024,"Active, not recruiting",Interventional
3091,BFH-BC,ESM Versus OM ：A Randomized Controlled Trial,"December 1, 2020","December 31, 2022",Unknown status,Interventional
3092,RT 1901,Hypofractionated Versus Conventional Fractionation Radiotherapy,July 2019,December 2020,Unknown status,Interventional
3093,MC1732,Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery,"November 20, 2018","November 20, 2023","Active, not recruiting",Interventional
3094,ET19-084 - CICA-RT,Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients,"June 6, 2020","October 9, 2022",Unknown status,Interventional
3095,A5481160,"Demographics, Characteristics, Treatment Patterns and Clinical Outcomes of Palbociclib Treated Patients in Israel","December 6, 2020","October 6, 2021",Completed,Observational
3096,21623,Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer,"July 3, 2022","January 26, 2023",Withdrawn,Interventional
3097,CASE10116,Breast Reconstruction Following Breast Cancer in Very High Risk Patients,"May 31, 2019",July 2022,Withdrawn,Interventional
3098,2021/271,Effect of Laughter Therapy on Perceived Stress and Quality of Life,"February 17, 2022","June 12, 2022",Completed,Interventional
3099,CASE5Y21,A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose,"October 19, 2022","June 30, 2025",Recruiting,Interventional
3100,University in Zielona Gora,Inertial Rehabilitation in Women After Mastectomy,"April 2, 2019","July 24, 2019",Completed,Interventional
3101,T148/2020,Exercise and Tumor Blood Flow in Breast Cancer Patients,"September 7, 2020","December 31, 2024",Recruiting,Interventional
3102,ICO-2019-16,Satisfaction and QUality of Life After Breast REconstruction,"September 3, 2019","November 25, 2019",Completed,Observational
3103,ISI dV SP - NSM-01,Robotic vs. Open NSM for Early Stage Breast Cancer,April 2023,December 2026,Not yet recruiting,Interventional
3104,ATOPE18,Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program,"September 1, 2019","December 31, 2022",Recruiting,Interventional
3105,ChungnamNU.J1,VR-based Intervention for Cognitive Restoration,"December 10, 2019","December 31, 2024",Recruiting,Interventional
3106,EC/2017/1261,Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes,"October 15, 2018","December 31, 2023",Recruiting,Interventional
3107,M21REO,"Association of Silicone Breast Implant Reconstruction and -Enlargement With Overall Wellbeing, Lymphoma and Auto-immune Disease","July 1, 2022","June 1, 2025",Not yet recruiting,Observational
3108,EORTC-2129-BCG,TREAT ctDNA Elacestrant,"May 1, 2023","May 1, 2030",Not yet recruiting,Interventional
3109,22-001501,Characterization of TRPC6 to Predict and Prevent Chemotherapy Related Cardiac Toxicity and Heart Failure in Patients With Breast Cancer,"August 18, 2022","September 1, 2027",Recruiting,Observational
3110,NCI-2021-11793,Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer,"March 15, 2022","March 14, 2024",Recruiting,Interventional
3111,ET19-283,Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma,October 2020,October 2030,Not yet recruiting,Observational
3112,2019-4433,Angiomammography and Neoadjuvant Chemotherapy,"January 3, 2018","June 30, 2024",Recruiting,Interventional
3113,THERMOEDEME,Spa Therapy for Upper Limb Lymphoedema,"June 20, 2019",December 2022,Unknown status,Interventional
3114,C3621001,Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC,"November 27, 2018","September 27, 2021",Terminated,Interventional
3115,LSB-12345,Intraoperative Use of ClearEdge Device in Breast Conserving Surgery,"October 10, 2022","December 31, 2024",Recruiting,Interventional
3116,108511,Breathwork App for Cancer Survivors,"November 17, 2021","May 31, 2023",Recruiting,Interventional
3117,202101421A0,Pilot Study of Single-port Robot-assisted Nipple-sparing Mastectomy,"July 30, 2022","August 1, 2023",Recruiting,Interventional
3118,960-CSP-USA_DenseBreasts_USS1,A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts,"April 15, 2018","April 30, 2019",Terminated,Interventional
3119,PROICM 2018-09 BSA,Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity,"May 23, 2019",June 2024,Recruiting,Observational
3120,211521,nCCR for Chemotherapy Related Cognitive Impairment Randomized Study,"August 1, 2022","March 1, 2025",Recruiting,Interventional
3121,BC-P30(FZQ),Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy,"June 10, 2022",November 2026,Recruiting,Interventional
3122,2017-0672,"LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas","April 27, 2018","June 30, 2024",Recruiting,Interventional
3123,2019-4432,Screening Contrast-enhanced Mammography,"December 12, 2018",December 2024,Recruiting,Observational
3124,22-508,Implantable Microdevice for TNBC - Pilot Study,May 2023,"September 1, 2028",Not yet recruiting,Interventional
3125,NCC2021-0335,Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant,"November 15, 2021","December 31, 2028",Enrolling by invitation,Observational
3126,LET,Lymphedema Treatment Registry,October 2021,January 2023,Not yet recruiting,Observational
3127,Pectoral nerve block in breast,Pectoral Nerve Block During Mastectomy,"April 1, 2023","December 30, 2024",Not yet recruiting,Interventional
3128,TNBC,Epidemiology of TNBC in Asyut Clinical Oncology Department,"November 1, 2022",December 2023,Not yet recruiting,Observational
3129,NU 18B05,Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast,"February 17, 2020","June 25, 2024",Recruiting,Interventional
3130,20476,Immune Effects in Patients Treated With Whole Breast Irradiation,"October 1, 2018",March 2020,Unknown status,Interventional
3131,ICRCTSU/2019/10068,PreOperative Endocrine Therapy for Individualised Care With Abemaciclib,"December 23, 2020","March 31, 2032",Recruiting,Interventional
3132,EU001,Magseed Pro(R)/ Sentimag(R) Gen3,"March 2, 2023","December 31, 2024",Not yet recruiting,Interventional
3133,2018-63,Does Chemotherapy Train the Mutation of the Pig-A Gene? (PIGA),"January 10, 2019","January 10, 2021",Unknown status,Interventional
3134,2020-06245,Effects of Expectations and Body Image in Breast Reconstruction,"February 1, 2021","December 31, 2024",Recruiting,Observational
3135,18-168,"Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue","September 17, 2018","August 31, 2024","Active, not recruiting",Interventional
3136,2021-A01407-34,Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration,"April 15, 2022","April 15, 2023",Not yet recruiting,Interventional
3137,soh-Med-21-02-05,Modified Pectoral Nerve Block Versus Serratus Plane Block,"May 20, 2021","August 20, 2023",Not yet recruiting,Interventional
3138,CIMPAX BREAST,Continuous Serrates Plane Block in Axillary Dissection,"June 13, 2018","June 13, 2020",Unknown status,Interventional
3139,18D.003,"Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence","July 31, 2019","October 31, 2023",Recruiting,Interventional
3140,YOUNGBC-20,Detection and Analysis of MBC With Heterogeneous ER Expression,"January 15, 2022","December 15, 2022",Completed,Observational
3141,20-002505,Mayo Designed Soft Tissue Ultrasound-Detectable Marker,"November 2, 2020","April 7, 2022",Completed,Interventional
3142,XianganHXiamenU,NIR Fluorescent Molecular Probe for the Identification of Breast Tissue,"February 17, 2023","January 29, 2024",Recruiting,Interventional
3143,YOUNGBC-21,Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab,"October 1, 2022","May 1, 2023","Active, not recruiting",Observational
3144,201900572,The SONImage Study,"December 5, 2019",July 2025,Recruiting,Interventional
3145,MEDOPP459,Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%,May 2023,October 2024,Not yet recruiting,Interventional
3146,MedOPP485,A PoC Study to Evaluate Treatments Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population,"September 30, 2023","March 30, 2028",Not yet recruiting,Interventional
3147,09.2019.866,Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy,"October 20, 2019","March 30, 2020",Unknown status,Interventional
3148,A5481128,Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.,"October 19, 2019","April 1, 2022",Completed,Observational
3149,YOUNGBC-3,500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI,"May 14, 2018","May 15, 2019",Completed,Observational
3150,020-008,Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC,"October 15, 2020","December 1, 2023",Recruiting,Interventional
3151,YOUNGBC-14,Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine,"January 15, 2020","June 15, 2021",Completed,Observational
3152,LQiao,HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC,"January 1, 2020","January 1, 2023",Recruiting,Interventional
3153,2021157,Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer,"September 1, 2022","September 1, 2024",Not yet recruiting,Interventional
3154,2020-KY-051,Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction,"August 6, 2020","July 14, 2021",Completed,Interventional
3155,YOUNGBC-25,Negative ER Expression Assessed by 18F-FES PET/CT in the MBC With ER-positive Primary Tumor,"December 1, 2022",May 2023,Recruiting,Observational
3156,BC-09374,LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema,"June 30, 2021","December 27, 2025",Recruiting,Interventional
3157,Shengjing-LCG011,"Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC","February 10, 2022","December 31, 2027",Recruiting,Interventional
3158,2021-02902,PACED-digitized Support During Adjuvant Endocrine Therapy,"October 25, 2021",September 2024,Recruiting,Interventional
3159,GCO 19-0477,"Vaccination With Flt3L, Radiation, and Poly-ICLC","April 5, 2019",March 2025,Recruiting,Interventional
3160,202100318,Testosterone & Tamoxifen Trial,"November 10, 2022","January 3, 2024",Recruiting,Interventional
3161,19-458,A Study of the Use of Text Message Reminders to Take Palbociclib,"December 27, 2019","December 27, 2023","Active, not recruiting",Interventional
3162,S1904,Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE),"September 1, 2020","June 1, 2028",Recruiting,Interventional
3163,Seno_Ex_MAC 003,Comparison of Conventional With Sonography Assisted Breast Surgery After Neoadjuvant Chemotherapy,"October 1, 2018","April 1, 2023",Recruiting,Interventional
3164,E2018210,Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients,"January 1, 2019","April 1, 2023",Unknown status,Observational
3165,CL(3204),Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms,"February 10, 2022",December 2023,Recruiting,Interventional
3166,211-2018,MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC,"November 8, 2018",June 2021,Unknown status,Interventional
3167,AAAO1760,CBPR - BRCA Genetic Testing Among Orthodox Jews,"March 13, 2018","January 29, 2019",Completed,Interventional
3168,J17120,"Cancer, Obesity/Overweight and Insomnia Study","June 12, 2018","November 30, 2020",Completed,Interventional
3169,1712078374,"Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome","February 28, 2018","June 15, 2022",Completed,Interventional
3170,D17168,The Prone to Supine Breast MRI Trial,"July 12, 2018","July 31, 2020",Completed,Interventional
3171,ShandongCHI-14,Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC,"January 1, 2021","June 1, 2022",Unknown status,Observational
3172,2020-KY-007,The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome,"January 1, 2022","December 31, 2030",Not yet recruiting,Interventional
3173,DELFINO trial,"Density Lowering Effect of ""OFS Add on to TMX""(DELFINO Trial)","September 3, 2018","October 2, 2023",Recruiting,Interventional
3174,PRISMA,Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application,November 2022,June 2025,Not yet recruiting,Interventional
3175,3125001,Safety and Pharmacokinetics of ODM-209,"April 17, 2019",October 2023,"Active, not recruiting",Interventional
3176,ShandongCHI-16,"Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis","January 1, 2021","March 1, 2022",Unknown status,Interventional
3177,ERAS-ABR,ERAS in Autologous Breast Reconstruction: A Pilot RCT,"November 5, 2019","June 30, 2020",Completed,Interventional
3178,ProFertil,Use of GnRHa During Chemotherapy for Fertility Protection,"March 31, 2023","January 31, 2032",Not yet recruiting,Interventional
3179,MEDOPP240,Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients,"October 23, 2020","July 31, 2024","Active, not recruiting",Interventional
3180,TQB3616-I-0001,A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics,"March 1, 2019","September 30, 2021",Unknown status,Interventional
3181,BreastIls-1605,Endogenous Mechanisms of Inactivation of the Endothelium Tumor,"January 31, 2018",October 2019,Unknown status,Observational
3182,7964,Clinical Validation of an Artificial Intelligence Algorithm to Help Interpret Mammograms,"April 20, 2021","December 31, 2022",Recruiting,Observational
3183,18-00309,Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy,"December 13, 2019",April 2024,Recruiting,Interventional
3184,2005P002282,Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions,"September 29, 2020","June 24, 2021",Completed,Observational
3185,2023-9333,The MARVIN Chatbots to Provide Information for Different Health Conditions,"May 1, 2023","December 31, 2034",Not yet recruiting,Interventional
3186,STUDY00020501,"Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study","March 18, 2022","September 30, 2024",Recruiting,Interventional
3187,[2016]124,Serratus Plane Block in Preventing Postoperative Pain of Mastectomy,"August 1, 2018","December 1, 2019",Completed,Interventional
3188,IIT2018-04-MCARTHUR-NEOHP,Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab,"January 25, 2019",July 2025,Recruiting,Interventional
3189,MCP Study,Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong,"August 6, 2018","December 31, 2023",Recruiting,Interventional
3190,STUDY00000194,"Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases","June 12, 2020","September 13, 2021",Withdrawn,Interventional
3191,mastectomy coverage formula 20,New Formula to Predict the Need for Reconstructive Coverage Following Mastectomy,"August 15, 2020","November 15, 2020",Completed,Observational
3192,KC19EEDT0031,Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery,"September 24, 2020",June 2026,Recruiting,Interventional
3193,SIB2232,SMART-ER: Symptom Monitoring With Patient-reported Outcomes,"October 3, 2022","June 9, 2023",Recruiting,Interventional
3194,22-008,Onvansertib + Paclitaxel In TNBC,"September 30, 2022","February 15, 2029",Recruiting,Interventional
3195,1807188-16,FUSCC Refractory TNBC Umbrella (FUTURE),"October 18, 2018","December 1, 2022",Recruiting,Interventional
3196,OSU-20429,Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel,"October 7, 2021","December 31, 2024",Recruiting,Interventional
3197,2020/295,"The PreQ-20 TRIAL, a Prospective Cohort Study of Patients Undergoing Prepectoral Breast Reconstruction","June 22, 2020",December 2026,Recruiting,Interventional
3198,SunYatsenU2H-LQ4,"A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC","April 1, 2021","September 1, 2033",Recruiting,Interventional
3199,Phaon1,Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy,"March 1, 2021","January 1, 2026","Active, not recruiting",Interventional
3200,SUGBG-2021002,Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach,"October 1, 2021","July 1, 2023",Recruiting,Interventional
3201,S2018-2450-0001,Distress Reduction by Activity Tracking and Activity Enhancement by Mobile Support Group in Oncology,"January 7, 2019","November 16, 2020",Completed,Interventional
3202,IIT-0016,Exercise and Compression for Lymphedema,"May 27, 2022","May 31, 2024",Recruiting,Interventional
3203,N.sativavsRID BreastCancerpt.,Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients,"January 24, 2023",April 2024,Recruiting,Interventional
3204,00130272,PhysioTouch for Treatment of Radiation Fibrosis,December 2018,April 2020,Withdrawn,Interventional
3205,URCC-18007,Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors,"June 28, 2019","March 24, 2024",Recruiting,Interventional
3206,jcl2020-2 breast cancer,3D Printed Bolus in Post-mastectomy Radiotherapy,"March 1, 2020","April 20, 2021",Unknown status,Interventional
3207,OP-1250-003,Phase 1b Combo w/ Ribociclib and Alpelisib,"August 31, 2022","August 31, 2024",Recruiting,Interventional
3208,38285020.8.0000.0072,"Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer","December 17, 2020","January 17, 2022",Completed,Interventional
3209,17-001546,Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation Dermatitis,"April 11, 2018","November 25, 2019",Completed,Observational
3210,TMP-0315-2018,Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel),"April 9, 2020",June 2023,Recruiting,Interventional
3211,21-3117.cc,Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC,"January 4, 2022","December 1, 2022",Withdrawn,Interventional
3212,IRB00103558,Resistance Training to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors,"December 10, 2018","March 12, 2020",Completed,Interventional
3213,ICOnnectat-BC,"Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer Survivors","January 1, 2021","June 30, 2022",Unknown status,Interventional
3214,20-028,Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA),"July 2, 2020","December 30, 2025",Recruiting,Interventional
3215,C3441038,Korea Post Marketing Surveillance (PMS) Study of Talzenna®,May 2024,"November 30, 2026",Not yet recruiting,Observational
3216,2,Effects of Extracorporeal Shock Wave Therapy Added To Complex DecongestiveTherapy In Patıent With Lymphedeme,"July 1, 2022","January 15, 2024",Recruiting,Interventional
3217,STU-2022-0091,Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy,"March 8, 2022",February 2024,Recruiting,Interventional
3218,ICO-2021-36,Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique,September 2022,September 2023,Not yet recruiting,Observational
3219,2021-0048-B,Erector Spinae Block vs. Placebo Block Study,September 2022,August 2023,Not yet recruiting,Interventional
3220,Breastblock,Regional Anesthesia for Breast Surgery,"May 29, 2019",June 2022,Unknown status,Interventional
3221,OMS-I141 (KEYNOTE-890),Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC,"October 11, 2018",August 2024,Recruiting,Interventional
3222,L424,Cancer Surveillance and Support,"March 22, 2021",September 2023,Recruiting,Observational
3223,BHP0111,Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza),"August 1, 2019","September 20, 2021",Completed,Interventional
3224,18-001926,Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors,"October 7, 2019","June 1, 2024",Recruiting,Interventional
3225,20CX6399,Histolog Comparison to Standard Histology,"June 4, 2021",December 2023,"Active, not recruiting",Observational
3226,REDHEMOPACH,Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy,"March 1, 2020","February 14, 2023",Completed,Interventional
3227,PMC_TTAC-0001_06 / KEYNOTE-C14,Olinvacimab With Pembrolizumab in Patients With mTNBC,"September 30, 2021","August 30, 2026",Recruiting,Interventional
3228,INSPIRE-001,Intercostobrachial Nerve Sparing to Reduce Post-Surgical Pain,"October 15, 2019","December 1, 2020",Unknown status,Interventional
3229,STUDY00149312,Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC,"December 5, 2022",December 2025,Recruiting,Interventional
3230,IIT2021-10-Giuliano-OmitRT,Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response,May 2022,May 2028,Not yet recruiting,Interventional
3231,VICCBRE2256,Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort,"May 30, 2023","May 30, 2037",Recruiting,Interventional
3232,Patient reported outcome,Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery,"March 1, 2023","September 1, 2024",Not yet recruiting,Observational
3233,EAZ171,Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer,"June 27, 2019","June 1, 2023","Active, not recruiting",Interventional
3234,2017/62,Effects of Slow-Stroke Back Massage on CRF,"June 18, 2018","April 15, 2019",Completed,Interventional
3235,17-001864,SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer,"April 7, 2019","December 6, 2021",Completed,Interventional
3236,SCHBCC-N031,An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.,"May 15, 2020","November 15, 2023",Recruiting,Interventional
3237,20429001,Central Obesity and Cancer Prevention for Chinese American Women,"October 16, 2019",December 2020,Unknown status,Interventional
3238,2000020335,"Lifestyle, Exercise, and Nutrition Study Early After Diagnosis","January 2, 2018","December 31, 2023","Active, not recruiting",Interventional
3239,KN026-CHN-001,Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer,"September 17, 2018","August 30, 2023","Active, not recruiting",Interventional
3240,Pro00103527,mHealth Behavioral Cancer Pain Intervention for Medically Undeserved Patients,"October 20, 2021","January 31, 2025",Recruiting,Interventional
3241,21-374,A Study of Tumor Imaging With Multispectral Optoacoustic Tomography,"July 27, 2022","July 27, 2023",Recruiting,Observational
3242,CBCRP 23AB-1400,Reducing Breast Cancer Risk in Korean American Women,"March 16, 2019","December 31, 2019",Completed,Interventional
3243,EJERDIETLINF,Reduction of Lymphedema Secondary to Breast Cancer,"May 17, 2021","May 17, 2024","Active, not recruiting",Interventional
3244,MC02/04/19,"A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)","July 13, 2020",July 2023,Recruiting,Interventional
3245,22-5074,Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE),June 2023,December 2027,Not yet recruiting,Interventional
3246,STUDY00018789,StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients,"December 1, 2022","March 1, 2024",Not yet recruiting,Interventional
3247,SCHBCC-SOAPET,Sentinel Node Biopsy Vs Observation After Axillary PET,"September 4, 2019","September 1, 2027",Recruiting,Interventional
3248,3212,"A Survey to Assess Knowledge, Attitudes & Practices in Surgeons With Regards to Breast Conservation Surgery & Mastectomy","April 2, 2019","October 31, 2019",Completed,Observational
3249,ATADEK-2022/08/20,The Effect of Manual Lymph Drainage in the Treatment of Breast Edema,"May 30, 2022","January 15, 2023",Recruiting,Interventional
3250,2018-06,Early Detection of Imaging-derived Subclinical Cardiac Injuries,"January 24, 2019","September 2, 2024",Recruiting,Observational
3251,OBU-BC-Ⅱ-077,"Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer","October 20, 2022","October 20, 2024",Not yet recruiting,Interventional
3252,RG1005296,"Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer","April 20, 2022","June 30, 2027",Recruiting,Interventional
3253,B7391012,A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer,"May 31, 2023","August 16, 2025",Not yet recruiting,Observational
3254,ONCO-FIRE,ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data Reusability,June 2023,December 2025,Not yet recruiting,Observational
3255,2021-01534,Effect of Breast Implants om Mammography Screening,"May 12, 2021","December 31, 2023","Active, not recruiting",Observational
3256,RD19/123502,Plant Sterol INtervention for Cancer Prevention (PINC),"February 10, 2020","December 31, 2021",Recruiting,Interventional
3257,091-19,Study on Physical Activitys Relationship With Cancer and Cognition,"September 30, 2019","July 15, 2021",Completed,Interventional
3258,PR139/21,Axillary Reverse Mapping in Breast Cancer,"June 1, 2021","December 1, 2023",Recruiting,Interventional
3259,2021.341,Project Breast47: Effect of an Educational Intervention,"January 15, 2022","June 26, 2022",Completed,Interventional
3260,17-361,BEFORE Decision Aid Implementation Study,"September 1, 2018","December 31, 2019",Unknown status,Interventional
3261,PPMP_INO,Persistant Post-mastectomy Pain in Breast Cancer : Incidence and Risk Factors,"December 10, 2018","March 7, 2021",Completed,Observational
3262,Overcome project,"Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone Metastases","February 7, 2022",February 2024,Recruiting,Interventional
3263,DS8201-A-A103,DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein,"April 2, 2018","September 28, 2022",Completed,Interventional
3264,Xiangan Hospital of XMU,Artificial Intelligence Analysis of Fluorescence Image to Intraoperatively Detect Metastatic Sentinel Lymph Node.,"November 1, 2021","December 1, 2024",Recruiting,Observational
3265,OBU-BJ-BB-BC-II-007,Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy,"November 20, 2021","December 31, 2024",Recruiting,Interventional
3266,NU 21B01,"Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study","November 28, 2022","July 1, 2024",Recruiting,Interventional
3267,COOL-CLIN-2022-01,Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss,"August 15, 2022","March 15, 2024",Not yet recruiting,Interventional
3268,110.01-2018-GES-0001,Automated Breast Ultrasound as an Adjunct to Screening Digital Breast Tomosynthesis,August 2018,August 2021,Withdrawn,Observational
3269,NURS-IIR-IUSCCC-0748,Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms,"November 16, 2020","July 27, 2021",Completed,Observational
3270,2020-1243,Music and Surgery Associated With Relationship and Satisfaction,"September 21, 2020","December 31, 2021",Unknown status,Interventional
3271,OSU-19085,Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer,"November 1, 2020","December 31, 2021",Withdrawn,Interventional
3272,SYSUCC-012,GM1 Prophylaxis for WBRT Related Cognitive Dysfunction,"May 15, 2020","December 31, 2024",Recruiting,Interventional
3273,UUBreast01,Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ,"March 1, 2020","December 30, 2027",Recruiting,Interventional
3274,IMPACTT,Impact of a Patient Decision Aid Intervention,"November 15, 2022",June 2024,Recruiting,Interventional
3275,1/2020,Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective,"August 8, 2018","February 4, 2019",Completed,Observational
3276,CBBCT2018CIH,The Technical Operations And Standard Clinical Application Protocol of CBBCT in Diagnostic Process of Breast Cancer,"January 1, 2018","December 31, 2020",Completed,Interventional
3277,30-225 ex 17/18,Laser vs Hyaluronic Acid for GSM in Breast Cancer,"January 24, 2019","December 31, 2023",Recruiting,Interventional
3278,ITSligo SG,Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema,"October 30, 2020","January 31, 2022",Unknown status,Interventional
3279,STUDY00003067,Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding,"January 1, 2021","June 30, 2023","Active, not recruiting",Interventional
3280,PROICM 2019-02 PRA,"Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic "" Patient Reported Outcome "") on Breast-related Quality of Life","September 28, 2020","June 30, 2025",Recruiting,Interventional
3281,850366,"The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients","February 1, 2023","February 1, 2025",Not yet recruiting,Interventional
3282,060021-HMO-CTIL,"Health Care Disparities in Culturally Diverse, Special Needs & Disadvantaged Populations - Bridging the Gap","September 26, 2021","July 1, 2023",Recruiting,Observational
3283,2018/13,Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer,"November 12, 2018","December 31, 2022",Completed,Interventional
3284,A095053,Breast Screening - Risk Adaptive Imaging for Density,"May 28, 2019","October 31, 2026",Recruiting,Interventional
3285,MC210301,"Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study","January 27, 2023","December 31, 2033",Recruiting,Observational
3286,202302077,Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial),"April 30, 2023","October 31, 2024",Not yet recruiting,Interventional
3287,Yunwei Wei 2019-09-12,Study on Skin Microbiome of HFS,"September 10, 2019","October 15, 2020",Unknown status,Observational
3288,2.510.081,PILATES METHOD ON THE UPPER LIMBS FUNCTIONALITY,"May 1, 2018","January 30, 2019",Completed,Interventional
3289,K170702J,Follow-up of Elderly Patients in Ambulatory Surgery,"January 1, 2018","March 1, 2019",Unknown status,Observational
3290,GX-I7-CA-006,Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899),"March 27, 2019",April 2024,"Active, not recruiting",Interventional
3291,R17137,Thermal Suit With Forced-air Warming in Breast Cancer Surgery,"February 20, 2018","July 6, 2018",Completed,Interventional
3292,2021-395,Efficacy of Cilostazol in Prevention of Peripheral Neuropathy,"March 28, 2022","December 30, 2022",Completed,Interventional
3293,IC 2018-09,Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR),"February 2, 2021","August 2, 2023",Recruiting,Interventional
3294,NeoCAT,A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs,"December 1, 2022","September 1, 2025",Recruiting,Interventional
3295,AAAR9515,The CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL,"April 25, 2019",April 2023,"Active, not recruiting",Interventional
3296,2019-01395CE3508,Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients,"September 15, 2020","December 31, 2024",Recruiting,Observational
3297,RG1007463,"Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer","July 19, 2021","August 16, 2022",Terminated,Interventional
3298,PA191001001,Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery,"July 1, 2019","September 1, 2020",Completed,Interventional
3299,18070604,A Study of Serum Folate Levels in Patients Treated With Olaparib,"July 21, 2020",June 2024,"Active, not recruiting",Interventional
3300,1613494-3,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,"August 28, 2020","September 1, 2022",Unknown status,Observational
3301,2021198-1,Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer,"March 31, 2022","December 31, 2025",Recruiting,Interventional
3302,PROTOCOL-M7-037,Micrima MARIA Data Collection for Machine Learning Study,"January 27, 2022","March 31, 2023",Recruiting,Interventional
3303,201801105,RANKL Inhibition and Breast Tissue Biomarkers,"June 1, 2018","December 3, 2018",Completed,Interventional
3304,202004120MINB,The Effect of Intraoperative Dexmedetomidine on Postoperative Morphine Requirements After Breast Cancer Surgery,"April 20, 2021","July 1, 2025",Recruiting,Interventional
3305,CHIR-05-IMTAD,Ideal Marker for Targeted Axillary Dissection,"January 1, 2021","May 30, 2023",Recruiting,Observational
3306,EAQ201,COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation,"December 2, 2021","October 30, 2024",Recruiting,Observational
3307,STUDY00001356,IIT2020-20-SHIRAZIP-WALK: Nature Walks,"June 21, 2021",December 2023,Recruiting,Interventional
3308,PANTHERA,Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire,"April 1, 2018","December 31, 2023",Recruiting,Observational
3309,IC 2020-04,ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery,"June 28, 2021","August 1, 2023",Recruiting,Interventional
3310,Remimazolam_recovery,Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol,"August 2, 2022","December 21, 2022",Completed,Interventional
3311,BIOC-046,A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide,"September 7, 2022","January 1, 2025",Recruiting,Observational
3312,RECHMPL21_0525,Tridimensional Geometric Modeling of the Breast,"March 31, 2022","December 1, 2023","Active, not recruiting",Interventional
3313,2022037,Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer,"September 10, 2022","August 10, 2024",Not yet recruiting,Interventional
3314,Q122-2001,Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor,"October 24, 2018","September 9, 2020",Completed,Interventional
3315,S64410,UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research,"November 30, 2020",September 2035,Recruiting,Interventional
3316,MC1689,"Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer","March 27, 2018","May 1, 2023",Suspended,Interventional
3317,2017C0165,Cancer Activity and Lifestyle Measurement Study,"January 4, 2019",November 2024,"Active, not recruiting",Observational
3318,2017-0301,Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers,"January 1, 2019","February 1, 2026",Withdrawn,Interventional
3319,S59396,Cancer Related Cognitive Impairment After Chemotherapy: Evaluation of Potential Therapeutic Interventions,"October 1, 2018","September 30, 2021",Unknown status,Interventional
3320,1105/18,The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patients Dream Study,"April 1, 2019","April 1, 2021",Completed,Interventional
3321,RFID,Breast Localization: RFID Tags vs Wire Localization,"May 15, 2021","November 15, 2023",Recruiting,Observational
3322,SP11631,Trial to Compare the Efficacy and Safety of F-627 and GRAN®,"April 12, 2018","June 19, 2019",Completed,Interventional
3323,EKNZ 2015-026,Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus,March 2020,September 2021,Withdrawn,Interventional
3324,5505,PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES,"March 20, 2023","May 2, 2026",Not yet recruiting,Observational
3325,H-37314,Translating Research Into Practice,"August 6, 2018",June 2023,"Active, not recruiting",Interventional
3326,852666,Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts,"April 10, 2023",April 2024,Enrolling by invitation,Interventional
3327,Three birds with one stone,Three Birds With One Stone,"September 1, 2021",December 2023,"Active, not recruiting",Interventional
3328,XZP-3287-1001,A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors,"May 22, 2018","December 30, 2022",Unknown status,Interventional
3329,I 56617,"Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers","June 28, 2018","March 15, 2023",Terminated,Interventional
3330,TAK-676-1003,A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers,"September 9, 2021","February 18, 2024",Recruiting,Interventional
3331,STUDY00022229,ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer,"July 30, 2023","July 31, 2025",Not yet recruiting,Interventional
3332,CR108557,"A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults","December 6, 2018","March 12, 2019",Completed,Interventional
3333,UPCC 25920,Pilot Study of an NTproBNP Guided Strategy of Cardioprotection,"March 18, 2021",June 2025,Recruiting,Interventional
3334,MEDOPP243,"DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease","May 25, 2020","April 4, 2023",Completed,Interventional
3335,4901,An Enhanced Artificial Intelligence Breast MRI Interpretation System,April 2019,July 2020,Unknown status,Interventional
3336,22-269,Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial),"September 8, 2022","February 28, 2025",Recruiting,Interventional
3337,2016-051-000001- 1731,The Role of Circadian Rhythms in Cancer-Related Symptoms,"June 1, 2020",June 2022,Unknown status,Observational
3338,Yvonne Wengstrom,Sensorimotor Training Using Whole Body Vibration Exercise to Reduce Chemotherapy-induced Peripheral Neuropathy,"October 17, 2022","April 25, 2024",Recruiting,Interventional
3339,4-2019-0795,Improvement of Patient Experience and Healthcare Providers Productivity Using Virtual Reality in the Field of Radiation Therapy,"March 13, 2020",October 2021,Unknown status,Interventional
3340,20180569-01H,Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study,"January 2, 2020",August 2023,Recruiting,Interventional
3341,None yet,An Observational Prospective Cohort Study Using an Actigraphy Device.,"May 15, 2018","August 31, 2018",Completed,Observational
3342,REaCT-Hold BMA,Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer,"October 9, 2020",November 2024,Recruiting,Interventional
3343,2020-0761,Evaluation of Mailers Promoting Mammogram Screening,"October 2, 2020","October 5, 2021",Completed,Interventional
3344,202005217,Implementing BREASTChoice Into Practice,"November 4, 2020","April 30, 2023","Active, not recruiting",Interventional
3345,Abbreviated Breast MRI,Abbreviated Breast MRI in Cancer Detection,"April 1, 2019",March 2022,Unknown status,Observational
3346,SBI-CIP 20-002,Fluorescence Imaging of Carcinoma During Breast Conserving Surgery,"April 27, 2021",December 2023,Recruiting,Interventional
3347,DS8201-A-U106,DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer,"February 10, 2020",March 2024,Recruiting,Interventional
3348,A2018-002,Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations,"February 26, 2018",December 2021,Unknown status,Interventional
3349,STUDY00016221,Nurse AMIE for Echo Show: Randomized Control Trial,"February 2, 2021","February 28, 2022",Completed,Interventional
3350,2669,Prospective Observational Study for Breast Microcalcifications Classification With Artificial Intelligence Techniques,"July 22, 2022","July 25, 2025",Recruiting,Observational
3351,PR275/20,Impact of Systematic Shaving on Margins,"October 7, 2020","October 16, 2023",Recruiting,Interventional
3352,X-PACT 101,"X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma","December 8, 2021",February 2025,Recruiting,Interventional
3353,SHF-WBI,Super Hypofractionated Irradiation For Whole Breast Treatment,"January 23, 2021","December 10, 2026",Recruiting,Interventional
3354,MCC-20257,Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk,"January 30, 2020","January 19, 2023","Active, not recruiting",Observational
3355,19-07020531,Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study,"June 30, 2020","December 31, 2026",Recruiting,Interventional
3356,DS8201-A-U105,Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer,"June 20, 2018",July 2022,"Active, not recruiting",Interventional
3357,NAUTILUS study,No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography,"September 15, 2020","December 31, 2027","Active, not recruiting",Interventional
3358,BrUOG 387,TAS-116 Plus Palbociclib in Breast and Rb-null Cancer,"May 1, 2023",April 2025,Not yet recruiting,Interventional
3359,Instituto Nacional do Câncer,Effectiveness of Compressive Bandage Use in Seroma Prevention,"November 8, 2021","March 30, 2023",Not yet recruiting,Interventional
3360,HP-LY-CL-2063,Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE),"June 7, 2018",December 2024,"Active, not recruiting",Interventional
3361,2008222-12,Accuracy of VABB Elite 10G Versus BARD 14G CNB,"November 1, 2020","June 30, 2022","Active, not recruiting",Interventional
3362,2019-0837-002,Capsular Contracture After PMRT Using Prepectoral Versus Subpectoral Implant-based Breast Reconstruction: PREPER Trial,"June 1, 2020","June 30, 2025",Not yet recruiting,Interventional
3363,9785,Non-contrast DWI for Supplemental Screening,"July 16, 2018",July 2028,Enrolling by invitation,Observational
3364,BCP24,To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes,"October 20, 2018","June 30, 2022",Recruiting,Interventional
3365,IRB00083573,Cardiac Outcomes With Near-Complete Estrogen Deprivation,"September 2, 2022",December 2027,Recruiting,Interventional
3366,CCR5199,ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab,"March 2, 2022","March 16, 2026",Recruiting,Interventional
3367,HVST-HEMO-20,The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage,"November 8, 2021",November 2022,Recruiting,Interventional
3368,1708018471,Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome,"January 22, 2018","July 31, 2021",Completed,Observational
3369,APBI Registry,Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT),June 2021,December 2024,Withdrawn,Observational
3370,STUDY00019979,Women In Steady Exercise Research - Window of Opportunity for Exercise and Tumor Biology,"July 29, 2022",December 2024,Recruiting,Interventional
3371,109489,Time Restricted Eating on Cancer Risk,"May 4, 2022","May 1, 2024",Recruiting,Interventional
3372,IIT2019-14-SHIRAZIP-SWEAT,Streaming Web-based Exercise At Home: A Pilot Study,"July 7, 2020","March 30, 2023",Completed,Interventional
3373,SGNTUC-019,Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations,"January 11, 2021","May 31, 2025",Recruiting,Interventional
3374,EORTC-1984-BCG,Chemo-free BRCA-targeted Neoadjuvant Strategy,"September 1, 2022","February 18, 2030",Not yet recruiting,Interventional
3375,H-43277,Wrist Cooling for Hot Flashes Clinical Trial,"March 5, 2023",January 2024,Recruiting,Interventional
3376,Oncolact2020,Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact,"May 11, 2022","May 5, 2024",Recruiting,Interventional
3377,OE20/2020,Effectiveness of Cohesive Bandage on Axillary Web Syndrome After,"January 10, 2019",December 2021,Unknown status,Interventional
3378,GNC-035-101（V1.1）,"A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors","September 15, 2021",June 2023,Withdrawn,Interventional
3379,2022-0880,Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation,"April 5, 2023","November 1, 2028",Recruiting,Interventional
3380,ABCB1 in Paclitaxel Neuropathy,ABCB1 SNPs as Predictors of PIPN,"March 1, 2018","January 31, 2020",Completed,Observational
3381,ACT16432,Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors,"March 29, 2021","January 13, 2025",Recruiting,Interventional
3382,AAAT8817,IMPACT Trial: Intervention to iMProve AdherenCe Equitably,"August 31, 2021","October 31, 2026",Recruiting,Interventional
3383,19-07020533,Prospective Randomized Study of Accelerated Radiation Therapy (PRART),"November 21, 2019","December 31, 2025",Recruiting,Interventional
3384,PSIBBR,Prepectoral and Subpectoral Implant-based Breast Reconstruction,"January 1, 2021","November 30, 2022",Unknown status,Interventional
3385,THRIVORSBH-01,Physical Activity Platform to Improve Bone Health in Cancer Survivors,"January 21, 2019","March 1, 2020",Completed,Interventional
3386,20190516,Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib,"March 1, 2020","June 28, 2021",Completed,Interventional
3387,RECHMPL20_0614,Assessment of Cryotherapys Analgesic Impact in Anti-aromatase-induced Arthralgia,"May 1, 2023","March 1, 2025",Not yet recruiting,Interventional
3388,RD19/121361,Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy,"August 22, 2019","June 30, 2022",Unknown status,Interventional
3389,BRAVEHeartV1,Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart,"September 15, 2018",August 2023,"Active, not recruiting",Interventional
3390,R/19.08.578,Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap.,"August 24, 2019","February 28, 2022",Unknown status,Interventional
3391,DHP107_Bioimaging,A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor,"July 3, 2018","December 24, 2018",Completed,Interventional
3392,18-5029,Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities,"December 17, 2019","December 1, 2021",Recruiting,Interventional
3393,201902048MINC,Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ,"April 30, 2019","December 31, 2025",Recruiting,Interventional
3394,050811,Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer,November 2018,December 2020,Unknown status,Interventional
3395,0594,The Genomic Medicine at VA Study,"July 17, 2020","September 30, 2025",Recruiting,Interventional
3396,APHP201173,BENEFIT OF MECHANICAL ISCHEMIC PRECONDITIONING ON TOLERANCE OF ADIPOSE TISSUE TO ISCHEMIA REPERFUSION OF TYPE DIEP (DEEP INFERIOR EPIGASTRIC PERFORATOR) FREE FLAPS.,May 2022,May 2024,Not yet recruiting,Interventional
3397,2019-001,Evolution of the Physical Condition in Treated Cancer Patients,"September 17, 2019","June 1, 2021",Unknown status,Interventional
3398,19-315,Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment,"December 20, 2019",December 2024,Recruiting,Observational
3399,2022P000354,Evaluating the Impact of an Equity Focused Dashboard and Clinical Support,"March 24, 2022","June 30, 2023",Recruiting,Interventional
3400,UMCC 2019.125,Altering Lipids for Tolerance of Aromatase Inhibitor Therapy,"July 28, 2020",May 2023,"Active, not recruiting",Interventional
3401,SB-2101,Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy,"May 25, 2022","April 30, 2025",Recruiting,Observational
3402,00001137,Improving Genetic Counseling for BRCA+ Mothers,"July 1, 2020","December 31, 2025",Recruiting,Interventional
3403,2017/2805,Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery,"January 3, 2018","December 31, 2023","Active, not recruiting",Observational
3404,C3661001,A Study of PF-06873600 in People With Cancer,"March 7, 2018","November 28, 2024","Active, not recruiting",Interventional
3405,4-2020-0430,The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction,"July 8, 2020","October 10, 2021",Completed,Interventional
3406,N16PRB,Preoperative Breast Irradiation,"March 12, 2018","August 9, 2018",Terminated,Interventional
3407,CASE10119,"Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography","March 15, 2022",August 2024,Recruiting,Interventional
3408,21-012300,Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain,"February 22, 2022","March 15, 2024",Recruiting,Interventional
3409,Breast MRI,Non-mass Enhancement in Breast MRI,March 2020,September 2021,Unknown status,Observational
3410,KY-Q-2021-182,Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis,"March 1, 2022","December 31, 2024",Recruiting,Interventional
3411,DOLPHIN,Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment,"February 18, 2021","December 31, 2023",Recruiting,Observational
3412,METC20-099,External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery,"July 12, 2021",October 2026,Recruiting,Interventional
3413,D8534C00001,Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6),"June 30, 2021","November 26, 2027",Recruiting,Interventional
3414,NUV-422-03,Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC,September 2022,September 2026,Withdrawn,Interventional
3415,CLEE011ARU01,"A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia","July 27, 2021","June 30, 2025",Recruiting,Observational
3416,FIS-APBI-2019-02,Accelerated Partial Irradiation of the Breast: New Altered Fractionation,"October 15, 2019","June 15, 2026",Recruiting,Observational
3417,17/0774,Extended Follow up of the TARGIT-A Trial,"August 16, 2018","January 31, 2023",Recruiting,Observational
3418,OSU-18094,Evaluation of Perforator Phase Contrast Angiography in Developing Surgery Plans for Patients With Breast Cancer Undergoing Breast Reconstruction With Free-Flap Methods After Mastectomy,"January 1, 2023","July 31, 2024",Withdrawn,Interventional
3419,21-3100.cc,Second Opinions in Oncology,"May 14, 2021",June 2024,"Active, not recruiting",Observational
3420,10840098-604.01.01-E.184,"Effectiveness of PNF Training for Improving for Muscle Strength, Function, and Pain After Axillary Lymph Node Dissection","December 12, 2019","July 1, 2021",Completed,Interventional
3421,Breast Cancer Chemotherapy,Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses,"August 3, 2020","November 3, 2022",Recruiting,Interventional
3422,STUDY02001039,"21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial","March 15, 2022","June 15, 2022",Not yet recruiting,Interventional
3423,CSCS,Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors,"June 3, 2022",December 2023,Recruiting,Interventional
3424,2020/6422,"Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy.","December 31, 2020","January 31, 2022",Unknown status,Interventional
3425,2022-0150,A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care,"August 25, 2022","December 31, 2023",Recruiting,Interventional
3426,2007-0003,Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism,January 2019,January 2021,Withdrawn,Interventional
3427,2-028-22,Chemotherapy Induced Cognitive Impairment,"December 15, 2022","June 30, 2024",Recruiting,Observational
3428,GEN-602-CT-101,Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer,"March 1, 2019",December 2023,"Active, not recruiting",Interventional
3429,CASE2119,A Study of the Use of AirXpanders AeroForm in Patients Undergoing Post-Mastectomy Radiation Therapy,"July 15, 2019","June 1, 2022",Withdrawn,Interventional
3430,STUDY00000228,RCT Comparing ESPB Solutions in Breast Surgery,"December 4, 2020",December 2023,Recruiting,Interventional
3431,PRESIONA20,Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program,"January 1, 2021","January 1, 2024",Recruiting,Interventional
3432,IPAC,Optimizing the Management of Patients With Oral Therapy,"March 19, 2018","May 22, 2021",Unknown status,Interventional
3433,CTMS# 18-0135,Demonstration of a Novel Approach Using Surface-Image Guidance to Improve Delivery of Breast Radiotherapy,"January 16, 2019",December 2024,Suspended,Interventional
3434,3734,Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD),"October 4, 2021",September 2026,Recruiting,Observational
3435,6077,Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density Categorization,September 2021,July 2022,Not yet recruiting,Observational
3436,2022LS100,Assessing the Time Demands of Cancer,"May 1, 2023","December 31, 2030",Not yet recruiting,Observational
3437,STX-478-101,First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumor,April 2023,"June 1, 2026",Recruiting,Interventional
3438,18-486,Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease,"January 16, 2019",January 2024,Recruiting,Interventional
3439,20-124,The Effect of Acupuncture on Cancer-Related Cognitive Difficulties,"April 6, 2021",April 2025,Recruiting,Interventional
3440,2019-02661,Added Value of Preoperative Contrast Enhanced Mammography in Staging of Malignant Breast Lesions,"November 2, 2020","December 31, 2023",Recruiting,Interventional
3441,110181,Probiotics and Breast Health,"July 2, 2019","December 31, 2021",Completed,Interventional
3442,IRB-55153,"Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts","April 28, 2021","April 15, 2023",Recruiting,Interventional
3443,GS3,GlobalSurg 3: Quality and Outcomes in Global Cancer Surgery,"April 1, 2018","November 30, 2018",Unknown status,Observational
3444,20953,"Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer","March 31, 2021","June 30, 2025",Withdrawn,Interventional
3445,QT MG PRE Phase 1,Understanding Patient Experience and Preferences for the QT Scanner Compared to Mammography,"August 6, 2019","December 30, 2022",Suspended,Observational
3446,MC1932,TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol,"August 21, 2019","September 30, 2025",Recruiting,Interventional
3447,2018-A011828-47,Assessment of Health Related Quality of Life in Women Who Underwent Breast Reconstruction After Radical Surgery,"May 4, 2019","May 4, 2025",Recruiting,Observational
3448,EXPLLN21-01,A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG,"May 1, 2023","March 1, 2025",Not yet recruiting,Interventional
3449,22-457,Losartan in Prevention of Radiation-Induced Heart Failure,January 2023,"December 1, 2023",Not yet recruiting,Interventional
3450,GW10029,"Assessing the Sensitivity of ""SureTouch™"" in Women Undergoing Diagnostic and Screening Mammography","January 4, 2019","February 10, 2021",Terminated,Interventional
3451,GCC1950,First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies,"February 14, 2022",November 2026,Recruiting,Interventional
3452,2020-0501,Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications,"March 23, 2021","April 30, 2023",Recruiting,Observational
3453,Erector block after mastectomy,Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy.,"January 1, 2023","August 30, 2023",Recruiting,Interventional
3454,2021-0025,Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge,"April 15, 2021","April 30, 2024",Recruiting,Interventional
3455,HCI148669,Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System,"August 2, 2022","August 1, 2027",Recruiting,Interventional
3456,CBYL719CKR01,A Post Marketing Surveillance on Piqray in Korea,"June 29, 2022","May 12, 2027",Recruiting,Observational
3457,21/59848,Lymphaticovenous Anastomosis as Treatment for Lymphedema,"May 11, 2022","January 31, 2024",Recruiting,Interventional
3458,221-005,Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®,"November 13, 2019","September 11, 2020",Completed,Interventional
3459,228012,Impact of Topical Tranexamic Acid in Breast Reconstruction,"March 30, 2023","September 30, 2024",Recruiting,Interventional
3460,RECHMPL20_0005-UF7919,Hepatitis C Screening Paired With Mammography,"March 23, 2022","March 23, 2025",Recruiting,Observational
3461,INT31/19,Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases,"October 15, 2019","March 31, 2022",Unknown status,Interventional
3462,P.T.REC/012/002615,Aquatic Versus Land Based Exercise on Lymphedema Post Mastectomy,"July 1, 2018","November 30, 2019",Completed,Interventional
3463,Telerehab CH Usability,Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study,"June 7, 2021","December 31, 2021",Completed,Observational
3464,ICO-N-2018-15,Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec),"December 24, 2019","December 24, 2023","Active, not recruiting",Observational
3465,B00394,Automated Low Dose Risk Assessment Mammography (ALDRAM),"February 22, 2019","February 16, 2023",Completed,Interventional
3466,CKMW-1801,Compass Course: Efficacy Study,"March 2, 2018","May 1, 2021",Completed,Interventional
3467,EGC101,A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers,"May 16, 2022","January 24, 2023",Completed,Interventional
3468,69HCL20_1018,Remediation for Mild Cognitive Deficits After Cancer,"December 17, 2021","July 17, 2025",Recruiting,Interventional
3469,300.08-2018-Samsungmedison-S,Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms,"September 20, 2018","January 31, 2020",Unknown status,Interventional
3470,ICO-A-2020-10,Electrotherapy in the Management of Myofascial Syndrome,"January 5, 2022",April 2024,Recruiting,Interventional
3471,INT157/17,Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial,"July 1, 2018","December 31, 2020",Unknown status,Interventional
3472,13155,ciNPT in Autologous Abdominal Tissue Breast Reconstruction,October 2021,October 2022,Not yet recruiting,Interventional
3473,IRB20-0528,Low-dose Imaging Technique (LITE),June 2020,November 2021,Unknown status,Interventional
3474,BO40933,"A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.","June 11, 2019","January 4, 2022",Completed,Interventional
3475,2018-0345-1105,Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot Study,"March 27, 2019","December 31, 2020",Unknown status,Observational
3476,NL67696.068.18,Functional MRI Study Reconstructed Breasts,"February 11, 2020","December 31, 2021",Unknown status,Interventional
3477,UW17032,Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention,"November 19, 2019","March 10, 2020",Terminated,Interventional
3478,MedOPP321,"ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL","June 2, 2021",May 2024,Recruiting,Interventional
3479,RECHMPL21_0379,Cancer Predictive Score on Breast MRI,"January 1, 2021","September 30, 2022",Enrolling by invitation,Observational
3480,2017-8737,Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction,"August 15, 2018","October 15, 2019",Unknown status,Interventional
3481,AP2204-50104,Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery,"May 10, 2022","May 25, 2023",Recruiting,Interventional
3482,IRB-53132,LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy,"September 10, 2021","June 1, 2030",Recruiting,Interventional
3483,5160378,Effect of Resveratrol on Serum IGF2 Among African American Women,"April 24, 2019","June 30, 2024",Suspended,Interventional
3484,R.21.11.1523,Comparison of Different Volumes Spread of Erector Spinae Block in Post Mastectomy Pain Syndrome Management,"December 12, 2021","September 1, 2022",Recruiting,Interventional
3485,CYP003,A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers,February 2023,February 2025,Recruiting,Interventional
3486,315581,Randomised Trial Comparing Biological Matrices With Synthetic Meshes,"August 1, 2022","July 31, 2025",Not yet recruiting,Interventional
3487,2022000438,Clinical Outcomes and Patient Satisfaction With Use of the Amma System,"August 22, 2022",October 2024,Recruiting,Observational
3488,CTB in Breast surgery,Ultrasound Guided Costotransverse Block for Breast Cancer Surgery,"January 6, 2020","April 29, 2020",Completed,Interventional
3489,RS1307/20,Prognostic Relevance of Coagulation Activation in RIsk Assessment and Stratification,"January 21, 2020","December 31, 2023",Recruiting,Observational
3490,H-18041465,Pain Phenotyping of Patients With Bone Cancer Pain,"February 5, 2019","February 1, 2023",Unknown status,Observational
3491,RIS42756,Remote Time-restricted EAting DeliverY,"July 7, 2022","July 6, 2023",Recruiting,Interventional
3492,YH32367-101,Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor,"August 26, 2022","October 6, 2026",Recruiting,Interventional
3493,18-294,"Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship","September 11, 2018",September 2024,"Active, not recruiting",Observational
3494,2021.127,Music Intervention for Preoperative Anxiety and Acute Pain Among Mastectomy Patients,"June 5, 2021","March 27, 2022",Completed,Interventional
3495,2020-0974,Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics,"December 15, 2020","October 31, 2023",Recruiting,Observational
3496,HP-00088085,GammaPod Registry and Quality of Life Nomogram,"January 3, 2019",December 2027,Recruiting,Observational
3497,ShantouCH,Lidocaine Mucilage-ICG as an Optical Agent for Tumor Delineation During Breast-conserving Surgery,"August 20, 2020",January 2024,Recruiting,Interventional
3498,HYACOM,"Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies","October 11, 2022",July 2024,Recruiting,Interventional
3499,NL82061.096.22,Evaluating the Use of Magnetic Resonance Imaging and Contrast Enhanced Mammography After MagTrace® Use,"November 23, 2022","March 31, 2023",Not yet recruiting,Observational
3500,36264PR116/2/23,Vitamin C on Acute and Chronic Post Mastectomy Pain,"April 1, 2023","December 1, 2024",Not yet recruiting,Interventional
3501,MCC-20335,Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses,"October 27, 2020",November 2023,Recruiting,Observational
3502,00101494,Technology-Based Cancer Screening Intervention,"January 4, 2022",July 2025,Enrolling by invitation,Interventional
3503,ETK00-2020-0103,Effects of Clinical Pilates and Yoga Training in Lymphedema,"October 29, 2021","February 14, 2023",Completed,Interventional
3504,DIVA-001,"Randomized, Controlled Trial With Hybrid Fractional Laser","August 10, 2018","June 15, 2021",Completed,Interventional
3505,PRO00030436,The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure,"March 3, 2018","March 21, 2021",Completed,Interventional
3506,JS2021-6-1,Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction,"April 8, 2021","April 30, 2025",Recruiting,Interventional
3507,20180335,An Investigator Initiated Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx System,"January 11, 2019","August 1, 2029",Recruiting,Interventional
3508,DRBX201901/PRO,A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection,"July 4, 2019","December 23, 2019",Completed,Interventional
3509,21-04,Performance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery,"December 5, 2022","July 15, 2024",Recruiting,Interventional
3510,A221505,Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer,"February 1, 2018",August 2035,"Active, not recruiting",Interventional
3511,UC-0107/1803,Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast,"May 10, 2019","November 13, 2034",Recruiting,Interventional
3512,SHS-An-1-2022,Nociception Level Monitor (NOL) During Guided Analgesic Delivery in Breast Surgeries,"January 1, 2022",March 2025,Enrolling by invitation,Interventional
3513,R01CA249419,The Engaging Primary Care in Cancer Survivorship (EPICS) Study,"September 21, 2021","May 31, 2025",Enrolling by invitation,Interventional
3514,STU 072016-058,Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity,"July 1, 2018",March 2023,Enrolling by invitation,Interventional
3515,DS1103-074,A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors,"April 10, 2023","June 30, 2026",Not yet recruiting,Interventional
3516,NEUROTOX,Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy,"January 1, 2022","April 1, 2023",Recruiting,Observational
3517,Biofeedback_based_music,Effects of Biofeedback-based Music Program Using a Smart Device Application on Perioperative Sleep Quality.,"February 2, 2023","June 30, 2023",Not yet recruiting,Interventional
3518,IRB-21-28,Can Chronic Post-surgical Pain be Reduced by Preserving Intercostobrachial Nerve During Axillary Lymph Node Dissection? : A Randomized Controlled Trial,"January 30, 2022","October 1, 2022",Enrolling by invitation,Interventional
3519,BREAST-Pyrotinib,Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC,"June 1, 2019","December 1, 2023",Not yet recruiting,Interventional
3520,ELEGANT - ET18-262,Satisfaction & Efficacy of Compression Using Surgical Gloves in Chemo-induced Peripheral Neuropathies,"September 30, 2019","September 30, 2023","Active, not recruiting",Observational
3521,A5481065,Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®,"February 8, 2018","August 8, 2025",Recruiting,Observational
3522,L19-065,Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction,"June 1, 2022","June 1, 2026",Recruiting,Interventional
3523,HP-00068503,Cardiac MRI Biomarker Testing (GCC 1618),"February 1, 2018","September 9, 2022",Terminated,Observational
3524,TQB211-III-01,A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.,"November 11, 2018",October 2021,Unknown status,Interventional
3525,AP2110-30111,Erector Spinae Plane Block Versus Serratus Anterior Block on Post Mastectomy Pain Syndrome,"November 1, 2021","December 30, 2022",Recruiting,Interventional
3526,IRB202101449,UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization,"August 2, 2022","June 30, 2023",Recruiting,Interventional
3527,NL72808.068.20,AFT: Introduction of a Full Breast Reconstructive Method,"December 9, 2020",October 2026,Recruiting,Observational
3528,IIT2021-01-Shiao-CSF1Ri,Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation,"March 30, 2023","December 1, 2024",Not yet recruiting,Interventional
3529,R17096,Intraoperative Tissue Identification by Analyzing Surgical Smoke,"October 9, 2019","December 26, 2019",Completed,Observational
3530,WHITE TEA,White Tea for Prevention of Chemotherapy Induced Mucositis,"September 2, 2020",July 2023,"Active, not recruiting",Interventional
3531,2017/15,Study of the Impact of DPD Activity on the Efficacy of Capecitabine,"July 20, 2020",April 2025,Recruiting,Interventional
3532,A222101,Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II),"March 31, 2023","May 31, 2030",Not yet recruiting,Interventional
3533,AP2014-50103,Dexmedetomidine in Erector Spinae Block in Postoperative Analgesia,"July 1, 2021","September 30, 2021",Completed,Interventional
3534,DMT-2015.002,Delphinus SoftVue™ ROC Reader Study,"September 23, 2018","September 23, 2018",Completed,Observational
3535,21-318,Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery,"August 23, 2021",August 2023,"Active, not recruiting",Interventional
3536,KY2019,Recurrence Risk Evaluation by 21-gene Detection,"January 1, 2019","February 1, 2019",Completed,Observational
3537,S61864,Magnetic Seed Localisation for Nonpalpable Breast Lesions,"September 10, 2018","May 23, 2019",Completed,Observational
3538,IRAS 283017,Comparison of Patient Reported Outcome Measures Using the BREAST-Q Questionnaire in Patients Undergoing Pre Versus Sub-pectoral Implant Based Immediate Breast Reconstruction.,"September 1, 2019",December 2022,Unknown status,Observational
3539,BXU572940,Doxil/Caelyx BE Study,"August 1, 2023","April 1, 2024",Not yet recruiting,Interventional
3540,62/19-06-18,Guided Imagery & Music in Cancer,"July 1, 2018","December 31, 2020",Unknown status,Interventional
3541,ZUH-MICB-UMPR,The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.,"November 29, 2019","December 8, 2021",Completed,Interventional
3542,20/WS/0110,Contrast-Free Magnetic Resonance Imaging for Breast Disease,"July 6, 2021",July 2024,Recruiting,Observational
3543,RG1007834,Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy,"July 10, 2021","April 30, 2041","Active, not recruiting",Interventional
3544,KCT001,"Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study","August 5, 2020","May 28, 2021",Completed,Interventional
3545,HE641269,Efficacy of Parecoxib Combined With Paracetamol in Mastectomy,"March 28, 2023","May 10, 2023",Recruiting,Interventional
3546,AIUR trial,The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy,May 2023,February 2026,Not yet recruiting,Interventional
3547,S-20200094,Lymphedema Screening,"October 5, 2020",October 2021,Unknown status,Interventional
3548,ATADEK 2021-14/18,Aromatherapy Methods in Reducing Anxiety Before Breast Biopsy,"August 1, 2021","June 1, 2022",Recruiting,Interventional
3549,LBS-CA-PTL-033,HydroMARK Post-market Clinical Follow-up Study,"February 16, 2021",December 2023,Recruiting,Observational
3550,19-665,CONFIRM: Magnetic Resonance Guided Radiation Therapy,"May 1, 2021","June 18, 2024",Recruiting,Interventional
3551,RECHMPL18_0244,Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication,"April 26, 2019","October 22, 2026",Recruiting,Interventional
3552,TBio-4101-001,A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors,"January 17, 2023","June 30, 2024",Recruiting,Interventional
3553,UCCS19102,Memory and Attention Adaptation Training-Geriatrics (MAAT-G),"June 12, 2020","March 1, 2023",Recruiting,Interventional
3554,UCCS20127,Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II,"April 2, 2021","September 1, 2024",Recruiting,Interventional
3555,U21-08-4519,Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning,"August 1, 2022","August 1, 2023",Recruiting,Observational
3556,RCB: 2022-A01349-34,Algology in Oncology Osteopathic Support (ALGOS),"January 11, 2023","December 8, 2024",Recruiting,Interventional
3557,211820931,Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis,"May 2, 2018","February 10, 2022",Completed,Interventional
3558,CTC-SMMiL-E-1901,Feasibility of a New Technology for Isolating Circulating Tumour Cells,"March 11, 2020",December 2023,Recruiting,Interventional
3559,LCI-BRE-VITD-001,A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation,"September 16, 2021",December 2024,Recruiting,Interventional
3560,CLEE011A2412B,Roll-over Study to Allow Continued Access to Ribociclib,"July 7, 2022","February 16, 2028",Recruiting,Interventional
3561,PB-2020-01,ARGONAUT: Stool and Blood Sample Bank for Cancer Patients,"July 1, 2022","December 31, 2025",Recruiting,Observational
3562,OX2022-203-01,Study To Assess Safety And Efficacy Of AsiDNA In Combination With Olaparib In Participants With Recurrent Solid Tumors,"February 20, 2023",April 2027,Recruiting,Interventional
3563,2018-0561,"ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors","January 24, 2019","July 26, 2023",Recruiting,Interventional
3564,IRB00180383,e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English,"July 14, 2019","August 17, 2020",Completed,Interventional
3565,ID-RCB: 2018-A03356-49,Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis,"July 4, 2019","December 17, 2020",Completed,Interventional
3566,2011684,Radiofrequency Chip for Localization of Non-Palpable Breast Lesions,"October 18, 2018","April 19, 2021",Completed,Interventional
3567,2021/058,Novel Skin Care Product for the Management of Acute Radiodermatitis,"February 1, 2022",June 2023,Recruiting,Interventional
3568,CDK-002-101,"A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors","September 15, 2020","December 23, 2022",Completed,Interventional
3569,SAPB for MRM 2.0,Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point,"December 1, 2021","June 30, 2022",Recruiting,Interventional
3570,2020_16,"Metabolism, Circadian Rhythms and Ovarian Function","February 24, 2022",February 2025,Recruiting,Observational
3571,TJ107001STM202,Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors,"December 22, 2021",February 2024,Recruiting,Interventional
3572,2015C0090,Tango for Neuropathy Among Breast Cancer Survivors,"August 15, 2021","August 14, 2023",Recruiting,Interventional
3573,Study-21-00112,Mammography and Breast Arterial Calcification: An Information-Sharing Trial,"September 29, 2021",March 2026,Recruiting,Interventional
3574,2020-013-00US3,A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors,"August 9, 2021",March 2024,Recruiting,Interventional
3575,NeuroMod-PCCI,Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment,"November 2, 2021",August 2023,Recruiting,Interventional
3576,D8530C00004,"A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833","September 17, 2020","January 7, 2021",Completed,Interventional
3577,19-5250.0,Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy,"November 1, 2019","November 1, 2022",Suspended,Interventional
3578,STU 2019-1099,Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity,"December 17, 2019",December 2023,Suspended,Interventional
3579,2020.253 NL72539.029.20,Supervised Exercise to Promote Infiltration of NK-cells Into the Tumor,"January 6, 2021","July 25, 2022",Completed,Interventional
3580,A5481173,Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies,"July 7, 2022","April 19, 2026",Recruiting,Interventional
3581,RCT Pristina 2/TR,Self-compression Mammography in Clinical Practice,"January 25, 2018","December 31, 2020",Completed,Interventional
3582,2021-0568-001,A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia,"December 16, 2021","October 31, 2025",Recruiting,Interventional
3583,STUDY00143316,Sexual Health Empowerment for Womens Health,"November 11, 2019","March 31, 2024","Active, not recruiting",Interventional
3584,2019P001434-1,Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey,"March 17, 2020","June 29, 2020",Completed,Observational
3585,19-238,Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction,"July 5, 2019",July 2023,Recruiting,Interventional
3586,FDRT-BC007,Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery,"July 1, 2018","June 30, 2028",Recruiting,Interventional
3587,IRMA,Immediate Breast Reconstruction Following Mastectomy (IRMA),"January 1, 2018","June 30, 2026",Recruiting,Observational
3588,PMPS 1,Incidence and Factors Affecting the Development and Outcome of Post Mastectomy Pain Syndrome,August 2021,September 2022,Not yet recruiting,Observational
3589,2004-219-1119,Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy,"July 13, 2020","August 15, 2021",Completed,Interventional
3590,2000031319,The In4M Study: Integrating 4 Measures to Assess Physical Function in Cancer Patients,"January 27, 2022",August 2024,Recruiting,Observational
3591,DS1062-A-J101,First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01),"January 31, 2018","January 1, 2025",Recruiting,Interventional
3592,CMUH110-REC1-122,Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care® Gel,August 2021,June 2022,Recruiting,Interventional
3593,IIT-ePRO,A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys,"March 30, 2022","October 1, 2023",Recruiting,Interventional
3594,ICO-2020-22,"Breast Reconstruction by Exclusive Lipomodulin : Feasibility, Evaluation of the Aesthetic Result and Quality of Life","November 26, 2020","February 5, 2021",Completed,Observational
3595,22-091,Culturally Aware AET Non-Initiation Intervention,December 2022,"July 1, 2023",Not yet recruiting,Interventional
3596,UTK-IRB-22-07195,Womens Interventions for Sexual Health: WISH,"November 22, 2022",September 2023,Recruiting,Interventional
3597,ERC#2020-3379-10190,Outcomes of Local Perforator Flaps in Oncoplastic Surgery,"April 18, 2020","June 30, 2021",Completed,Observational
3598,PROICM 2018-07 BPR,Memory Perception Assessment in Central/Non-central Nervous System Cancers,"May 10, 2019","October 30, 2023",Recruiting,Interventional
3599,5271,"SEroma Reduction pOst MAstectomy ""SEROMA Study""","October 7, 2019",July 2022,Unknown status,Interventional
3600,ZG01012019,Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction,"January 1, 2019","July 1, 2021",Unknown status,Interventional
3601,PO18091,Per-operative Exploration of the Peri-pancreatic Lymphatic Pathways During Pancreatic Surgical Resection,"October 22, 2018","October 22, 2020",Unknown status,Interventional
3602,22-197,The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment,"July 11, 2022",July 2025,Recruiting,Interventional
3603,21-055,Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy,"February 19, 2021","February 19, 2024",Recruiting,Observational
3604,1955K,Multicentric Risk Evaluation of Autologous Fat Grafting Procedure,"June 1, 2019",June 2020,Unknown status,Observational
3605,20-5111,The Person-centered Evolution of Radiotherapy Services in Ontario Study,"August 13, 2020",August 2024,"Active, not recruiting",Interventional
3606,PROICM 2020-06 BIO,Pain Monitoring After Breast Biopsy: Benefit of E-health,"February 9, 2021",August 2023,Recruiting,Interventional
3607,IRB-46373,Phase 2 Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma,"March 22, 2019",July 2025,Recruiting,Interventional
3608,UPCC 21220,CTNNA1 Familial Expansion Study,"March 16, 2021","January 1, 2024",Recruiting,Observational
3609,2019_NOV_CP_001,Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications,"June 18, 2020",April 2023,Recruiting,Interventional
3610,DEGENCA,"Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the ""Massive Parallel Sequencing"" on Circulating Tumor DNA","June 14, 2018",June 2021,Unknown status,Interventional
3611,IRB-2022- 1451,Axillary Versus Primary Breast Approach for Second-stage Breast Reconstruction,December 2022,December 2024,Not yet recruiting,Interventional
3612,ASO.RianGen.22.02,Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery,"September 7, 2022","November 7, 2023",Enrolling by invitation,Interventional
3613,19-00222,Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises,"June 1, 2019","September 1, 2019",Completed,Interventional
3614,C4431001,A Study of PF-07260437 in Advanced or Metastatic Solid Tumors,"October 7, 2021","September 25, 2025",Recruiting,Interventional
3615,M336,Comparison of Erector Spinae Plane Block With Serratus Anterior Plane Block for Breast Surgery,"August 1, 2018","September 15, 2019",Completed,Interventional
3616,MAGREES,Effectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast Lesions,"March 20, 2022","March 6, 2023",Completed,Observational
3617,KIA 2018/155,The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery,"September 1, 2018","February 26, 2019",Completed,Interventional
3618,B-1206-158-005,Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts,"December 1, 2020","December 30, 2021",Withdrawn,Interventional
3619,190311,Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction,"October 20, 2022","March 31, 2025",Recruiting,Interventional
3620,20-021,Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection,"January 22, 2020",January 2024,Recruiting,Interventional
3621,202200395A3,"Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia","August 17, 2022","December 31, 2025",Recruiting,Interventional
3622,PECS in Breast Cancer Surgery,PECS Block With Bupivacaine Vs Bupivacaine and Dexmedetomidine in Modified Radical Mastectomy,"March 1, 2020","July 1, 2020",Unknown status,Interventional
3623,HREBA.CC-19-0354,Protein Needs Study,"April 26, 2021","December 31, 2025",Recruiting,Interventional
3624,Analgesia in breast surgey,Combined PECS II and Transversus Plane Blocks Versus Erector Spinae Block in Modified Radical Mastectomy,"February 8, 2021","December 1, 2022",Unknown status,Interventional
3625,159-2019,Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization,"May 16, 2021","December 31, 2023",Recruiting,Interventional
3626,9778,MRI Characterization of Mammographically Detected DCIS,"April 20, 2018",April 2032,Recruiting,Observational
3627,LCCC1920,Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention,"October 30, 2019","June 6, 2022",Completed,Interventional
3628,MCC-19650,Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1,"January 10, 2019","April 11, 2022",Terminated,Interventional
3629,2018-05-0009,Living Well After Breast Surgery,"February 18, 2019","June 11, 2021",Completed,Interventional
3630,DCIS Cryo,Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ,"November 1, 2021","November 1, 2026",Recruiting,Interventional
3631,STU00214745,Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage,"July 12, 2022",July 2023,Recruiting,Interventional
3632,ENTheR,Exploratory Study on Therapy for Breath Hold in Radiotherapy,"April 18, 2019","January 3, 2020",Completed,Interventional
3633,Michal Nissim 2,"Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients","September 1, 2022","August 30, 2027",Not yet recruiting,Interventional
3634,IUSCC-0533,Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias,"December 14, 2018","December 14, 2018",Withdrawn,Interventional
3635,Version 1.1.6,Magnetic Occult Lesion Localization and Imaging (MOLLI),"May 28, 2018","January 1, 2020",Completed,Interventional
3636,GALENO 1,Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies,"June 20, 2019","September 1, 2021",Unknown status,Interventional
3637,MMSTD1Pecs2,Establishing Technique for PECS2 Catheter Insertion,"November 1, 2018","November 30, 2019",Completed,Interventional
3638,875329,Training Data Collection & AI Development,"July 31, 2022","April 10, 2023","Active, not recruiting",Interventional
3639,ST-067-001,"Phase 1a and Phase 2 Study for PK, PD, Safety and Preliminary Efficacy of ST-067","August 6, 2021","January 30, 2025",Recruiting,Interventional
3640,H-40045,Scalable Communication Modalities for Returning Genetic Research Results,"March 6, 2023",June 2024,Recruiting,Interventional
3641,SYSKY-2023-122-02,Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge,"March 2, 2023","May 30, 2024",Recruiting,Interventional
3642,TRV-002,Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs,December 2022,June 2024,Recruiting,Observational
3643,KOU KAEK 2018/487,Comparison of Bi-level Erector Spine Plane Block and Combined Pectoral I-II Block in Breast Surgery,"January 1, 2020","January 15, 2021",Completed,Interventional
3644,TREM-1,Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis,"April 1, 2022","December 31, 2024",Recruiting,Interventional
3645,RC31/17/0335,Quality of Life in Patients With Standard External Compared to Custom-made Breast Prosthesis.,"January 28, 2021",February 2022,Unknown status,Interventional
3646,201912245RINB,Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia,"March 23, 2020","December 31, 2025",Not yet recruiting,Interventional
3647,KND-QX-CXXT,Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System,"March 31, 2021","December 31, 2021",Unknown status,Observational
3648,ALTERTASTE,Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy,July 2021,December 2022,Unknown status,Observational
3649,CUT_DN_02,Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus,December 2022,June 2023,Not yet recruiting,Interventional
3650,Pro00052823,Tissue Expansion in Breast Reconstruction Without Drains,"February 25, 2019","October 2, 2020",Completed,Observational
3651,PKUPH10B001,Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physicians Choice,December 2019,December 2021,Unknown status,Interventional
3652,19.58/ONCO19.08,PBMT for the Management of CIA ( HAIRLASER ),"June 17, 2020","December 31, 2022",Recruiting,Interventional
3653,CCS1477-01,Study to Evaluate CCS1477 in Advanced Tumours,"July 23, 2018",March 2024,Recruiting,Interventional
3654,CO-338-098,A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR),"June 28, 2019","April 22, 2022",Terminated,Interventional
3655,CIRCADIAN,Chemotherapy-induced Circadian Rhythm Disruption,"December 14, 2019",February 2023,Recruiting,Observational
3656,UBP-A103-HER2,"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers","March 5, 2018","April 2, 2019",Completed,Interventional
3657,UMCC 2021.071,Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study,"March 15, 2022","August 29, 2022",Completed,Interventional
3658,Pro00040035,Home-Based Physical Activity Intervention for Taxane-Induced CIPN,"August 14, 2020","September 30, 2024",Recruiting,Interventional
3659,18-6047,The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease,"September 11, 2019",September 2023,Recruiting,Interventional
3660,Real-HER2,Real World Study on the Efficacy and Safety of Anti-HER2 Therapy,"June 1, 2020","October 1, 2022",Recruiting,Observational
3661,PI2018068,Peer Support Program in Cancer Patients Elkar Laguntza,"June 1, 2020","December 31, 2023",Recruiting,Interventional
3662,Metimedi-202,OMT-111 for Terminal Stage Solid Tumors,October 2020,October 2022,Unknown status,Interventional
3663,CBCSG-040,Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA),"June 26, 2018","December 31, 2023",Recruiting,Interventional
3664,NUV-422-02,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors,"December 8, 2020","August 31, 2022",Terminated,Interventional
3665,UBT 2022-01,A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection,"January 7, 2023","May 31, 2024",Recruiting,Interventional
3666,2020-A01534-35,A Proximity-incentive Strategy for Cervical Cancer Screening,"September 16, 2021",March 2025,Recruiting,Interventional
3667,181367,Physical Activity Intervention for Young Cancer Survivors,"September 1, 2019","September 30, 2020",Completed,Interventional
3668,PRO00041443,Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction,"March 1, 2022","July 1, 2026",Recruiting,Interventional
3669,19SM5221,Development and Validation of a Tumour Oxygenation Monitoring Probe,"August 9, 2019",June 2020,Unknown status,Observational
3670,METCZ20190024,The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy,"May 31, 2019","June 1, 2020",Completed,Interventional
3671,22-01024342,Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation,April 2023,December 2028,Not yet recruiting,Interventional
3672,PUMA-NER-9501,HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib,"March 14, 2019","January 21, 2021",Terminated,Observational
3673,SY-5609-101,"A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors","January 23, 2020",July 2024,"Active, not recruiting",Interventional
3674,MCC-20487,Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease,"December 10, 2020","November 1, 2024",Recruiting,Interventional
3675,DWI breast cancer,Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities,"December 1, 2018",October 2019,Unknown status,Observational
3676,2022/73,The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings,"April 30, 2022","October 30, 2022",Not yet recruiting,Interventional
3677,TBMZ-Radio-boron gel,Preventive Effect of Boron-based Gel on Radiation Dermatitis,"February 4, 2019","December 21, 2019",Completed,Interventional
3678,0141-19-RMB,Characterization of Skin Microbiome Profile and its Correlation to Radiation Dermatitis,"November 1, 2020",November 2021,"Active, not recruiting",Observational
3679,BT5528-100,Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression,"November 7, 2019","December 31, 2024",Recruiting,Interventional
3680,2021P000209,Mapping and Quantifying Lymphatic Drainage of the Arms Alternate Pathway,"April 1, 2022",August 2025,Recruiting,Observational
3681,REaCT-TEMPO,Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance,April 2023,April 2029,Not yet recruiting,Interventional
3682,SYSKY-2022-117-01,Endoscopic Breast Conserving Surgery With Intra-operative Navigation System,"January 1, 2022",December 2024,Recruiting,Interventional
3683,IRB 22-211,Global Cardio Oncology Registry,"July 1, 2022","July 1, 2027",Recruiting,Observational
3684,PROT-P2-024,M5 vs. M6 Comparison Study With a Sub Study Into the Dielectric Constant of Aspirated Cyst Fluid,"February 19, 2019","January 23, 2020",Completed,Interventional
3685,2022-0454,Vapocoolant Analgesia for Breast Lymphoscintigraphy,"March 1, 2023","August 31, 2023",Recruiting,Interventional
3686,Pro00101109,Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS),"October 12, 2021","January 31, 2022",Completed,Interventional
3687,22-071,A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction,"March 23, 2022",March 2024,Recruiting,Interventional
3688,ZL-2306-006,A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment,"February 3, 2020","March 2, 2022",Terminated,Interventional
3689,OTT-15-02,"Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)",January 2021,January 2022,Unknown status,Interventional
3690,CONFIDENCE-01,CONFIDENCE Registry,"September 11, 2020","September 30, 2024",Enrolling by invitation,Observational
3691,K 2020-9716,[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors,"November 23, 2022","December 31, 2025",Recruiting,Interventional
3692,NCC20180327,Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion,"October 15, 2019","June 15, 2021",Unknown status,Interventional
3693,3121_MATFIH22,"First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Immediate Breast Reconstruction After Mastectomy for Cancer","July 1, 2022","October 31, 2025",Recruiting,Interventional
3694,Modi-1-001,"Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer","April 7, 2022","June 30, 2026",Recruiting,Interventional
3695,20-437,Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement,"May 17, 2021","April 1, 2023","Active, not recruiting",Interventional
3696,16-01,Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging,"September 10, 2018","September 1, 2021",Terminated,Interventional
3697,IEO 1002/,Evaluation of the Effectiveness of Prepectoral Breast Reconstruction,"September 3, 2019","December 31, 2023",Recruiting,Interventional
3698,3271,PBI for Breast In Situ Carcinoma of Intermediate Low Risk as Local Adjuvant Treatment,"January 9, 2023",December 2029,Recruiting,Interventional
3699,21-559,Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study,"October 31, 2022","January 31, 2025",Recruiting,Interventional
3700,LCCC2139,Comparison of CE-DBT and MRI in Patients With Known Breast Lesions,"March 13, 2023",October 2024,Recruiting,Interventional
3701,NK-101,FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors,"January 18, 2018","December 15, 2020",Completed,Interventional
3702,1903399639,High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT),December 2022,April 2024,Not yet recruiting,Interventional
3703,18-00684,Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP),"July 31, 2018","October 23, 2023","Active, not recruiting",Observational
3704,MCC-19-15167,Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video,"November 1, 2021","December 31, 2023",Recruiting,Interventional
3705,CASE5117,Drain-Less Abdominally Based Breast Reconstruction Using Lysine-Derived Urethane Adhesive,"November 1, 2020","September 1, 2021",Withdrawn,Interventional
3706,CASE10117,Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction,"March 30, 2018","July 1, 2020",Withdrawn,Interventional
3707,Medipol Hospital 18,ESPB and RIB for Pain Management Following Mastectomy Surgery,"February 16, 2021","December 20, 2021",Completed,Interventional
3708,18-431,Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung,"January 16, 2019",January 2024,"Active, not recruiting",Interventional
3709,SPI-POZ-203,A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies,"December 23, 2019","March 29, 2022",Terminated,Interventional
3710,STUDY21070030,CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study,"February 1, 2022",November 2026,Recruiting,Interventional
3711,E2018124,Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients,"June 16, 2018","October 31, 2021",Unknown status,Interventional
3712,2140-002,A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002),"October 7, 2020","August 15, 2023","Active, not recruiting",Interventional
3713,2019(S073),Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules,"January 18, 2019","February 18, 2020",Unknown status,Observational
3714,21-288,A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer,"September 14, 2021","September 14, 2024",Recruiting,Interventional
3715,OSU-21198,Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery,"December 1, 2021","June 15, 2022",Completed,Observational
3716,RadOnc,Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy,"July 1, 2020",December 2022,Unknown status,Interventional
3717,INX-315-01,"Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer","March 28, 2023",June 2026,Recruiting,Interventional
3718,JSKN003-101,First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors,"September 2, 2022","December 30, 2024",Recruiting,Interventional
3719,20-275,Testing a New Imaging Agent to Identify Cancer,"November 30, 2020","November 30, 2024",Recruiting,Interventional
3720,018-781,DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation,"March 11, 2019","March 11, 2024",Recruiting,Observational
3721,IGAR-TO-007,IGAR-Breast TeleOp Trial,"January 1, 2019","December 31, 2019",Unknown status,Interventional
3722,Laser LabCorp #001,Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics,"December 15, 2021","November 2, 2022",Suspended,Interventional
3723,2020-04936,Mammography Screening With Artificial Intelligence (MASAI),"April 12, 2021","April 12, 2025","Active, not recruiting",Interventional
3724,NCC2962,Multi-center Study of Deep Learning AI in Breast Mass,"August 12, 2021","August 31, 2023",Recruiting,Observational
3725,IRB-50877,Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution,January 2023,December 2023,Not yet recruiting,Interventional
3726,PER-19-04,Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.,"December 1, 2021",September 2023,Recruiting,Interventional
3727,KL166-I-01-CTP,A Study of A166 in Patients With Advanced Solid Malignant Tumors,"August 9, 2018","December 31, 2023",Recruiting,Interventional
3728,PROTOCOL-P2-054,The ABC Study: Assessment of Breast Density Classification,"February 16, 2022","October 31, 2022",Recruiting,Interventional
3729,254-18,Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales,"August 1, 2020","December 31, 2025",Recruiting,Interventional
3730,B076201420067,Zhongnan Hospital of Wuhan University,"March 15, 2021","December 31, 2022",Unknown status,Interventional
3731,MIP-2019-001,BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory),"January 15, 2021","June 15, 2024",Not yet recruiting,Interventional
3732,21051,Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults,"August 24, 2021","June 30, 2022",Completed,Interventional
3733,DE-17-17,Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection,"September 16, 2020","August 20, 2021",Completed,Interventional
3734,CLINP-001013,Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction,January 2023,April 2023,Not yet recruiting,Observational
3735,201701045,Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach,"January 9, 2018","October 24, 2018",Completed,Interventional
3736,E20210210,Breast Mesh Used in Two-staged Breast Reconstruction,"August 1, 2021","August 1, 2026",Recruiting,Interventional
3737,ICO-2021-05,"Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life","February 21, 2022","February 21, 2025",Recruiting,Observational
3738,735CLD Rev.04,The ClearCoast™ Magnetic Resonance Outcome PMS Study,"June 24, 2021","January 1, 2025",Recruiting,Observational
3739,CLP-0004,A Retrospective Breast Reconstruction Study,"November 20, 2019","June 1, 2022",Completed,Observational
3740,EMC-0124-18,Evaluation of the SmartBx System for Breast Biopsy,"June 10, 2019","September 1, 2019",Completed,Interventional
3741,LYL797-101,A Study to Investigate LYL797 in Adults With Solid Tumors,"March 29, 2022",September 2026,Recruiting,Interventional
3742,2834,TIVA Admnistration and Autologous Fat Transfer in Breast Reconstruction,"September 1, 2019","March 30, 2020",Completed,Interventional
3743,APHP220816,Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients,"April 1, 2023","April 1, 2026",Not yet recruiting,Observational
3744,IC 2021 07,Opioid Free Versus Opioid Based Anaesthesia for Secondary Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.,"December 7, 2022","March 15, 2026",Recruiting,Interventional
3745,GEN1B-01,Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications,"December 19, 2018","December 30, 2020",Suspended,Interventional
3746,GOG-8023,Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer,January 2100,,Not yet recruiting,Observational
3747,IIT2018-25-MITA-NEOBREADS,NEOBREADS: Neoadjuvant Breast Diet Study,"March 21, 2019","August 17, 2021",Terminated,Interventional
3748,2020-00493,Red Bull Energy Drink Intake After Autologous Microsurgical Breast Reconstruction,"May 11, 2020","January 1, 2023",Recruiting,Interventional
3749,20210817-01H,TAP vs QL for Postoperative Analgesia After DIEP Free Flap Breast Reconstruction,April 2022,March 2023,Not yet recruiting,Interventional
3750,CIRB Ref. No: 2019/2090,Accessible Cancer Care to Enable Support for Survivors Programme,"October 1, 2019",October 2021,Unknown status,Interventional
3751,20295,Dermacell ADM Without Basement Membrane,"September 1, 2018","May 1, 2021",Unknown status,Interventional
3752,TO-TAS0728-101,A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities,"April 6, 2018","June 9, 2022",Terminated,Interventional
3753,124.03-2017-GES-0005,Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow,"January 4, 2018","January 9, 2018",Completed,Interventional
3754,IIT2018-21-AMERSI-BREADS,BREADS: Breast Adjuvant Diet Study,"February 4, 2020",January 2024,Recruiting,Interventional
3755,PSG SOMAVAC,Evaluation of SOMAVAC 100 Sustained Vacuum System,"May 1, 2021","October 30, 2022",Completed,Observational
3756,FMSU2017-003,Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing,"June 30, 2018","November 19, 2018",Completed,Observational
3757,3-2021-0468,Pectoralis Nerve Block and Quality of Recovery in Mastectomy Patients,"February 23, 2022","March 24, 2025",Recruiting,Interventional
3758,IB 2019-01,Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors,"March 31, 2021",March 2025,Recruiting,Interventional
3759,2022-010,F-Tryptophan PET/CT in Human Cancers,"September 29, 2022","December 31, 2024",Recruiting,Interventional
3760,Reader-02 Study,Optoacoustic Images Versus Imagio® Ultrasound,"July 30, 2019","November 3, 2019",Completed,Interventional
3761,20-03,"A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy","March 5, 2021","August 18, 2022",Completed,Interventional
3762,YWBC-002,Prevention and Treatment of Pyrrolitinib-associated Diarrhea,"May 16, 2020","April 30, 2023",Recruiting,Interventional
3763,PER-19-03,Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.,"August 3, 2020","July 27, 2021",Completed,Observational
3764,2019-1176,Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction,"October 13, 2020","December 31, 2022",Recruiting,Interventional
3765,2018-4107,Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy,"April 7, 2018","December 10, 2019",Completed,Interventional
3766,2021-0290,Effect of Neurotization on QoL and Sensory Restoration,April 2023,January 2024,Not yet recruiting,Interventional
3767,0180910/16,The Combination of PECS II Block and Parasternal Block for Radical Mastectomy,"December 1, 2018","April 12, 2019",Completed,Interventional
3768,ETNA-CRCI,Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI),"March 30, 2022","January 20, 2025",Recruiting,Observational
3769,INTRUSION,INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701,February 2023,May 2025,Not yet recruiting,Interventional
3770,2019-A00121-56,Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure,"May 2, 2019",June 2023,"Active, not recruiting",Observational
3771,2018-9409,Intra-Operative Radiation Registry,"August 9, 2018","August 9, 2024",Recruiting,Observational
3772,R.22.09.1830,Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery,"September 1, 2022","December 30, 2022",Recruiting,Interventional
3773,SCOUT2021,Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc ),"April 1, 2022",March 2024,Recruiting,Interventional
3774,PROICM 2019-07 PRE,Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction,"December 11, 2020",June 2027,Recruiting,Interventional
3775,2022-A01940-43,Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL,"April 1, 2023","October 1, 2024",Not yet recruiting,Interventional
3776,Reader-01,"Imagio Feasibility Multi-Reader, Multi-Case Study","November 13, 2018","December 9, 2018",Completed,Interventional
3777,2020-0980,What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care,"January 21, 2021","October 31, 2023",Recruiting,Observational
3778,STUDY00025461,Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms,"April 17, 2023","June 23, 2023",Not yet recruiting,Interventional
3779,19D.203,Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast Findings,"June 23, 2020","January 27, 2023",Completed,Interventional
3780,BCD-178-1,"A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers","August 8, 2022","January 31, 2024","Active, not recruiting",Interventional
3781,2019P003607-11,Data Analysis for Drug Repurposing for Effective Alzheimers Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole,"November 1, 2022",February 2023,"Active, not recruiting",Observational
3782,SHR6390-I-114,Study of SHR6390 in Renal Insufficiency and Healthy Subjects,"December 18, 2022","September 28, 2023",Recruiting,Interventional
3783,19-005445,Determining Molecular Drivers of Radiation Dermatitis,"February 21, 2021",March 2024,Enrolling by invitation,Observational
3784,2204MDJ,Testing Video Information About Mammography Screening,"June 16, 2020","July 30, 2020",Unknown status,Interventional
3785,mastectomy regional anesthesia,Regional Anesthesia for Modified Radical Mastectomy With Axillary Lymph Node Dissection,"April 1, 2020","January 31, 2023",Completed,Interventional
3786,PECS 2019,The Analgesic Efficacy of the Pectoral Nerves Block Versus Local Anesthetic Infiltration After Mastectomy,"November 1, 2019","June 30, 2021",Unknown status,Interventional
3787,R-2017/UEM11,Acute Effect of Chromatic Environment During Chemotherapy,"April 15, 2018","December 15, 2020",Unknown status,Interventional
3788,IBIO-302,Food Effect Study of D-0502 Tablet in Healthy Volunteers,"October 23, 2018","April 17, 2019",Completed,Interventional
3789,LAE203CN2101,PhI to Solid Tumors and PhII to Locally Advanced or mTNBC,"June 12, 2021","July 30, 2024",Recruiting,Interventional
3790,SN132D CSP final version 6.0,A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer,"August 23, 2019","November 30, 2022",Completed,Interventional
3791,2022-1151,Implementation of Population Breast Cancer Genetic Services in Federally Qualified Health Centers (FQHC),August 2023,December 2027,Not yet recruiting,Interventional
3792,2020-3,Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System,"February 21, 2020","December 31, 2023",Recruiting,Observational
3793,CIRB Ref. No: 2017/3139,Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS),"June 18, 2018","September 1, 2022",Recruiting,Observational
3794,LCCC1754,UNC Pleural Fluid Registry,"January 24, 2018","January 24, 2050",Recruiting,Observational
3795,Tomosymthesis,Tomosymthesis for Breast Mass Lesion Characterization,"September 1, 2021","October 1, 2023",Not yet recruiting,Observational
3796,NINTAU,ConquerFear-Group: A Psychological Intervention for Fear of Cancer Recurrence,"October 21, 2019","June 22, 2022",Completed,Interventional
3797,BCA-AI,Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography,"April 5, 2018","May 4, 2020",Completed,Observational
3798,21-002713,3D Ultrasound Microvessel Imaging for Breast Masses,"August 19, 2021","April 20, 2024",Recruiting,Interventional
3799,LIVFOU-930411,Pectoral Nerves Block vs Wound Infiltration for Partial Mastectomy - a Prospective Randomized Trial.,"February 19, 2021","May 1, 2022",Completed,Interventional
3800,21-BI-1607-01,BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid Tumors,"July 28, 2022",December 2026,Recruiting,Interventional
3801,20-378,Researching the Effect of Exercise on Cancer,"October 2, 2020","October 2, 2024",Recruiting,Interventional
3802,2019-A0872-55,Study on Skin Toxicities Induced by Cancer Treatments,"November 25, 2020","July 25, 2024",Recruiting,Interventional
3803,CAAA504A12101,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.,"October 14, 2021","November 10, 2023",Recruiting,Interventional
3804,20190701041GH,Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development,June 2020,June 2025,Recruiting,Observational
3805,D6900C00001,First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies,"October 18, 2021","June 30, 2025",Recruiting,Interventional
3806,HNCH-BC004,A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity,"August 28, 2020","April 21, 2022",Completed,Interventional
3807,CMUH106-REC2-117,Evaluation of the Efficacy of Acupuncture in Chemotherapy Induced Peripheral Neuropathy,"June 27, 2018","October 10, 2020",Unknown status,Observational
3808,20200491,Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences,"July 1, 2021","December 31, 2024",Recruiting,Interventional
3809,2019-06214,Psychological Effects of Implant Loss,"March 1, 2020","December 31, 2025",Recruiting,Observational
3810,PRO2021-1428,Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer,"January 1, 2022","December 31, 2026",Not yet recruiting,Interventional
3811,ZN-A-1041-101,Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors,"October 15, 2020","June 30, 2024",Recruiting,Interventional
3812,HCC 21-265,"Dignity, Legacy, Advocacy, and Support for Advanced Cancer: Reimagined End of Life Care in the Black Community","March 13, 2022",June 2025,Recruiting,Interventional
3813,HNCH-BC007,GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel,"September 9, 2020","August 22, 2022",Withdrawn,Interventional
3814,2020-0498,Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome,"March 23, 2022","March 23, 2022",Withdrawn,Interventional
3815,NBE-002-01,NBE-002 in Patients With Advanced Solid Tumors,"June 19, 2020",December 2025,"Active, not recruiting",Interventional
3816,1B-22-2,"In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors","January 9, 2023","January 9, 2026",Recruiting,Interventional
3817,PROT002 - Test Plan 01 Rev A,Blue Note Therapeutics Product BNT 103 Usability and User Engagement,"September 1, 2021","December 31, 2021",Completed,Interventional
3818,Gen 2 - 01,Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System,"August 19, 2021","February 17, 2022",Completed,Interventional
3819,PROT001,Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment,"May 15, 2021","September 1, 2022",Terminated,Interventional
3820,MW05-2020-CP301,Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF,"September 21, 2020","November 5, 2022",Completed,Interventional
3821,BYON5667.002,Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985,"January 10, 2022","December 31, 2024","Active, not recruiting",Interventional
3822,UZBRU_VHH2_1,Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT,"November 5, 2019",April 2023,Recruiting,Interventional
3823,v24-9-2017,Psyhosomatic Medicine in Oncologic and Cardiac Disease Study,"March 27, 2018",December 2022,Unknown status,Observational
3824,19-007547,"Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial","September 1, 2020","December 31, 2024",Recruiting,Interventional
3825,Pro00092817,VR Ultrasound Guided Breast Localization,"January 13, 2021","January 7, 2022",Completed,Interventional
3826,Pro00112215,The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures,"September 15, 2021",October 2022,Enrolling by invitation,Interventional
3827,Ageing-NIO,"Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques","April 27, 2020","April 10, 2027",Recruiting,Observational
3828,5R44CA203608,LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge),"October 26, 2020","February 15, 2024",Recruiting,Interventional
3829,M16-573,A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors,"July 13, 2018","April 30, 2023","Active, not recruiting",Interventional
3830,ACROPOLI (SOLTI-1904),Efficacy of Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors,"April 12, 2021","December 11, 2024","Active, not recruiting",Interventional
3831,NL52329.075.15,Intra-individual Comparison of Conventional and Digital PET/CT Scanners,"January 8, 2018","September 13, 2019",Completed,Interventional
3832,DPCVC,Diagnostic Power Comparison Between VOCs and CTCs,"June 15, 2019","December 31, 2020",Unknown status,Observational
3833,AAAT2490,AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc,"May 3, 2022",December 2026,Recruiting,Interventional
3834,0S-20-6,Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy,"December 18, 2020","June 18, 2024",Recruiting,Observational
3835,SRNSM,"Examining the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Skin Reducing Nipple Sparing Mastectomy and Implant Based Breast Reconstruction, and Comparing it to Classic Skin- Sparing Mastectomy and Implant- Based Breast Reconstructive Surgeries","April 18, 2020","April 5, 2027",Recruiting,Observational
3836,CMP-001-009,A Trial to Find Out if Vidutolimod Together With Cemiplimab is Safe and if it Works in Adult Participants With Advanced Cancer or Metastatic Cancer,"November 30, 2021","March 7, 2027",Recruiting,Interventional
3837,SS-SP01-201904,Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents,"July 18, 2020","December 31, 2022",Recruiting,Interventional
3838,5890-001,Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001),"February 18, 2018","October 25, 2024","Active, not recruiting",Interventional
3839,H19-03343,Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy,"June 11, 2020","December 31, 2024",Recruiting,Interventional
3840,BPI-2358-106 phase 3,Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia,"October 23, 2019","September 25, 2025","Active, not recruiting",Interventional
3841,EK 1623/2020,Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection,"July 1, 2020","December 1, 2023",Recruiting,Interventional
3842,TRX518-004,A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors,"May 20, 2019","July 14, 2020",Terminated,Interventional
3843,20200110,Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients,"April 3, 2020","December 30, 2021",Recruiting,Interventional
3844,ASPB vs ESBP for mastectomy,Comparison Between Serratus Anterior Plane Block and Erector Spinae Plane Block for Mastectomy,"October 1, 2019","July 30, 2020",Completed,Interventional
3845,2018-01,Quantitative Evaluation of the Breasts Morphological Variations During Radiotherapy: MorphoBreast3D,"February 22, 2018","May 7, 2020",Completed,Interventional
3846,TYKM1602101,A Study of TY-302 in Patients With Advanced Solid Tumors,"December 7, 2020",December 2023,Recruiting,Interventional
3847,BrUOG 351,BrUOG 351: PRE-OPERATIVE APBI USING NIBB,March 2019,"January 21, 2020",Withdrawn,Interventional
3848,PI-3958,Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit?,"February 2, 2019","January 30, 2021",Completed,Observational
3849,KL264-01,"Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies","February 28, 2020",December 2025,Recruiting,Interventional
3850,Medipol Hospital 26,Different Volumes of Erector Spinae Plane Block for Breast Surgery,"January 27, 2022","March 30, 2023",Recruiting,Interventional
3851,NeoVAB,Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB),"June 7, 2019","August 30, 2021",Unknown status,Interventional
3852,16-136,Ipilimumab and Nivolumab in Leptomeningeal Metastases,"February 15, 2018","July 22, 2021",Completed,Interventional
3853,SGN228-001,A Study of SGN-CD228A in Advanced Solid Tumors,"September 3, 2019","March 9, 2023",Terminated,Interventional
3854,1612017795,Web-based Family History Tool,"September 9, 2019","December 31, 2022",Completed,Interventional
3855,7902-005,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005),"February 12, 2019","December 22, 2023","Active, not recruiting",Interventional
3856,UUBreast02,PREMs on PROMs in Breast Disease (PREMs_PROMs),"September 1, 2019","April 30, 2021",Completed,Interventional
3857,2021-0842,Single Step Lesion Annotation and Localization of Suspicious Breast Lesions,"April 11, 2022","November 1, 2023",Recruiting,Interventional
3858,GN19HS442,"Augmented Reality (AR): The Future of ""Patient Information Leaflets","November 30, 2020","March 30, 2022",Recruiting,Interventional
3859,06-2020/1,Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory,"January 13, 2020","May 1, 2022",Completed,Observational
3860,MCC-21622,Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies,"January 12, 2023",January 2026,Recruiting,Interventional
3861,SIBP-03-01,A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.,"October 26, 2020","October 26, 2023",Recruiting,Interventional
3862,IRB00047335,Speeding Recovery From Pain and Opioid Use,November 2018,June 2020,Withdrawn,Interventional
3863,217510,Microbiome and Association With Implant Infections,"September 28, 2021","December 31, 2025",Recruiting,Interventional
3864,RIN20230039,Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure,May 2023,February 2024,Not yet recruiting,Interventional
3865,4-2019-0834,Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction,"May 14, 2020","December 4, 2022","Active, not recruiting",Observational
3866,UI/EC/20/0275,The Effect of Octreotide on Wound Drainage After Mastectomy,"December 18, 2020","December 2, 2021",Completed,Interventional
3867,AB-201-01,A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors,"March 1, 2023",April 2027,Not yet recruiting,Interventional
3868,IOM-040369,Patient Preference for Pegfilgrastim (Neulasta®) Application Forms,"June 25, 2018","September 10, 2019",Completed,Interventional
3869,233,Effect of tDCS of the Motor Cortex on Chemotherapy Induced Nausia and Vomiting,"January 1, 2018",September 2019,Unknown status,Interventional
3870,TQB3616-I-02,Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects,"July 6, 2021","August 30, 2021",Completed,Interventional
3871,MAR-BAS-18-005,The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy,"October 7, 2020",August 2024,Recruiting,Interventional
3872,107709,Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in Women,"November 5, 2019","August 12, 2020",Terminated,Interventional
3873,20-1456,Improving Cancer Screening and Follow-up in Community Health Centers,"April 1, 2023","September 30, 2023",Not yet recruiting,Interventional
3874,UTN: U1111-1278-1680,CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR,July 2022,July 2023,Not yet recruiting,Interventional
3875,19-104,The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea (CINV) and Vomiting,"August 30, 2021","October 30, 2023",Recruiting,Interventional
3876,MASCT-I-1003,A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor,"April 19, 2018",July 2020,Unknown status,Interventional
3877,REC/RCR&AHS/22/0511,Effects Of Lymphatic Drainage on Axillary Web Syndrome,"April 15, 2022","January 5, 2023",Recruiting,Interventional
3878,18-264,Enhancing Cancer Prevention and Control Pathways-Native Health Initiative,"June 1, 2021",December 2023,Recruiting,Interventional
3879,KY20202093-F-1,Clinical Study of 68Ga Labeled HER2 Affibody Analogues,"June 1, 2022","December 1, 2023",Not yet recruiting,Interventional
3880,P050001 TiLOOP® Bra Pocket,"Post Market Clinical Follow Up to ""Patient Reported Outcome"" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket)","July 4, 2019",March 2023,"Active, not recruiting",Observational
3881,2021-0262,Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study),"April 7, 2022","December 30, 2023",Recruiting,Interventional
3882,262180,Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane,"September 14, 2021",June 2025,Recruiting,Interventional
3883,H18-02014,CARA Treatment Pilot Study for Breast Positioning,"October 8, 2018","November 18, 2019",Completed,Interventional
3884,IRB19-2074,Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine),"July 13, 2020",April 2023,Recruiting,Interventional
3885,TG1819ONC,A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors,"April 21, 2020",January 2024,Recruiting,Interventional
3886,STUDY00018917,The PAI Trial for Breast and Colon Cancer Survivors,"April 12, 2022","April 12, 2022",Withdrawn,Interventional
3887,STUDY00002789,CONTIGO - Informing Latinas About HBOC Risk,"June 1, 2021","December 31, 2025",Enrolling by invitation,Interventional
3888,S66520,Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors,"December 27, 2022",December 2025,Recruiting,Interventional
3889,P.T.REC/012/002677,Effectiveness of Low Level Laser Therapy on Insulin Resistance and Inflammatory Biomarkers,"July 1, 2020","September 1, 2023",Recruiting,Interventional
3890,ISPY-P1.01,ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer,"July 28, 2021","November 17, 2021",Withdrawn,Interventional
3891,NCI-2017-01921,Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery,"October 31, 2018","February 22, 2023","Active, not recruiting",Interventional
3892,"2016-051-000001, 1835",Investigating Public Enthusiasm for Mammography Screening in Denmark,"November 6, 2020","January 4, 2021",Completed,Interventional
3893,CF21163B,Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome,"October 13, 2021","August 31, 2024",Recruiting,Interventional
3894,D-FR-01072-002,"Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)","May 14, 2019","October 10, 2019",Terminated,Interventional
3895,Breast-Nektaria,The Impact of Pecs Blocks on Postmastectomy Pain Syndrome,"August 1, 2020","March 31, 2022",Completed,Interventional
3896,1413727,An Intimacy Intervention for Couples Completing Breast or Prostate Cancer,"December 9, 2019","December 31, 2020",Completed,Interventional
3897,1049/2018,Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy,"May 18, 2018","February 28, 2021",Completed,Observational
3898,20200426,Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants,"September 9, 2021","October 10, 2021",Completed,Interventional
3899,VALO-001,START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer,"February 2, 2023",January 2024,Recruiting,Interventional
3900,IMU R204/2017,Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients,"December 26, 2018","June 30, 2021",Completed,Interventional
3901,LCCC1915,3-D Super Resolution Ultrasound Microvascular Imaging,"May 26, 2022",October 2024,Recruiting,Interventional
3902,RiphahIU Shafaq,Effects of Active Release Technique (ART) on Pectoralis Minor Tightness in Post Mastectomy Women.,"August 10, 2022","January 15, 2023",Completed,Interventional
3903,CRX100-001,Study of CRX100 in Patients With Advanced Solid Tumors,"January 8, 2021",March 2025,Recruiting,Interventional
3904,HREBA.CC-20-0077,Time-restricted Eating in Survivors Trial,"August 5, 2020","July 28, 2021",Completed,Interventional
3905,TST-9-H,Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid Tumors,"November 10, 2022","January 10, 2024",Withdrawn,Interventional
3906,OCOG-2022-RAPID2,A Randomized Trial of Five Fraction Partial Breast Irradiation,October 2022,July 2031,Not yet recruiting,Interventional
3907,20181004,Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer,"July 1, 2019","October 5, 2020",Completed,Interventional
3908,18-571,EHR-embedded OCDT in Breast or GI Cancer,"March 13, 2019","November 23, 2021",Completed,Interventional
3909,R19-159,Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction,"July 14, 2021","September 29, 2023","Active, not recruiting",Interventional
3910,2018B0521,Southeast Asian Womens Health Project,"October 16, 2020",September 2023,Recruiting,Interventional
3911,287482,ARTISS a Single-centre Randomised Control Study,"February 1, 2022","August 1, 2023",Recruiting,Interventional
3912,HR-BLTN-DDI-07,Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects,"March 8, 2022","August 2, 2022",Completed,Interventional
3913,201612723,NR in Chemo-induced Peripheral Neuropathy,"November 8, 2019","February 24, 2022",Terminated,Interventional
3914,2012285106,Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizona,"April 28, 2022","July 30, 2023",Recruiting,Observational
3915,AWS,Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome,"December 1, 2021","December 4, 2023",Recruiting,Interventional
3916,2022-0328,"Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics","November 23, 2022","June 1, 2023",Recruiting,Interventional
3917,20/007-E_TFM,Study of the Effectiveness of Supervised vs. Non-Supervised Therapeutic Exercise in Cancer Patients,June 2020,November 2021,Unknown status,Interventional
3918,0352-2189,"A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis","April 25, 2023","June 10, 2024",Not yet recruiting,Interventional
3919,HCI128055,[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma,"December 11, 2020","June 30, 2024",Recruiting,Interventional
3920,180097,Olaparib in People With Malignant Mesothelioma,"July 11, 2018","October 21, 2020",Completed,Interventional
3921,190134,Vaccine Response With NT-I7,"April 19, 2023","May 19, 2025",Recruiting,Interventional
3922,TH1902-CTR-0001,TH1902 in Patients With Advanced Solid Tumors,"March 4, 2021",March 2023,"Active, not recruiting",Interventional
3923,18112,64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy,"November 3, 2021","December 1, 2023",Recruiting,Interventional
3924,KY20172047-1,Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction,"July 30, 2018","December 30, 2025",Recruiting,Interventional
3925,BREAST HEMATOMA,Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis,"October 1, 2022","December 15, 2022",Completed,Observational
3926,mRNA-2752-P101,Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies,"November 27, 2018","April 1, 2025",Recruiting,Interventional
3927,1380800-R,Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments,"April 25, 2022","December 31, 2023",Recruiting,Interventional
3928,7621,Opening the Conversation Study,"September 1, 2021","December 31, 2024",Recruiting,Interventional
3929,TomBakerCC,Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery,"June 10, 2019","April 16, 2021",Completed,Interventional
3930,SVIFT Nodal Trial,Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation,"June 1, 2021","December 31, 2027",Recruiting,Interventional
3931,CASE1Z21,Patient Recall of Cancer Screening and Diagnosis,June 2023,June 2024,Recruiting,Interventional
3932,IRB00075787,Mastectomy Flap Temperature Study,"September 29, 2022",October 2023,Recruiting,Interventional
3933,HB-AT-001,Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan,"May 25, 2019","May 27, 2022",Completed,Interventional
3934,ART4215C001,A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors,"September 13, 2021",August 2025,Recruiting,Interventional
3935,D161100000816006,Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion,"September 8, 2018","December 31, 2019",Completed,Observational
3936,Duke-NUS,Marital Satisfaction and Sexual Health of Female Cancer Patients in Singapore,"November 1, 2018",July 2022,Recruiting,Interventional
3937,226947,SS-INQ Information Needs Questionnaire in Sjögrens Syndrome,"October 12, 2018","July 21, 2021",Completed,Observational
3938,SKNA pilot,Measurement of the Skin Sympathetic Nerve Activity,"August 31, 2018","November 1, 2018",Completed,Interventional
3939,IIT2018-05-ASHER-IMPROV2,LOL: Its All Improv After Cancer!™,"August 2, 2019",July 2025,"Active, not recruiting",Interventional
3940,OU-SCC Virtual Reality,Virtual Reality Software to Reduce Stress in Cancer Patients,April 2023,April 2025,Not yet recruiting,Interventional
3941,2020-A03205-34,"Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)","September 1, 2021",December 2022,Recruiting,Interventional
3942,OPERA2,Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA),"November 1, 2018","November 1, 2019",Completed,Interventional
3943,201907039,RANKL Inhibition and Mammographic Breast Density,"August 27, 2019","August 31, 2026",Recruiting,Interventional
3944,TaiHao BR-USCAD VT 20-249,Evaluation of TaiHao Breast Ultrasound Diagnosis Software,"August 15, 2020","November 1, 2020",Completed,Interventional
3945,UMCC 2021.004,Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors,"May 12, 2021","August 8, 2022",Completed,Interventional
3946,UPMREB 2021-140-01,Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis,"September 1, 2021",December 2022,Recruiting,Interventional
3947,15/LO/1038 BRACELET,Breast: Recovery After Axillary Node Clearance - Evaluating Limbs With E-Technology (the BRACELET Study),"April 23, 2018","December 30, 2021",Unknown status,Observational
3948,KS01,Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery,"May 1, 2019","October 1, 2019",Completed,Interventional
3949,MS-268-2019,Effectiveness of Ultrasound Guided Erector Spinae Plane Block Against Ultrasound Guided Serratus Anterior Block in Modified Radical Mastectomy,"January 10, 2020","May 20, 2020",Completed,Interventional
3950,BoCCE,Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE),"July 24, 2021",December 2022,Unknown status,Interventional
3951,875329B,Real-Life Pilot Feasibility Study (LC_RLP_PUC1),"January 15, 2023","October 15, 2023",Recruiting,Interventional
3952,MS-536-2021,Dexmedetomidine Versus Dexamethasone as Adjuncts in Erector Spinae Plane Block in Modified Radical Mastectomy,"December 15, 2020","March 15, 2022",Completed,Interventional
3953,Gyn F-Chem,Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy,"February 1, 2018","November 1, 2021",Terminated,Interventional
3954,PROICM 2019-06 COH,Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session,"February 14, 2020","January 14, 2022",Completed,Interventional
3955,NCCH1905,Asian Multicenter Prospective Study of ctDNA Sequencing,"November 1, 2021","December 31, 2024",Recruiting,Observational
3956,D3614C00004,A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body,"February 1, 2021","March 25, 2021",Completed,Interventional
3957,1449,Pre-pectoral Versus Sub-pectoral Implant Placement in Immediate Breast Reconstruction,"August 22, 2019","December 30, 2023",Recruiting,Interventional
3958,RocuMAST,Effect of Rocuronium on BIS Values,"January 3, 2023","March 31, 2023",Recruiting,Observational
3959,CHD22_0002,Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy,"October 5, 2022","August 1, 2024",Recruiting,Interventional
3960,CLINP-001001,Motiva Flora Tissue Expander PMCF,"December 14, 2020","June 15, 2023",Recruiting,Interventional
3961,1920306,Purpose in Life Survey,"August 1, 2022","August 31, 2024",Enrolling by invitation,Observational
3962,17-VIN-0855,A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition,May 2018,November 2018,Unknown status,Interventional
3963,2022-01423-01,Optimizing Postoperative Recovery After Breast Reconstruction With Autologous Tissue (BestDIEP),"May 2, 2022","December 31, 2026",Recruiting,Observational
3964,2019-0557,Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients,"September 25, 2019","December 19, 2019",Completed,Interventional
3965,Breast 2019,PCR Based CEUS in BI RADS 4A Nodules,"April 1, 2019","December 30, 2021",Unknown status,Observational
3966,D0817C00098,Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib,"August 4, 2020","January 8, 2025",Enrolling by invitation,Interventional
3967,2017-377,The Effect of Double Injection Erector Spinae Plane Block on Postoperative Pain Following Breast Surgery,"February 3, 2018","March 7, 2018",Completed,Interventional
3968,IZKSZ3_188408 / 1,The DIALOGUE Study: Swiss-Korean Billateral Collaboration,"April 15, 2022","December 31, 2024",Recruiting,Interventional
3969,2018-94,Comparison of Erector Spinae Plane Block With Thoracic Paravertebral Block for Breast Surgery,"March 28, 2018","August 20, 2018",Completed,Interventional
3970,ORIN1001-C1,Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.,"July 1, 2020","June 30, 2023","Active, not recruiting",Interventional
3971,UMCC 2020.041,Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias,"April 16, 2021",February 2023,Recruiting,Interventional
3972,H-42207 GAIL-N,C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N),"April 23, 2019",December 2038,Recruiting,Interventional
3973,Esogu Anesthesia,Comparison of Erector Spina Plane Block and Thoracic Epidural Block,"January 11, 2021","March 31, 2021",Completed,Interventional
3974,TED16925,Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors,"August 16, 2021","October 31, 2025",Recruiting,Interventional
3975,Telerehab CH Feasibility,Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study,"February 9, 2022","September 30, 2022",Recruiting,Interventional
3976,RPC006,A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.,"January 20, 2021","July 28, 2023","Active, not recruiting",Interventional
3977,BEX15859,"Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women","June 15, 2021","August 19, 2021",Completed,Interventional
3978,waitingroom,Anxiety on the First Day of Chemotherapy,"November 1, 2020","March 3, 2022",Unknown status,Interventional
3979,CP-10-001,In Vivo Smart Biopsy Device Protocol In Radiology,"March 14, 2019","March 31, 2020",Unknown status,Interventional
3980,REB16-1463,Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors,October 2020,January 2023,Unknown status,Interventional
3981,UF-STO-ETG-003,Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types,"November 3, 2021",December 2024,Recruiting,Interventional
3982,UMCC 2020.157,Lighting Intervention for Cancer-related Fatigue,"July 15, 2021",May 2023,Recruiting,Interventional
3983,OnkoFit II,Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy,"August 1, 2020","August 1, 2025",Recruiting,Interventional
3984,R7075-ONC-2009,REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors,"December 21, 2020","April 1, 2026",Recruiting,Interventional
3985,CART-TnMUC1-01,A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers,"October 10, 2019","October 31, 2036","Active, not recruiting",Interventional
3986,PT06-01,A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors,"September 1, 2020","December 30, 2021",Unknown status,Interventional
3987,2019/2944,Cryotherapy in Breast B3 Lesions,"September 15, 2021","October 15, 2022",Recruiting,Interventional
3988,SPI-POZ-501,A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib,"October 5, 2018","April 5, 2026","Active, not recruiting",Interventional
3989,LCB-1801-001,A Study of NI-1801 in Patients With Mesothelin Expressing Solid Cancers,"April 29, 2022","September 30, 2025",Recruiting,Interventional
3990,PECS vs SAP,Comparing the Quality of Analgesia With Pectoral Nerve Block and Serratus Plane Block in Modified Radical Mastectomy,"April 1, 2022","July 30, 2022",Completed,Interventional
3991,2020-000495-37,"Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer","November 12, 2020","September 19, 2022",Completed,Interventional
3992,2018-0175,Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo,"July 1, 2019",December 2021,Unknown status,Interventional
3993,2021-082,DIEP Flap Surgery and Intraabdominal Pressure,"April 19, 2021","January 25, 2022",Completed,Observational
3994,012018CONTROL,Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines,"January 1, 2019","February 28, 2023","Active, not recruiting",Interventional
3995,18232,Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY),"July 3, 2019","March 31, 2024",Recruiting,Observational
3996,R19258,The LYSA (Linking You to Support and Advice) Trial,"March 13, 2021",September 2023,"Active, not recruiting",Interventional
3997,2020/03FEV/065,Mechanically-Assisted and Non-Invasive Ventilation for Breathing-related Tumor Motion Mitigation.,"July 3, 2020","September 30, 2022",Unknown status,Interventional
3998,2012-001-108,Ramosetron on Late PONV (Postoperative Nausea and Vomiting),"December 17, 2020","October 31, 2021",Completed,Interventional
3999,HREC/74777/Alfred-2021,Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial,"July 27, 2022",February 2028,Recruiting,Interventional
4000,7905,Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief,"December 4, 2020","January 1, 2023",Recruiting,Interventional
4001,ARX788-1711,"A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)","March 20, 2018",December 2023,"Active, not recruiting",Interventional
4002,69HCL18_0492,Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture),"February 14, 2023","December 1, 2024",Recruiting,Interventional
4003,BB-1701-101,A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors,"July 28, 2020",December 2023,Recruiting,Interventional
4004,D9720C00001,Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies,"November 12, 2020","January 15, 2026",Recruiting,Interventional
4005,XuanWuH-NK,Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells,"October 26, 2018","September 30, 2022",Unknown status,Interventional
4006,FPX-01-01,A Phase 1/2 Study of [225Ac]-FPI-1434 Injection,"January 17, 2019",June 2026,Recruiting,Interventional
4007,RAPA-201-STP-01,RAPA-201 Therapy of Solid Tumors,"August 1, 2021","December 31, 2024",Recruiting,Interventional
4008,HC-404-FCP-2011,A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD),"June 8, 2021","March 8, 2024",Recruiting,Interventional
4009,assuitu faculty of medicine,Outcomes of Breast Conservative Surgery for Post Chemotherapy Tumour Size After Response to Neoadjuvant Chemotherapy,"June 1, 2021","December 1, 2024",Recruiting,Interventional
4010,STUDY00015358,Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact,"March 18, 2021","February 14, 2025","Active, not recruiting",Interventional
4011,ONCX-NAV-G201,A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors,"August 5, 2022","December 15, 2024",Recruiting,Interventional
4012,CRUKD/22/002,HMBD-001 in Advanced HER3 Positive Solid Tumours,"November 10, 2021",September 2026,Recruiting,Interventional
4013,042201,Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted,"September 19, 2022","March 1, 2027",Recruiting,Interventional
4014,DCC-2036-01-004,A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors,"January 2, 2019","November 1, 2022","Active, not recruiting",Interventional
4015,NM1F-T1-01,"A First-in-human, Phase I, Open-label, Multicenter Study of NM1F Administered as Monotherapy and in Combination With Pembrolizumab to Patients With Advanced Solid Tumors.",March 2023,September 2026,Not yet recruiting,Interventional
4016,213409,A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study,"April 16, 2021","November 13, 2025","Active, not recruiting",Interventional
4017,ICO-2020-06,Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ,"February 3, 2021","August 1, 2033",Recruiting,Interventional
4018,OMO-103-01,"Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours","April 28, 2021",December 2024,"Active, not recruiting",Interventional
4019,849679,RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR),"April 14, 2022","February 1, 2024",Recruiting,Interventional
4020,UC-0101/1709,Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours,"June 20, 2018","December 30, 2024","Active, not recruiting",Interventional
4021,4-2020-0165,Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery,"April 8, 2020","April 7, 2030",Recruiting,Observational
4022,ZN-A-1041-101-US,A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors,"October 15, 2020","November 30, 2023",Recruiting,Interventional
4023,UW21084,Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy,"June 1, 2022",May 2025,Recruiting,Interventional
4024,IRB#56402,Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study,"August 25, 2021",December 2023,Enrolling by invitation,Observational
4025,TAEK-VAC-HerBy-001,TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer,"August 10, 2020",June 2026,Recruiting,Interventional
4026,C4161001,PF-07104091 as a Single Agent and in Combination Therapy,"September 16, 2020","January 7, 2026",Recruiting,Interventional
4027,MORAb-202-G000-201,"A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types","August 6, 2020","March 31, 2025",Recruiting,Interventional
4028,18-27025,SCOPE-Chinese Women Study,"July 20, 2020","December 30, 2021",Completed,Interventional
4029,APHP210583,Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests,"March 15, 2022","March 14, 2024",Not yet recruiting,Observational
4030,19-652,"Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers","December 1, 2020","December 31, 2024","Active, not recruiting",Interventional
4031,BESTa,"Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs","March 1, 2023","December 31, 2024",Recruiting,Interventional
4032,SOLTI-1804,HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a),"December 13, 2019","December 15, 2024",Recruiting,Interventional
4033,M19-037,"A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors","May 21, 2019","November 12, 2023","Active, not recruiting",Interventional
4034,2020-00256; ch18Weber4,Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC,"July 28, 2020",March 2033,Recruiting,Interventional
4035,OSU-21313,A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer,"April 6, 2022","December 31, 2024",Recruiting,Interventional
4036,AN0025S0103,AN0025 and Pembrolizumab Combination in Advanced Solid Tumors,"August 20, 2020","November 28, 2025",Recruiting,Interventional
4037,202202104,Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients,"January 20, 2023",December 2026,Recruiting,Observational
4038,Medipol Hospital 9,Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy Surgery,"March 23, 2020","February 20, 2021",Completed,Interventional
4039,69HCL18_0369,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients,"December 4, 2018","January 4, 2028",Recruiting,Interventional
4040,2019/629,Breast Density Measurements in Digital Mammography and Breast Tomosynthesis Systems of Different Pixel Size,"October 1, 2019",August 2020,Unknown status,Observational
4041,200023,Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors,"October 27, 2020","December 31, 2023",Recruiting,Interventional
4042,RB-vs-RG-BCS,"Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving Surgeries","April 18, 2020","April 5, 2027",Recruiting,Observational
4043,CHANCES-IPC 2021-008,A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors,"January 26, 2022",July 2024,Recruiting,Interventional
4044,17-694,Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia,"May 10, 2018","June 28, 2019",Terminated,Interventional
4045,SLS17-201/MK3475-770,Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers,"June 28, 2019","April 30, 2023","Active, not recruiting",Interventional
4046,AP2207-30110,Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine in Bilevel Erector Spinae Plane Block in Breast Surgeries,"October 27, 2022","November 10, 2023",Recruiting,Interventional
4047,2015-KAEK-64-22-09,High Intensity vs Low Intensity Resistive Exercise In Patient With Upper Extremity Lymphedema,"November 15, 2022","February 7, 2023",Completed,Interventional
4048,FZPL-Ⅲ-301-OC,A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients,"April 30, 2019","December 31, 2022","Active, not recruiting",Interventional
4049,2022-0329,Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.,"November 18, 2022","May 31, 2023",Recruiting,Interventional
4050,CLODIS,Local Compression Seroma DIminution Objective (CLODIS),"November 18, 2018",October 2020,Unknown status,Interventional
4051,KE-0254/92/2018,ESP in Breast Surgery Due to Cancer,"February 1, 2021","August 17, 2021",Completed,Interventional
4052,2019-001982-34,Measuring Oncological Value of Exercise and Statin,"April 17, 2023","December 31, 2027",Not yet recruiting,Interventional
4053,G423 Multi TP,Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.,"February 16, 2021","November 1, 2021",Completed,Interventional
4054,201803061RIND,Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 Kilograms,"May 28, 2018",May 2019,Unknown status,Interventional
4055,192004,"KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer","September 26, 2022","December 31, 2028",Recruiting,Interventional
4056,RIPH3-RNI18/NEUROTAX,Involvement of SK3 Calcium Channel in Taxane Neuropathy,"February 6, 2019","June 12, 2020",Completed,Observational
4057,22339,Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors,"June 6, 2023","October 31, 2024",Not yet recruiting,Interventional
4058,TAS2940-101,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer,"September 16, 2021",June 2025,Recruiting,Interventional
4059,Bio2738,Shoulder Rehabilitation Using a Mobile App Following Breast Reconstruction,"April 28, 2022",May 2023,Recruiting,Interventional
4060,20252,Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety,"October 30, 2019","February 16, 2021",Completed,Interventional
4061,2021-PrMa-RWiberg,"Prophylactic Mastectomy: Prospective Evaluation of the Correlation Between Skin Flap Thickness, Residual Glandular Tissue and Skin Necrosis by Imaging and Clinical Examination","August 25, 2022","December 31, 2027",Recruiting,Observational
4062,STM-IRB-22B-001,Development and Testing of a TTDSS for Cancer Patients,"July 25, 2022","April 6, 2024",Recruiting,Interventional
4063,69HCL20_0346,Impact of the COVID-19 Pandemic in Gynecological Oncology,"May 6, 2020","November 30, 2020",Completed,Observational
4064,21-5539,Rehabilitation for People With Advanced Cancer,"December 2, 2022","April 30, 2024",Recruiting,Interventional
4065,2018-1361,Physical Activity Promotion for Breast and Endometrial Cancer Survivors,"September 8, 2020",November 2024,"Active, not recruiting",Interventional
4066,MC1713,A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ,"April 1, 2019","June 1, 2023",Recruiting,Interventional
4067,HREBA.CC-18-0028,The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery During Chemotherapy Treatment,"June 1, 2018","January 1, 2024",Recruiting,Interventional
4068,E-SN@P PROJECT-IPC 2017-029,Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment,"December 30, 2020","December 30, 2023",Not yet recruiting,Interventional
4069,PASCA,A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.,"December 24, 2020","April 24, 2028",Recruiting,Interventional
4070,H-49731,Improving Comprehensive Care of Cancer Patients,"April 1, 2022",June 2025,Recruiting,Interventional
4071,BrUOG 390,BrUOG 390: Neoadjuvant Treatment With Talazoparib,"March 29, 2021",January 2027,"Active, not recruiting",Interventional
4072,EC/2018/0315,Hormone Replacement Trial Against ALzheimers Disease,"April 17, 2018","December 31, 2023",Recruiting,Interventional
4073,CIMS-2019-01,4FMFES-PET Imaging of Endometrial and Ovarian Cancers,"September 1, 2018","August 31, 2023",Recruiting,Interventional
4074,XL102-101,Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101),"February 10, 2021",October 2024,Recruiting,Interventional
4075,Dnr 2019-04151,Exercise as Medicine for People With Cancer Sweden,"January 11, 2022",November 2024,Recruiting,Interventional
4076,2021-001624-17,Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy,"February 25, 2022",December 2027,Recruiting,Interventional
4077,GCO 21-0012,Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials,"December 24, 2022",April 2025,Recruiting,Interventional
4078,2018-0004,Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery,"May 2, 2019","April 30, 2024",Recruiting,Interventional
4079,TJ-IRB20211129,68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients,"December 18, 2021","December 30, 2025",Recruiting,Observational
4080,823981A,Oncology Episode Payment Model in Hawaii,"August 1, 2018","January 31, 2025","Active, not recruiting",Interventional
4081,NIT-110 (KEYNOTE PNA60),NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors,"June 10, 2020","May 20, 2024",Recruiting,Interventional
4082,69HCL19_0731,"Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis","May 8, 2020","October 2, 2020",Completed,Observational
4083,BT-001.01,A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors,"February 25, 2021","April 30, 2025",Recruiting,Interventional
4084,EAQ161CD,Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting,"January 8, 2019",December 2023,"Active, not recruiting",Observational
4085,Pro00106186,Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study),"September 20, 2021","July 31, 2024",Recruiting,Interventional
4086,G-5097-2019,Evaluation of Postoperative Nausea and Vomiting Incidence in Patients With Mastectomy Surgery According to Apfel Risk Scoring System,"June 1, 2020","August 31, 2020",Completed,Observational
4087,Laser treatment,Laser Treatment of Genito-urinary Syndrome in Women,"October 1, 2022","December 31, 2026",Not yet recruiting,Interventional
4088,NIMAO/2016/PC-01,Kinetics of Perioperative Circulating DNA in Cancer Surgery,"January 22, 2018","November 11, 2018",Completed,Observational
4089,IIT-2021-CANINE,To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment,"February 23, 2021","March 28, 2025","Active, not recruiting",Observational
4090,PROICM 2017-05 BAL,Analysis of Circulating Tumor Markers in Blood,"May 29, 2018","May 29, 2023",Recruiting,Interventional
4091,Breast Biopsy,The Effect of Education Given at Different Times Before a Breast Biopsy,"August 1, 2020","October 30, 2020",Completed,Interventional
4092,GOP,Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide,March 2018,March 2020,Unknown status,Interventional
4093,2018P000084,Evaluation of ADM Soft Tissue Reinforcement,"April 1, 2020","April 1, 2022",Unknown status,Observational
4094,IRB00167074,Sensory Restoration After DIEP Flap Neurotization,"December 1, 2020","December 31, 2025",Recruiting,Interventional
4095,NIP IT!,Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!),"July 20, 2022",June 2026,Recruiting,Observational
4096,CDKY709A12101C,Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.,"May 7, 2019","March 29, 2024","Active, not recruiting",Interventional
4097,IRB#21-001169,Postoperative Opt-In Narcotics Treatment in Breast,"January 1, 2022","January 1, 2023",Not yet recruiting,Interventional
4098,PRO 1676,A Digimed Oncology PharmacoTherapy Registry,"September 6, 2019",March 2022,Unknown status,Observational
4099,Pro00102260,Hypertension Management in Cancer Patients,"December 10, 2019","January 31, 2023",Suspended,Interventional
4100,19829,"A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein","July 2, 2020","April 30, 2024","Active, not recruiting",Interventional
4101,00011271,HeartPhone Cancer Survivors Trial 2019,"April 23, 2019","December 31, 2020",Terminated,Interventional
4102,CE3220.,Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.,"January 1, 2021","January 1, 2025",Not yet recruiting,Interventional
4103,METCZ20220056,EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery,"February 1, 2023","December 1, 2023",Not yet recruiting,Interventional
4104,RC31/17/0350,Use of Compression Bandages in the Prevention of Post-mastectomy Lymphoceles,"August 16, 2021","November 1, 2022",Recruiting,Interventional
4105,19-179,Acupuncture Pilot Study for Cancer-related Cognitive Function,"July 1, 2019",July 2023,"Active, not recruiting",Interventional
4106,180276,Promotora Navigator - Culturally Appropriate Patient Navigator,"June 7, 2018","October 15, 2018",Completed,Interventional
4107,213353,Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer,"October 3, 2019","January 12, 2022",Terminated,Interventional
4108,ebeddows,Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy,"July 8, 2020","December 31, 2024",Recruiting,Interventional
4109,IFCT-1703,Her2-positive Lung Cancer Treated With Dedicated Drug,"May 17, 2019",July 2023,"Active, not recruiting",Interventional
4110,69HCL17_0642,Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study,"November 28, 2019",October 2022,Recruiting,Observational
4111,CS001-SA,Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia,"April 30, 2019",May 2020,Unknown status,Interventional
4112,MSK8/22,The Effect of Rhomboid Intercostal Block and Serratus Anterior Plane Block on Postoperative Respiratory Functions,September 2022,November 2022,Not yet recruiting,Interventional
4113,JAB-2485-1001,JAB-2485 Activity in Adult Patients With Advanced Solid Tumors,"December 20, 2022",August 2026,Recruiting,Interventional
4114,BA3021-001,CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2),"June 27, 2018","June 30, 2023",Recruiting,Interventional
4115,PVMEDCT202201,Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk,"September 30, 2022","June 30, 2023",Recruiting,Observational
4116,2020-05-001B,Regional Anesthesia in Breast Surgery,"December 1, 2020","November 30, 2021",Unknown status,Interventional
4117,PRT2527-01,A Study of PRT2527 in Participants With Advanced Solid Tumors,"February 14, 2022",December 2023,Recruiting,Interventional
4118,13104,Tranexamic Acid for Alloplastic Breast Reconstruction,August 2022,August 2024,Not yet recruiting,Interventional
4119,RECHMPL22_0024,Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC),"June 16, 2022","September 1, 2024",Recruiting,Interventional
4120,21-369,A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer,"September 20, 2021","September 20, 2023",Recruiting,Interventional
4121,120134,NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT,September 2022,October 2025,Not yet recruiting,Interventional
4122,Pro00078230,Erector Spinae Plane Block Versus Paravertebral Block,"May 29, 2018","April 27, 2021",Completed,Interventional
4123,18-000948,Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes.,"July 24, 2018","April 10, 2021",Completed,Interventional
4124,20-08,Prospective Case Collection Study for New Mammography Technologies,"December 10, 2021","December 1, 2025",Recruiting,Interventional
4125,AP2001-50504,Erector Spinae Block Versus PECS Block Type II for Breast Surgeries,"March 19, 2020","March 10, 2021",Completed,Interventional
4126,FMBSURECS/30042019/Ali,Efficacy of Serratus Anterior Plane Block Mastectomy,"May 7, 2019","December 1, 2019",Completed,Interventional
4127,21-192,TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance),"August 1, 2021","November 1, 2022",Completed,Interventional
4128,SBT6290-101,A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors,March 2022,"March 31, 2022",Withdrawn,Interventional
4129,SAHZhejiangU 123,Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules,"January 1, 2019","December 31, 2021",Unknown status,Observational
4130,CRYO for Mastectomy (DoD),Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy,"September 15, 2022","May 14, 2026",Enrolling by invitation,Interventional
4131,FMASUMD45/2021,Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity,"June 1, 2021",June 2023,Recruiting,Interventional
4132,PT3465,Effect of Thera Band Exercises on Adhesive Capsulitis Post Mastectomy,"January 10, 2021","January 5, 2022",Completed,Interventional
4133,Lishui Peoples Hospital,Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors,"February 13, 2019","December 31, 2021",Unknown status,Interventional
4134,HAN2014005-CT02,"Evaluation of the Efficacy and Safety of A High Molecular Weight, Natural Hyaluronic Acid Vaginal Gel in Women With Genitourinary Syndrome of Menopause","March 1, 2020","August 13, 2022",Completed,Interventional
4135,SHEBA-19-6136-RS-CTIL,Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors,"February 24, 2020","December 30, 2022",Unknown status,Interventional
4136,GS-US-417-5937,Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants,"November 4, 2020","January 13, 2021",Completed,Interventional
4137,2021/01159,Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI,June 2022,"April 4, 2027",Not yet recruiting,Interventional
4138,SOGUG-2016-A-IEC(PRO)-12,Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL),"February 6, 2018","May 12, 2022",Completed,Interventional
4139,CCR5653,Accelerated Body Diffusion-Weighted MRI Using Artificial Intelligence,"May 6, 2022",April 2025,Enrolling by invitation,Observational
4140,PPP005-Ph2/3-01,Cannabis Oil and Radiation Therapy for the Management of Pain,"March 14, 2018","November 30, 2018",Terminated,Interventional
4141,AAAS9968,Hair Care Product Use Among Women Of Color,"March 31, 2021",July 2023,Recruiting,Interventional
4142,METCZ2019016,Seroma Reduction and Drain Free Mastectomy,"June 26, 2020",December 2023,Recruiting,Interventional
4143,1190532,Chilean Maternal & Infant Cohort Study II (CHiMINCs-II),"June 1, 2019","April 30, 2023","Active, not recruiting",Observational
4144,HSL 2016-83,Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.,"February 15, 2018","February 16, 2020",Unknown status,Interventional
4145,IMM2902-101,"IMM2902, a HER2/SIRPα Bispecific mAb-Trap Antibody-receptor Fusion Protein, in Patients With HER2-expressing Advanced Solid Tumors","June 20, 2022",December 2024,Recruiting,Interventional
4146,NOX66-005,A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors,"October 25, 2021","February 28, 2024",Recruiting,Interventional
4147,CCR5063,Evaluation of an Educational Intervention for Women With Breast Pain,"May 31, 2019","September 30, 2019",Unknown status,Interventional
4148,BGB-3111-108,A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects,"June 7, 2018","July 2, 2018",Completed,Interventional
4149,2020/14MAI/273,Serum Neurofilament Light (NFL) in Surgery Under General Anaesthesia (GA) Compared to Surgery With Hypno-analgesia (Hyp),"September 1, 2020","February 28, 2023",Recruiting,Interventional
4150,B4T2-PRC-IIT-001,A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors,"September 14, 2022","December 31, 2026",Recruiting,Interventional
4151,PROACTIVE,"Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness","December 15, 2021","December 31, 2025",Recruiting,Interventional
4152,2017-02028,"Efficacy of the ""Consilium"" Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients","March 5, 2018","October 10, 2020",Terminated,Observational
4153,JS001-PMS-CO1,Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .,"February 15, 2020","July 5, 2023",Not yet recruiting,Observational
4154,875351,Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project,"February 1, 2021","December 31, 2023",Recruiting,Interventional
4155,CX-839-011,Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors,"May 20, 2019","July 29, 2020",Terminated,Interventional
4156,Pro00037562,Apple Womens Health Study,"November 14, 2019",November 2029,Recruiting,Observational
4157,16-010491,Preventing Lymphedema in Axillary Lymph Node Dissection,"April 10, 2018","February 1, 2024","Active, not recruiting",Interventional
4158,INT17676,A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects,"July 27, 2021","October 28, 2022",Completed,Interventional
4159,829785,Effect of PARP Inhibitors on Glomerular Filtration Rate,"February 3, 2020","July 1, 2021",Terminated,Observational
4160,ESG401-101,Study of ESG401 in Adults With Solid Tumors,"September 14, 2021",April 2025,Recruiting,Interventional
4161,GS-US-382-1587,Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels,"August 19, 2022",November 2023,Recruiting,Interventional
4162,20221202,Primary Lesion Treatment for Bone Metastases,March 2023,March 2026,Not yet recruiting,Interventional
4163,KSCM-CRD-001,KeraStat(R) Cream for Radiation Dermatitis,"April 11, 2018","November 6, 2018",Completed,Interventional
4164,201707042,Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography,"December 13, 2018","November 30, 2024",Recruiting,Interventional
4165,201810102MINC,Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?,"April 25, 2019","April 8, 2021",Unknown status,Interventional
4166,IRB 20-488,CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer,"July 14, 2020",August 2023,"Active, not recruiting",Observational
4167,1237087,A Mind-Body Intervention for Hot Flash Management,"November 15, 2018",August 2023,Recruiting,Interventional
4168,P.T.REC/012/003747,Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy,"May 20, 2022","March 28, 2023",Recruiting,Interventional
4169,GIHSYSU-26,"RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer","December 15, 2022","December 25, 2025",Not yet recruiting,Interventional
4170,GO-1,SHARON: A Clinical Trial for Metastatic Cancer With an Inherited BRCA or PALB2 Mutation Using Chemotherapy and Patients Own Stem Cells,"January 13, 2021",December 2024,Recruiting,Interventional
4171,BRCA-ACP.2022,Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers,"November 1, 2023","December 31, 2024",Not yet recruiting,Interventional
4172,20,Early Detection of Heart Problems in Cancer Patients Receiving Chemotherapy,March 2020,"May 28, 2020",Withdrawn,Observational
4173,JK08.1.01,"A Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, in Patients With Unresectable Locally Advanced or Metastatic Cancer","October 17, 2022","February 20, 2026",Recruiting,Interventional
4174,NC762-01,A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors,"June 30, 2021",October 2024,Recruiting,Interventional
4175,PARPA-293-001,Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors,"November 25, 2019","December 30, 2023",Recruiting,Interventional
4176,INT 36/18,Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients,"December 3, 2018",December 2023,Recruiting,Interventional
4177,17237,HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases,"August 31, 2018","August 31, 2023",Recruiting,Interventional
4178,209514,Pilot Study of Pancreatic Cancer Screening,"January 20, 2022","January 31, 2032",Recruiting,Observational
4179,MER-XMT-2056-1,A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2,"January 24, 2023",November 2025,Suspended,Interventional
4180,Klotho _ LRP-6 _ GC,Klotho _ LRP-6 _ Gastric Adenocarcinoma,"April 1, 2023","April 1, 2024",Not yet recruiting,Observational
4181,ZL-2306-912 ALTER-OC-02,Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors,"April 1, 2021","February 28, 2023",Unknown status,Interventional
4182,CEP1:4/2016,BRCA Main Home Nutritional Intervention-random Study,"June 1, 2018","May 31, 2020",Unknown status,Interventional
4183,Chemobrain Study,Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies,March 2021,September 2023,Not yet recruiting,Interventional
4184,XB002-101,Study of XB002 in Subjects With Solid Tumors (JEWEL-101),"June 7, 2021","October 7, 2024",Recruiting,Interventional
4185,KlusPharma,Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene,"July 16, 2018",December 2022,"Active, not recruiting",Interventional
4186,AJIRB-MED-THE-18-236,Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG,"November 6, 2018","March 24, 2021",Completed,Interventional
4187,20/PR/0222,Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing,"February 18, 2021","August 1, 2023","Active, not recruiting",Observational
4188,JTU-6H-20210227001,Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery,"March 1, 2021","February 28, 2025","Active, not recruiting",Interventional
4189,69HCL22_0275,Control Cohort CTRL COH,"September 16, 2022","September 16, 2027",Not yet recruiting,Interventional
4190,REPLAMOD,Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser Treatment,"December 3, 2019","December 1, 2021",Completed,Interventional
4191,BTC-HER2,Trastuzumab in HER2-positive Biliary Tract Cancer,"June 1, 2019","January 4, 2021",Completed,Interventional
4192,CASE2117,Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer,October 2018,October 2020,Withdrawn,Interventional
4193,GOUDET 2018,Study and Monitoring of Multiple Endocrine Neoplasia Type 1,"April 5, 2019",November 2029,Recruiting,Observational
4194,H-38855,Ruxolitinib for Premalignant Breast Disease,"May 13, 2018",January 2025,Recruiting,Interventional
4195,FF-2018-084,Does Pecs II Block Reduce the Incidence of Post Mastectomy Pain Syndrome (PMPS)? A Cross Sectional Study,"March 6, 2018","February 20, 2019",Completed,Observational
4196,2018-03,SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY,"January 31, 2018","January 31, 2023",Unknown status,Observational
4197,4-2019-0648,Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy,"June 23, 2020",March 2023,Unknown status,Interventional
4198,TG-iConquerFear,Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors,April 2023,September 2025,Not yet recruiting,Interventional
4199,P2101,The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing,"July 2, 2021",May 2034,Recruiting,Observational
4200,TCM-padia001,Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine,"October 8, 2021","October 8, 2022",Recruiting,Interventional
4201,GO43860,"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors","October 20, 2022","October 31, 2025",Recruiting,Interventional
4202,C/35/2017,MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour,"April 10, 2019","December 31, 2022","Active, not recruiting",Interventional
4203,2018-003115-21,Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors,September 2020,"December 5, 2024",Withdrawn,Interventional
4204,EC29,Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase,"July 1, 2020",December 2023,Recruiting,Interventional
4205,2021/117,Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia,"February 28, 2022",January 2030,Recruiting,Interventional
4206,Health consortium maresme,Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain,"April 1, 2022","June 1, 2026",Recruiting,Interventional
4207,HS-10502-101,A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors,"April 1, 2023","October 1, 2026",Not yet recruiting,Interventional
4208,STUDY00023183,Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer,"July 19, 2022","December 31, 2023",Enrolling by invitation,Interventional
4209,201903142,Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors,"May 29, 2019","December 31, 2025",Recruiting,Observational
4210,DCC-2036-01-003,A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors,"September 19, 2018","October 1, 2022","Active, not recruiting",Interventional
4211,E-19-3943,Erector Spina Plane Block Versus Deep Serratus Anterior Plane Block for Post Mastectomy Analgesia,"July 7, 2019","February 26, 2020",Completed,Interventional
4212,CASE6118,Free Flap Breast Reconstruction Using Virtual Surgical Planning and 3-D Modeling,"December 1, 2020",December 2023,"Active, not recruiting",Interventional
4213,MCART-006,Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases,"October 30, 2022","December 31, 2024",Recruiting,Interventional
4214,PRO1184-001,PRO1184 for Advanced Solid Tumors,"December 7, 2022",September 2025,Recruiting,Interventional
4215,ONC-392-001,"Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC","September 16, 2020","December 31, 2024",Recruiting,Interventional
4216,2021-04840,Lymphedema After Urologic Surgery,"March 14, 2022",January 2030,Recruiting,Observational
4217,BPI-2358-105 phase 3,Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3,"May 29, 2018","February 8, 2021",Completed,Interventional
4218,HCC 20-064,Telehealth and Memory Study,"March 18, 2021","May 31, 2025",Recruiting,Interventional
4219,E-19-773,"A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan","October 23, 2019",December 2023,Recruiting,Interventional
4220,STUDY00003387,Exercise and Nutrition Interventions During Chemotherapy K07,"April 15, 2019",June 2024,Recruiting,Interventional
4221,MCART-002,Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis,"March 12, 2021","January 1, 2024",Recruiting,Interventional
4222,SBT6050-201,A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers,"February 8, 2022","July 7, 2022",Terminated,Interventional
4223,ARRAY-818-103,Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors,"January 2, 2018","April 30, 2023","Active, not recruiting",Interventional
4224,Niraparib-5001,A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea,"March 16, 2020","December 1, 2024",Recruiting,Observational
4225,LINDA,Study To Evaluate The Sensitivity Of The Linda Thermal Device,"August 30, 2021","January 30, 2023",Recruiting,Observational
4226,MC210302,Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer,"July 1, 2021","December 31, 2023",Recruiting,Interventional
4227,QSPainRelief-patientCNS,"QSPainRelief-patientCNS : Clinical Biomarkers of Nociception, Sedation and Cognition","March 15, 2021","September 30, 2024",Not yet recruiting,Interventional
4228,CARTIER,Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial),"August 2, 2019","November 30, 2025",Recruiting,Interventional
4229,The Swedish DIRECT study,Direct Information to At-risk Relatives,"February 6, 2020","December 31, 2025",Enrolling by invitation,Interventional
4230,CKAF156A2104,"Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir","March 9, 2022","October 17, 2022",Completed,Interventional
4231,B3271007,Safety and Efficacy of Trastuzumab BS,"August 31, 2023","September 8, 2025",Not yet recruiting,Observational
4232,Elasto Trial,Comparison of Real-time and Shear Wave Elastography,"March 1, 2018","December 31, 2022","Active, not recruiting",Interventional
4233,Soh-Med-22-09-01,Ultrasonography Screening for Breast Lesions During Pregnancy and Lactation,November 2022,June 2024,Not yet recruiting,Observational
4234,N201810002,Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients,"October 29, 2019","November 30, 2020",Completed,Interventional
4235,MastoVit150,Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases,"January 11, 2020","June 10, 2022",Completed,Interventional
4236,CASE1219,Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach,"September 1, 2019",December 2024,Recruiting,Interventional
4237,OCOG-2021-ELISA,Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS),"November 23, 2022","May 31, 2035",Recruiting,Observational
4238,CHIRCOLREC-IPC 2018-017,Prospective Database for Colonic or Rectal Resection Surgery Patients,March 2021,December 2071,Not yet recruiting,Observational
4239,RELI/19/Der-Rdt/001,Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.,"November 2, 2020","February 16, 2023",Completed,Interventional
4240,GS-US-467-5643,"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies","September 15, 2021",May 2028,Recruiting,Interventional
4241,PRO00031416,Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors,"June 1, 2019","June 30, 2023",Recruiting,Interventional
4242,7635,Cannabinoids for Taxane Induced Peripheral Neuropathy,"September 1, 2019","August 30, 2021",Terminated,Interventional
4243,VAC for HPV,Video-Assisted Counseling for HPV Vaccination,"August 30, 2018","June 30, 2019",Unknown status,Interventional
4244,ONCB-006-19F,Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer,"April 19, 2023","April 1, 2027",Not yet recruiting,Interventional
4245,70781,Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover,"March 21, 2022","August 31, 2026",Recruiting,Interventional
4246,1407426,Family History Study on Cancer Risk,"July 1, 2020","August 31, 2025",Recruiting,Interventional
4247,PRS-343-PCS_08_18,PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors,"August 21, 2018","July 1, 2021",Unknown status,Interventional
4248,NL72939.078.20,Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia?,"January 1, 2022","December 1, 2023",Recruiting,Interventional
4249,HCI105691,Fatigue Interventions in Cancer (Exercise Intervention),"February 26, 2018","February 1, 2023","Active, not recruiting",Interventional
4250,49/20 b,Breast Reconstruction in Previously Irradiated Breast,"June 6, 2020","January 25, 2021",Completed,Observational
4251,AP2007-50104,Comparison of Duloxetine Versus Pregabalin,"December 20, 2020",April 2021,Unknown status,Interventional
4252,PRO00032593,Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy,"August 12, 2019","April 14, 2020",Terminated,Interventional
4253,H00020209,Dotarem vs Gadobutrol Contrast for Breast MRI,"March 1, 2021","February 28, 2024",Recruiting,Interventional
4254,ROR2103,"Evaluating Patient Reported Outcomes in Radiation Therapy, The PRO-RT Study","March 2, 2022","December 30, 2023",Recruiting,Observational
4255,BG01-2002,Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors,"January 22, 2021","December 30, 2023",Recruiting,Interventional
4256,Rhomboid,Analgesic Effects of Rhomboid Block,"June 1, 2019","August 20, 2021",Recruiting,Interventional
4257,KY-2021-012,A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2,"June 30, 2022","December 31, 2024",Not yet recruiting,Observational
4258,49/20,Adjuvant Radiotherapys Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous Reconstruction,"June 6, 2020","January 25, 2021",Completed,Observational
4259,GC101 TIL-ST-01,A Phase I Study on Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) for the Treatment of Advanced Malignant Solid Tumors,"July 30, 2022","April 30, 2025",Recruiting,Interventional
4260,IM014-032,Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants,"August 2, 2020","October 26, 2020",Completed,Interventional
4261,CEEGOG EX-02,Tracers for Endometrial Cancer Sentinel Node Labeling,"January 1, 2021","January 1, 2024",Recruiting,Interventional
4262,93 /1801/2021,Lifting Effect on Recovery After Mastectomy,September 2022,December 2024,Not yet recruiting,Interventional
4263,2020-3627-1407,"SSI Rates in Patients Undergoing Mastectomy Without Reconstruction- A Multicenter, Double-blinded RCT.","November 1, 2020","December 31, 2022",Unknown status,Interventional
4264,OTH267,Iraqi Trial for Lung Cancer Screening,"June 1, 2018",April 2022,Unknown status,Interventional
4265,Pro00054854,The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors,"November 22, 2021","September 14, 2028",Recruiting,Observational
4266,MF 22-02,Idiopathic Granulomatous Mastitis Combination Therapy,"April 16, 2022",September 2023,Recruiting,Interventional
4267,2019-0989,Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physicians Choice (TPC) in Patients With HER2-positive Solid Tumor,"December 30, 2019","December 30, 2019",Unknown status,Interventional
4268,UCSD IIT 150729,Histology-Independent Study of Palbociclib in Patients With Advanced Cancer,"July 1, 2018","February 1, 2024",Withdrawn,Interventional
4269,P.T.REC/012/003464,Impact of Scapular Mobilization And Strengthening Exercises on Shoulder Function Post Mastectomy,"January 1, 2022","July 20, 2022",Completed,Interventional
4270,BPX603-201A,Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors,"December 7, 2020","January 2, 2027",Recruiting,Interventional
4271,KEEP-G 07,Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer,"August 1, 2022",July 2025,Recruiting,Interventional
4272,2021-0611,"Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases","January 20, 2022","April 30, 2023",Recruiting,Interventional
4273,13022260-300-180785,Effect of Exercise in the Management of Peripheral Neuropathy,"September 1, 2020","April 30, 2023","Active, not recruiting",Interventional
4274,INCB 123667-101,Study of INCB123667 in Subjects With Advanced Solid Tumors,"July 5, 2022","July 30, 2026",Recruiting,Interventional
4275,ICO-2020-19,Clinico-biological Data Collection Study of Metastatic Lung Cancer,October 2022,October 2031,Not yet recruiting,Interventional
4276,CRUKD/21/004- Treatment Arm 4,"DETERMINE Trial Treatment Arm 4: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations","March 7, 2023",October 2029,Recruiting,Interventional
4277,NU22-09-00539,Prostate Cancer Screening With Abbreviated MRI Protocol,"May 1, 2022","December 31, 2025",Recruiting,Interventional
4278,2019-A03336-51,Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy,"September 28, 2020",December 2023,Recruiting,Interventional
4279,09.2020.125,Efect of Erector Spina Plane Block on Mastectomy,"November 1, 2020","February 25, 2021",Completed,Interventional
4280,ANAE-341-19,Improving Tissue Oxygenation in Breast Reconstruction Surgery,"July 12, 2019",December 2023,Recruiting,Interventional
4281,01-2/141 27,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,"July 1, 2020","August 1, 2020",Completed,Interventional
4282,KF2019#1,KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug,"May 11, 2022","December 31, 2022",Recruiting,Interventional
4283,Vein-project,Training of Arms to Reduce Pain With Peripheral Venous Catheter,"February 28, 2023","December 31, 2025",Recruiting,Interventional
4284,thoracic sympathectomy,Radiofrequency Thoracic Sympathectomy for Chronic Postmastectomy Pain; Randomized Placebo Controlled Study,"April 1, 2018","January 1, 2020",Completed,Interventional
4285,20-240,Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases,"September 15, 2021",February 2026,Recruiting,Interventional
4286,Debio 1143-106,Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143,"April 8, 2019","April 6, 2022",Completed,Interventional
4287,457,Diagnostic Value of Bronchoscopic and Thoracoscopic Frozen Section Biopsies in Patients With Pleuropulmonary Tumors,"June 15, 2022","December 30, 2023",Not yet recruiting,Interventional
4288,D8410C00001,Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies,"June 24, 2022","December 8, 2025",Recruiting,Interventional
4289,229510,Combination Therapy in Cancers With Mutations in DNA Repair Genes,"April 1, 2023","December 31, 2027",Not yet recruiting,Interventional
4290,38RC17.291,EssaiClinique_CBSM,"September 1, 2018","February 1, 2020",Terminated,Observational
4291,034-2020,Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies,"March 2, 2020",March 2025,"Active, not recruiting",Observational
4292,Estim Breast,Electrical Stimulation for Improving Postoperative Breast Sensation,"July 1, 2023","August 31, 2025",Not yet recruiting,Interventional
4293,228-17-EP,Chemotherapy-Related Changes in Neurocognitive Function and Symptoms in Colorectal Cancer Patients: A Pilot Study,"January 22, 2018","November 25, 2020",Completed,Observational
4294,YS-RVON-001,Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors,"January 14, 2022",December 2023,Recruiting,Interventional
4295,RG1006143,Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization,"November 18, 2020","June 30, 2022",Completed,Interventional
4296,ZL-2306-914,Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma,"February 1, 2021","July 30, 2023",Recruiting,Interventional
4297,2019-8890,Clinical Evaluation of CEM-guided Biopsy,"October 8, 2019","October 6, 2021",Completed,Observational
4298,2021-KY-073,The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study,"April 1, 2022","March 30, 2025",Recruiting,Observational
4299,SNK01-102,Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers,March 2021,February 2023,Withdrawn,Interventional
4300,C4551001,Study of PF-07248144 in Advanced or Metastatic Solid Tumors,"November 16, 2020","November 8, 2026",Recruiting,Interventional
4301,ONT-380-011,Effects of Tucatinib on Cardiac Repolarization in Healthy Participants,"December 6, 2018","March 11, 2019",Completed,Interventional
4302,KCSG-ST18-20,AZD8186 and Paclitaxel in Advanced Gastric Cancer,"May 14, 2019","December 31, 2022",Unknown status,Interventional
4303,HCC 20-117,GIST and Memory and Attention Adaptation Training,"January 12, 2021",June 2024,Recruiting,Interventional
4304,EXGEFATU,"Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes","February 18, 2021",October 2023,Recruiting,Observational
4305,HEM-ONCO-013,CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer,"July 1, 2021",July 2024,Recruiting,Interventional
4306,FESPET,FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment,"January 1, 2020","December 1, 2021",Unknown status,Observational
4307,22-501,Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC),"November 28, 2022","December 31, 2025",Enrolling by invitation,Interventional
4308,STUDY00002021,Study of Sulphoraphane in Chronic Kidney Disease,"May 2, 2022","December 1, 2023",Recruiting,Interventional
4309,OLATRA,Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma,"June 21, 2018","July 27, 2022",Completed,Interventional
4310,ELVN-002-001,ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer,"March 20, 2023",July 2026,Recruiting,Interventional
4311,FN-1501-UP1,A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML,"July 23, 2018","February 11, 2022",Terminated,Interventional
4312,ILYAD1_2019,Initiative in LYon for Lung cAncer Screening Development - Prevalence Study,"October 31, 2020","January 14, 2021",Completed,Observational
4313,RBN-2397-19-001,"Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors","August 1, 2019","July 31, 2023",Recruiting,Interventional
4314,STUDY00000334,Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers,"June 4, 2019","October 1, 2020",Completed,Interventional
4315,OPT-IN Research Protocol,"Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring","October 6, 2022","December 6, 2023",Recruiting,Interventional
4316,2017-A02018-45,OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients,"January 6, 2018","March 31, 2023",Unknown status,Interventional
4317,919/2020/Oss/IOR,"Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma","March 10, 2021","December 31, 2024",Recruiting,Observational
4318,CX-5461-04,"Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation","September 8, 2021",June 2024,Recruiting,Interventional
4319,MC16C2,Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors,"March 1, 2019","February 22, 2021",Completed,Interventional
4320,NL75863.068.21,Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer,"June 1, 2022","October 1, 2024",Not yet recruiting,Interventional
4321,20-009,Pre-consultation Compassion Among Patients Referred to a Cancer Center,"June 1, 2021",August 2022,Recruiting,Interventional
4322,PUMCH-NM-11/041,68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis,"November 1, 2021","December 1, 2022",Recruiting,Interventional
4323,ISU104-001,"Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors","April 27, 2018","December 31, 2021","Active, not recruiting",Interventional
4324,BR/2019/487,Binaural Music Study,"January 14, 2020","March 31, 2020",Completed,Interventional
4325,ATADEK/2022.11,Genital Laser Treatment in Postmenopausal Patients,"December 1, 2022","December 1, 2023",Not yet recruiting,Interventional
4326,60116787-020/34123,Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients,"September 15, 2022","February 15, 2023",Completed,Interventional
4327,BARBEN 2020,Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older,November 2021,November 2021,Withdrawn,Observational
4328,CHUB-Hystocor,Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer,"July 10, 2018","March 2, 2020",Withdrawn,Interventional
4329,BLU-222-1101,(VELA) Study of BLU-222 in Advanced Solid Tumors,"April 7, 2022","September 30, 2026",Recruiting,Interventional
4330,Soh-Med-22-09-16,Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study,"October 1, 2022","June 1, 2023",Recruiting,Observational
4331,Shengjing-LJY05,The Effect of Gravity on the Occurrence of Lactational Mastitis,"January 1, 2022","January 31, 2024",Recruiting,Observational
4332,CHUBX 2015/17,Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT,"June 18, 2018","January 8, 2019",Completed,Interventional
4333,1766419-7,Storytelling Intervention for African Americans Living With Hypertension,"July 14, 2022","February 13, 2023",Recruiting,Interventional
4334,NUV-868-01,NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors,"March 29, 2022",February 2026,Recruiting,Interventional
4335,436,Effects of Clinical Pilates Exercises in Patients With Rheumatoid Arthritis,"December 24, 2018",October 2019,Unknown status,Interventional
4336,200155,"Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta ""Trap""/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)","November 24, 2020","May 31, 2024","Active, not recruiting",Interventional
4337,2021-BRV-004,Scaffold-guided Breast Surgery,"June 15, 2022","June 20, 2026",Recruiting,Interventional
4338,PREDICT,The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor,"November 12, 2019","January 16, 2023","Active, not recruiting",Observational
4339,EJC001,Compassion Meditation for Cancer Survivor-Caregiver Dyads,"March 14, 2018","January 11, 2020",Completed,Interventional
4340,CHU-426,Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Neuropathies,"January 14, 2019","March 23, 2019",Completed,Observational
4341,PHOX-CLI_001,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours","July 18, 2022","July 31, 2026",Recruiting,Interventional
4342,NICSO,NICSO National Study: Physician - Nurse Monitoring Project About Oncological Adverse Events,"March 1, 2018","January 31, 2022",Completed,Interventional
4343,BJK-Z-F18HN-202010-YZGK,Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT,"March 29, 2021","June 2, 2022",Completed,Interventional
4344,A-ER-109-415,Effect of Reconditioning Exercise on Older Adults With Urinary Tract Cancer Following Curative Surgery,"August 11, 2021","May 20, 2022",Recruiting,Interventional
4345,2-107-05-162,Investigation of the Strategy of Preventing Post-operative Opioid-induced Hyperalgesia,"January 11, 2019","December 31, 2019",Unknown status,Interventional
4346,IRAS307166,How Does Skin Tone Affect Quantitative Photoacoustic Imaging,"October 1, 2022","October 15, 2023",Not yet recruiting,Observational
4347,20.60-onco20.07,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,"August 3, 2020","March 22, 2021",Completed,Interventional
4348,YBCSG-21-04,Granisetron Transdermal Patch for Prophylaxis of Delayed CINV,"June 10, 2021","December 30, 2023",Not yet recruiting,Interventional
4349,SamanRostambeigi,Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity,"November 12, 2020","December 2, 2021",Completed,Interventional
4350,20190131,Study of AMG 650 in Adult Participants With Advanced Solid Tumors,"March 11, 2020","February 15, 2023",Completed,Interventional
4351,999916161,The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs,"June 5, 2019","June 17, 2019",Withdrawn,Observational
4352,IRB00038262,"The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems","January 30, 2018","March 12, 2019",Terminated,Interventional
4353,IRB00095260,Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors,"January 22, 2018","March 31, 2019",Completed,Interventional
4354,TapeK_Gesso_ABM_PSO,Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture.,April 2021,January 2022,Unknown status,Interventional
4355,29BRC18-0005 (VinMetAtezo),Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer,"January 24, 2019","February 23, 2022",Completed,Interventional
4356,1000-1,Womens Assessed Cardiovascular Evaluation With MCG,"October 15, 2020","July 21, 2022",Completed,Observational
4357,OPTIMUM,Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy,"April 1, 2022","October 30, 2024",Recruiting,Interventional
4358,R-17-360,Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy,"January 11, 2018","March 1, 2020",Unknown status,Observational
4359,2017-003582-10,Immunotherapy In Locally Advanced Rectal Cancer,"April 1, 2019",December 2023,"Active, not recruiting",Interventional
4360,BIC4VMR,Breakthrough Improvement Collaborative for Ventral Mesh Rectopexy,"March 1, 2023","March 1, 2025",Not yet recruiting,Observational
4361,2017_43,Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases,"March 15, 2019",March 2024,Recruiting,Interventional
4362,4397,Social Risk Factors and Discrimination in Cancer Survivorship,"May 5, 2022","September 30, 2026",Recruiting,Interventional
4363,00000001,Effects of Selected Exercise Program on Microcirculation and Lymphedema in Postmastectomy Patients,March 2022,May 2022,Not yet recruiting,Interventional
4364,IRB-2019-118,Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery,"November 1, 2020","April 15, 2023",Recruiting,Interventional
4365,RGC-1501-001,Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy,"July 1, 2023","June 30, 2025",Not yet recruiting,Interventional
4366,19CX5601,PROState Pathway Embedded Comparative Trial,"September 8, 2020","August 31, 2022",Completed,Observational
4367,20-03021615,FaCT Trial (Facilitated Cascade Testing Trial),"July 21, 2021",November 2023,Recruiting,Interventional
4368,210026,Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma,"September 29, 2021","June 1, 2028",Recruiting,Interventional
4369,702576,Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo,"November 1, 2020",December 2022,Recruiting,Interventional
4370,MT-5111_001,Study of MT-5111 in HER2-positive Solid Tumors,"November 12, 2019",May 2025,Recruiting,Interventional
4371,APHP180576,18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma,September 2022,September 2027,Not yet recruiting,Observational
4372,2020-1255,High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies,"April 24, 2022","January 31, 2025",Recruiting,Interventional
4373,RC2022_prg.15,Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease),"March 1, 2023","December 31, 2023",Recruiting,Interventional
4374,IEO 1740,68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET,"May 12, 2022","May 12, 2023",Recruiting,Observational
4375,UW 19-436,A Resilience Promotion Program for Parents of Children With Cancer,"August 13, 2019","July 21, 2020",Completed,Interventional
4376,EDGE 000339,"SHIFTPLAN: an RCT Investigating the Effect of a Shift Work Intervention on Fatigue, Sleep and Health.",October 2022,August 2023,Not yet recruiting,Interventional
4377,METCZ20210156,Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients,"September 1, 2022","September 1, 2024",Recruiting,Interventional
4378,2000031462,Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases,"February 21, 2023",June 2024,Recruiting,Interventional
4379,METCZ20210103,Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients,"August 1, 2021","August 20, 2021",Completed,Interventional
4380,2017/184 HP,VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer,"May 5, 2019","November 5, 2022",Unknown status,Interventional
4381,20-002000,Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer,"April 8, 2021","December 31, 2024","Active, not recruiting",Interventional
4382,18.068,PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer,"December 1, 2018",December 2024,Recruiting,Interventional
4383,Soh-Med-22-03-01,IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag Governorate,June 2022,June 2023,Recruiting,Observational
4384,2020-3547,Impact of Aerobic Exercise on Immune Response and Side Effects of Cancer Treatments,"November 4, 2020","October 4, 2022",Completed,Interventional
4385,CTM-N2D,Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour,"December 1, 2019","March 1, 2021",Unknown status,Interventional
4386,IMT-009-101,Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas,"November 28, 2022",April 2025,Recruiting,Interventional
4387,B.30.2.ATA.0.01.00/1/6,Ultrasound-guided Paravertebral Block Versus Mid-point Transverse Process Pleura Block in Mastectomy Surgery,"March 26, 2020","April 20, 2021",Completed,Interventional
4388,SYSKY-2022-019-02,Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC,"June 28, 2022","June 28, 2026",Recruiting,Interventional
4389,2019-02Obs-CHRMT,Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients,"June 17, 2019","January 31, 2022",Completed,Observational
4390,CHGH-IRB:(864)110-10,The Effect of Nursing Education Intervention on Womens Health Literacy of Plasticizers,"September 1, 2021","July 1, 2022",Recruiting,Interventional
4391,PROT-CI2021,US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism,"March 9, 2022","December 31, 2026",Not yet recruiting,Interventional
4392,CP-MGC018-01,MGC018 With or Without MGA012 in Advanced Solid Tumors,"November 21, 2018",June 2023,"Active, not recruiting",Interventional
4393,RTX-224-01,RTX-224 Monotherapy in Patients With Solid Tumors,"January 12, 2022","November 30, 2022",Terminated,Interventional
4394,2021-A01625-36,Clinical and Cyto-histological Evaluation of Fractional CO2 Laser Treatment on Genito-Urinary Syndromes of Menopause Related to Vaginal Atrophy,"December 9, 2021","January 15, 2025",Recruiting,Interventional
4395,SGNB7H4V-001,A Study of SGN-B7H4V in Advanced Solid Tumors,"January 12, 2022","January 31, 2027",Recruiting,Interventional
4396,ShuangHoH,Smart Home Care of Cloud Base ECG on the Cardiotoxicity Prevention on the Cancer Patients.,"July 1, 2021","June 30, 2023",Not yet recruiting,Observational
4397,P130935,"Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy","April 14, 2021",April 2022,Recruiting,Interventional
4398,2000029793,Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma,"February 24, 2023","July 30, 2028",Recruiting,Interventional
4399,794/2020/Farm/IOR,Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse,"March 1, 2021",July 2027,Recruiting,Interventional
4400,CMUH109-REC2-101,Evaluation of the Efficacy of Chinese Herbal Medicine in Patients With Obesity,"November 1, 2020","November 1, 2021",Unknown status,Observational
4401,RNI 2021 LEBRETON 3 (EVIGE),Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System,"September 7, 2022","December 31, 2023",Recruiting,Observational
4402,SBNK-YJ-2020-016-02,Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas,"November 3, 2020","October 31, 2025",Recruiting,Interventional
4403,ThirdMMUb,Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors,"August 20, 2019","October 20, 2023",Not yet recruiting,Interventional
4404,2693-CL-0307,A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause,"July 30, 2020","June 13, 2022",Completed,Interventional
4405,2020NZKY-062-01,The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel Disease,"September 1, 2020","March 1, 2022",Completed,Interventional
4406,2021-13614,Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color,"October 24, 2022","January 3, 2024",Recruiting,Interventional
4407,MER-XMT-1660-1,A Study of XMT-1660 in Participants With Solid Tumors,"August 15, 2022",January 2026,Recruiting,Interventional
4408,no: P.T.REC/012/002774,"Aerobic Exercise With Diet Induces Hormonal, Metabolic, and Psychological Changes","January 1, 2021","May 20, 2023",Recruiting,Interventional
4409,SBNK-YJ-2019-006-02,Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas,"February 13, 2020","November 30, 2023",Recruiting,Interventional
4410,1648/2019,"Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases","November 1, 2019","October 1, 2023",Recruiting,Observational
4411,2020/900/88,Assessment of the Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause,"April 1, 2021","November 1, 2021",Completed,Interventional
4412,DF1001-001,Study of DF1001 in Patients With Advanced Solid Tumors,"November 11, 2019",December 2025,Recruiting,Interventional
4413,STUDY00000224,Connecting Families to Overcome Ovarian Cancer,"July 24, 2021",April 2024,Recruiting,Interventional
4414,2693-CL-0304,A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause,"July 10, 2019","January 4, 2022",Completed,Interventional
4415,ZUH-ITP-MBCS,ITP Block: Single or Multiple Injection?,"February 26, 2023","March 5, 2023",Recruiting,Interventional
4416,1 TP2AH000076-01-00,Evaluation of Momentary Affect Regulation - Safer Sex Intervention,"June 19, 2021","June 30, 2024",Recruiting,Interventional
4417,21-007867,Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers,"February 3, 2022","November 30, 2023","Active, not recruiting",Interventional
4418,Masters thesis,The Effect of Art-Based Mandala on Mental Health in Bone Marrow Transplant Patients,"January 15, 2022","May 15, 2022",Completed,Interventional
4419,22072,A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting,"November 3, 2022","April 27, 2023","Active, not recruiting",Observational
4420,CPI-006-001,CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers,"April 25, 2018",December 2025,"Active, not recruiting",Interventional
4421,HKG-KZ-PRAD-103,"Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC","June 1, 2018","December 1, 2021",Withdrawn,Observational
4422,RG1001812,Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants,"October 28, 2019","November 19, 2020",Completed,Interventional
4423,25922,Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition,"February 15, 2023","June 1, 2024",Not yet recruiting,Interventional
4424,2693-CL-0305,A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause,"March 17, 2020","April 20, 2022",Completed,Interventional
4425,PET/CT in malignancy,Validity of Mediastinal Blood Pool SUV Ratio,"June 1, 2022","December 30, 2023",Not yet recruiting,Observational
4426,2021-A01570-41,Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology,"March 29, 2022",October 2023,Recruiting,Interventional
4427,2693-CL-0302,A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2,"July 10, 2019","April 23, 2021",Completed,Interventional
4428,2693-CL-0301,A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause,"July 11, 2019","August 11, 2021",Completed,Interventional
4429,AssiutNT,Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer,"September 1, 2021",July 2024,Recruiting,Observational
4430,PUMCH-NM-RR,68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients,"August 16, 2022","December 31, 2023",Recruiting,Interventional
4431,HKG-Bng-HCC-100,HCC Screening Using DNA Methylation Changes in ctDNA,"August 20, 2018","November 1, 2020",Completed,Observational
4432,IX-2021-DS-LEARN,LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology,"January 31, 2023","January 31, 2026",Not yet recruiting,Observational
4433,1-1-7-05-114,Decision Support for the Renal Replacement Therapy With End-stage Renal Disease,"April 18, 2019","January 28, 2020",Completed,Interventional
4434,Pro00101102,Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions,"May 26, 2019","March 16, 2020",Terminated,Observational
4435,ALXN2040-HV-102,Potential Drug Interaction Between ALXN2040 and Rosuvastatin,"February 1, 2023","April 5, 2023",Completed,Interventional
4436,NL66650.041.18,The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study,"February 1, 2019","February 1, 2024",Recruiting,Observational
4437,21083,Narrative Exposure Therapy to Reduce Symptoms of Traumatic Stress in Cancer Survivors,"March 4, 2022",September 2023,"Active, not recruiting",Interventional
4438,NCI-2020-01206,Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer,"July 14, 2020","December 31, 2023",Recruiting,Interventional
4439,STUDY00144314,KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice,"November 18, 2020","July 1, 2024",Recruiting,Interventional
4440,19-068,OPTimizing Treatment Focused Genetic Testing IN Cancer,"December 19, 2019","December 31, 2028","Active, not recruiting",Interventional
4441,69HCL21_0409,"CAncer, NUtrition and Taste 2","January 27, 2022","April 27, 2023",Recruiting,Interventional
4442,HALO Dx 001,Phase I Human Analytics (HALO) Study,"March 16, 2022",March 2037,Recruiting,Observational
4443,D8532C00003,A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole,"October 4, 2022","December 28, 2022",Completed,Interventional
4444,UC-0107/1603,Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 3 Bone-only Metastases,"January 24, 2018","July 24, 2027",Recruiting,Interventional
4445,AK_2021_HP,Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients,"May 18, 2022",December 2023,Enrolling by invitation,Interventional
4446,C4391001,Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors,"September 23, 2020","February 13, 2026",Recruiting,Interventional
4447,ICO-2020-14,"Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery","September 29, 2021",September 2023,Recruiting,Interventional
4448,20-2458.cc,Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.,"February 5, 2021","September 30, 2024",Recruiting,Interventional
4449,844554,TumorGlow Intraoperative Molecular Imaging (IMI),"December 23, 2023","January 14, 2026",Not yet recruiting,Interventional
4450,GCT1047-01,Research Trial to Study Safety of GEN1047 (DuoBody®-CD3xB7H4) in Participants With Malignant Solid Tumors,"December 13, 2021","January 31, 2025",Recruiting,Interventional
4451,659/2017BO1,Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac,"May 9, 2018","May 9, 2027",Recruiting,Interventional
4452,SYSU_AI01,Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics,"September 1, 2020","September 1, 2020",Unknown status,Observational
4453,HSC-SPH-20-1117,Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention,"November 16, 2022","September 29, 2024",Not yet recruiting,Interventional
4454,XL092-001,A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors,"March 20, 2019",November 2024,Recruiting,Interventional
4455,B2017-113R,Tumor Landscape Pathological Diagnosis by Large Tissue Sections,"January 1, 2018","June 30, 2021",Unknown status,Observational
4456,PH-FAPGA-01/22,A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors,April 2023,January 2024,Not yet recruiting,Interventional
4457,GCT1029-01,GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors,"April 30, 2018","October 12, 2021",Terminated,Interventional
4458,FPA150-001,FPA150 in Patients With Advanced Solid Tumors,"March 27, 2018","May 10, 2021",Completed,Interventional
4459,STU-2019-0522,Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM),"February 1, 2020","September 24, 2021",Completed,Observational
4460,HEALED_CPS3,Health and Energy Through Active Living Every Day (HEALED) After Cancer Pilot Intervention for Cancer Survivors,"May 15, 2019","October 1, 2019",Unknown status,Interventional
4461,PJ-KS-KY-2019-134,The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients,"December 20, 2019","November 11, 2022",Unknown status,Observational
4462,PY314-1-01,A Study of PY314 in Subjects With Advanced Solid Tumors,"October 29, 2020","October 28, 2023",Recruiting,Interventional
4463,LAUMCRH.YJ1.16/Jul/2019,Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery,"July 17, 2019","January 17, 2022",Unknown status,Interventional
4464,DMT-2019.002,Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3),"February 8, 2020","March 3, 2020",Completed,Observational
4465,DMT-2019.001,Delphinus SoftVue™ ROC Reader Study,"June 8, 2019","July 2, 2019",Completed,Observational
4466,AD10,KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method),January 2023,December 2023,Not yet recruiting,Observational
4467,CASE7Y16,A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors,"March 14, 2018","October 25, 2019",Completed,Observational
4468,1474/19,Trigger Point Injections for Post-Mastectomy Pain Syndrome,"January 3, 2020","December 3, 2023",Recruiting,Interventional
4469,CNZV930X2101,A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.,"July 18, 2018","October 17, 2022",Terminated,Interventional
4470,TirolGESUND,"TirolGESUND: Baseline-controlled Comparison of the Effects of Fasting Dietary Intervention or Smoking Cessation Combined With Exercise in Healthy Female Tyrolean Volunteers Aged 30-60 on Epigenetic and Multi-omic Biomarkers of Health, Ageing, and Disease","April 21, 2021",August 2023,"Active, not recruiting",Interventional
4471,R20-3896L,PECS Block in Partial Mastectomy for Postoperative Pain Control,"September 1, 2019","November 1, 2020",Unknown status,Interventional
4472,69HCL19_0992,Interest of Virtual Reality to Prevent Cancer Patient Anxiety Before Chemotherapy or an Invasive Act,"October 7, 2020","December 7, 2022",Recruiting,Interventional
4473,201805930,Comparison of Pre-op and Post-op Pectoralis Nerve Block,"March 12, 2019","October 31, 2021",Completed,Interventional
4474,12345,Primary Care Clinical Excellence Incentive Study,"November 1, 2019","January 1, 2021",Completed,Interventional
4475,2018-0075,Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery,"October 8, 2018","March 1, 2024",Recruiting,Interventional
4476,LOCAL/2020/DR-01,18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions,"January 1, 2020","February 29, 2020",Completed,Observational
4477,IRB-300003680,Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy,"July 6, 2020","November 25, 2021",Completed,Interventional
4478,HSC-MS-16-0467,Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies,December 2018,December 2019,Withdrawn,Interventional
4479,PJ-KS-KY-2019-135,"Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy","October 1, 2019",October 2021,Unknown status,Observational
4480,2021/03-12,Effects of US-guided SAPB During Breast Surgery,"March 1, 2021","September 30, 2021",Completed,Interventional
4481,D0817R00010,OLAP (OLAparib Regulatory Post-marketing Surveillance),"February 1, 2021","December 31, 2024",Recruiting,Observational
4482,201610,Predicting Chronic Pain Following Breast Surgery,"July 19, 2021","December 31, 2023",Recruiting,Observational
4483,VAR-2021-12,Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy,"December 20, 2022",November 2023,Recruiting,Interventional
4484,WVU010518,Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy,"June 12, 2018","June 30, 2022",Suspended,Interventional
4485,NUSMart NM,Evaluating the Relative Effectiveness of Two Front-of-pack Nutrition Labels,"July 31, 2018","December 3, 2018",Completed,Interventional
4486,XmAb22841-01,A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors,"May 29, 2019","February 16, 2023",Completed,Interventional
4487,PREDAPT,A Multicenter Cancer Biospecimen Collection Study,"February 5, 2020",February 2027,Recruiting,Observational
4488,SC103,Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors,"June 13, 2019",December 2023,Recruiting,Interventional
4489,ACE1702-001,ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors,"May 19, 2020",June 2024,Recruiting,Interventional
4490,RP12146-2101,"Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, a PARP Inhibitor, in Patients With Locally Advanced or Metastatic Solid Tumors","October 5, 2021",August 2023,Recruiting,Interventional
4491,RG1005815,"Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study","February 19, 2020","August 31, 2023",Enrolling by invitation,Interventional
4492,HH-PRT-0001,Development and Validation of Harbinger Health Test for Early Cancer Detection,"June 21, 2022","July 3, 2025",Recruiting,Observational
4493,MP01,Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours,January 2024,January 2027,Not yet recruiting,Interventional
4494,AD07,GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method),January 2023,December 2023,Not yet recruiting,Observational
4495,5688,Psychosocial Transitional Group Pragmatic Trial,"May 1, 2023","December 31, 2024",Not yet recruiting,Interventional
4496,RG1005140,"Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer","October 18, 2021","March 30, 2026",Recruiting,Interventional
4497,BT8009-100,Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumor Malignancies,"July 17, 2020",December 2025,Recruiting,Interventional
4498,HN20190929,PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma,"July 30, 2019","July 30, 2022",Recruiting,Interventional
4499,STUDY00018000,EXERCISING TOGETHER for Couples Coping With Cancer,"January 18, 2019","October 1, 2023","Active, not recruiting",Interventional
4500,00003543,Comorbidities And Reducing inEquitieS,"May 5, 2021","June 30, 2023","Active, not recruiting",Interventional
4501,OSU-19199,Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM),"November 17, 2020","December 31, 2023",Recruiting,Interventional
4502,KB-0742-1001,A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma,"February 8, 2021",December 2025,Recruiting,Interventional
4503,GQ1001X2101,Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors,"July 7, 2020","May 1, 2024",Recruiting,Interventional
4504,21820,"A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors","October 11, 2022","May 4, 2027",Recruiting,Interventional
4505,NL 70691.091.19,TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention,"March 1, 2020","February 17, 2040",Recruiting,Interventional
4506,ORM-5029-01-001,Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors,"October 3, 2022",October 2025,Recruiting,Interventional
4507,NCI-2017-01232,PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery,"March 16, 2018","March 27, 2024","Active, not recruiting",Interventional
4508,PRT3645-01,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors,"December 27, 2022",December 2024,Recruiting,Interventional
4509,123glioma,Correlation Between SPECT/CT and IDH Mutation in Brain Glioma,November 2022,December 2023,Not yet recruiting,Observational
4510,HMBD-002-V4C26-01,"A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab","January 1, 2022",January 2025,Recruiting,Interventional
4511,NCH04-2020,"Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery","July 1, 2020","December 31, 2023",Recruiting,Observational
4512,BakircayU/D208,Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function,"March 6, 2021","May 15, 2022",Completed,Observational
4513,RG1121550,Clinical Outcomes for Offering Genetic Testing in a Tiered Approach,"August 3, 2020","December 31, 2021",Completed,Interventional
4514,KYL[2020091],Surgical Intervention for Refractory Granulomatous Lobular Mastitis,"November 1, 2020","June 30, 2027",Recruiting,Interventional
4515,TJ004309STM103,A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors,"November 2, 2021",June 2023,"Active, not recruiting",Interventional
4516,AP1904-50102,Magnesium and Ketamine in Postoperative Analgesia,"November 1, 2019","December 1, 2020",Completed,Interventional
4517,GCT1044-01,A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors,"July 15, 2020","October 29, 2021",Terminated,Interventional
4518,SZMC-0216-22,A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC,"January 20, 2023","December 31, 2028",Not yet recruiting,Interventional
4519,7465-CL-202,A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202),"March 9, 2020","July 31, 2024","Active, not recruiting",Interventional
4520,ELU-FRα-1,A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα),"September 13, 2021","March 15, 2025",Recruiting,Interventional
4521,IMP7068 - 101,The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors,"February 25, 2021","August 30, 2023",Recruiting,Interventional
4522,D0818R00008,A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer,"July 3, 2023","September 15, 2023",Not yet recruiting,Observational
4523,2000028592,Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care,"July 14, 2021",March 2025,Recruiting,Observational
4524,D17062,Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity,"March 1, 2018","February 14, 2022",Completed,Interventional
4525,SGNPDL1V-001,A Study of SGN-PDL1V in Advanced Solid Tumors,"October 25, 2022","December 31, 2026",Recruiting,Interventional
4526,22/006-P,Palliative Care Costs for Outpatient Setting Management in Catalunya,"April 1, 2023","March 31, 2024",Not yet recruiting,Observational
4527,SAIL-002,Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity,"May 1, 2018","October 24, 2018",Completed,Interventional
4528,101,CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors,"February 2, 2021",December 2024,Recruiting,Interventional
4529,PREFER,PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine,"April 19, 2021",April 2023,Recruiting,Observational
4530,ASN004-101,Study of ASN004 in Patients With Advanced Solid Tumors,"December 10, 2021","March 31, 2026",Recruiting,Interventional
4531,C3881001,PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors,"October 4, 2018","March 30, 2022",Terminated,Interventional
4532,TT420X1103,Study of TT-00420 Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors,"July 14, 2021","December 1, 2022",Recruiting,Interventional
4533,RP2-001-18,Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors,"October 17, 2019",July 2023,Recruiting,Interventional
4534,M18HAR,Health After eaRly Menopause Due to Oophorectomy,"February 11, 2019","January 1, 2022",Unknown status,Observational
4535,8259,PostmenopausAL heaLth And DIseAse (PALLADIA) Study,"October 1, 2021","December 31, 2025",Recruiting,Observational
4536,20-458,Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients,"November 16, 2021",August 2025,Recruiting,Observational
4537,STUDY00020679,SMMART Adaptive Clinical Treatment (ACT) Trial,"December 1, 2022","March 31, 2026",Not yet recruiting,Interventional
4538,M20COM,The Prospective Observational COMPRAYA Cohort Study,"June 18, 2021",June 2035,Recruiting,Observational
4539,21-508,Video Education With Result Dependent dIsclosure,"August 4, 2022","September 1, 2026",Recruiting,Interventional
4540,CPG-01-001,COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.,"September 6, 2018",December 2023,"Active, not recruiting",Interventional
4541,TJCC-LC-20190108,Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC,"March 1, 2019","December 1, 2020",Unknown status,Interventional
4542,2000026840,Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC,May 2023,August 2025,Not yet recruiting,Interventional
4543,S1714,Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer,"March 1, 2019","February 28, 2026","Active, not recruiting",Observational
4544,2020/2706,Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes,"August 1, 2020","March 31, 2021",Completed,Observational
4545,INCB 106385-102,INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors,"February 3, 2021","December 29, 2023",Recruiting,Interventional
4546,GCT1046-01,GEN1046 Safety Trial in Patients With Malignant Solid Tumors,"May 14, 2019",December 2024,Recruiting,Interventional
4547,127-CL-01,Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors,"October 10, 2019","August 30, 2023","Active, not recruiting",Interventional
4548,Pro00077309,Prevent Cancer- Greenville,"November 8, 2018","November 8, 2029",Recruiting,Observational
4549,KY1044-CT01,Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer,"January 28, 2019",November 2024,Recruiting,Interventional
4550,UAB30,A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer,"October 1, 2020","August 1, 2024",Recruiting,Interventional
4551,MCC-20086,Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance,"August 15, 2019","April 9, 2021",Completed,Interventional
4552,Oncoplastic breast surgeries,The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction,"December 19, 2022","September 1, 2024",Recruiting,Interventional
4553,105909,Influence of Chemotherapy on Postural Control in Women With Cancer,"October 7, 2020","December 31, 2022",Recruiting,Observational
4554,XmAb20717-01,A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors,"July 10, 2018","September 6, 2022",Completed,Interventional
4555,PBC017,Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer,"February 20, 2020","April 30, 2023",Recruiting,Interventional
4556,19ON033,Vibrational Spectroscopy for Endometrial Cancer Diagnosis,"January 19, 2020",November 2024,Recruiting,Observational
4557,Parameters of resistence,Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.,"January 1, 2021",March 2022,Recruiting,Observational
4558,NCI-2017-01979,"Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery","April 20, 2018","April 20, 2018",Withdrawn,Interventional
4559,NCI-2018-01375,"Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study","April 9, 2019","May 1, 2023","Active, not recruiting",Observational
4560,Pro20170001392,"Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability","March 8, 2018","October 2, 2023",Recruiting,Interventional
4561,A005D-E01-201,[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR),"July 3, 2018","July 5, 2019",Terminated,Interventional
4562,A212102,Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection,"August 1, 2022",February 2025,Recruiting,Observational
4563,TAP_Sett17,Kinesio Tex Tape in Reducing Edema and Seroma After Complex Reconstructive Breast Surgery,"April 3, 2018","July 1, 2020",Unknown status,Interventional
4564,CPO-100-US-101,Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors,"March 24, 2021","March 1, 2025",Recruiting,Interventional
4565,IRB00058758,Paclitaxel Therapeutic Drug Monitoring in Cancer Patients,"November 11, 2019",December 2023,Recruiting,Observational
4566,20-117,Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors,"April 10, 2020",April 2024,"Active, not recruiting",Interventional
4567,19-002006,Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer,"May 16, 2019","December 31, 2022","Active, not recruiting",Interventional
4568,Plasticity Longitudinal cANcer,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET),"November 16, 2021","September 15, 2025",Recruiting,Interventional
4569,2021-025,Ask Questions (ASQ):Implementation of a Communication Intervention,"August 25, 2021",August 2023,Recruiting,Interventional
4570,ATRC-101-A01,A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies,"February 11, 2020",March 2025,Recruiting,Interventional
4571,ST101-101,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors,"July 1, 2020",January 2024,Recruiting,Interventional
4572,190143,Non-Viral TCR Gene Therapy,"April 19, 2023","December 31, 2029",Recruiting,Interventional
4573,CYT-0851-01,A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors,"October 9, 2019",December 2023,Recruiting,Interventional
4574,MC210102,"Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study","March 31, 2022","February 24, 2025",Recruiting,Interventional
4575,17573,A Study of Lasmiditan in Healthy Volunteers,"February 15, 2021","July 6, 2021",Completed,Interventional
4576,NCI-2020-13883,"Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial","March 5, 2021","March 31, 2026",Recruiting,Interventional
4577,TT00420CN04,To Evaluate Efficacy and Safety of TT-00420 as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors,"April 13, 2022",August 2024,Recruiting,Interventional
4578,ONCR-177-101,"Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors","May 20, 2020",July 2028,"Active, not recruiting",Interventional
4579,SGNSTNV-001,A Study of SGN-STNV in Advanced Solid Tumors,"January 18, 2021","March 31, 2026",Recruiting,Interventional
4580,2021-0299,Tumor Treating Fields Therapy in Combination With Chemotherapy for the Treatment of Advanced Solid Tumors Involving the Abdomen or Thorax,"April 29, 2022","September 1, 2026",Recruiting,Interventional
4581,SKL27969C001,"Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients","September 12, 2022",September 2024,Recruiting,Interventional
4582,ACE-Pan tumor-02,ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02),"November 5, 2021","April 20, 2022",Withdrawn,Interventional
4583,HCC 20-266,Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC),"October 28, 2021",December 2029,Recruiting,Interventional
4584,2019-0239,Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives,"August 21, 2019","December 31, 2022",Recruiting,Observational
4585,D9090C00003,A Study to Assess the Effect of Multiple Doses of AZD5462 on the Pharmacokinetics (PK) of Drugs in Healthy Participants,"June 30, 2022","September 12, 2022",Completed,Interventional
4586,FT500-101,FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors,"February 15, 2019","November 15, 2022",Completed,Interventional
4587,17364,A Study of LY3435151 in Participants With Solid Tumors,"October 28, 2019","March 5, 2020",Terminated,Interventional
4588,180043,Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy,"January 30, 2018","September 30, 2019",Terminated,Observational
4589,NCI-2020-06906,Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations,"December 29, 2020","December 1, 2023",Recruiting,Interventional
4590,INT 48/21,Quantifying Systemic Immunosuppression to Personalize Cancer Therapy,"March 10, 2022","May 17, 2024",Recruiting,Observational
4591,IDE161-001,A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors,March 2023,September 2025,Not yet recruiting,Interventional
4592,AK2018_1,18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer,"January 3, 2019","November 18, 2019",Completed,Interventional
4593,FT536-101,FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors,"May 31, 2022",April 2027,Recruiting,Interventional
4594,STUDY00000719,Adaptive Symptom Self-Management Immunotherapy Study,"May 1, 2023","August 1, 2027",Not yet recruiting,Interventional
4595,DV001,The Effect of Androgen Receptor Polymorphism on Endometrial Cancer,"April 1, 2022","April 1, 2024",Not yet recruiting,Observational
4596,JZP712-201,Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors,"March 3, 2022","June 23, 2024",Recruiting,Interventional
4597,TMPS-101,Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors,"March 15, 2022","July 1, 2025",Recruiting,Interventional
4598,CancerDyads,Improving Survivorship Among Minority Cancer Dyads,"July 1, 2021","December 31, 2024",Withdrawn,Interventional
4599,IIBSP-ECV-2019-103,Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT),"March 12, 2020",October 2023,Recruiting,Observational
4600,CCI-2003,Study of MEM-288 Oncolytic Virus in Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC),"February 23, 2022",November 2025,Recruiting,Interventional
4601,00000441,Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction,"February 4, 2020","February 4, 2022",Unknown status,Interventional
4602,SGNB6A-001,A Study of SGN-B6A in Advanced Solid Tumors,"June 8, 2020","October 31, 2024",Recruiting,Interventional
4603,MLB-PK-001,A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer,December 2022,December 2024,Not yet recruiting,Interventional
4604,XmAb23104-01,A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3),"May 1, 2019",September 2025,Recruiting,Interventional
4605,2020-0439,Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors,"January 20, 2021","February 3, 2025",Recruiting,Interventional
4606,CYH33-G102,Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.,"September 28, 2020","January 28, 2024",Recruiting,Interventional
4607,20-410,Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer,"January 23, 2021",December 2023,Recruiting,Interventional
4608,202101,Comprehensive Outcomes for After Cancer Health,"June 23, 2022",December 2023,Recruiting,Interventional
4609,NB-ND021 (NM21-1480)-101,A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors,"August 19, 2020",January 2025,Recruiting,Interventional
4610,SBT6050-101,A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors,"July 27, 2020",December 2022,"Active, not recruiting",Interventional
4611,17-262-01,REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies,"March 15, 2018","May 9, 2022",Terminated,Interventional
4612,UC-IMM-2101,Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO,"March 8, 2022","March 7, 2025",Recruiting,Interventional
4613,ADCT-301-103,Study of ADCT-301 in Patients With Selected Advanced Solid Tumors,"November 9, 2018","December 8, 2022",Terminated,Interventional
4614,170177,Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer,"April 11, 2018","September 16, 2019",Terminated,Interventional
4615,TPST-1120-001,TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers,"March 20, 2019","June 23, 2024","Active, not recruiting",Interventional
4616,180032,Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer,"January 31, 2018","August 24, 2020",Completed,Interventional
4617,VICC SUPP 2112,Improving Care After Inherited Cancer Testing,"August 5, 2022",December 2028,Recruiting,Interventional
4618,IB2022-03,Streamlined Geriatric and Oncological Evaluation Based On IC Technology,April 2023,January 2026,Not yet recruiting,Interventional
4619,PR148/21,Axillary Lymph Node Dissection vs Axillary Radiotherapy in Positive Sentinel Node After Neoadjuvant Therapy,"June 1, 2021","June 1, 2026",Recruiting,Interventional
4620,A9001502,Treatment Resistance Following Anti-cancer Therapies,"February 13, 2019","December 14, 2020",Terminated,Interventional
4621,2020-117,DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer,"February 10, 2021","August 31, 2025",Recruiting,Interventional
4622,NCI-2020-05428,"Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer","February 1, 2021","December 31, 2023",Recruiting,Interventional
4623,2021-0175,Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors,"December 14, 2022","December 14, 2022",Withdrawn,Interventional
4624,CCT303-406-mST01,A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors,"July 9, 2020","October 29, 2023",Recruiting,Interventional
4625,6B-20-1,18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases,"February 15, 2021","February 15, 2025","Active, not recruiting",Interventional
4626,NRG-BN009,Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery,"December 15, 2020","January 31, 2030",Recruiting,Interventional
4627,TCR2-21-01,A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer,"June 21, 2022",December 2027,Recruiting,Interventional
4628,2018-01,Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors,"August 23, 2018","March 31, 2022",Completed,Observational
4629,NCI-2020-05956,Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV,"November 4, 2020","November 2, 2025",Recruiting,Interventional
4630,Pro9646,Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy,"June 25, 2019",June 2022,Recruiting,Observational
4631,CA052-002,A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors,"May 27, 2021","September 15, 2026",Recruiting,Interventional
4632,IMX-110-001,IMX-110 in Patients With Advanced Solid Tumors,"February 15, 2018","July 15, 2023",Recruiting,Interventional
4633,IIR 17-127,Measuring and Improving the Safety of Test Result Follow-Up,"October 1, 2018","September 1, 2023","Active, not recruiting",Interventional
4634,WPH 2201,A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads,"August 15, 2022","September 30, 2023",Not yet recruiting,Interventional
4635,IRB20-0462,The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care,"February 7, 2022","March 31, 2028",Recruiting,Interventional
4636,XmAb808-01,"Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors","December 14, 2022",December 2027,Recruiting,Interventional
4637,2019-1091,Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases,"January 15, 2021","May 1, 2025","Active, not recruiting",Interventional
4638,INT156-19,Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment,"June 25, 2020","February 28, 2023",Completed,Observational
4639,02-MX-003,ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation,"September 7, 2021",February 2028,Recruiting,Observational
4640,VAR-2022-04,Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy,December 2022,October 2023,Not yet recruiting,Interventional
4641,Phase 1 SV-101,Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors,"February 1, 2023","December 31, 2023",Recruiting,Interventional
4642,NYPC ERC# 2019-002,Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors,"January 24, 2022",January 2027,Recruiting,Interventional
4643,TTX-080-001,TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers,"July 14, 2020","June 1, 2024",Recruiting,Interventional
4644,P.T.REC/012/003744,Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema,"June 29, 2022","June 1, 2023",Recruiting,Interventional
4645,P.T.REC/012/004199,Effect of Wii-console Based Exercise on Shoulder Range of Motion for Post-mastectomy Lymphedema Patients,"November 1, 2022",June 2023,Recruiting,Interventional
4646,Doaa Atef,Virtual Reality Versus Proprioceptive Neuromuscular Facilitation on Postmastectomy Lymphedema,"June 30, 2018","August 31, 2019",Completed,Interventional
4647,09.2018.466,Reliability of Subcutaneous Echogenicity (SEG) Grade and Subcutaneous Echo-free Space (SEFS) Grade,"July 1, 2018","August 13, 2018",Completed,Observational
4648,0752-20-HMO,Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers,"April 1, 2022","December 30, 2027",Recruiting,Interventional
4649,OCEL-01,A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers,"October 6, 2020",November 2022,Recruiting,Interventional
4650,ILBS-VASMPCa-103,Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects .,"November 1, 2021","December 5, 2021",Completed,Interventional
4651,NuTide:303,NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours,February 2023,January 2025,Not yet recruiting,Interventional
4652,IC 2020-11_ALCINA4,Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4,"May 27, 2022","November 30, 2027",Recruiting,Interventional
4653,AMT-151-01,AMT-151 in Patients With Selected Advanced Solid Tumours,"January 25, 2023","October 30, 2024",Recruiting,Interventional
4654,MDNA11-01,A Beta-only IL-2 ImmunoTherapY (ABILITY) Study,"August 27, 2021","December 30, 2024",Recruiting,Interventional
4655,SGNTGT-001,A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer,"May 29, 2020","April 30, 2025",Recruiting,Interventional
4656,PT199X1101,Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor,"June 23, 2022",January 2024,Recruiting,Interventional
4657,GB1275-1101 (KEYNOTE-A36),GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma,"August 13, 2019","April 11, 2022",Terminated,Interventional
4658,IB2022-02,Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene,"February 7, 2023",January 2048,Recruiting,Observational
4659,INCAGN 2385-101,A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies,"June 18, 2018","October 7, 2020",Completed,Interventional
4660,IB 2017-01,A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors,"May 4, 2018","December 31, 2025",Recruiting,Interventional
4661,INCAGN 2390-101,A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies,"September 24, 2018","August 18, 2021",Completed,Interventional
4662,NU04,.Exercise and Follow-up After a Mastectomy,"January 1, 2018","July 30, 2018",Completed,Interventional
4663,STUDY00001436,Enhance the Use of Genetic Counseling and Testing in Latinas,"February 24, 2020","January 31, 2022",Completed,Interventional
4664,20430,HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics,"December 30, 2021","December 31, 2024",Recruiting,Interventional
4665,STUDY00015588,Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial,"April 1, 2020","February 27, 2026",Recruiting,Interventional
4666,IRB00092505,Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy,May 2023,March 2028,Not yet recruiting,Interventional
4667,NX-1607-101,A Study of NX-1607 in Adults With Advanced Malignancies,"September 29, 2021","February 28, 2025",Recruiting,Interventional
4668,GLP-CDK-1009,Evaluation of GLR2007 for Advanced Solid Tumors,"July 15, 2020","July 29, 2022",Completed,Interventional
4669,0S-17-4,"Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer","August 30, 2018","September 24, 2020",Withdrawn,Observational
4670,Teleclub_cam,Telerehabilitation in Oncology Patients,"July 1, 2020",December 2020,Unknown status,Interventional
4671,AS-IRB-BM-17056,Taiwan Cancer Moonshot Project,"February 21, 2022","December 31, 2035",Recruiting,Observational
4672,HZDH20-002,Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.,"March 4, 2021","March 1, 2023",Recruiting,Interventional
4673,Pro00100029,Calming Alternatives Learned During MRI-Guided Breast Biopsy,"October 16, 2018","June 20, 2019",Completed,Interventional
4674,2022-0712,Feasibility Study: IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer) Intervention,"June 30, 2023","October 31, 2027",Not yet recruiting,Interventional
4675,2018-0439,Genetic Education in BRCA Families,"May 1, 2020","June 30, 2024",Enrolling by invitation,Interventional
4676,CR109080,A Study of Lazertinib (JNJ-73841937) in Healthy Participants,"September 17, 2021","February 10, 2022",Completed,Interventional
4677,GIMI-IRB-20004,4SCAR-CD44v6 T Cell Therapy Targeting Cancer,"June 1, 2020","December 31, 2023",Recruiting,Interventional
4678,2020-0079-E,Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program,"June 14, 2021",April 2024,Recruiting,Interventional
4679,EOC317X1101,Study of EOC317 in Chinese Patients With Advanced Solid Tumors,"May 29, 2018","November 29, 2020",Unknown status,Interventional
4680,IRB00056774,Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors,"October 1, 2020","March 7, 2024","Active, not recruiting",Interventional
4681,EAQ202,Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials,"October 28, 2021","January 25, 2025",Recruiting,Interventional
4682,SYNERGY-AI,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,"January 1, 2018",June 2025,Recruiting,Observational
4683,V937-013,A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013),"October 28, 2020","July 31, 2023","Active, not recruiting",Interventional
4684,10000045,"T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers","March 8, 2022","April 5, 2026",Recruiting,Interventional
4685,19-006717,Cancer Genetic Testing in Ethnic Populations,"December 13, 2019","October 15, 2023",Recruiting,Interventional
4686,ATLAS-101,A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies,"August 12, 2020",January 2023,Recruiting,Interventional
4687,19-151,Personalized Disease Prevention,"August 5, 2022","October 31, 2025",Recruiting,Interventional
4688,21-00715,Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain,"January 4, 2022",October 2025,Recruiting,Interventional
4689,TAC01-HER2-03,TAC T-cells for the Treatment of HER2-positive Solid Tumors,"April 19, 2021",February 2025,Recruiting,Interventional
4690,UW17009,Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer,"January 17, 2018","September 2, 2022",Completed,Interventional
4691,UMCC 2021.076,Methods for Increasing Genetic Testing Uptake in Michigan,"April 21, 2022",March 2027,Recruiting,Interventional
4692,H19-04010,Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity,"June 17, 2020",October 2024,Recruiting,Interventional
4693,F/N-R19-3893L,Effect of Hemp-CBD on Patients With CIPN,"May 27, 2020","April 1, 2023","Active, not recruiting",Interventional
4694,CRUKD/21/005,TT-702 in Patients With Advanced Solid Tumours.,"January 19, 2022",September 2025,Recruiting,Interventional
4695,Adela-EDMRD-001,cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease,"May 3, 2022",December 2026,Recruiting,Observational
4696,YXLL-KY-2022(057),Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients,"July 10, 2022","January 10, 2023",Completed,Interventional
4697,ISI dV Xi-NSM,Robotic-Assisted da Vinci Xi Prophylactic Nipple-Sparing Mastectomy,"March 26, 2021","December 30, 2028",Recruiting,Interventional
4698,16712,A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer,"April 10, 2018","October 3, 2020",Completed,Interventional
4699,HREBA.CC-20-0098,EXCEL: Exercise for Cancer to Enhance Living Well,"September 2, 2020","December 31, 2027",Recruiting,Interventional
4700,IPO/PI134,Impact of Group Psychological Interventions on Extracellular Vesicles in People Who Had Cancer,"September 1, 2021",September 2021,Unknown status,Interventional
4701,IMM2520-001,"IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors","March 23, 2023","October 26, 2025",Not yet recruiting,Interventional
4702,Cancer Genetic Counseling.PSI,Assessment Psychological Distress for Cancer Heredity Test,"October 1, 2018","December 31, 2021",Unknown status,Observational
4703,OM-GRPR-02,Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors,"December 22, 2022",January 2025,Recruiting,Interventional
4704,17493,A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors,"June 13, 2019","August 24, 2024",Recruiting,Interventional
4705,LOXO-IDH-20002,Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations,"October 16, 2020",May 2023,Recruiting,Interventional
4706,1623168,Healthy Moms: Prenatal Counseling for Postpartum Health,"February 1, 2021","June 15, 2023","Active, not recruiting",Interventional
4707,1,Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions,June 2022,"January 1, 2026",Not yet recruiting,Interventional
4708,11190071,Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients,"January 9, 2020","October 31, 2023","Active, not recruiting",Observational
4709,PACT-0101,A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors,"July 3, 2019","August 12, 2022",Suspended,Interventional
4710,PROICM 2021-05 SER,Quantifying Systemic Immunosuppression to Personalize Cancer Therapy,"July 7, 2022",March 2024,Withdrawn,Interventional
4711,IRB-300002068,Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health,"March 4, 2020","August 31, 2024",Recruiting,Interventional
4712,0000-0001-5580-7256,Education Intervention in Patients With Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.,"January 1, 2019","May 1, 2021",Unknown status,Interventional
4713,2017-0319,Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF,"December 18, 2018","December 31, 2024",Recruiting,Interventional
4714,TRV-003,Mass Response of Malignant Fluid Cells as a Biomarker for Rapid Therapy Guidance,"July 15, 2022",July 2026,Recruiting,Observational
4715,ATOS-016R,Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density,"December 21, 2021","December 31, 2025",Recruiting,Interventional
4716,HSP70CTC,Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells,"February 17, 2021",May 2022,Recruiting,Observational
4717,Pro00104093,Assessing the Immunogenicity of pING-hHER3FL,"July 13, 2020","December 1, 2024",Recruiting,Interventional
4718,VNC-236-101,Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer,"January 24, 2023",December 2024,Recruiting,Interventional
4719,Metabolic Cancer 001,"Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer","May 23, 2022","September 23, 2027",Withdrawn,Interventional
4720,19-000756,Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues,"November 5, 2019","October 17, 2031",Recruiting,Interventional
4721,7339-002,"Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)","December 12, 2018","December 1, 2025",Recruiting,Interventional
4722,2018-001744-62,Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors,"April 12, 2019",April 2025,Suspended,Interventional
4723,20-533,Pembrolizumab And Lenvatinib In Leptomeningeal Metastases,"March 8, 2021","December 1, 2022",Recruiting,Interventional
4724,D9950C00001,First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours,"August 18, 2020","May 2, 2023","Active, not recruiting",Interventional
4725,19-011472,"Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study","June 30, 2020","July 15, 2024","Active, not recruiting",Interventional
4726,7684A-005,MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005),"September 16, 2021","February 22, 2027",Recruiting,Interventional
4727,2017-0719,Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT,"July 10, 2018","October 1, 2024",Recruiting,Interventional
4728,1801,9-ING-41 in Patients With Advanced Cancers,"January 4, 2019",November 2025,Recruiting,Interventional
4729,MOHCCN-O,Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O),"June 13, 2022",October 2026,Recruiting,Observational
4730,STU00209558,Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic,"August 19, 2019","December 31, 2019",Completed,Observational
4731,IJB-IRAES-2020,Immunological Variables Associated to ICI Toxicity in Cancer Patients,"September 1, 2022","December 1, 2024",Recruiting,Interventional
4732,IRB00229163,Behavioral Weight Loss Program for Cancer Survivors in Maryland,"September 22, 2020","June 30, 2023","Active, not recruiting",Interventional
4733,ON-1002,"A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer","August 9, 2019","November 18, 2021",Completed,Interventional
4734,SGN47M-001,A Safety Study of SGN-CD47M in Patients With Solid Tumors,"July 17, 2019","September 14, 2020",Terminated,Interventional
4735,TP-CA-001,Tempus Priority Study: A Pan-tumor Observational Study,"October 19, 2020","October 19, 2030",Recruiting,Observational
4736,P-MUC1C-ALLO1-001,P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors,"February 15, 2022",April 2039,Recruiting,Interventional
4737,NTI1GSA,"Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid","January 1, 2022",December 2023,Recruiting,Interventional
4738,FT538-102,FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors,"October 15, 2021","August 5, 2025",Recruiting,Interventional
4739,CBX-12-101,Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors,"May 3, 2021",April 2024,Recruiting,Interventional
4740,OHSN-REB#20170381-01H,Randomized Trial of eOncoNote,"February 5, 2018","February 17, 2021",Completed,Interventional
4741,H-43405 VISTA,"Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors","December 14, 2020","December 30, 2038",Recruiting,Interventional
4742,QUILT-2.025,QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.,"August 10, 2018","December 30, 2020",Unknown status,Interventional
4743,ZZTIL-012,Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors,"January 1, 2021","January 1, 2035",Recruiting,Interventional
4744,202211038RINA,Microscopy Imaging of Whole-mount Stained Human Tissues,"January 10, 2023","December 31, 2024",Not yet recruiting,Observational
4745,20201421,"With Love, Grandma (""Con Cariño, Abuelita"") Pilot Study","February 22, 2023","May 31, 2024",Recruiting,Interventional
4746,YSCH-01-0000,Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study,"November 30, 2021","December 31, 2023",Recruiting,Interventional
4747,SNB101P01,"Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors","October 21, 2020","December 31, 2023",Recruiting,Interventional
4748,1224/2018,Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy,"February 3, 2020","February 3, 2024",Recruiting,Interventional
4749,438-IO-101,Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors,"May 11, 2022",June 2024,Recruiting,Interventional
4750,831-IO-101,Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors,"March 31, 2022",December 2024,Recruiting,Interventional
4751,BHP0120,A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation,"November 18, 2020","September 19, 2024",Recruiting,Interventional
4752,CDX527-01,A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies,"August 4, 2020",April 2023,"Active, not recruiting",Interventional
4753,HREBA.CC-22-0196,LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study,"November 24, 2022","May 30, 2024",Recruiting,Observational
4754,Meet-URO 12,Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy,"August 27, 2019","September 1, 2021",Completed,Interventional
4755,NC318-01,A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors,"September 28, 2018",April 2023,"Active, not recruiting",Interventional
4756,STR-004-001,Strata PATH™ (Precision Indications for Approved Therapies),"November 19, 2021","November 19, 2029",Recruiting,Interventional
4757,Pro00103249,Symptom Management for YA Cancer Survivors,"January 22, 2020","October 1, 2025",Recruiting,Interventional
4758,21850,Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors,"November 21, 2019","June 30, 2025",Recruiting,Interventional
4759,180049,Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer,"September 6, 2018","March 23, 2028",Recruiting,Interventional
4760,ARC-5 (AB928CSP0005),A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies,"July 24, 2018","September 3, 2021",Completed,Interventional
4761,201809177,PROactive Evaluation of Function to Avoid CardioToxicity,"March 13, 2019","March 2, 2023",Terminated,Interventional
4762,2020-2110,Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel,"February 14, 2020","September 4, 2020",Completed,Interventional
4763,AVS4TL - 0921,Avera/Sema4 Oncology and Analytics Protocol,"November 1, 2021","December 31, 2026",Recruiting,Observational
4764,IIT2020-24-SHIRAZIP-BURN,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors,"January 10, 2022","March 9, 2024",Recruiting,Interventional
4765,PY159-2-01,A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors,"November 10, 2020","April 7, 2023",Recruiting,Interventional
4766,C3651010,Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia,"May 11, 2021","August 9, 2022",Completed,Interventional
4767,Palliach,Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care,February 2021,July 2022,Unknown status,Interventional
4768,DPM401,Study to Evaluate the Safety of Nanoxel M Inj.,"September 18, 2019",August 2024,Recruiting,Observational
4769,BR-DTX-OS-401,Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor,"June 10, 2020","June 24, 2021",Completed,Observational
4770,TAK-500-1001,A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors,"April 26, 2022","March 20, 2025",Recruiting,Interventional
4771,PRT1419-02,A Study of PRT1419 in Patients With Advanced Solid Tumors,"August 11, 2021","February 6, 2023",Completed,Interventional
4772,IIT2020-13-GRESHAM-ELLY,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients,"December 2, 2020","July 8, 2022",Recruiting,Interventional
4773,2018-0663,Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients,"February 1, 2021","July 31, 2023",Recruiting,Interventional
4774,APHP190973,Integrated Care Pathway in Oncology (PASSION),"February 21, 2020","December 31, 2022","Active, not recruiting",Observational
4775,C3441037,A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors,"December 21, 2020","July 22, 2022",Completed,Interventional
4776,CE 07-14-2020,Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer,"March 1, 2021","December 31, 2024",Recruiting,Interventional
4777,ELVCAP-001-01,Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors,"September 29, 2020",June 2023,"Active, not recruiting",Interventional
4778,143631,"Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.","March 4, 2020","July 15, 2021",Withdrawn,Interventional
4779,202100484,Early Ageing During Therapy in AYA Cancer Patients,"February 10, 2022",October 2023,Recruiting,Observational
4780,ZZITICI-004,Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors,"November 1, 2018","November 1, 2033",Recruiting,Interventional
4781,QBS-72S-1001,"Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S","July 20, 2020","December 22, 2022",Completed,Interventional
4782,2440LM-002,DNX-2440 for Resectable Colorectal Liver Metastasis,"February 15, 2021","December 31, 2023",Recruiting,Interventional
4783,MX-011-219,Project CADENCE (CAncer Detected Early caN be CurEd),"July 7, 2022",May 2025,Recruiting,Observational
4784,DB-1303-O-1001,A Study of DB-1303 in Advanced/Metastatic Solid Tumors,"January 31, 2022",October 2025,Recruiting,Interventional
4785,VISTA-101,A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101),"March 3, 2023","December 31, 2024",Recruiting,Interventional
4786,ZZICI3-015,Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors,"November 1, 2021","October 30, 2025",Recruiting,Interventional
4787,ALS-6000-101,"A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours","July 16, 2021","June 30, 2023",Recruiting,Interventional
4788,AA1809,Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors,"December 17, 2018","January 19, 2022",Completed,Interventional
4789,PMV-586-101,The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE),"October 29, 2020","July 14, 2026",Recruiting,Interventional
4790,R231-A14057,Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.,"September 1, 2020","October 1, 2022",Completed,Observational
4791,AMXT1501-102,Oral AMXT 1501 Dicaprate in Combination With IV DFMO,"November 29, 2022","March 31, 2024",Recruiting,Interventional
4792,201909133,Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers,"January 15, 2021","September 30, 2023",Recruiting,Interventional
4793,ROOT,The Registry of Oncology Outcomes Associated With Testing and Treatment,"May 5, 2021","October 1, 2031",Recruiting,Observational
4794,FPI-1966-101,A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours,"April 20, 2022",December 2026,Recruiting,Interventional
4795,MYCT001,The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology),"March 21, 2019","March 12, 2024",Recruiting,Observational
4796,JAB-3312-1002,A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China,"June 10, 2020",December 2023,Recruiting,Interventional
4797,707-IO-101,Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies,"June 9, 2021",July 2025,Recruiting,Interventional
4798,UW18101,Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction,"February 1, 2019","November 1, 2021",Completed,Interventional
4799,JAB-3312-1001,"A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors","September 26, 2019",March 2024,Recruiting,Interventional
4800,PAL-E602-001,Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01),"February 11, 2022",June 2025,Recruiting,Interventional
4801,340-74,CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC),"September 13, 2018",March 2021,Withdrawn,Interventional
4802,PRO17070414,Self-Advocacy Serious Game in Advanced Cancer,"December 13, 2018","March 18, 2021",Completed,Interventional
4803,MAPreminder1,UCLA Health Patient Health Maintenance Text Reminder,"March 23, 2023","June 30, 2024",Not yet recruiting,Interventional
4804,MFLeong,RCT of Acceptance and Commitment Therapy Versus Mindfulness-based Stress Reduction in Head and Neck Cancer,"July 1, 2021","June 30, 2024",Not yet recruiting,Interventional
4805,1100,NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy,"January 16, 2019","May 30, 2028",Recruiting,Interventional
4806,MAPinitial,UCLA Health Patient Health Maintenance Outreach Text Message,"March 9, 2023","June 30, 2024",Enrolling by invitation,Interventional
4807,MAPreminder2,UCLA Health Patient Health Maintenance With Interactive Text Reminder,"May 23, 2023","June 30, 2024",Not yet recruiting,Interventional
4808,G190165,Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites,"July 30, 2019","April 14, 2023","Active, not recruiting",Interventional
4809,JSKN003-102,To Evaluate the Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors,"March 1, 2023","December 31, 2025",Not yet recruiting,Interventional
4810,RAIN-3202,Milademetan in Advanced/Metastatic Solid Tumors,"November 1, 2021",August 2024,Recruiting,Interventional
4811,05-2019,Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection,"May 4, 2020","December 30, 2024","Active, not recruiting",Observational
4812,56160922.7.3001.5274,Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds,April 2023,April 2024,Not yet recruiting,Interventional
4813,PN #1082409C,Post Market Clinical Follow-up Study on da Vinci® Robotic-assisted Prophylactic Nipple Sparing Mastectomy With Breast Reconstruction,"January 18, 2022",January 2024,Recruiting,Observational
4814,A222001,Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer,"July 30, 2021",March 2023,Recruiting,Interventional
4815,CH1701,CH1701 for Prevention and Treatment of Radiation Burns,"July 5, 2019","December 1, 2020",Unknown status,Interventional
4816,D0816C00020,Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients,"January 30, 2018","March 10, 2022",Completed,Interventional
4817,K01CA190659,Culturally Appropriate Nutrition Communication for Mexican American Women,"March 25, 2019","December 25, 2022","Active, not recruiting",Interventional
4818,TOS-358-001,A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors,"February 15, 2023",December 2025,Recruiting,Interventional
4819,UW19-183,"The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence","July 21, 2021","December 31, 2023",Recruiting,Interventional
4820,2011P002580-207,Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints,"March 10, 2021","May 16, 2022",Completed,Observational
4821,SI-B003-101,"A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors","November 10, 2020",May 2023,Recruiting,Interventional
4822,PROT004,Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer,"March 10, 2022","December 15, 2022","Active, not recruiting",Interventional
4823,EK 1612/2018,Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing,"November 1, 2018","June 30, 2022",Completed,Interventional
4824,202006168,Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome,"April 9, 2021","October 31, 2023",Recruiting,Interventional
4825,FT-003,"Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy","June 11, 2019",December 2037,Recruiting,Observational
4826,BO41929,A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors,"May 24, 2021","May 16, 2022",Terminated,Interventional
4827,IRB202201399 -N-R,A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials,"January 1, 2023","August 31, 2027",Not yet recruiting,Interventional
4828,FLX475-02,Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab,"September 25, 2018",December 2023,Recruiting,Interventional
4829,2019-A02135-52,Exome Analysis (Complexe vs Simple) to Help the Therapeutic Decision for the Precision Medicine,"August 25, 2020","September 15, 2029",Recruiting,Interventional
4830,18-504,Smartphone Technology to Alleviate Malignant Pain (STAMP),"November 1, 2018","May 1, 2022",Completed,Interventional
4831,DB-1305-O-1001,First-in-human Study of DB-1305 for Advanced/Metastatic Solid Tumors,"July 19, 2022","June 30, 2025",Recruiting,Interventional
4832,TAS0612-101,A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer,"October 15, 2020",June 2024,Recruiting,Interventional
4833,IIT2021-07-Atkins-CARMA,Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial,"October 7, 2022","August 31, 2024","Active, not recruiting",Interventional
4834,1948-CL-0101,"A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors","July 2, 2018","June 30, 2023","Active, not recruiting",Interventional
4835,CO-338-100,A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes,"November 21, 2019","July 15, 2022",Terminated,Interventional
4836,STUDY00020629,Identifying and Caring for Individuals With Inherited Cancer Syndrome,"March 9, 2020","June 10, 2030",Recruiting,Interventional
4837,E7766-G000-101,Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101,"February 24, 2020","July 26, 2022",Completed,Interventional
4838,NRG-GU006,BIOMARKER TRIAL of APALUTAMIDE and RADIATION for RECURRENT PROSTATE CANCER,"April 27, 2018","October 31, 2028","Active, not recruiting",Interventional
4839,BBI-20201001,A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors,"February 24, 2020","October 31, 2026",Recruiting,Interventional
4840,ZWI-ZW49-101,A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers,"April 15, 2019",August 2025,Recruiting,Interventional
4841,SAHoWMU-CR2021-02-404,Gastric Cancer Marker Detection and Its Kit Development,"January 1, 2021","December 30, 2030",Recruiting,Observational
4842,BVAC-B-P1,Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care,"February 26, 2018","May 13, 2019",Completed,Interventional
4843,IDE397-001,Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion,"April 14, 2021","June 30, 2024",Recruiting,Interventional
4844,MDK-703-102,A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors,"February 8, 2023",September 2025,Recruiting,Interventional
4845,19-011444,Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ,"July 26, 2021","December 31, 2026",Recruiting,Interventional
4846,ATTCK-34-01,Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers,"March 13, 2019","March 12, 2020",Terminated,Interventional
4847,BDTX-189-01,"A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.","December 19, 2019","September 16, 2022",Terminated,Interventional
4848,DB-1310-O-1001,A Study of DB-1310 in Advanced/Metastatic Solid Tumors,"April 7, 2023","August 31, 2026",Not yet recruiting,Interventional
4849,NRG-GU009,"Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial","December 15, 2020","December 31, 2033",Recruiting,Interventional
4850,7101,Womens Knowledges About Gynaecological Aftercare,"July 1, 2018",July 2019,Unknown status,Observational
4851,17504,A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer,"January 16, 2020","June 20, 2022",Completed,Interventional
4852,DGD-44-065,Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years,"March 24, 2021","December 31, 2028",Recruiting,Interventional
4853,22-OBU-SH-CA-II-019,Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy,December 2022,October 2024,Not yet recruiting,Interventional
4854,20220586-01H,Reexamining Her Cardiovascular Risk - Ottawa WomeNs Longitudinal Cohort Study,"April 17, 2023","May 24, 2024",Not yet recruiting,Interventional
4855,D8532C00004,"Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers","June 13, 2022","December 13, 2022",Completed,Interventional
4856,CLIN-17-008,Study of the Safety and Effectiveness of Motiva Implants®,"April 6, 2018","February 28, 2033","Active, not recruiting",Interventional
4857,200-04,A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.,"February 26, 2021","December 23, 2024",Recruiting,Observational
4858,Ad-p53-002,Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.,"October 1, 2018","December 31, 2022",Unknown status,Interventional
4859,TUMAGNOSTIC(CP506-001),Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI,"April 1, 2023",May 2026,Not yet recruiting,Interventional
4860,20210104,A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression,"September 23, 2022","July 28, 2026",Recruiting,Interventional
4861,01GS,Early Detection of Five Common Cancers Using the ctDNA Analysing Test,"April 10, 2022",December 2023,Recruiting,Observational
4862,217228,First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors,"March 22, 2022","December 29, 2025",Recruiting,Interventional
4863,FT516-102,FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors,"September 7, 2020","January 27, 2023",Completed,Interventional
4864,19-110,Minnesota Care Coordination Effectiveness Study,"June 14, 2021","December 31, 2023","Active, not recruiting",Observational
4865,IMC-F106C-101,Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors,"February 25, 2020",February 2026,Recruiting,Interventional
4866,TK-Onko,Evaluation of a Oncology Day Care Unit Programme With Two Different Focuses,"July 14, 2020","May 1, 2022",Completed,Interventional
4867,Pro00103812,Neoadjuvant Immunotherapy in Brain Metastases,"November 4, 2020","June 17, 2021",Terminated,Interventional
4868,17894,Taking Time to Connect: A Study of Programs for Hispanic Mothers Diagnosed With Cancer and Their Children,"April 16, 2019","September 30, 2022",Completed,Interventional
4869,M19-345,"Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of ABBV-151 as a Single Agent and in Combination With ABBV-181 in Participants With Locally Advanced or Metastatic Solid Tumors","February 21, 2019","April 11, 2024",Recruiting,Interventional
4870,21-00072,Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy,"April 26, 2021","March 29, 2022",Completed,Interventional
4871,20246,"Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants","March 2, 2020","December 7, 2020",Completed,Interventional
4872,UW21090,The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer,"November 17, 2021","February 7, 2023",Completed,Interventional
4873,18-222,GENetic Education Risk Assessment and TEsting Study,"May 8, 2019","December 31, 2027","Active, not recruiting",Interventional
4874,4830-001,Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001),"July 11, 2018","November 4, 2025",Recruiting,Interventional
4875,2020-002766-14,Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab,"April 7, 2021",March 2027,Recruiting,Interventional
4876,17-01135,Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome,"March 1, 2019","March 31, 2025",Recruiting,Observational
4877,2019-00134,Vitamin D3 - Omega3 - Home Exercise - HeALTHy Aging and Longevity Cohort,"November 26, 2019","December 31, 2023",Enrolling by invitation,Observational
4878,AG0315OG/CTC0140,RegoNivo vs Standard of Care Chemotherapy in AGOC,"June 1, 2021","June 1, 2026",Recruiting,Interventional
4879,63646,Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer,"June 24, 2022","October 15, 2026",Recruiting,Interventional
4880,19-007,DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement,"March 22, 2019",March 2023,Withdrawn,Observational
4881,2018-01B,Stool Collection Sub-Study of Exact Sciences Protocol 2018-01,"July 21, 2020","May 25, 2022",Completed,Observational
4882,201617079.3,Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following BCS,"June 1, 2018","June 30, 2021",Unknown status,Interventional
4883,IOSI-COVID19-001,A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study,"February 25, 2021","March 21, 2023",Completed,Observational
4884,C4221015,A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer,"December 21, 2020","November 15, 2026",Recruiting,Interventional
4885,ARRAY-818-202,An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer,"June 4, 2019","June 30, 2024","Active, not recruiting",Interventional
4886,03.CP.0.3,Study to Evaluate VORTX Rx (Theresa),"March 21, 2018","July 17, 2019",Completed,Interventional
4887,0482-001,A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001),"June 19, 2019","February 19, 2025",Recruiting,Interventional
4888,GO42144,"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation","July 29, 2020","November 30, 2024",Recruiting,Interventional
4889,Ordu55,Nutrition Education and Quality of Life in Cancer Cachexia,"March 1, 2022","January 1, 2023",Not yet recruiting,Interventional
4890,ORDU551,"Slimming Myokines, Cancers,Nutritional and Psychology Support","August 1, 2022","August 1, 2024",Not yet recruiting,Interventional
4891,ONO-4059-09,Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study),"December 29, 2021","July 1, 2026",Recruiting,Interventional
4892,19741,"Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug","September 30, 2019","April 11, 2023","Active, not recruiting",Interventional
4893,GOG-8030,Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199,January 2100,,Not yet recruiting,Observational
4894,JTX-8064-101,"Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors","January 12, 2021",January 2024,Recruiting,Interventional
4895,IBC0966-I/IIa,Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors,"August 31, 2021",December 2025,Recruiting,Interventional
4896,"019/026/ICI, CEI/1330/18",Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients,"March 2, 2020","February 15, 2022",Unknown status,Interventional
4897,LCH-112020,Subzero and Scorpion Trial,"November 16, 2020","September 1, 2023",Recruiting,Interventional
4898,HP-00070946,Exercise Effect on Chemotherapy-Induced Neuropathic Pain,"March 1, 2018",June 2023,"Active, not recruiting",Interventional
4899,18HLGENE03,Evaluation of the Adhesion to the GENEPY Network,"August 1, 2019","December 31, 2020",Unknown status,Observational
4900,FGCL-4592-898,A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies,"March 16, 2022","May 12, 2023",Recruiting,Interventional
4901,2000034075,Buprenorphine Integration Research and Community Health,"January 24, 2023","May 31, 2026",Recruiting,Interventional
4902,CR108454,A Study of Participants With Advanced Prostate Cancer in Canada,"April 12, 2018","July 9, 2026","Active, not recruiting",Observational
4903,APHP180586,Evaluating Effectiveness of a Communication Facilitator : A Randomized Trial,January 2020,June 2021,Unknown status,Interventional
4904,NCI-2020-07841,Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer,"January 4, 2021","June 30, 2024",Recruiting,Interventional
4905,S60857,FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study,"March 13, 2019","December 31, 2025",Recruiting,Interventional
4906,MO19/127559,Tolerance of Anti-Cancer Therapy in the Elderly,"November 1, 2020","June 1, 2023",Recruiting,Observational
4907,RPCR-breast 01,Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT),"August 15, 2022",June 2027,Recruiting,Observational
4908,T30-0002,Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood,September 2018,May 2019,Unknown status,Interventional
4909,WP-2021-03,Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy,June 2022,August 2024,Not yet recruiting,Observational
4910,CAMH2_1001,"A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer","September 14, 2021","January 17, 2025",Recruiting,Interventional
4911,CIRB Ref. No: 2019/2135,Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial,"October 24, 2019","June 9, 2022",Unknown status,Interventional
4912,Nigeria World Cancer Walk 2022,"Step up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among Nigerians","February 5, 2022","February 5, 2022",Not yet recruiting,Interventional
4913,NRG-HN010,"Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) for Recurrent, Metastatic, or Unresectable HER2-Positive Salivary Gland Cancer","September 30, 2022","July 31, 2028",Recruiting,Interventional
4914,D081SC00001Sub,Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort),"June 24, 2021","March 31, 2026","Active, not recruiting",Interventional
4915,FatebenefratelliH,Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging,"April 1, 2021","December 31, 2030",Recruiting,Observational
4916,D081SC00001,Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer,"October 31, 2018","October 30, 2022","Active, not recruiting",Interventional
4917,2019P001434-2,Examining Validity and Reliability of the Shared Decision Making Process Survey in Adults With Depression,"April 29, 2020","December 30, 2020",Completed,Observational
4918,H18-02052,BREAST ADM Trial for Alloplastic Breast Reconstruction,"November 25, 2020","December 31, 2021",Unknown status,Interventional
4919,REG-114-2019,Histopathologic Effect of Calcium Electroporation on Cancer in the Skin,"April 20, 2020","February 1, 2024",Recruiting,Interventional
4920,20-0270-E,Family History App in Personalized Medicine,"September 20, 2021",December 2023,"Active, not recruiting",Interventional
4921,PRO00104179,Onco-primary Care Networking to Support TEAM-based Care,"June 14, 2021","March 31, 2024",Recruiting,Interventional
4922,SJHH_PSPM,Post SBRT Pulmonary Metastasectomy (PSPM) Trial,"July 14, 2020","December 31, 2023",Recruiting,Interventional
4923,823871-iGame,Digital Intervention for the Modification of Lifestyles (iGame),"September 1, 2021","September 28, 2023",Not yet recruiting,Interventional
4924,2018-0419,Pediatric Reporting of Adult-Onset Genomic Results,"November 25, 2020","June 30, 2024",Recruiting,Interventional
4925,2019-00965,The SERENITY Study: Online Mindfulness-Based Cancer Recovery for Patients With Gynecological Cancer,"December 19, 2019","September 30, 2022",Completed,Interventional
4926,COALESE/2021/103,Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy,"September 1, 2022","March 1, 2024",Recruiting,Interventional
4927,BC 09915,Lymphedema After Gyneco-oncologic Treatment,"June 1, 2022","June 30, 2025",Recruiting,Observational
4928,7013,MRI in Ductal Carcinoma in Situ (DCIS),"February 26, 2018",February 2019,Unknown status,Observational
4929,2017_71,PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Pagets Disease of the Vulva (EMPV).,"August 27, 2019",August 2024,Recruiting,Interventional
4930,22-200,"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer","March 31, 2023","March 25, 2032",Not yet recruiting,Observational
4931,PYC001,The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments,"October 1, 2018","September 15, 2020",Unknown status,Interventional
4932,22-01516,NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation,"April 1, 2023","October 1, 2026",Not yet recruiting,Interventional
4933,2U01HG007292-05,Cancer Health Assessments Reaching Many,"August 15, 2018","December 31, 2023","Active, not recruiting",Interventional
4934,20201224,Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate,May 2021,December 2024,Not yet recruiting,Interventional
4935,CTMS# 19-0069,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0,"July 17, 2019","June 3, 2023","Active, not recruiting",Interventional
4936,E2019453,Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.,"January 1, 2020","December 31, 2022",Unknown status,Interventional
4937,21-103,A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer,"April 9, 2021","April 9, 2024","Active, not recruiting",Interventional
4938,ABCSG C08,ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer,"February 14, 2019",December 2026,Recruiting,Interventional
4939,PCA001,Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer,"January 30, 2023",April 2027,Recruiting,Interventional
4940,CASE1121,Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction,April 2023,July 2023,Not yet recruiting,Interventional
4941,Nigeria Cancer Walk,"Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians","February 1, 2020","February 1, 2020",Completed,Interventional
4942,20172841,The PREDICT Registry for DCIS Patients With DCISionRT Testing,"February 27, 2018",November 2035,Suspended,Observational
4943,RC31/18/0440,Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase,"November 20, 2018","June 28, 2019",Unknown status,Observational
4944,SDLNOC,Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy,"June 1, 2021","December 31, 2021",Recruiting,Observational
4945,20-565,Comparing Two Different Surgical Techniques for Breast Reconstruction,"January 14, 2021","December 13, 2021",Withdrawn,Interventional
4946,Arabic BREAST-Q,Validity and Reliability of Arabic Version of Breast Questionnaire,"April 1, 2023","July 1, 2023",Not yet recruiting,Interventional
4947,UPCC 11919,Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients,"August 17, 2020","January 1, 2024",Recruiting,Interventional
4948,2021-1211,Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients,"February 28, 2022","December 31, 2023",Recruiting,Observational
4949,segmental thoracic TEA-spinal,US-guided Thoracic Spinal Epidural Anesthesia VS GA for Abdominal and Breast Surgeries,"March 1, 2022","October 14, 2022",Completed,Interventional
4950,IRB-22-34,Comparison of Patient Satisfaction in Post-operative Breast Surgery Patients Having Physical Clinic and Tele Clinic Follow up: A Randomized Controlled Trial,"December 1, 2022",August 2023,Enrolling by invitation,Interventional
4951,PSCI-19-112,Diminish Chemotherapy Related Side Effects Through Patient Education,"March 24, 2021","December 31, 2023",Recruiting,Interventional
4952,LSHBSWMBC,Screening of Cancer Through Novel Female Specific Biomarkers,"May 15, 2019","December 31, 2019",Unknown status,Observational
4953,2016-0463,REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction,"February 13, 2018","August 6, 2021",Completed,Interventional
4954,IIT-0013,MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1),"August 23, 2021",August 2023,Recruiting,Interventional
4955,BND and RND,Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection,"January 1, 2018","December 31, 2018",Unknown status,Interventional
4956,TheNethersole,Effects of Music Intervention Combined With Progressive Muscle Relaxation in Cancer Patients,"March 8, 2022","August 10, 2022",Completed,Interventional
4957,1655,Cell-free DNA in Hereditary And High-Risk Malignancies,"July 1, 2018",October 2023,Recruiting,Observational
4958,N-111012422,Diet Effect on Cancer Treatment Outcome,"October 12, 2022","December 14, 2023","Active, not recruiting",Interventional
4959,302,"177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)","August 31, 2022","December 31, 2024",Withdrawn,Interventional
4960,MC01/01/19,Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE),"May 29, 2019",May 2022,Unknown status,Interventional
4961,Colorectal Cancer,Colorectal Cancer Awareness in Turkey,"May 1, 2019","August 15, 2019",Unknown status,Observational
4962,LCCC1748,Academic-Industrial Partnership for Translation of Acoustic Angiography,"March 25, 2019","May 25, 2021",Completed,Interventional
4963,1992110-1,Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education,"March 7, 2023",March 2025,Recruiting,Observational
4964,CSC-20200324,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,"March 30, 2020","December 31, 2020",Unknown status,Observational
4965,69HCL22_0466,Lung Cancer Screening Implementation Among Employees at Lyon Hospital,"September 13, 2022","September 12, 2024",Not yet recruiting,Interventional
4966,IMPACNEO,IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV Patients,"November 11, 2019","June 30, 2023",Recruiting,Interventional
4967,0029-20-ZIV,Smurf2 Gene Expression in Urinary Tract Tumors,December 2021,December 2023,Not yet recruiting,Observational
4968,HKG-KZ-LNG-102,Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA,"July 1, 2018","July 19, 2019",Terminated,Observational
4969,GCO 19-2707,To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer,"October 1, 2020","October 1, 2023",Withdrawn,Interventional
4970,LIFT project,Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project),"August 20, 2021","February 28, 2024",Recruiting,Observational
4971,RECO_CT29A,Investigation of Urinary Biomarkers for the Detection of Prostate Cancer,July 2023,April 2024,Suspended,Interventional
4972,INT 292/20,Lung Cancer Prevention Screening Programme in Italy,"September 17, 2022",September 2026,Recruiting,Interventional
4973,STUDY21020095,Efficacy of a Self-advocacy Serious Game Intervention,"August 22, 2022","August 31, 2026",Recruiting,Interventional
4974,D967MC00001,A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations,"December 30, 2020","January 17, 2028","Active, not recruiting",Interventional
4975,UHHeidelberg,Decision Aid to Support Advanced Cancer Patients,"October 1, 2019","April 1, 2023",Recruiting,Interventional
4976,R01CA205025,Understanding the Post-Surgical Non-Small Cell Lung Cancer Patients Symptom Experience,"June 4, 2019",April 2024,Recruiting,Interventional
4977,2019-PVSEP,Drugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase,January 2020,March 2020,Unknown status,Observational
4978,HCB/2021/0130,Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer,"January 1, 2021","May 1, 2023",Recruiting,Interventional
4979,S1614,Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors,"February 21, 2019","February 28, 2027","Active, not recruiting",Interventional
4980,TMHPO1763,A Pilot Study on HPV and Cervical Cancer Screening in Mumbai,April 2018,May 2018,Unknown status,Interventional
4981,002.1,Telegenetics or In-Person Genetic Counselling,"February 1, 2021",February 2024,Recruiting,Observational
4982,LIFT,Longitudinal Investigation of Cancer-related Fatigue,March 2019,June 2025,Withdrawn,Observational
4983,2767,The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer,"September 1, 2020","August 31, 2023",Recruiting,Observational
4984,APHP210359,Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer (HRPCa-II),"October 1, 2022","November 1, 2027",Not yet recruiting,Interventional
4985,M16VIB,Vinorelbine in Advanced BRAF-like Colon Cancer,"March 1, 2018","March 1, 2020",Unknown status,Interventional
4986,EPOC1903,Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer,"December 1, 2020",June 2024,"Active, not recruiting",Interventional
4987,CASE2118,Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye,"November 22, 2019",August 2023,Suspended,Interventional
4988,PARALUC,Pneumonitis After Radiotherapy for Lung Cancer,"September 1, 2020",June 2024,Recruiting,Interventional
4989,CTC20200417,Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy,"June 2, 2020","January 21, 2021",Completed,Interventional
4990,09.2019.1026,Prognostic Value of Body Composition in Lung Cancer,"January 1, 2019","July 1, 2019",Completed,Observational
4991,CASE4119,The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction,"November 1, 2021","January 1, 2024",Recruiting,Interventional
4992,EC/GOVT/24/IRB23,Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO ),"August 31, 2018","February 28, 2021",Completed,Observational
4993,CFTSp195,A Survey Exploring Health and Screening Tests in People Treated for Hodgkin Lymphoma,"June 1, 2021","September 28, 2021",Completed,Observational
4994,04/20,Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer,"May 11, 2020","May 11, 2024",Recruiting,Observational
4995,29BRC20.0021,Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism,"September 8, 2020","September 8, 2028",Recruiting,Interventional
4996,MRI in urinary bladder tumors,Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection,"April 1, 2023","December 1, 2024",Not yet recruiting,Observational
4997,CRUKD/21/004 - Treatment Arm 2,"DETERMINE Trial Treatment Arm 2: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition",April 2023,October 2029,Not yet recruiting,Interventional
4998,20201491,Culturally Tailored Nurse Coaching Study for Cancer Symptom Management,"September 23, 2021","May 31, 2023",Recruiting,Interventional
4999,32900654326,"TPVB, PECSB, ESPB for Postmastectmy Pain","April 10, 2019","August 10, 2021",Completed,Interventional
5000,ReDA 13176,A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.,April 2023,April 2029,Not yet recruiting,Interventional
5001,64121317.4.1001.5330,Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial),"June 1, 2018","March 1, 2022","Active, not recruiting",Interventional
5002,3-2020-0038,Intraoperative Radiation Therapy for Resectable Pancreatic Cancer,"April 2, 2020","April 1, 2026",Recruiting,Interventional
5003,2018PS02,Pharmacist and Data Driven Quality Improvement in Primary Care,"September 16, 2020","June 30, 2021",Completed,Observational
